SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
------------------
FORM 10-K
(mark one)
[ X ] Annual Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934 for the fiscal year ended December 30, 1995
[ ] Transition Report Pursuant to Section 13 or 15(d) of the Securities
Exchange Act of 1934
Commission file number 1-8002
THERMO ELECTRON CORPORATION
(Exact name of Registrant as specified in its charter)
Delaware 04-2209186
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
81 Wyman Street, P.O. Box 9046
Waltham, Massachusetts 02254-9046
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (617) 622-1000
Securities registered pursuant to Section 12(b) of the Act:
Name of each exchange
Title of each class on which registered
------------------- -------------------
Common Stock, $1.00 par value New York Stock Exchange
Preferred Stock Purchase Rights
Securities registered pursuant to Section 12(g) of the Act:
None
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months, and (2) has been subject to the
filing requirements for at least the past 90 days. Yes [ X ] No [ ]
Indicate by check mark if disclosure of delinquent filers pursuant to Item
405 of Regulation S-K is not contained herein, and will not be contained,
to the best of the Registrant's knowledge, in definitive proxy or
information statements incorporated by reference into Part III of this Form
10-K or any amendment to this Form 10-K. [ ]
The aggregate market value of the voting stock held by nonaffiliates of the
Registrant as of January 26, 1996, was approximately $4,625,253,000.
As of January 26, 1996, the Registrant had 87,927,556 shares of Common
Stock outstanding.
DOCUMENTS INCORPORATED BY REFERENCE
Portions of the Registrant's Annual Report to Shareholders for the year
ended December 30, 1995, are incorporated by reference into Parts I and II.
Portions of the Registrant's definitive Proxy Statement for the Annual
Meeting of Shareholders to be held on May 21, 1996, are incorporated by
reference into Part III.
PAGE
<PAGE>
PART I
Item 1. Business
(a) General Development of Business
Thermo Electron Corporation and its subsidiaries (the Company or the
Registrant) develop, manufacture, and market environmental monitoring and
analysis instruments; biomedical products including heart-assist devices,
respiratory care equipment, and mammography systems; paper-recycling and
papermaking equipment; alternative-energy systems; industrial process
equipment; and other specialized products. The Company also provides
environmental, laboratory, and metallurgical services and conducts
advanced-technology research and development. The Company performs its
business through divisions and wholly owned subsidiaries, as well as
majority-owned subsidiaries that are partially owned by the public or by
private investors.
A key element in the Company's growth has been its ability to commercialize
innovative products and services emanating from research and development
activities conducted at the Company's various subsidiaries and divisions.
The Company's strategy has been to identify business opportunities arising
from social, economic, and regulatory issues and to seek a leading market
share through the application of proprietary technology. As part of this
strategy, the Company continues to focus on the acquisition of
complementary businesses that can be integrated into its existing core
businesses to leverage the Company's access to new markets.
The Company believes that maintaining an entrepreneurial atmosphere is
essential to its continued growth and development. In order to preserve
this atmosphere, the Company has adopted a strategy of spinning out certain
of its businesses into separate subsidiaries and having these subsidiaries
sell a minority interest to outside investors. The Company believes that
this strategy provides additional motivation and incentives for the
management of the subsidiaries through the establishment of subsidiary-
level stock option incentive programs, as well as capital to support the
subsidiaries' growth. The Company's wholly and majority-owned subsidiaries
are provided with centralized corporate development, administrative,
financial, and other services that would not be available to many
independent companies of similar size. As of March 11, 1996, the Company
had 16 subsidiaries that have sold minority equity interests, 12 of which
are publicly traded and 4 of which are privately held. In addition, two
subsidiaries have privately sold debentures that will be convertible into
shares of common stock of these subsidiaries upon completion of their
initial public offerings.
The Company is a Delaware corporation and was incorporated in 1956. The
Company completed its initial public offering in 1967 and was listed on the
New York Stock Exchange in 1980. The principal executive office of the
Company is 81 Wyman Street, Waltham, Massachusetts 02254-9046 (telephone:
617-622-1000).
2PAGE
<PAGE>
(b) Financial Information About Industry Segments
The Company's products and services are divided into six segments:
Instruments, Alternative-energy Systems, Process Equipment, Biomedical
Products, Environmental Services, and Advanced Technologies. Products or
services within a particular segment are provided by more than one
subsidiary, and certain subsidiaries' products or services are included in
more than one segment. The principal products and services offered by the
Company in the six industry segments are described in detail below (see
"Principal Products and Services"). Financial information concerning the
Company's industry segments is summarized in Note 15 to Consolidated
Financial Statements in the Registrant's 1995* Annual Report to
Shareholders and is incorporated herein by reference.
(c) Description of Business
(i) Principal Products and Services
Instruments
The Company, through its Thermo Instrument Systems Inc. subsidiary, is a
worldwide leader in the development, manufacture, and marketing of
analytical, monitoring, process control, and imaging, inspection, and
measurement instruments used to identify and analyze air pollution,
radioactivity, complex chemical compounds, toxic metals, and other elements
in a broad range of liquids and solids, as well as to control, monitor,
image, inspect, and measure various industrial processes and life sciences
phenomena.
Thermo Instrument historically has expanded both through the acquisition of
companies, product lines, and technologies and through internal development
of new products and technologies. During the past several years Thermo
Instrument has completed a number of complementary acquisitions that have
provided additional technologies, specialized manufacturing or product
development expertise, and broader capabilities in marketing and
distribution. In 1995, Thermo Instrument's acquisitions included Gould
Instrument Systems, Inc. and the Analytical Instrument Division of
Analytical Technology, Inc.
On March 1, 1995, Thermo Instrument entered into an agreement with Fisons
plc (Fisons) to acquire the Scientific Instruments Division of Fisons for
approximately 202 million British pounds sterling. On April 13, 1995,
Thermo Instrument announced that it had received a "second request" for
information regarding the transaction from the U.S. Federal Trade
Commission (FTC). After extensive discussions with Fisons and the FTC, in
January 1996, Thermo Instrument withdrew its original pre-merger
notification filing under the Hart-Scott-Rodino Antitrust Improvements Act
(the HSR Act), and submitted a new filing with respect to a modified form
of the acquisition. On February 15, 1996, Thermo Instrument announced that
the FTC had granted early termination of the waiting period under the HSR
Act with respect to the modified acquisition and, on March 1, 1996, Thermo
Instrument announced that it had received clearance from U.K. antitrust
regulatory authorities. The form of the acquisition cleared by the FTC and
the U.K. authorities excludes from the businesses to be acquired by Thermo
Instrument substantially all of the mass spectrometer businesses of Fisons
and a high-resolution mass spectrometer/inductively-coupled plasma product.
These businesses accounted for slightly less than 20% of the 1995
* References to 1995, 1994, and 1993 herein are for the fiscal years ended
December 30, 1995, December 31, 1994, and January 1, 1994, respectively.
3PAGE
<PAGE>
revenues of Fisons' Scientific Instruments Division. The new purchase price
is expected to be slightly less than 150 million British pounds sterling
and will be subject to a post-closing adjustment based on the net asset
value of the acquired businesses as of the closing date. The modified
acquisition is still subject to the consent of certain third parties and
the satisfaction of other closing conditions.
Thermo Instrument has adopted Thermo Electron's spinout strategy in an
effort to more clearly focus its many analytical technologies on their more
specific niche markets. To date, Thermo Instrument has completed an initial
public offering of ThermoSpectra Corporation, has privately offered equity
in Thermo BioAnalysis Corporation, and has privately sold convertible
debentures in Thermo Optek Corporation and ThermoQuest Corporation.
ThermoSpectra develops, manufactures, and markets precision imaging,
inspection, and measurement instruments based on high-speed data
acquisition and digital processing technologies to provide industrial and
research customers with integrated systems that address their specific
needs. ThermoSpectra's products include digital oscillographic recorders
and data acquisition systems that continuously measure and monitor signals
from various sensors; digital storage oscilloscopes (DSOs) capable of
taking hundreds of millions of measurements per second of transient signals
or short bursts of data; X-ray microanalyzers used as accessories to
electron microscopes to provide elemental materials analysis as a
supplement to the microscope's imaging capabilities; nondestructive X-ray
inspection systems for process monitoring and quality control applications;
and confocal laser scanning microscopes that use laser light to generate
precise optical images primarily for life science applications.
Thermo BioAnalysis develops, manufactures, and sells capillary
electrophoresis, matrix-assisted laser desorption/ionization time-of-flight
(MALDI-TOF) mass spectrometry, and health physics instrumentation.
Capillary electrophoresis is a powerful separation technique based on a
combination of chromatographic and electroanalytical technologies.
MALDI-TOF mass spectrometers measure the weight of the components of a
sample and identify inorganic chemical components and/or inorganic elements
contained within the sample. Thermo BioAnalysis' health physics division
manufactures and sells radiation detection and counting instrumentation and
sophisticated radiation monitoring systems to the nuclear industry
throughout the world. In February 1996, Thermo BioAnalysis acquired
Dynatech Laboratories Worldwide from Dynatech Corporation, which designs,
manufactures, and markets products used in the immunoassay segment of the
bioinstrumentation market. Immunoassay is an analytical method widely used
in pharmaceutical and biopharmaceutical research, as well as for clinical
testing of patient samples.
Thermo Optek is a leader in the development, manufacture, and marketing of
products used for both elemental and molecular analysis. These products are
based on several optical spectroscopy techniques, including Atomic Emission
(AE), Atomic Absorption (AA), and Fourier transform infrared (FT-IR) and
FT-Raman technologies.
4PAGE
<PAGE>
Thermo Optek's AE and AA spectrometers identify and measure trace
quantities of metals and other elements in a wide variety of materials,
including environmental samples (such as soil, water, and wastes), foods,
drugs, cosmetics, and alloys. Thermo Optek sells its products to a range of
customers from manufacturing industries to service industries to government
and university laboratories. Thermo Optek is a leading manufacturer of
FT-IR and FT-Raman spectrometers, which nondestructively determine the
chemical composition and physical properties of materials. These
instruments are used in chemical research, industrial quality control, and
process monitoring, and for solving a wide variety of materials-analysis
problems.
ThermoQuest is a leading manufacturer of commercial mass spectrometers and
has pioneered many of the significant developments and applications of mass
spectrometry. ThermoQuest's mass spectrometry products identify and measure
the components of a sample for organic chemical compounds or for inorganic
compounds. These instruments are used by customers in research and the
production of pharmaceuticals; in environmental analysis and pollution
control; in biochemistry; in analysis of foods, chemicals, and
petrochemicals; and in health and forensic sciences. ThermoQuest also
manufactures high performance liquid chromatographs, gas chromatographs,
and related instruments and equipment used principally in the research and
development and production monitoring of pharmaceuticals and chemicals, and
for environmental monitoring. These instruments separate the chemical
components of substances for purposes of identification and measurement.
Thermo Instrument's wholly owned businesses manufacture monitoring
instruments for two principal markets: the detection and measurement of
nuclear radiation, and the monitoring of air pollutants including toxic and
combustible gases.
The Company's nuclear radiation monitoring instruments detect and measure
alpha, beta, gamma, neutron, and X-ray radiation emitted by natural sources
and by radioactive materials used in nuclear power plants and certain
governmental, industrial, and medical facilities. The Company is a major
supplier of instruments and systems that are manufactured to European
standards for personnel protection and environmental monitoring. The
Company also manufactures industrial gauging and process control
instruments used principally by manufacturers of flat-sheet materials,
including metals, plastics, rubber, paper, and fibers.
The Company's air-monitoring instruments measure pollutants in ambient air
and from stationary sources such as industrial smoke stacks. The principal
pollutants measured are oxides of nitrogen, sulfur dioxide, carbon
monoxide, ozone, and volatile organic compounds (VOCs). These instruments
are used by utility and industrial customers to ensure compliance with
environmental regulations, by government agencies to monitor air quality,
and by research facilities. The Occupational Safety and Health
Administration's safety requirements for protecting workers from toxic or
explosive atmospheres in confined spaces are addressed with the Company's
detectors, instruments, and systems for sensing, monitoring, and warning of
such dangers.
5PAGE
<PAGE>
In addition, the Company manufactures equipment that provides on-line,
real-time analysis of elements in bulk raw materials, such as coal and
cement.
The Company manufactures and markets a number of process monitoring,
analysis, and control systems including: analog and digital recorders for
continuous process industries; process and laboratory analytical
instruments and monitors to detect lethal gases for the oil, gas, and
petrochemical industries; supervisory control and data acquisition software
for process monitoring and operator interface in a variety of industrial
processes; and turnkey, integrated systems to control networks of distant
oil and gas wells.
The Company also manufactures and markets process gauges and noncontacting
and nonintrusive process control instrumentation to measure liquid levels,
density, weight, and flows for a variety of industries. The Company's X-ray
fluorescence instruments allow for the nondestructive analysis of inorganic
elements. Applications include alloy identification, on-line process
monitoring and quality control, characterization of toxic metals in soil,
and thickness and/or composition of semiconductor thin films.
The 1995 acquisition of ATI's Analytical Instrument Division added to the
Company's product offerings in several analytical areas, notably in
ultraviolet visual spectrometry and thermogravimetric analysis.
Alternative-energy Systems
The Company's Alternative-energy Systems segment includes the operation
and, prior to 1994, the construction and sale of independent (nonutility)
power plants. This segment also includes the manufacture, sale, and
servicing of industrial refrigeration systems; natural gas and marine
engines; packaged cooling and cogeneration systems; and steam turbines and
compressors.
Alternative-energy Power Plants
Through its Thermo Ecotek Corporation subsidiary, the Company designs,
develops, owns, and operates independent (nonutility) electric power
generation facilities that use a range of environmentally responsible
combustion technologies. Since 1987, the Company has owned and operated
facilities fueled by agricultural and wood waste, including urban wood
waste (referred to as "biomass"). The Company currently operates seven
facilities representing total electric generating capacity of approximately
140 megawatts. The Company develops and operates its facilities through
joint ventures or limited partnerships in which the Company has a majority
interest or through wholly owned subsidiaries.
Thermo Ecotek intends to pursue project development and acquisition
opportunities both in the U.S. and internationally. Projects are expected
to include power generation and "clean-fuels" production and processing
facilities, and may include natural gas infrastructure facilities and
investments in other environmental businesses in the future.
6PAGE
<PAGE>
The facilities that are leased by the Company are owned by institutional
investors and leased on a long-term basis to the Company or to joint
ventures or partnerships in which the Company has ownership interests. The
Company uses internal funds for preconstruction development expenses and
generally obtains external financing for construction. The Company has
equity ownership interests in three operating plants. The Company may make
additional significant equity investments in future projects. The process
of locating, developing, financing, and constructing power plants is highly
complex, lengthy, and expensive and only a small percentage of the power
projects that the Company evaluates or pursues results in operating
projects.
In August 1995, Thermo Ecotek, through two wholly owned subsidiaries,
entered into a Limited Partnership Agreement with KFX Wyoming, Inc., a
subsidiary of KFX Inc. (KFX), to develop, construct, and operate a
subbituminous coal-beneficiation plant to be located near Gillette,
Wyoming. The plant, which is expected to begin commercial operation in late
1996, will employ certain patented clean coal technology.
Thermo Ecotek also entered into an agreement with KFX under which Thermo
Ecotek acquired 3,000,000 shares of KFX common stock, or approximately 14%
of the outstanding stock of KFX, for $2.00 per share, and obtained the
rights to purchase up to 51% of KFX common stock at certain times through
2000.
In July 1995, Thermo Ecotek entered into an agreement to invest $15 million
in a 185 megawatt combined cycle, steam-turbine electric generation
facility located in Puerto Plata, Dominican Republic, owned by Smith/Enron
Cogeneration Limited Partnership (SECLP), contingent upon the satisfaction
by the facility of certain performance tests. In other international
projects, Thermo Ecotek has two plants under development in India, and has
begun development efforts in the Czech Republic, to provide environmentally
friendly power generation.
Waste-recycling Facility
In early 1994, the Company completed construction and commenced operation
of a 2,100-ton-per-day municipal solid waste-recycling facility (the
Recycling Facility) in San Diego County, California (the County). The
construction of the Recycling Facility was financed by the issuance of
$133.7 million principal amount of bonds by the California Pollution
Control Financing Authority (the CPCFA Bonds). The County is a party to
these financing arrangements and is responsible for payment of the facility
debt in the event of County defaults. The obligations are nonrecourse to
the Company for events of County default.
The Company entered into a 24-year agreement with the County under which
the Company, for a service fee, was committed to recycle materials
recovered from the County's waste stream to reduce the volume of remaining
waste. During 1995, the County ceased delivering waste to the facility and
defaulted on certain payment obligations to the Company. The County was
also not in compliance with certain covenants of its agreements with the
bank group that provided the facility financing. As a result of the
preceding events, the Company wrote off its net investment in the facility
during 1995. (See also "Management's Discussion and Analysis of Financial
Condition and Results of Operations" incorporated by reference into Item 7
hereof.)
7PAGE
<PAGE>
Other
The Company, through its Thermo Power Corporation subsidiary, develops,
manufactures, markets, and services environmentally sound and economically
efficient industrial refrigeration equipment, natural gas-fueled and
low-emission natural gas engines for vehicular and stationary applications,
lift-truck engines, marine engines, and commercial cooling and cogeneration
units.
Through its industrial refrigeration business, the Company provides
environmentally sound solutions to the refrigeration needs of the
food-processing, petrochemical, and pharmaceutical industries. More than
80% of the Company's refrigeration products operate on ammonia, a
nonozone-depleting alternative to the chlorofluorocarbon refrigerants
gradually being phased out by government regulations. The 1994 acquisition
of NuTemp, Inc., which rents and sells new and remanufactured commercial
cooling and industrial refrigeration equipment, broadens the product lines
and services the Company offers.
Many of Thermo Power's products are powered by its low-emission dedicated
natural gas-fueled TecoDrive(R) engines. Thermo Power has supplied major
fleet operators such as United Parcel Service and the U.S. Postal Service
with TecoDrive engines to power some of their alternative-fuel vehicles.
Thermo Power also manufactures natural gas engines for stationary
applications, including compressor drives. Other products that operate with
TecoDrive engines include cooling and cogeneration systems and gas
engine-driven refrigeration systems. The Company also manufactures gasoline
and LPG (liquefied petroleum gas) engines for lift trucks and gasoline
engines for marine applications, primarily "cruiser" class boats ranging in
size from 25 to 45 feet.
In addition, the Company conducts sponsored research and development on
advanced systems for clean combustion, including a low-cost system for
converting a diesel-fueled engine to operate solely on natural gas without
major modifications to the engine.
Through its ThermoLyte Corporation subsidiary, formed in March 1995, Thermo
Power is developing a line of propane-powered lighting products, including
flashlights, area lights or lanterns, and hazard lights. These products
will be based on proprietary technology for a rigid mantle, the "bulb" in
gas lighting products.
The Company's Alternative-energy Systems segment also includes its Peter
Brotherhood Ltd. subsidiary, a U.K.-based manufacturer of steam turbines
and compressors.
Process Equipment
The Company designs, manufactures, and sells advanced, custom-engineered
processing machinery, including paper-recycling and papermaking equipment,
metallurgical thermal-processing systems, and electroplating systems.
8PAGE
<PAGE>
Paper-recycling and Papermaking Equipment
Through its Thermo Fibertek Inc. subsidiary, the Company designs and
manufactures processing machinery and accessories for the paper-recycling
and papermaking industries. The Company's principal products include
custom-engineered systems and equipment for the preparation of wastepaper
for conversion into recycled paper, and accessory equipment and related
consumables important to the efficient operation of papermaking machines.
The Company has developed technologically advanced equipment for the
preparation of white recycled fiber (e.g. printing and office paper,
newsprint, and tissue). The Company sells in countries outside the Pacific
Rim technologically advanced equipment for the preparation of brown
recycled fiber (e.g. corrugated boxes and paper bags) pursuant to a license
from Aikawa Iron Works Co., Ltd., a leading Japanese manufacturer of this
equipment.
Thermo Fibertek also designs and manufactures accessories used in the
papermaking industry, including doctor blades and showers that perform
on-line continuous cleaning of the fabrics and rolls used in the
papermaking process. This cleaning process is important to papermakers
because it reduces machine breakdowns, extends the life of consumable paper
machine fabrics, and improves paper quality. Thermo Fibertek also
manufactures forming tables, vacuum systems, and water-management systems.
In December 1994, a wholly owned subsidiary of the Company entered into a
$145 million contract for engineering, procurement, and construction
services for an office wastepaper de-inking facility located in Menominee,
Michigan. Completion of construction is expected in 1996. Thermo Fibertek
is supplying approximately $16 million of equipment and services under the
contract over a two-year period.
Metallurgical Thermal-processing Systems
The Company, through a division of its Thermo TerraTech Inc. subsidiary
(formerly Thermo Process Systems Inc.), designs, manufactures, and sells
computer-controlled, custom-engineered thermal-processing systems used to
treat primary metals and metal parts.
The Company also manufactures electroplating systems, heavy metal and
waste-treatment systems, and aqueous cleaning systems that offer an
alternative to the use of ozone-damaging solvents in a variety of
production processes.
Biomedical Products
The Company's Biomedical Products segment comprises a number of different
businesses. The Company made several acquisitions in 1995, including Bird
Medical Technologies, Inc. and Bennett X-Ray Corporation.
Thermo Cardiosystems Inc., a majority-owned subsidiary of Thermedics Inc.,
has developed two versions of an implantable left ventricular-assist system
(LVAS): a pneumatic system that can be controlled by either a bedside
console or portable unit, and an electric system that features an internal
electric motor powered by an external battery-pack worn by the patient.
9PAGE
<PAGE>
These devices are designed to perform substantially all or part of the
pumping function of the left ventricle of the natural heart for patients
suffering from cardiovascular disease. Unlike a total artificial heart
system, an LVAS allows the natural heart to remain in place to assist the
heart when it is unable to provide sufficient cardiac function to maintain
life. In October 1994, the U.S. Food and Drug Administration (FDA) granted
approval for commercial sale of the pneumatic LVAS. With this approval, the
pneumatic system is available for sale to cardiac centers throughout the
United States. In April 1994, the Company received the European Conformity
Mark (CE Mark) for the commercial sale of the pneumatic LVAS in all
European Community countries. The electric version of the LVAS, which
received the CE Mark in August 1995, is currently being used in clinical
trials in the U.S. for patients awaiting heart transplants and may not be
sold commercially in this country until it has received approval from the
FDA. In December 1995, the FDA approved the protocol for conducting
clinical trials using Thermo Cardiosystems' electric LVAS as an alternative
to transplant. It is implanted both as a bridge to transplant and as an
alternative to heart transplants in Europe.
The Company's wholly owned International Technidyne Corporation subsidiary
is a leading manufacturer of hemostasis management products, including
blood coagulation-monitoring instruments. International Technidyne also
manufactures and markets skin-incision devices that can draw minute but
medically significant blood samples through precisely controlled incisions.
Nicolet Biomedical Inc., another wholly owned subsidiary of the Company, is
a leading manufacturer of biomedical instruments for assessing muscle,
nerve, sleep, hearing, and brain blood-flow disorders and for related work
in clinical neurophysiology. These instruments are used in hospitals,
clinics, universities, private practice medical offices, and medical
research facilities by physicians and technologists for routine clinical
testing and intra-operative monitoring. Nicolet Biomedical also
manufactures systems that record and display spontaneous brain waves in the
form of a topographic colored "map." Such maps of brain activity are used
in conjunction with other measurements to assist in the diagnosis of
various neurologic disorders.
Trex Medical Corporation, a majority owned subsidiary of ThermoTrex
Corporation, is a leading manufacturer of low-dose X-ray mammography
equipment and minimally invasive needle-biopsy systems. In 1992, the
Company introduced a digital imaging mammography system designed to target
only a specific area of the breast where a suspicious lesion has been
detected, creating a digital image of the lesion on a video monitor within
seconds of taking an X-ray. The advantage of digital imaging is that the
radiologist can manipulate and enhance the image quality to scrutinize
subtle differences that may go undetected on a film-based X-ray. The
Company is developing a digital imaging system capable of imaging the whole
breast rather than just a specific area. The FDA is currently evaluating
whether this type of screening system will require a premarket approval
application or a 510(k) application. The Company does not expect to submit
data to the FDA seeking market clearance for its full-breast digital
imaging system before the end of 1996.
10PAGE
<PAGE>
Trex Medical's needle-biopsy systems provide a less-invasive alternative to
conventional surgical biopsies. Compared with open surgery, these needle
techniques are less traumatic to the patient, result in less scarring,
which can affect the accuracy of future mammograms, and are performed on an
outpatient basis at significantly lower cost.
Acquired in September 1995, Bennett X-Ray Corporation, a subsidiary of Trex
Medical, is a leading manufacturer of general-purpose and specialty
radiographic systems, including mammography systems. Bennett manufactures
office-based radiographic systems, which are cost-effective units generally
used in doctors' offices and surgi-care centers. In 1993, Bennett broadened
its focus by offering the more sophisticated, more expensive systems
typically used in hospitals. Bennett entered the hospital market with
systems based on its patented high-frequency generator, which permits
shorter exposure times that result in lower radiation doses and greater
image contrast and resolution.
ThermoLase Corporation, a majority-owned subsidiary of ThermoTrex,
manufactures skin-care, bath, and body products sold through salons, spas,
and stores, including the lotion that is an integral part of the
laser-based SoftLight(SM) system that has been developed for the removal of
unwanted hair.
Bird Medical Technologies, Inc. was acquired by Thermo Electron in August
1995. Bird Medical Technologies develops, manufactures, and sells
respiratory care equipment and accessories and infection-control products
to hospitals, subacute care facilities, outpatient surgical centers,
doctors, dentists, the military, as well as other manufacturers.
Environmental Services
Through its Thermo TerraTech subsidiary, the Company provides comprehensive
laboratory-based environmental testing and analysis, as well as design and
construction inspection of water supply and wastewater treatment
facilities, natural resource management consultation, surveying and site
planning, transportation engineering services, solid waste management
services, and building services.
In February 1995, Thermo TerraTech acquired Elson T. Killam Associates
Inc., which provides environmental consulting and engineering services and
specializes in wastewater treatment and water resources management.
In May 1995, Thermo TerraTech acquired substantially all of the assets of
Lancaster Laboratories, Inc. and its affiliate Clewmark Holdings
(collectively Lancaster Laboratories). Lancaster Laboratories, based in
Lancaster, Pennsylvania, is a provider of high-quality analytical services
to the environmental, food, and pharmaceutical industries.
Thermo Remediation Inc., a majority-owned subsidiary of Thermo TerraTech,
provides soil-remediation services from a network of regional centers.
These soil-remediation centers thermally treat soils to remove and destroy
hydrocarbon contamination caused by leaking storage tanks, spills
accumulated at manufactured-gas plants and refineries, and from other
sources. Thermo Remediation also operates a waste fluids-recycling facility
11PAGE
<PAGE>
through a fluids-recovery company based in Arizona, and offers services in
nuclear remediation and health safety at radioactivity contaminated sites.
Through Thermo Remediation's December 1995 acquisition of Remediation
Technologies, Inc., the Company also offers a broad array of remedial
solutions, including bioremediation and the application of risk-based
corrective actions such as brownfield development. A majority-owned
subsidiary of Thermo TerraTech, Thermo EuroTech N.V. (formerly J. Amerika
N.V.), provides waste-oil recycling, underground tank removal, and other
environmental services from its Netherlands-based operation.
In addition, metallurgical heat-treating services are provided for
customers in the automotive, aerospace, defense, and other industries. The
Company also provides metallurgical fabrication services, principally on
high-temperature materials, for customers in the aerospace, medical,
electronics, and nuclear industries.
Advanced Technologies
The Company's ThermoTrex subsidiary conducts sponsored research and
development and is also attempting to commercialize new products based on
advanced technologies it has developed in its laboratories. Sponsored
research and development conducted by ThermoTrex, principally for the U.S.
government, includes basic and applied research in electro-optic and
electro-acoustic systems, signal processing, materials technology, and
lasers.
ThermoTrex is currently developing a passive microwave camera intended to
"see" through clouds and fog to enhance safety in aerial navigation, the
Sonic CT(TM) (computed tomography) system for the early detection of breast
cancer, and a blood-flow measurement system, called the Doppler CT, for the
diagnosis and monitoring of peripheral vascular disease. Because
ThermoTrex's products are at different stages of development and subject to
different levels of regulatory approval, no assurance can be given that the
necessary approvals for any of the projects will be obtained on a timely
basis, or at all, or that any of them will eventually result in
commercially viable products.
In April 1995, ThermoLase received clearance from the FDA to commercially
market its laser-based hair-removal system, SoftLight. The SoftLight system
uses a low-energy dermatology laser, in combination with a laser-absorbing
lotion, to remove hair. On October 30, 1995, ThermoLase opened its first
pilot retail center, Spa Thira, in La Jolla, California. Currently, this is
the only location where the SoftLight process is available. ThermoLase has
signed leases for Spa Thira locations in Dallas and Beverly Hills, and
plans to begin opening additional centers in the second half of calendar
1996. In January 1996, ThermoLase formed a joint venture to market the
SoftLight process in Japan.
Through Thermedics' Thermo Sentron Inc. (formerly Ramsey Technology, Inc.)
subsidiary, the Company manufactures high-speed precision weighing and
inspection equipment for industrial production and packaging lines serving
two principal markets: packaged goods and bulk materials. The packaged
goods market includes a wide range of checkweighing equipment and metal
detectors that can be integrated at various stages in production lines for
12PAGE
<PAGE>
process control and quality assurance and are sold primarily to customers
in the food processing and pharmaceutical industries. The bulk materials
product line includes conveyor belt scales, solids level measurement and
conveyor monitoring devices, and sampling systems, all sold primarily to
customers in the mining and material processing industries, as well as
electric utilities, chemical, and other manufacturing companies.
Through the Orion laboratory products division of Analytical Technology,
Inc., acquired by Thermedics in December 1995, the Company manufactures
electrochemistry, microweighing, process, and other instruments used to
analyze the chemical composition of foods, beverages, and pharmaceuticals
and detect contaminants in environmental and high-purity water samples.
Based on technology that has been used to develop instruments sold by the
Company for the detection of nitrogen-based compounds, the Company
developed the EGIS(R) system for screening people, baggage, and electronic
equipment, such as personal computers, for the presence of a wide range of
explosives, including the plastic explosives that have proven difficult to
detect using conventional methods. In 1992, the Company introduced a
high-speed product quality assurance system based on its vapor-detection
technology for use in bottling lines in the carbonated beverage industry
(the Alexus(R) system). The Alexus system is currently being used to ensure
product quality in more than 200 bottling lines worldwide. In 1994, the
Company introduced a new system to the bottled water industry, and it
continues to develop new technologies for product quality applications in
response to consumer demand for product quality and regulatory influences.
Thermo Voltek Corp., a majority-owned subsidiary of Thermedics, designs,
develops, and manufactures electronic test instruments that test electronic
and electrical systems and components for electromagnetic compatibility
(EMC), offers EMC-consulting and systems-integration services, acts as a
distributor of a broad range of EMC-testing products, and manufactures
power-conversion systems for use in telecommunications equipment. Thermo
Voltek also designs, manufactures, and markets high-voltage power
conversion systems, modulators, fast-response protection systems, and
related high-voltage equipment for industrial, medical, and environmental
processes, and defense and scientific research applications.
The Company's wholly owned Coleman Research Corporation subsidiary,
acquired in March 1995, provides systems integration, systems engineering,
and analytical services to government and commercial customers in fields of
information technology, energy and the environment, software engineering,
launch systems, advanced radar imaging, and health systems.
Publicly and Privately Held Subsidiaries
In 1983, the Company adopted a strategy of having certain subsidiaries sell
a minority interest in a public or private offering to outside investors.
An important goal of this strategy is to provide the entrepreneurial
atmosphere and focused performance incentives of a separate business. As of
March 11, 1996, the Company had 16 subsidiaries that have sold minority
equity interests, 12 of which are publicly traded and 4 of which are
privately held. In addition, two subsidiaries have privately sold
debentures that will be convertible into shares of common stock of these
subsidiaries upon the completion of their initial public offerings.
13PAGE
<PAGE>
Thermedics Inc. develops, manufactures, and markets product quality
assurance systems, precision weighing and inspection equipment, explosives-
detection devices, microweighing and electrochemistry instruments, as well
as biomaterials and other biomedical products. Thermedics' products are
included in the Company's Biomedical Products and Advanced Technologies
segments.
Thermo Cardiosystems Inc., a majority-owned subsidiary of Thermedics,
develops, manufactures, markets, and sells implantable left
ventricular-assist systems designed to perform substantially all or
part of the pumping function of the left ventricle of the natural
heart for patients suffering from cardiovascular disease. Thermo
Cardiosystems' products are included in the Company's Biomedical
Products segment.
Thermo Voltek Corp., a majority-owned subsidiary of Thermedics,
designs, manufactures, and markets instruments that test electronic
systems and components for electromagnetic compatibility, and provides
related distribution and consulting services. Thermo Voltek also
designs and manufactures high-voltage power conversion systems for
research and commercial applications, and specialized power supplies
for telecommunications equipment. Thermo Voltek's products are
included in the Company's Advanced Technologies segment.
Thermo Instrument Systems Inc. develops, manufactures, and markets
analytical, monitoring, and process control instruments used to detect and
measure air pollution, nuclear radioactivity, complex chemical compounds,
toxic metals, and other elements in a wide range of materials as well as to
control and monitor various industrial processes. Thermo Instrument's
products represent the Company's Instruments segment.
ThermoSpectra Corporation, a majority-owned subsidiary of Thermo
Instrument, develops, manufactures, and markets precision imaging,
inspection, and measurement instruments based on high-speed data
acquisition and digital processing technologies.
Thermo BioAnalysis Corporation, a majority-owned, privately held
subsidiary of Thermo Instrument, develops, manufactures, and sells
instrumentation for the analytical biochemistry, biopharmaceutical,
and health physics instrumentation markets. It comprises four
operations that specialize in capillary electrophoresis;
matrix-assisted laser desorption/ionization time-of-flight mass
spectrometry; health physics instrumentation; and immunoassays, which
are analytical methods widely used in pharmaceutical and
biopharmaceutical research, as well as for clinical testing of patient
samples.
Thermo Optek Corporation, a wholly owned, privately held subsidiary of
Thermo Instrument, is a worldwide leader in the development,
manufacture, and marketing of optical and energy-based analytical
instruments. These instruments are used in the quantitative and
qualitative chemical analysis of elements and molecular compounds in a
wide variety of solids, liquids, and gases.
14PAGE
<PAGE>
ThermoQuest Corporation, a wholly owned, privately held subsidiary of
Thermo Instrument, develops, manufactures, and sells mass
spectrometers, liquid chromatographs, and gas chromatographs for the
environmental, pharmaceutical, and industrial marketplaces. These
analytical instruments are used in the quantitative and qualitative
chemical analysis of organic and inorganic compounds at ultra-trace
levels of detection.
Thermo TerraTech Inc. provides environmental services and infrastructure
planning and design encompassing a range of specializations within
consulting and design, soil and water remediation, and laboratory testing.
Thermo TerraTech also provides metal-treating services. Thermo TerraTech's
products and services are included in the Company's Environmental Services
and Process Equipment segments.
Thermo Remediation Inc., a majority-owned subsidiary of Thermo
TerraTech, is a leading provider, to clients nationwide, of services
for the recycling of petroleum-contaminated soils and fluids as well
as manufactured-gas plant and refinery wastes. Thermo Remediation is
also a major supplier of nuclear remediation and safety services at
radioactively contaminated sites, and is a leader in the application
of bioremediation technology. Thermo Remediation's services are
included in the Company's Environmental Services segment.
Thermo EuroTech N.V., a majority-owned, privately held subsidiary of
Thermo TerraTech, provides environmental services in the Netherlands,
including recycling waste oils, testing, removal, and installation of
underground storage tanks, and groundwater cleanup. Thermo EuroTech's
services are included in the Company's Environmental Services segment.
Thermo Power Corporation manufactures, markets, and services industrial
refrigeration equipment; natural gas engines for vehicular and stationary
applications; natural gas-fueled cooling and cogeneration systems;
lift-truck engines; and marine engines. Thermo Power also conducts
sponsored research and development on advanced systems for clean combustion
and other high-efficiency gas-fueled devices. Thermo Power's products are
included in the Company's Alternative-energy Systems segment.
ThermoLyte Corporation, a majority-owned, privately held subsidiary of
Thermo Power, was formed in March 1995 to develop and commercialize a
line of propane-powered lighting products, including flashlights, area
lights or lanterns, and hazard lights.
ThermoTrex Corporation manufactures and markets mammography and needle-
biopsy systems for the early detection of breast cancer, and develops
advanced technologies that it is incorporating into commercial products for
the medical imaging, personal-care, and avionics industries. ThermoTrex's
products are included in the Company's Advanced Technologies and Biomedical
Products segments.
15PAGE
<PAGE>
ThermoLase Corporation, a majority-owned subsidiary of ThermoTrex, has
developed a laser-based system for the removal of unwanted hair, and
manufactures skin-care and other personal-care products sold through
salons, spas, and stores. ThermoLase's hair-removal system, called
SoftLight, is included in the Company's Advanced Technologies segment,
and its skin-care products are included in the Company's Biomedical
Products segment.
Trex Medical Corporation, a majority-owned privately held subsidiary
of ThermoTrex, designs, manufactures, and markets mammography
equipment and minimally invasive stereotactic needle biopsy systems
used for the detection of breast cancer, as well as office-based
general radiography equipment. Trex Medical's products are included in
the Company's Biomedical Products segment.
Thermo Fibertek Inc. develops, manufactures, and markets a range of
equipment and accessory products for the domestic and international paper
industry, including de-inking and stock-preparation equipment, and
water-management systems for paper recycling. Thermo Fibertek's products
are included in the Company's Process Equipment segment.
Thermo Ecotek Corporation develops and operates independent (nonutility)
power plants that use clean combustion technology and alternative-energy
sources, such as agricultural waste. The Company is also now involved in
engineered clean fuels, as well as a range of other environmentally sound
technologies. Thermo Ecotek's operations are included in the Company's
Alternative-energy Systems segment.
(ii) New Products
The Company's business includes the development and introduction of new
products and may include entry into new business segments. The Company has
made no commitments to new products that require the investment of a
material amount of the Company's assets, nor does it have any definitive
plans to enter new business segments that would require such an investment
(see Section (xi) "Research and Development").
(iii) Raw Materials
Thermo Cardiosystems relies upon several custom-designed components and
materials supplied by other companies to manufacture its LVAS. In 1992,
several suppliers of such components and materials notified Thermo
Cardiosystems that they intended to exit the biomedical market. While the
Company believes that it will be able to develop new sources of, or
alternatives to, these materials and components, no assurance can be given
that the Company will develop such sources or alternatives in a timely
manner, or that the FDA will approve the use of any such alternative
materials or components.
Except as described above, in the opinion of management, the Company has a
readily available supply of raw materials for all of its significant
products from various sources and does not anticipate any difficulties in
obtaining the raw materials essential to its business.
16PAGE
<PAGE>
(iv) Patents, Licenses, and Trademarks
The Company considers patents to be important in the present operation of
its business. Except for ThermoLase's patents for its laser-based
hair-removal system, the Company does not consider any patent, or related
group of patents, to be of such importance that its expiration or
termination would materially affect the Company's business taken as a
whole. The Company seeks patent protection for inventions and developments
made by its personnel and incorporated into its products or otherwise
falling within its fields of interest. Patent rights resulting from work
sponsored by outside parties do not always accrue exclusively to the
Company and may be limited by agreements or contracts.
The Company protects some of its technology as trade secrets and, where
appropriate, uses trademarks or registers its products. It also enters into
license agreements with others to grant and/or receive rights to patents
and know-how.
(v) Seasonal Influences
There are no significant seasonal influences on the Company's sales of
products and services.
(vi) Working Capital Requirements
There are no special inventory requirements or credit terms extended to
customers that would have a material adverse effect on the Company's
working capital.
(vii) Dependency on a Single Customer
No single customer accounted for more than 10% of the Company's total
revenues in any of the past three years. The Advanced Technologies segment
derived approximately 27%, 13%, and 23% of its revenues in 1995, 1994, and
1993, respectively, from contracts with various agencies of the U.S.
government and approximately 23% of its revenues in 1994 from one customer
for a process-detection instrument. In connection with the development of
power plants, the Company typically enters into long-term power supply
contracts with a single customer for the sale of power generated by each
plant. The Alternative-energy Systems segment derived 16% of its revenues
in 1995 and 1994 and 9% of its revenues in 1993, from Pacific Gas &
Electric and 15%, 19%, and 18% of its revenues in 1995, 1994, and 1993,
respectively, from Southern California Edison.
17PAGE
<PAGE>
(viii) Backlog
The Company's backlog of firm orders at year-end 1995 and 1994 was as
follows:
(In thousands) 1995 1994
-------------------------------------------------------------------------
Instruments $188,700 $139,600
Alternative-energy Systems 112,900 109,100
Process Equipment 114,800 199,000
Biomedical Products 77,100 37,300
Environmental Services 76,500 46,700
Advanced Technologies 117,200 206,500
-------- --------
$687,200 $738,200
======== ========
The Alternative-energy Systems segment backlog for 1994 has been restated
to exclude the backlog of the Recycling Facility (see "Alternative-energy
Systems" under section (c), "Description of Business").
Backlog includes the uncompleted portion of research and development
contracts and the uncompleted portion of certain equipment contracts that
are accounted for using the percentage-of-completion method. The Company
believes approximately 95% of the 1995 backlog will be filled during fiscal
1996.
(ix) Government Contracts
Approximately 9% of the Company's total revenues in 1995 were derived from
contracts or subcontracts with the federal government, which are subject to
renegotiation of profits or termination. The Company does not have any
knowledge of threatened or pending renegotiation or termination of any
material contract or subcontract.
(x) Competition
The Company is engaged in many highly competitive industries. The nature of
the competition in each of the Company's markets is described below:
Instruments
The Company is among the principal manufacturers of analytical instrumenta-
tion. Within the markets for the Company's analytical instrument products,
the Company competes with several large corporations with broad product
offerings, as well as numerous smaller companies that address only
particular segments of the industry or specific geographic areas. The
Company's instruments business generally competes on the basis of technical
advances that result in new products and improved price-performance ratios,
reputation among customers as a quality leader for products and services,
and active research and application-development programs. To a lesser
extent, the Company competes on the basis of price.
18PAGE
<PAGE>
Alternative-energy Systems
The worldwide independent power market consists of numerous companies,
ranging from small startups to multinational industrial companies. In
addition, a number of regulated utilities have created subsidiaries that
compete as nonutility generators. Nonutility generators often specialize in
market "niches," such as a specific technology or fuel (for example,
gas-fired cogeneration, refuse-to-energy, hydropower, geothermal, wind,
solar, wood or coal) or a specific region of the country where they believe
they have a market advantage. However, many nonutility generators,
including the Company, seek to develop projects on a best-available-fuel
basis. The Company competes primarily on the basis of project experience,
technical expertise, capital resources, and power pricing.
The Company's sale of industrial refrigeration systems is subject to
intense competition. The industrial refrigeration market is mature, highly
fragmented, and extremely dependent on close customer contacts. Major
industrial refrigeration companies, of which the Company is one, account
for approximately one-half of worldwide sales, with the balance generated
by many smaller companies. The Company competes principally on the basis of
its advanced control systems and overall quality, reliability, service, and
price. The Company believes it is a leader in remanufactured refrigeration
equipment. Its rental services business has one large competitor that
supplies rental equipment. The Company competes in this market based on
price, delivery time, and customized equipment.
The Company's sale of packaged cogeneration systems is subject to intense
competition, both direct and indirect. Direct competitors consist of
companies that sell cogeneration products resembling those sold by the
Company as well as electric utilities' pricing programs. Indirect
competitors include manufacturers of conventional heating and cooling
systems.
As the alternative-fuel engine market becomes fully developed, the Company
anticipates that competition, specifically in the market for natural gas
engines for vehicles, will be intense, and potential competitors may
include major automotive and natural gas companies and other companies that
have substantially greater financial resources than those of the Company.
The Company has experienced intense competition in the marine engine
business in recent years as some of its former customers have been acquired
by competitors following the vertical integration of the boating industry.
Competition is primarily on the basis of quality, reliability, and service.
Process Equipment
The Company faces significant competition in the markets for paper-
recycling and water handling equipment and papermachine accessories, and
competes in these markets primarily on the basis of quality, service,
technical expertise, and product innovation. The Company is a leading
supplier of accessory equipment for papermaking machines, and competes in
this market primarily on the basis of service, technical expertise, and
performance.
19PAGE
<PAGE>
The market for thermal-processing systems is subject to intense competition
worldwide. The Company is aware of at least eight companies that market a
number of products comparable to the Company's, but competition for
particular projects is typically limited to fewer companies. The Company
competes on the basis of several factors, including technical performance,
product quality and reliability, timely delivery, and often price.
Biomedical Products
Competition in the markets for most of the Company's biomedical products,
including those manufactured by Thermo Cardiosystems, ThermoTrex, Nicolet
Biomedical, ITC, and Bird Medical Technologies, is based to a large extent
upon technical performance.
The Company is aware of one other company that has submitted a PMA
application with the FDA for an implantable LVAS. The Company is unaware
whether this PMA application has been accepted for filing by the FDA. Also,
the Company is aware of one other company that has received approval by the
FDA Advisory Panel on Circulatory System Devices and subsequent commercial
approval for its cardiac-assist device. This is an external device that is
positioned on the outside of the patient's chest and is intended for
short-term use in the hospital environment. The Company is also aware that
a total artificial heart is currently undergoing clinical trials. The
requirement of obtaining FDA approval for commercial sale of an LVAS is a
significant barrier to entry into the U.S. market for these devices. There
can be no assurance, however, that FDA regulations will not change in the
future, reducing the time and testing required for others to obtain FDA
approval. In addition, other research groups and companies are developing
cardiac-assist systems using alternative technologies or concepts, one or
more of which might prove functionally equivalent to or more suitable than
the Company's systems. Among products that have been approved for
commercial sale, the Company competes primarily on the basis of
performance, service capability, reimbursement status, and price.
The Company is one of a number of competitors in the markets for
mammography and general radiographic systems and is one of two competitors
in the market for prone stereotactic needle biopsy systems. The Company
competes in these markets primarily on the basis of product features,
product performance, and reputation, as well as price and service. Many of
the Company's radiographic products are technologically innovative, and the
markets in which the Company competes with these products are characterized
by rapid technological change. The Company believes that in order for it to
be competitive in these markets it will be important for it to continue to
be technologically innovative.
Environmental Services
The Company competes in the market for soil-remediation services based on
its ability to offer customers superior protection from environmental
liabilities using a national network of cleanup facilities. The Company
believes that there are two other companies that operate fixed-site
thermal-treatment facilities for soil-remediation in multiple states.
However, the Company faces competition in local markets from landfills,
20PAGE
<PAGE>
other treatment technologies, and from companies competing with similar
technologies, which limits the prices that can be charged by the Company.
Pricing is therefore a major competitive factor for the Company.
The Company's metallurgical services business competes in specialty
machining services. Competition is based principally on services provided,
turnaround time, and price.
Hundreds of independent analytical testing laboratories and consulting
firms compete for environmental services business nationwide. Many of these
firms use equipment and processes similar to those of the Company.
Competition is based not only on price, but also on reputation for
accuracy, quality, and the ability to respond rapidly to customer
requirements. In addition, many industrial companies have their own
in-house analytical testing capabilities. The Company believes that its
competitive strength lies in certain niche markets within which the Company
is recognized for its expertise.
Advanced Technologies
In its contract research and development business, the Company not only
competes with other companies and institutions that perform similar
services, but must also rely on the ability of government agencies and
other clients to obtain allocations of research and development monies to
fund contracts with the Company. The Company competes for its research and
development programs principally on the basis of technical innovations. As
government funding becomes more scarce, particularly for defense projects,
the competition for such funding will become more intense. In addition, as
the Company's programs move from the development stage to commercializa-
tion, competition is expected to intensify.
The Company's Orion division competes with several international companies.
In the markets for the products made by its Orion division, the Company
competes on the basis of performance, service, technology, and price.
The Company's Thermo Sentron subsidiary competes with several international
and regional companies in the market for its products. Thermo Sentron's
competitors in the packaged goods market differ from those in the bulk
materials market. The principal competitive factors in both markets are
customer service and support, quality, reliability, and price.
The Company's product quality assurance systems compete with chemical-
detection systems manufactured by several companies and with other
technologies and processes for product quality assurance. Competition in
the markets for all of the Company's detection products is based primarily
on performance, service, and price.
There are a number of competing technologies for instruments that detect
explosives and narcotics, including makers of other chemical-detection
instruments as well as enhanced X-ray detectors. To date, the Federal
Aviation Administration (FAA) has not required that U.S. airports and
airlines buy advanced explosives-detection equipment. The Company believes
that companies, if any, whose devices are required by the FAA will have a
substantial competitive advantage in the United States.
21PAGE
<PAGE>
The Company is a leading supplier of pulsed electromagnetic interference
testing equipment in the U.S., and believes that it is also among the
leading suppliers in Europe and the Pacific Rim, other than Japan. The
Company competes in this market primarily on the basis of performance,
technical expertise, and reputation.
The Company estimates that there are approximately 20 companies that
independently manufacture and market high-voltage power supply systems of
the general type manufactured and marketed by Thermo Voltek. Thermo Voltek
competes for both contracts and commercial sales primarily on the basis of
technical expertise, product performance, and reputation.
The Company's Coleman Research subsidiary has numerous public and private
competitors in its various market segments. Coleman Research competes
primarily on the basis of price, technological performance, technical
expertise, and reputation.
(xi) Research and Development
During 1995, 1994, and 1993, the Company expended $266,104,000,
$229,200,000, and $176,316,000, respectively, on research and development.
Of these amounts, $167,120,000, $149,645,000, and $116,733,000,
respectively, were sponsored by customers and $98,984,000, $79,555,000, and
$59,583,000, respectively, were Company-sponsored. Approximately 930
professional employees were engaged full-time in research and development
activities at December 30, 1995.
(xii) Environmental Protection Regulations
The Company believes that compliance with federal, state, and local
environmental protection regulations will not have a material adverse
effect on its capital expenditures, earnings, or competitive position.
(xiii) Number of Employees
At December 30, 1995, the Company employed approximately 14,400 persons.
(d) Financial Information about Exports by Domestic Operations and about
Foreign Operations
Financial information about exports by domestic operations and about
foreign operations is summarized in Note 15 to Consolidated Financial
Statements in the Registrant's 1995 Annual Report to Shareholders and is
incorporated herein by reference.
22PAGE
<PAGE>
(e) Executive Officers of the Registrant
Present Title (Year First
Name Age Became Executive Officer)
--------------------------- --- --------------------------------------
George N. Hatsopoulos(1) 69 Chairman of the Board, President, Chief
Executive Officer, and Director (1956)
John N. Hatsopoulos(1) 61 Executive Vice President and Chief
Financial Officer (1968)
Robert C. Howard 65 Executive Vice President (1968)
Peter G. Pantazelos 65 Executive Vice President (1968)
Arvin H. Smith 66 Executive Vice President (1983)
William A. Rainville 54 Senior Vice President (1993)
John W. Wood Jr. 52 Senior Vice President (1995)
Paul F. Kelleher 53 Vice President, Finance and
Administration (1982)
(1) George N. Hatsopoulos and John N. Hatsopoulos are brothers.
Each executive officer serves until his successor is chosen or appointed
and qualified or until earlier resignation, death, or removal. All
executive officers, except Messrs. Rainville and Wood, have held comparable
positions with the Company for at least the last five years. Mr. Rainville
has been a Senior Vice President of the Company since 1993 and was a Vice
President of the Company from 1986 to 1993. Mr. Wood has been President and
Chief Executive Officer of Thermedics Inc. since 1984 and was a Vice
President of the Company from 1994 to 1995, prior to becoming a Senior Vice
President of the Company in 1995.
Item 2. Properties
The location and general character of the Company's principal properties by
industry segment as of December 30, 1995, are as follows:
Instruments
The Company owns approximately 1,446,000 square feet of office,
engineering, laboratory, and production space, principally in California,
Colorado, Wisconsin, Germany, and England, and leases approximately
1,596,000 square feet of office, engineering, laboratory, and production
space principally in California, Connecticut, Massachusetts, Ohio, Texas,
Wisconsin, and England, under leases expiring from 1996 to 2017.
Alternative-energy Systems
The Company owns approximately 358,000 square feet of office, engineering,
and production space, principally in Pennsylvania and England, and leases
approximately 320,000 square feet of office, engineering, laboratory, and
production space principally in Illinois and Michigan, under leases
expiring from 1996 to 2017.
23PAGE
<PAGE>
The Company operates four independent power plants in California, Maine,
and New Hampshire, under leases expiring from 2000 to 2010. The Company
owns three independent power plants in New Hampshire and California and a
waste-recycling facility in California.
Process Equipment
The Company owns approximately 1,160,000 square feet of office, laboratory,
and production space, principally in Connecticut, Massachusetts, New York,
France, and England, and leases approximately 308,000 square feet of
office, engineering, and production space principally in Michigan and
Wisconsin, under leases expiring from 1996 to 2004.
Biomedical Products
The Company owns approximately 248,000 square feet of office and production
space in California, Connecticut, and New Jersey, and leases approximately
587,000 square feet of office, engineering, laboratory, and production
space in California, Illinois, New York, and Texas, under leases expiring
from 1996 to 2009.
Environmental Services
The Company owns approximately 835,000 square feet of office, laboratory,
and production space, principally in California, Pennsylvania, Minnesota,
and the Netherlands, and leases approximately 540,000 square feet of
office, engineering, laboratory, and production space principally in
California, Massachusetts, New Hampshire, New Mexico, and Pennsylvania,
under leases expiring from 1996 to 2008.
The Company owns approximately 16 acres of land from which it provides
soil-remediation and fluid-recycling services in Arizona and Washington and
leases approximately 96 acres of land from which it provides soil-recycling
services in Maryland and South Carolina.
Advanced Technologies and Corporate Headquarters
The Company owns approximately 190,000 square feet of office space in
Massachusetts and New York, and leases approximately 1,119,000 square feet
of office, engineering, and laboratory space principally in Alabama,
California, Florida, Massachusetts, and Minnesota, under leases expiring
from 1996 to 2008.
The Company believes that its facilities are in good condition and are
suitable and adequate to meet its current needs, and that suitable
replacements are available on commercially reasonable terms for any leases
that expire in 1996 in the event that the Company is unable to renew such
leases on reasonable terms.
24PAGE
<PAGE>
Item 3. Legal Proceedings
The Company has participated in the operation of the Dade County Downtown
Government Center cogeneration facility in Miami, Florida, through a 50/50
joint venture of subsidiaries of the Company and Rolls-Royce, Inc. This
facility and the joint venture are involved in regulatory and other legal
proceedings at the Federal Energy Regulatory Commission, the Florida Public
Service Commission and in court. See the information pertaining to this
matter in Note 7 to Consolidated Financial Statements, and under the
caption "Management's Discussion and Analysis of Financial Condition and
Results of Operations," in the Registrant's 1995 Annual Report to
Shareholders (filed as Exhibit 13 to this Annual Report on Form 10-K),
which information is incorporated herein by reference.
Certain subsidiaries of the Company have been notified that the U.S.
Environmental Protection Agency (EPA) has determined that a release or a
substantial threat of a release of a hazardous substance, as defined in the
Comprehensive Environmental Response Compensation and Liability Act of 1980
(CERCLA or the Superfund law), occurred at sites to which chemical or other
wastes generated by the manufacturing operations of these companies may
have been sent. These notifications generally also allege that these
companies may be potentially responsible parties with respect to the
remedial actions needed to control or clean up any such releases. Under
CERCLA, responsible parties can include current and previous owners of the
site, generators of hazardous substances disposed of at the site, and
transporters of hazardous substances to the site. Each responsible party
can be jointly and severally liable, without regard to fault or negligence,
for all costs associated with site remediation. In each instance the
Company believes that it is one of several companies that received such
notification and who may likewise be held liable for any such remedial
costs.
The Company is also involved in situations under state environmental laws
with respect to certain other sites where remediation may be required. The
Company is conducting investigative or remediation activities at these
sites pursuant to arrangements with state environmental agencies.
The Company evaluates its potential liability as a responsible party for
these environmental matters on an ongoing basis subject to factors such as
the estimated remediation costs, the nature and duration of the Company's
involvement with the site, the financial strength of other potentially
responsible parties, and the availability of indemnification from previous
owners of acquired businesses. Estimated liabilities are accrued in
accordance with Statement of Financial Accounting Standards No. 5,
"Accounting for Contingencies." To date, the Company has not incurred any
significant liability with respect to any of these sites and anticipates
that future liabilities related to sites where the Company is currently a
potentially responsible party or is otherwise conducting investigative or
remediation activities, will not have a material adverse effect on its
business, results of operations, or financial position.
Item 4. Submission of Matters to a Vote of Security Holders
Not applicable.
25PAGE
<PAGE>
PART II
Item 5. Market for Registrant's Common Equity and Related Stockholder
Matters
Information concerning the market and market price for the Registrant's
common stock, $1.00 par value, and related matters, is included under the
sections labeled "Common Stock Market Information" and "Dividend Policy" in
the Registrant's 1995 Annual Report to Shareholders and is incorporated
herein by reference.
Item 6. Selected Financial Data
The information required under this item is included under the sections
"Ten Year Financial Summary" and "Dividend Policy" in the Registrant's 1995
Annual Report to Shareholders and is incorporated herein by reference.
Item 7. Management's Discussion and Analysis of Financial Condition and
Results of Operations
The information required under this item is included under the heading
"Management's Discussion and Analysis of Financial Condition and Results of
Operations" in the Registrant's 1995 Annual Report to Shareholders and is
incorporated herein by reference.
Item 8. Financial Statements and Supplementary Data
The Registrant's Consolidated Financial Statements as of December 30, 1995,
are included in the Registrant's 1995 Annual Report to Shareholders and are
incorporated herein by reference.
Item 9. Changes in and Disagreements with Accountants on Accounting and
Financial Disclosures
Not Applicable.
26PAGE
<PAGE>
PART III
Item 10. Directors and Executive Officers of the Registrant
The information concerning directors required under this item is
incorporated herein by reference from the material contained under the
caption "Election of Directors" in the Registrant's definitive proxy
statement to be filed with the Securities and Exchange Commission pursuant
to Regulation 14A, not later than 120 days after the close of the fiscal
year. The information concerning delinquent filers pursuant to Item 405 of
Regulation S-K is incorporated herein by reference from the material
contained under the heading "Disclosure of Certain Late Filings" under the
caption "Stock Ownership" in the Registrant's definitive proxy statement to
be filed with the Securities and Exchange Commission pursuant to Regulation
14A, not later than 120 days after the close of the fiscal year.
Item 11. Executive Compensation
The information required under this item is incorporated herein by
reference from the material contained under the caption "Executive
Compensation" in the Registrant's definitive proxy statement to be filed
with the Securities and Exchange Commission pursuant to Regulation 14A, not
later than 120 days after the close of the fiscal year.
Item 12. Security Ownership of Certain Beneficial Owners and Management
The information required under this item is incorporated herein by
reference from the material contained under the caption "Stock Ownership"
in the Registrant's definitive proxy statement to be filed with the
Securities and Exchange Commission pursuant to Regulation 14A, not later
than 120 days after the close of the fiscal year.
Item 13. Certain Relationships and Related Transactions
The information required under this item is incorporated herein by
reference from the material contained under the caption "Relationship with
Affiliates" in the Registrant's definitive proxy statement to be filed with
the Securities and Exchange Commission pursuant to Regulation 14A, not
later than 120 days after the close of the fiscal year.
27PAGE
<PAGE>
PART IV
Item 14. Exhibits, Financial Statement Schedules, and Reports on Form 8-K
(a), (d) Financial Statements and Schedules
(1) The financial statements set forth in the list below are
filed as part of this Report.
(2) The financial statement schedule set forth in the list below
is filed as part of this Report.
(3) Exhibits filed herewith or incorporated herein by reference
are set forth in Item 14(c) below.
List of Financial Statements and Schedules Referenced in this
Item 14
Information incorporated by reference from Exhibit 13 filed
herewith:
Consolidated Statement of Income
Consolidated Balance Sheet
Consolidated Statement of Cash Flows
Consolidated Statement of Shareholders' Investment
Notes to Consolidated Financial Statements
Report of Independent Public Accountants
Financial Schedule included herewith:
Schedule II: Valuation and Qualifying Accounts
All other schedules are omitted because they are not applicable
or not required, or because the required information is shown
either in the financial statements or in the notes thereto.
(b) Reports on Form 8-K
The Company filed a Current Report on Form 8-K dated November 28, 1995
announcing that it had entered into an agreement to sell its 4 1/4%
convertible subordinated debentures due 2003.
(c) Exhibits
See Exhibit Index on the page immediately preceding exhibits.
28PAGE
<PAGE>
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this Report to be signed on its
behalf by the undersigned, thereunto duly authorized.
Date: March 11, 1996
THERMO ELECTRON CORPORATION
By: George N. Hatsopoulos
---------------------
George N. Hatsopoulos
President and Chief Executive
Officer
Pursuant to the requirements of the Securities Exchange Act of 1934, this
report has been signed below by the following persons on behalf of the
Registrant and in the capacities indicated, as of March 11, 1996.
Signature Title
--------- -----
By: George N. Hatsopoulos President, Chief Executive Officer,
----------------------------- Chairman of the Board and Director
George N. Hatsopoulos
By: John N. Hatsopoulos Executive Vice President and Chief
----------------------------- Financial Officer
John N. Hatsopoulos
By: Paul F. Kelleher Vice President, Finance and Adminis-
----------------------------- tration (Chief Accounting officer)
Paul F. Kelleher
By: John M. Albertine Director
-----------------------------
John M. Albertine
By: Peter O. Crisp Director
-----------------------------
Peter O. Crisp
By: Elias P. Gyftopoulos Director
-----------------------------
Elias P. Gyftopoulos
By: Frank Jungers Director
-----------------------------
Frank Jungers
By: Robert A. McCabe Director
-----------------------------
Robert A. McCabe
By: Frank E. Morris Director
-----------------------------
Frank E. Morris
By: Donald E. Noble Director
-----------------------------
Donald E. Noble
By: Hutham S. Olayan Director
-----------------------------
Hutham S. Olayan
By: Roger D. Wellington Director
-----------------------------
Roger D. Wellington
29PAGE
<PAGE>
Report of Independent Public Accountants
----------------------------------------
To the Shareholders and Board of Directors of
Thermo Electron Corporation:
We have audited in accordance with generally accepted auditing
standards, the consolidated financial statements included in Thermo
Electron Corporation's Annual Report to Shareholders incorporated by
reference in this Form 10-K, and have issued our report thereon dated
February 15, 1996 (except with respect to the matters discussed in Note 16
as to which the date is March 1, 1996). Our audits were made for the
purpose of forming an opinion on those statements taken as a whole. The
schedule listed in Item 14 on page 28 is the responsibility of the
Company's management and is presented for purposes of complying with the
Securities and Exchange Commission's rules and is not part of the basic
consolidated financial statements. This schedule has been subjected to the
auditing procedures applied in the audits of the basic consolidated
financial statements and, in our opinion, fairly states in all material
respects the financial data required to be set forth therein in relation to
the basic consolidated financial statements taken as a whole.
Arthur Andersen LLP
Boston, Massachusetts
February 15, 1996
30PAGE
<PAGE>
SCHEDULE II
Thermo Electron Corporation
Valuation and Qualifying Accounts
(In thousands)
Year Ended December 30, 1995
Balance, Charged
Begin- to Costs Accounts Accounts Balance,
ning of and Recov- Written End of
Year Expenses Other(a) ered Off Year
------------------------------------------------------------------------
Allowance for
Doubtful
Accounts $21,664 $ 5,473 $ 6,886 $ 420 $(6,422) $28,021
========================================================================
Year Ended December 31, 1994
Balance, Charged
Begin- to Costs Accounts Accounts Balance,
ning of and Recov- Written End of
Year Expenses Other(a) ered Off Year
------------------------------------------------------------------------
Allowance for
Doubtful
Accounts $14,174 $ 4,225 $ 7,646 $ 268 $(4,649) $21,664
========================================================================
Year Ended January 1, 1994
Balance, Charged
Begin- to Costs Accounts Accounts Balance,
ning of and Recov- Written End of
Year Expenses Other(a) ered Off Year
------------------------------------------------------------------------
Allowance for
Doubtful
Accounts $11,341 $ 2,720 $ 1,532 $ 1,961 $(3,380) $14,174
========================================================================
(a) Allowances of businesses acquired during the year as described in Note
3 to Consolidated Financial Statements in the Registrant's 1995 Annual
Report to Shareholders.
31PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
2.1 Asset and Stock Purchase Agreement among the
Registrant, Thermo Instrument Corporation and Fisons
plc dated November 1, 1995 (filed as Exhibit 2.3 to
Thermo Instrument's Annual Report on Form 10-K for the
fiscal year ended December 31, 1994 and Exhibit 2 to
Thermo Instrument's Quarterly Report on Form 10-Q for
the quarter ended September 30, 1995 [File No. 1-9786]
and incorporated herein by reference). Pursuant to Item
601(b)(2) of Regulation S-K, schedules to this
Agreement have been omitted. The Company hereby
undertakes to furnish supplementally a copy of such
schedules to the Commission upon request.
3.1 Restated Certificate of Incorporation of the
Registrant, as amended (filed as Exhibit 3(i) to the
Registrant's Quarterly Report on Form 10-Q for the
quarter ended July 2, 1994 [File No. 1-8002] and
incorporated herein by reference).
3.2 By-laws of the Registrant, as amended (filed as Exhibit
3.2 to the Registrant's Annual Report on Form 10-K for
the fiscal year ended January 1, 1994 [File No. 1-8002]
and incorporated herein by reference).
4.1 Fiscal Agency Agreement dated July 29, 1992 between the
Registrant and Chemical Bank, pertaining to the
Registrant's 4 5/8% Senior Convertible Debentures due
1997 (filed as Exhibit 19 to the Registrant's Quarterly
Report on Form 10-Q for the quarter ended June 27, 1992
[File No. 1-8002] and incorporated herein by
reference).
Fiscal Agency Agreement dated as of April 15, 1994
between the Registrant and Chemical Bank, pertaining to
the Registrant's 5% Senior Convertible Debentures due
2001 (filed as Exhibit 4.1 to the Registrant's
Quarterly Report on Form 10-Q for the quarter ended
April 2, 1994 [File No. 1-8002] and incorporated herein
by reference).
Fiscal Agency Agreement dated as of January 3, 1996
between the Registrant and Chemical Bank pertaining to
the Registrant's 4 1/4% Subordinated Convertible
Debentures due 2003.
The Registrant agrees, pursuant to Item
601(b)(4)(iii)(A) of Regulation S-K, to furnish to the
Commission upon request, a copy of each instrument with
respect to other long-term debt of the Registrant or
its consolidated subsidiaries.
32PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
4.2 Rights Agreement dated as of January 19, 1996 between
the Registrant and The First National Bank of Boston,
which includes as Exhibit A the Form of Certificate of
Designations, as Exhibit B the Form of Rights
Certificate, and as Exhibit C the Summary of Rights to
Purchase Preferred Stock (filed as Exhibit 1 to the
Registrant's Registration Statement on Form 8-A,
declared effective by the Commission on January 31,
1996 [File No. 1-8002] and incorporated herein by
reference).
10.1 Thermo Electron Corporate Charter as amended and
restated effective January 3, 1993 (filed as
Exhibit 10.1 to the Registrant's Annual Report on Form
10-K for the fiscal year ended January 2, 1993
[File No. 1-8002] and incorporated herein by
reference).
10.2 Form of Severance Benefit Agreement with officers
(filed as Exhibit 10.15 to the Registrant's Annual
Report on Form 10-K for the fiscal year ended December
29, 1990 [File No. 1-8002] and incorporated herein by
reference).
10.3 Form of Indemnification Agreement with directors and
officers (filed as Exhibit 10.16 to the Registrant's
Annual Report on Form 10-K for the fiscal year ended
December 29, 1990 [File No. 1-8002] and incorporated
herein by reference).
10.4 Loan and Reimbursement Agreement dated as of December
1, 1991 among North County Resource Recovery
Associates; Union Bank of Switzerland; National
Westminster Bank PLC and Banque Paribas, New York
Branch, as lead managers; Credit Local de France as
co-lead manager; and Union Bank of Switzerland as
issuing bank and as agent (filed as Exhibit 10.39 to
the Registrant's Annual Report on Form 10-K for the
fiscal year ended January 2, 1993 [File No. 1-8002] and
incorporated herein by reference).
10.5 Amended and Restated Reimbursement Agreement dated as
of December 31, 1993 among Chemical Trust Company of
California as Owner Trustee; Delano Energy Company
Inc.; ABN AMRO Bank N.V., Boston Branch, for itself and
as Agent; The First National Bank of Boston, as
Co-agent; Barclays Bank PLC, as Co-agent; Societe
Generale, as Co-agent; and BayBank, as Lead Manager
(filed as Exhibit 10.5 to the Registrant's Annual
Report on Form 10-K for the fiscal year ended January
1, 1994 [File No. 1-8002] and incorporated herein by
reference).
33PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.6 Amended and Restated Participation Agreement dated as
of December 31, 1991 among Delano Energy Company Inc.;
Thermo Ecotek Corporation (formerly Thermo Energy
Systems Corporation); Chemical Trust Company of
California, as Owner Trustee; ABN AMRO Bank N.V.,
Boston Branch, as Co-agent; Bank of Montreal, as
Co-agent; Barclays Bank PLC, as Co-agent; Society
Generale, as Co-agent; BayBank, as Lead Manager; and
ABN AMRO Bank N.V., Cayman Island Branch, and joined in
by the Registrant (filed as Exhibit 10.6 to the
Registrant's Annual Report on Form 10-K for the fiscal
year ended January 1, 1994 [File No. 1-8002] and
incorporated herein by reference).
10.7 Turnkey Engineering, Procurement, Construction and
Initial Operation Agreement for a deinking pulp
facility dated as of November 1, 1994 between the
Registrant, as contractor, and Great Lakes Pulp
Partners I, L.P., as owner (filed as Exhibit 10.7 to
the Registrant's Annual Report on Form 10-K for the
fiscal year ended December 31, 1994 [File No. 1-8002]
and incorporated herein by reference). Pursuant to Item
601(b)(2) of Regulation S-K, schedules to this
Agreement have been omitted. The Company hereby
undertakes to furnish supplementally a copy of such
schedules to the Commission upon request.
10.8 - 10.20 Reserved.
10.21 Incentive Stock Option Plan of the Registrant (filed as
Exhibit 4(d) to the Registrant's Registration Statement
on Form S-8 [Reg. No. 33-8993] and incorporated herein
by reference). (Maximum number of shares issuable in
the aggregate under this plan and the Registrant's
Nonqualified Stock Option Plan is 9,035,156 shares,
after adjustment to reflect share increases approved in
1984 and 1986, share decrease approved in 1989, and
3-for-2 stock splits effected in October 1986, October
1993 and May 1995).
10.22 Nonqualified Stock Option Plan of the Registrant (filed
as Exhibit 4(e) to the Registrant's Registration
Statement on Form S-8 [Reg. No. 33-8993] and
incorporated herein by reference). (Plan amended in
1984 to extend expiration date to December 14, 1994;
maximum number of shares issuable in the aggregate
under this plan and the Registrant's Incentive Stock
Option Plan is 9,035,156 shares, after adjustment to
reflect share increases approved in 1984 and 1986,
share decrease approved in 1989, and 3-for-2 stock
splits effected in October 1986, October 1993 and May
1995).
34PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.23 Deferred Compensation for Directors of the Registrant
(filed as Exhibit 10.5 to the Registrant's Annual
Report on Form 10-K for the fiscal year ended January
3, 1987 [File No. 1-8002] and incorporated herein by
reference). (Maximum number of shares issuable is
452,812 shares, after adjustment to reflect share
increases approved in 1986 and 1992 and 3-for-2 stock
splits effected in October 1986, October 1993 and May
1995).
10.24 Equity Incentive Plan of the Registrant (filed as
Exhibit 10.1 to the Registrant's Quarterly Report on
Form 10-Q for the quarter ended July 2, 1994 [File No.
1-8002] and incorporated herein by reference). (Plan
amended in 1989 to restrict exercise price for SEC
reporting persons to not less than 50% of fair market
value or par value; maximum number of shares issuable
is 7,050,000 shares, after adjustment to reflect
3-for-2 stock splits effected in October 1993 and May
1995 and share increase approved in 1994).
10.25 Amended and Restated Directors' Stock Option Plan of
the Registrant (filed as Exhibit 10.25 to the
Registrant's Annual Report on Form 10-K for the fiscal
year ended December 31, 1994 [File No. 1-8002] and
incorporated herein by reference).
10.26 Thermo Electron Corporation - Thermedics Inc.
Nonqualified Stock Option Plan (filed as Exhibit 4 to a
Registration Statement on Form S-8 of Thermedics [Reg.
No. 2-93747] and incorporated herein by reference).
(Maximum number of shares issuable is 450,000 shares,
after adjustment to reflect share increase approved in
1988, 5-for-4 stock split effected in January 1985,
4-for-3 stock split effected in September 1985, and
3-for-2 stock splits effected in October 1986 and
November 1993).
10.27 Thermo Electron Corporation - Thermo Instrument Systems
Inc. (formerly Thermo Environmental Corporation)
Nonqualified Stock Option Plan (filed as Exhibit 4(c)
to a Registration Statement on Form S-8 of Thermo
Instrument [Reg. No. 33-8034] and incorporated herein
by reference). (Maximum number of shares issuable is
421,875 shares, after adjustment to reflect 3-for-2
stock splits effected in July 1993 and April 1995 and
5-for-4 stock split effected in December 1995).
35PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.28 Thermo Electron Corporation - Thermo Instrument Systems
Inc. Nonqualified Stock Option Plan (filed as Exhibit
10.12 to the Registrant's Annual Report on Form 10-K
for the fiscal year ended January 3, 1987 [File No.
1-8002] and incorporated herein by reference). (Maximum
number of shares issuable is 600,285 shares, after
adjustment to reflect share increase approved in 1988,
3-for-2 stock splits effected in January 1988, July
1993 and April 1995 and 5-for-4 stock split effected in
December 1995).
10.29 Thermo Electron Corporation - Thermo TerraTech Inc.
(formerly Thermo Process Systems Inc.) Nonqualified
Stock Option Plan (filed as Exhibit 10.13 to the
Registrant's Annual Report on Form 10-K for the fiscal
year ended January 3, 1987 [File No. 1-8002] and
incorporated herein by reference). (Maximum number of
shares issuable is 108,000 shares, after adjustment to
reflect 6-for-5 stock splits effected in July 1988 and
March 1989 and 3-for-2 stock split effected in
September 1989).
10.30 Thermo Electron Corporation - Thermo Power Corporation
(formerly Tecogen Inc.) Nonqualified Stock Option Plan
(filed as Exhibit 10.14 to the Registrant's Annual
Report on Form 10-K for the fiscal year ended January
3, 1987 [File No. 1-8002] and incorporated herein by
reference). (Amended in September 1995 to extend the
plan expiration date to December 31, 2005).
10.31 Thermo Electron Corporation - Thermo Cardiosystems Inc.
Nonqualified Stock Option Plan (filed as Exhibit 10.11
to the Registrant's Annual Report on Form 10-K for the
fiscal year ended December 29, 1990 [File No. 1-8002]
and incorporated herein by reference). (Maximum number
of shares issuable is 130,500 shares, after adjustment
to reflect share increases approved in 1990 and 1992,
3-for-2 stock split effected in January 1990, 5-for-4
stock split effected in May 1990, and 2-for-1 stock
split effected in November 1993).
10.32 Thermo Electron Corporation - Thermo Ecotek Corporation
(formerly Thermo Energy Systems Corporation)
Nonqualified Stock Option Plan (filed as Exhibit 10.12
to the Registrant's Annual Report on Form 10-K for the
fiscal year ended December 29, 1990 [File No. 1-8002]
and incorporated herein by reference).
36PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.33 Thermo Electron Corporation - ThermoTrex Corporation
(formerly Thermo Electron Technologies Corporation)
Nonqualified Stock Option Plan (filed as Exhibit 10.13
to the Registrant's Annual Report on Form 10-K for the
fiscal year ended December 29, 1990 [File No. 1-8002]
and incorporated herein by reference). (Maximum number
of shares issuable is 180,000 shares, after adjustment
to reflect 3-for-2 stock split effected in
October 1993).
10.34 Thermo Electron Corporation - Thermo Fibertek Inc.
Nonqualified Stock Option Plan (filed as Exhibit 10.14
to the Registrant's Annual Report on Form 10-K for the
fiscal year ended December 28, 1991 [File No. 1-8002]
and incorporated herein by reference). (Maximum number
of shares issuable is 600,000 shares, after adjustment
to reflect 2-for-1 stock split effected in September
1992 and 3-for-2 stock split effected in September
1995).
10.35 Thermo Electron Corporation - Thermo Voltek Corp.
(formerly Universal Voltronics Corp.) Nonqualified
Stock Option Plan (filed as Exhibit 10.17 to the
Registrant's Annual Report on Form 10-K for the fiscal
year ended January 2, 1993 [File No. 1-8002] and
incorporated herein by reference). (Maximum number of
shares issuable is 57,500 shares, after adjustment to
reflect 3-for-2 stock split effected in November 1993
and share increase approved in September 1995).
10.36 Thermo Electron Corporation - Thermo BioAnalysis
Corporation Nonqualified Stock Option Plan (filed as
Exhibit 10.31 to Thermo Power's Annual Report on Form
10-K for the fiscal year ended September 30, 1995 [File
No. 1-10573] and incorporated herein by reference).
10.37 Thermo Electron Corporation - ThermoLyte Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.32
to Thermo Power's Annual Report on Form 10-K for the
fiscal year ended September 30, 1995 [File No. 1-10573]
and incorporated herein by reference).
10.38 Thermo Electron Corporation - Thermo Remediation Inc.
Nonqualified Stock Option Plan (filed as Exhibit 10.33
to Thermo Power's Annual Report on Form 10-K for the
fiscal year ended September 30, 1995 [File No. 1-10573]
and incorporated herein by reference).
37PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.39 Thermo Electron Corporation - ThermoSpectra Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.34
to Thermo Power's Annual Report on Form 10-K for the
fiscal year ended September 30, 1995 [File No. 1-10573]
and incorporated herein by reference).
10.40 Thermo Electron Corporation - ThermoLase Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.35
to Thermo Power's Annual Report on Form 10-K for the
fiscal year ended September 30, 1995 [File No. 1-10573]
and incorporated herein by reference).
10.41 Thermo Electron Corporation - ThermoQuest Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.41
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
10.42 Thermo Electron Corporation - Thermo Optek Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.42
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
10.43 Thermo Electron Corporation - Thermo Sentron Inc.
Nonqualified Stock Option Plan (filed as Exhibit 10.43
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
10.44 Thermo Electron Corporation - Trex Medical Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.44
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
10.45 Thermo Ecotek Corporation (formerly Thermo Energy
Systems Corporation) Incentive Stock Option Plan (filed
as Exhibit 10.18 to the Registrant's Annual Report on
Form 10-K for the fiscal year ended January 2, 1993
[File No. 1-8002] and incorporated herein by
reference). (Maximum number of shares issuable in the
aggregate under this plan and the Thermo Ecotek
Nonqualified Stock Option Plan is 900,000 shares, after
adjustment to reflect share increase approved in
December 1993).
38PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.46 Thermo Ecotek Corporation (formerly Energy Systems
Corporation) Nonqualified Stock Option Plan (filed as
Exhibit 10.19 to the Registrant's Annual Report on
Form 10-K for the fiscal year ended January 2, 1993
[File No. 1-8002] and incorporated herein by
reference). (Maximum number of shares issuable in the
aggregate under this plan and the Thermo Ecotek
Incentive Stock Option Plan is 900,000 shares, after
adjustment to reflect share increase approved in
December 1993).
10.47 Thermo Ecotek Corporation (formerly Thermo Energy
Systems Corporation) Equity Incentive Plan (filed as
Exhibit 10.39 to Thermo Instrument's Annual Report on
Form 10-K for the fiscal year ended December 31, 1994
[File No. 1-9786] and incorporated herein by
reference).
10.48 Thermedics Inc. Incentive Stock Option Plan (filed as
Exhibit 10(d) to Thermedics' Registration Statement on
Form S-1 [Reg. No. 33-84380] and incorporated herein by
reference). (Maximum number of shares issuable in the
aggregate under this plan and the Thermedics
Nonqualified Stock Option Plan is 1,931,923 shares,
after adjustment to reflect share increases approved in
1986 and 1992, 5-for-4 stock split effected in January
1985, 4-for-3 stock split effected in September 1985
and 3-for-2 stock splits effected in October 1986 and
November 1993).
10.49 Thermedics Inc. Nonqualified Stock Option Plan (filed
as Exhibit 10(e) to Thermedics' Registration Statement
on Form S-1 [Reg. No. 33-84380] and incorporated herein
by reference). (Maximum number of shares issuable in
the aggregate under this plan and the Thermedics
Incentive Stock Option Plan is 1,931,923 shares, after
adjustment to reflect share increases approved in 1986
and 1992, 5-for-4 stock split effected in January 1985,
4-for-3 stock split effected in September 1985 and
3-for-2 stock splits effected in October 1986 and
November 1993).
10.50 Thermedics Inc. Equity Incentive Plan (filed as
Appendix A to the Proxy Statement dated May 10, 1993 of
Thermedics [File No. 1-9567] and incorporated herein by
reference). (Maximum number of shares issuable is
1,500,000 shares, after adjustment to reflect 3-for-2
stock split effected in November 1993).
10.51 Thermedics Inc. - Thermo Sentron Inc. Nonqualified
Stock Option Plan (filed as Exhibit 10.51 to Thermo
Cardiosystems' Annual Report on Form 10-K for the
fiscal year ended December 30, 1995 [File No. 1-10114]
and incorporated herein by reference).
39PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.52 Thermedics Inc. - Thermedics Detection Inc.
Nonqualified Stock Option Plan (filed as Exhibit 10.20
to the Registrant's Annual Report on Form 10-K for the
fiscal year ended January 2, 1993 [File No. 1-8002] and
incorporated herein by reference).
10.53 Thermedics Detection Inc. Equity Incentive Plan (filed as
Exhibit 10.69 to Thermo Instrument's Annual Report on Form
10-K for the fiscal year ended December 31, 1994 [File No.
1-9786] and incorporated herein by reference).
10.54 Thermo Cardiosystems Inc. Incentive Stock Option Plan
(filed as Exhibit 10(f) to Thermo Cardiosystems'
Registration Statement on Form S-1 [Reg. No. 33-25144]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the Thermo Cardiosystems Nonqualified Stock Option Plan
is 1,143,750 shares, after adjustment to reflect share
increase approved in 1992, 3-for-2 stock split effected
in January 1990, 5-for-4 stock split effected in May
1990, and 2-for-1 stock split effected in November
1993).
10.55 Thermo Cardiosystems Inc. Nonqualified Stock Option
Plan (filed as Exhibit 10(g) to Thermo Cardiosystems'
Registration Statement on Form S-1 [Reg. No. 33-25144]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the Thermo Cardiosystems Incentive Stock Option Plan is
1,143,750 shares, after adjustment to reflect share
increase approved in 1992, 3-for-2 stock split effected
in January 1990, 5-for-4 stock split effected in May
1990, and 2-for-1 stock split effected in November
1993).
10.56 Thermo Cardiosystems Inc. Equity Incentive Plan (filed
as Exhibit 10.46 to Thermo Instrument's Annual Report
on Form 10-K for the fiscal year ended December 31,
1994 [File No. 1-9786] and incorporated herein by
reference).
10.57 Thermo Voltek Corp. (formerly Universal Voltronics
Corp.) 1985 Stock Option Plan (filed as Exhibit 10.14
to Thermo Voltek's Annual Report on Form 10-K for the
fiscal year ended June 30, 1985 [File No. 0-8245] and
incorporated herein by reference). (Maximum number of
shares issuable is 200,000 shares, after adjustment to
reflect 1-for-3 reverse stock split effected in
November 1992 and 3-for-2 stock split effected in
November 1993).
40PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.58 Thermo Voltek Corp. (formerly Universal Voltronics
Corp.) 1990 Stock Option Plan (filed as Exhibit 10.2 to
Thermo Voltek's Annual Report on Form 10-K for the
fiscal year ended June 30, 1990 [File No. 1-10574] and
incorporated herein by reference). (Maximum number of
shares issuable is 400,000 shares, after adjustment to
reflect share increases in 1993 and 1994, 1-for-3
reverse stock split effected in November 1992 and
3-for-2 stock split effected in November 1993).
10.59 Thermo Voltek Corp. Equity Incentive Plan (filed as
Exhibit 10.49 to Thermo Instrument's Annual Report on
Form 10-K for the fiscal year ended December 31, 1994
[File No. 1-9786] and incorporated herein by
reference).
10.60 Thermo Sentron Inc. Equity Incentive Plan (filed as
Exhibit 10.57 to Thermo Cardiosystems' Annual Report on
Form 10-K for the fiscal year ended December 30, 1995
[File No. 1-10114] and incorporated herein by
reference).
10.61 Thermo Instrument Systems Inc. Incentive Stock Option
Plan (filed as Exhibit 10(c) to Thermo Instrument's
Registration Statement on Form S-1 [Reg. No. 33-6762]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the Thermo Instrument Nonqualified Stock Option Plan is
2,812,500 shares, after adjustment to reflect share
increase approved in 1990, 3-for-2 stock splits
effected in January 1988, July 1993 and April 1995 and
5-for-4 stock split effected in December 1995).
10.62 Thermo Instrument Systems Inc. Nonqualified Stock
Option Plan (filed as Exhibit 10(d) to Thermo
Instrument's Registration Statement on Form S-1 [Reg.
No. 33-6762] and incorporated herein by reference).
(Maximum number of shares issuable in the aggregate
under this plan and the Thermo Instrument Incentive
Stock Option Plan is 2,812,500 shares, after adjustment
to reflect share increase approved in 1990, 3-for-2
stock splits effected in January 1988, July 1993 and
April 1995 and 5-for-4 stock split effected in December
1995).
10.63 Thermo Instrument Systems Inc. Equity Incentive Plan
(filed as Appendix A to the Proxy Statement dated April
27, 1993 of Thermo Instrument [File No. 1-9786] and
incorporated herein by reference). (Maximum number of
shares issuable is 4,031,250 shares, after adjustment
to reflect share increase approved in December 1993,
3-for-2 stock splits effected in July 1993 and April
1995 and 5-for-4 stock split effected in December
1995).
41PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.64 Thermo Instrument Systems Inc. (formerly Thermo
Environmental Corporation) Incentive Stock Option Plan
(filed as Exhibit 10(d) to Thermo Environmental's
Registration Statement on Form S-1 [Reg. No. 33-329]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the Thermo Instrument (formerly Thermo Environmental)
Nonqualified Stock Option Plan is 1,160,156 shares,
after adjustment to reflect share increase approved in
1987, 3-for-2 stock splits effected in July 1993 and
April 1995 and 5-for-4 stock split effected in December
1995).
10.65 Thermo Instrument Systems Inc. (formerly Thermo
Environmental Corporation) Nonqualified Stock Option
Plan (filed as Exhibit 10(e) to Thermo Environmental's
Registration Statement on Form S-1 [Reg. No. 33-329]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the Thermo Instrument (formerly Thermo Environmental)
Incentive Stock Option Plan is 1,160,156 shares, after
adjustment to reflect share increase approved in 1987,
3-for-2 stock splits effected in July 1993 and April
1995 and 5-for-4 stock split effected in December
1995).
10.66 Thermo Instrument Systems Inc. - ThermoSpectra Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.51 to
Thermo Instrument's Annual Report on Form 10-K for the fiscal
year ended December 31, 1994 [File No. 1-9786] and
incorporated herein by reference).
10.67 Thermo Instrument Systems Inc. - Thermo BioAnalysis
Corporation Nonqualified Stock Option Plan (filed as Exhibit
10.64 to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No. 1-10114]
and incorporated herein by reference).
10.68 Thermo Instrument Systems Inc. - ThermoQuest Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.65 to
Thermo Cardiosystems' Annual Report on Form 10-K for the
fiscal year ended December 30, 1995 [File No. 1-10114] and
incorporated herein by reference).
10.69 ThermoSpectra Corporation Equity Incentive Plan (filed as
Exhibit 10.52 to Thermo Instrument's Annual Report on Form
10-K for the fiscal year ended December 31, 1994 [File No.
1-9786] and incorporated herein by reference).
10.70 Thermo BioAnalysis Corporation Equity Incentive Plan
(filed as Exhibit 10.67 to Thermo Cardiosystems' Annual
Report on Form 10-K for the fiscal year ended December
30, 1995 [File No. 1-10114] and incorporated herein by
reference).
42PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.71 Thermo Optek Corporation Equity Incentive Plan (filed
as Exhibit 10.68 to Thermo Cardiosystems' Annual Report
on Form 10-K for the fiscal year ended December 30,
1995 [File No. 1-10114] and incorporated herein by
reference).
10.72 ThermoQuest Corporation Equity Incentive Plan (filed as
Exhibit 10.69 to Thermo Cardiosystems' Annual Report on
Form 10-K for the fiscal year ended December 30, 1995
[File No. 1-10114] and incorporated herein by
reference).
10.73 ThermoTrex Corporation (formerly Thermo Electron
Technologies Corporation) Incentive Stock Option Plan
(filed as Exhibit 10(h) to ThermoTrex's Registration
Statement on Form S-1 [Reg. No. 33-40972] and
incorporated herein by reference). (Maximum number of
shares issuable in the aggregate under this plan and
the ThermoTrex Nonqualified Stock Option Plan is
1,945,000 shares, after adjustment to reflect share
increases approved in 1992 and 1993 and 3-for-2 stock
split effected in October 1993).
10.74 ThermoTrex Corporation (formerly Thermo Electron
Technologies Corporation) Nonqualified Stock Option
Plan (filed as Exhibit 10(i) to ThermoTrex's
Registration Statement on Form S-1 [Reg. No. 33-40972]
and incorporated herein by reference). (Maximum number
of shares issuable in the aggregate under this plan and
the ThermoTrex Incentive Stock Option Plan is 1,945,000
shares, after adjustment to reflect share increases
approved in 1992 and 1993 and 3-for-2 stock split
effected in October 1993).
10.75 ThermoTrex Corporation - ThermoLase Corporation
(formerly ThermoLase Inc.) Nonqualified Stock Option
Plan (filed as Exhibit 10.53 to ThermoTrex's Annual
Report on Form 10-K for the fiscal year ended
January 1, 1994 [File No. 1-10791] and incorporated
herein by reference).
10.76 ThermoTrex Corporation - Trex Medical Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.73
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
43PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.77 ThermoLase Corporation (formerly ThermoLase Inc.)
Incentive Stock Option Plan (filed as Exhibit 10.55 to
ThermoTrex's Annual Report on Form 10-K for the fiscal
year ended January 1, 1994 [File No. 1-10791] and
incorporated herein by reference). (Maximum number of
shares issuable in the aggregate under this plan and
the ThermoLase Nonqualified stock option plan is
2,800,000 shares, after adjustment to reflect share
increase approved in 1993 and 2-for-1 stock splits
effected in March 1994 and June 1995).
10.78 ThermoLase Corporation (formerly ThermoLase Inc.)
Nonqualified Stock Option Plan (filed as Exhibit 10.54
to ThermoTrex Corporation's Annual Report on Form 10-K
for the fiscal year ended January 1, 1994 [File No.
1-10791] and incorporated herein by reference) (Maximum
number of shares issuable in the aggregate under this
plan and the ThermoLase Incentive Stock Option Plan is
2,800,000 shares, after adjustment to reflect share
increases approved in 1993 and 2-for-1 stock splits
effected in March 1994 and June 1995).
10.79 ThermoLase Corporation Equity Incentive Plan (filed as
Exhibit 10.81 to Thermo TerraTech's Annual Report on
Form 10-K for the fiscal year ended April 1, 1995 [File
No. 1-9549] and incorporated herein by reference).
10.80 Trex Medical Corporation Equity Incentive Plan (filed
as Exhibit 10.77 to Thermo Cardiosystems' Annual Report
on Form 10-K for the fiscal year ended December 30,
1995 [File No. 1-10114] and incorporated herein by
reference).
10.81 Thermo Fibertek Inc. Incentive Stock Option Plan (filed
as Exhibit 10(k) to Thermo Fibertek's Registration
Statement on Form S-1 [Reg. No. 33-51172] and
incorporated herein by reference).
10.82 Thermo Fibertek Inc. Nonqualified Stock Option Plan
(filed as Exhibit 10(l) to Thermo Fibertek's
Registration Statement on Form S-1 [Reg. No. 33-51172]
and incorporated herein by reference).
10.83 Thermo Fibertek Inc. Equity Incentive Plan (filed as
Exhibit 10.60 to Thermo Instrument's Annual Report on
Form 10-K for the fiscal year ended December 31, 1994
[File No. 1-9786] and incorporated herein by
reference).
44PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.84 Thermo Power Corporation (formerly Tecogen Inc.)
Incentive Stock Option Plan, as amended (filed as
Exhibit 10(h) to Thermo Power's Quarterly Report on
Form 10-Q for the quarter ended April 3, 1993 [File No.
1-10573] and incorporated herein by reference).
(Maximum number of shares issuable in the aggregate
under this plan and the Thermo Power Nonqualified Stock
Option Plan is 950,000 shares, after adjustment to
reflect share increases approved in 1990, 1992 and
1993).
10.85 Thermo Power Corporation (formerly Tecogen Inc.)
Nonqualified Stock Option Plan, as amended (filed as
Exhibit 10(i) to Thermo Power's Quarterly Report on
Form 10-Q for the quarter ended April 3, 1993 [File No.
1-10573] and incorporated herein by reference).
(Maximum number of shares issuable in the aggregate
under this plan and the Thermo Power Incentive Stock
Option Plan is 950,000 shares, after adjustment to
reflect share increases approved in 1990, 1992 and
1993).
10.86 Thermo Power Corporation Equity Incentive Plan (filed
as Exhibit 10.63 to Thermo Instrument's Annual Report
on Form 10-K for the fiscal year ended December 31,
1994 [File No. 1-9786] and incorporated herein by
reference).
10.87 Thermo Power Corporation - ThermoLyte Corporation
Nonqualified Stock Option Plan (filed as Exhibit 10.84
to Thermo Cardiosystems' Annual Report on Form 10-K for
the fiscal year ended December 30, 1995 [File No.
1-10114] and incorporated herein by reference).
10.88 ThermoLyte Corporation Equity Incentive Plan (filed as
Exhibit 10.71 to Thermo Power's Annual Report on Form 10-K
for the fiscal year ended September 30, 1995 [File No.
1-10573] and incorporated herein by reference).
10.89 Thermo TerraTech Inc. (formerly Thermo Process Systems
Inc.) Incentive Stock Option Plan (filed as Exhibit
10(h) to Thermo TerraTech's Registration Statement on
Form S-1 [Reg. No. 33-6763] and incorporated herein by
reference). (Maximum number of shares issuable in the
aggregate under this plan and the Thermo TerraTech
Nonqualified Stock Option Plan is 1,850,000 shares,
after adjustment to reflect share increases approved in
1987, 1989, and 1992, 6-for-5 stock splits effected in
July 1988 and March 1989 and 3-for-2 stock split
effected in September 1989).
45PAGE
<PAGE>
EXHIBIT INDEX
Exhibit
Number Description of Exhibit Page
---------- ------------------------------------------------------- ----
10.90 Thermo TerraTech Inc. (formerly Thermo Process Systems
Inc.) Nonqualified Stock Option Plan (filed as Exhibit
10(i) to Thermo TerraTech's Registration Statement on
Form S-1 [Reg. No. 33-6763] and incorporated herein by
reference). (Maximum number of shares issuable in the
aggregate under this plan and the Thermo TerraTech
Incentive Stock Option Plan is 1,850,000 shares, after
adjustment to reflect share increases approved in 1987,
1989, and 1992, 6-for-5 stock splits effected in July
1988 and March 1989 and 3-for-2 stock split effected in
September 1989).
10.91 Thermo TerraTech Inc. (formerly Thermo Process Systems
Inc.) Equity Incentive Plan (filed as Exhibit 10.63 to
Thermedics' Annual Report on Form 10-K for the year
ended January 1, 1994 [File No. 1-9567] and
incorporated herein by reference). (Maximum number of
shares issuable is 1,750,000 shares, after adjustment
to reflect share increased approved in 1994).
10.92 Thermo TerraTech Inc. (formerly Thermo Process Systems
Inc.) - Thermo Remediation Inc. Nonqualified Stock
Option Plan (filed as Exhibit 10(l) to Thermo
TerraTech's Quarterly Report on Form 10-Q for the
fiscal quarter ended January 1, 1994 [File No. 1-9549]
and incorporated herein by reference).
10.93 Thermo Remediation Inc. Equity Incentive Plan (filed as
Exhibit 10.7 to Thermo Remediation's Registration
Statement on Form S-1 [Reg. No. 33-70544] and
incorporated herein by reference).
11 Computation of earnings per share.
13 Annual Report to Shareholders for the year ended
December 30, 1995 (only those portions incorporated
herein by reference).
21 Subsidiaries of the Registrant.
23 Consent of Arthur Andersen LLP.
27 Financial Data Schedule.
FISCAL AGENCY AGREEMENT
between
THERMO ELECTRON CORPORATION,
as Issuer
and
CHEMICAL BANK,
as Fiscal Agent
______________________
Dated as of January 3, 1996
______________________
U.S. $500,000,000 Principal Amount
4 1/4% Convertible Subordinated Debentures Due 2003
PAGE
<PAGE>
CONTENTS
Heading Page
1. The Securities 1
2. Appointment of Agents and Security Registrar 3
3. Registration of Transfer and Exchange;
Restrictions on Transfer 5
4. Closing Date; Exchange of Regulation S
Global Security 11
5. Payment 13
6. Redemption 15
7. Conversion of Securities 18
8. Surrendered Securities 24
9. Mutilated, Destroyed, Stolen or Lost Securities 25
10. Signatures 25
11. Agreements Concerning Agents 25
12. Offices, Resignation, Successors,
Etc. of Agents; Paying, Conversion and
Transfer Agencies 27
13. Taxes 30
14. Meetings and Votes of Holders 30
15. Merger, Consolidation or Sale of Assets 33
16. Governing Law 34
17. Amendments 35
18. Agent for Service of Process 35
19. Notices 35
20. Counterparts 37
PAGE
<PAGE>
Exhibit A- Form of Registered Security
Form of Bearer Security
Exhibit B- Form of Regulation S Global Security
Exhibit C- Form of Certificate to be given by the Euroclear
Operator or Cedel with respect to the exchange of
all or a portion of the Regulation S Global
Security for Bearer Securities
Exhibit D- Form of Certificate of Beneficial Ownership for
Bearer Securities to be provided to the Euroclear
Operator or Cedel
Exhibit E- Form of Certificate of Beneficial Ownership for
Registered Securities to be provided to the
Euroclear Operator or Cedel
Exhibit F- Form of Certificate to be given by the Euroclear
Operator or Cedel with respect to the exchange of
all or a portion of the Regulation S Global
Security for Registered Regulation S Securities
Exhibit G- Form of Transferee Letter
PAGE
<PAGE>
FISCAL AGENCY AGREEMENT, dated as of January 3, 1996 (this
_Agreement_), between THERMO ELECTRON CORPORATION, a corporation
duly organized and validly existing under the laws of the State
of Delaware (the "Company"), and CHEMICAL BANK, a banking
corporation duly organized and validly existing under the laws of
the State of New York (the "Fiscal Agent").
1. The Securities.
(a) The Company has, by a Subscription Agreement,
dated November 28, 1995 (the "Subscription Agreement"), among the
Company and the managers named therein (the "Managers"), agreed
to issue and sell to the Managers U.S. $500,000,000 aggregate
principal amount of its 4q% Convertible Subordinated Debentures
Due 2003 (hereinafter referred to as the "Initial Securities" and
together with the Over-Allotment Securities (as defined below),
if any, the "Securities"). In addition, the Company has granted
an option to the Managers to subscribe for up to an additional
U.S. $85,000,000 principal amount of Securities (the
"Over-Allotment Securities") solely to cover over-allotments, if
any. The amount of Securities that may be issued hereunder may
be increased by agreement between the Company and the Fiscal
Agent, and such additional securities shall be "Securities"
hereunder. Interest on the Securities shall be calculated on the
basis of a 360 day year comprised of twelve 30-day months.
(b) Pursuant to the Subscription Agreement, the
Managers (or their affiliates) may sell the Securities to (i)
persons who are not "U.S. Persons" (as such term is defined in
Regulation S promulgated by the United States Securities and
Exchange Commission (the "SEC") pursuant to the Securities Act of
1933, as amended (the "Securities Act")) in transactions that
meet the requirements of Regulation S, (ii) _qualified
institutional buyers" (as such term is defined in Rule 144A
promulgated by the SEC pursuant to the Securities Act and
hereinafter referred to as "QIBs") in reliance on Rule 144A (the
Securities that are resold by the Managers pursuant to Rule 144A
being hereinafter referred to as the "Rule 144A Securities") and
(iii) a limited number of _institutional accredited investors"
(within the meaning of Rule 501(a)(1), (2), (3) or (7)
promulgated by the SEC pursuant to the Securities Act)
("Institutional Accredited Investors") that, prior to their
purchase of any Securities, deliver to the Managers a letter
containing certain representations and agreements.
(c) A portion of the Securities will initially be
issued in the form of a temporary global debenture in bearer form
without coupons or conversion rights, which will be deposited
with a depository in London for Cedel and Euroclear for the
accounts of the subscribers of such Securities on the Closing
Date (as defined herein). Upon deposit of the temporary global
debenture, Cedel or Euroclear, as the case may be, will credit
each subscriber with a principal amount of Securities equal to
PAGE
<PAGE>
the principal amount thereof for which it has subscribed and paid
in the aggregate principal amount of the entire issue of
Securities less the aggregate principal amount of the Rule 144A
Securities and Accredited Investor Securities concurrently
issued, substantially in the form of Exhibit B hereto (the
"Regulation S Global Security"). As hereinafter provided, the
Regulation S Global Security may subsequently be exchanged for
Securities in printed definitive form either as (i) bearer
Securities ("Bearer Securities") in denominations of U.S. $1,000
and U.S. $10,000 and with interest coupons attached thereto,
representing the semi-annual interest payable thereon, or (ii)
fully registered Securities ("Registered Regulation S
Securities") in denominations of U.S. $1,000 and integral
multiples thereof, without coupons, or (iii) a beneficial
interest in the Rule 144A Global Security (as defined below), in
accordance with the provisions of Section 5(c). Bearer
Securities shall be substantially in the form of Exhibit A
hereto, including the coupons set forth therein. Registered
Regulation S Securities also shall be substantially in the form
of Exhibit A hereto. The Securities which are not Bearer
Securities or the Regulation S Global Security are hereinafter
collectively referred to as the "Registered Securities."
(d) The Rule 144A Securities will initially be issued
in the form of a global Security in the aggregate principal
amount of the Rule 144A Securities, which Security shall be in
substantially the form of Exhibit A hereto, and is hereinafter
referred to as the "Rule 144A Global Security." Such Rule 144A
Global Security shall be duly executed by the Company and
authenticated by the Fiscal Agent (as defined below) as
hereinafter provided and will be deposited on the Closing Date
with, or on behalf of, The Depositary Trust Company ("DTC") and
registered in the name of Cede & Co., as nominee of DTC. The
aggregate principal amount of the Rule 144A Global Security may
from time to time be increased or reduced by adjustments made in
the Security Register. Transfers of interests in the Rule 144A
Global Security will be subject to certain restrictions set forth
therein and described in Section 3 hereof.
(e) The Accredited Investor Securities will initially
be issued in fully registered form in minimum denominations of
U.S. $250,000 and integral multiples of U.S. $1,000 in excess
thereof, which Securities shall be in substantially the form of
Exhibit A hereto, and are hereinafter collectively referred to as
"Registered Accredited Investor Securities." Such Registered
Accredited Investor Securities shall be in definitive, fully
registered certificated form only and registered in the names of
such Institutional Accredited Investors or their nominees. Such
Institutional Accredited Investors may not elect to hold
Registered Accredited Investor Securities through DTC, Euroclear
or Cedel. The aggregate principal amount of the Registered
Accredited Investor Securities may be increased or reduced by
adjustments made in the Security Register. Transfers of
Registered Accredited Investor Securities will be subject to
PAGE
<PAGE>
certain restrictions set forth therein and described in Section 3
hereof.
(f) During the period beginning on the Closing Date
and ending on the date which is three years (or the then
applicable holding period under Rule 144(k) under the Securities
Act (or successor provision)) after the later of the date of
original issuance thereof and the last date on which the Company
or any affiliate of the Company was the owner thereof (or any
predecessor), all Rule 144A Securities, all Accredited Investor
Securities, all other Registered Securities and all Securities
issued upon registration of transfer of or in exchange for such
Securities, shall be "Restricted Securities" and shall be subject
to the restrictions on transfer in Section 3 hereof; provided,
however, that the term "Restricted Securities" shall not include
Registered Securities as to which such restrictions on transfer
have been terminated in accordance with Section 3(g) hereof. All
Restricted Securities shall bear the legend required by Section
3(f) hereof.
(g) The Securities will be convertible as provided in
Section 4 of the Registered Securities and the Bearer Securities
and Section 7 hereof. The Securities may be redeemed by the
Company as provided in Section 3 of the Registered Securities and
the Bearer Securities and Section 6 hereof. The Securities will
be subordinated as provided in Section 7 of the Registered
Securities and the Bearer Securities. The Registered Securities,
the Bearer Securities and the Regulation S Global Security shall
contain such appropriate insertions, omissions, substitutions and
other variations as are required or permitted by this Agreement
and may have such letters, numbers or other marks of
identification and such legends or endorsements placed thereon as
may, consistent herewith, be determined by the officer of the
Company executing such Securities, as evidenced by his execution
of such Securities.
(h) The Company in issuing the Securities shall use
CUSIP numbers, and the Fiscal Agent may use such CUSIP numbers in
any notice of redemption with respect to the Securities. The
Company shall obtain one CUSIP number for the Rule 144A
Securities and one for the Registered Regulation S Securities.
In addition, the Company shall obtain an ISIN number and a Common
Code for the Regulation S Global Security, the Bearer Securities
and the Registered Regulation S Securities.
(i) Pursuant to the Subscription Agreement, the
Managers (or their affiliates) may sell the Securities to persons
who are not persons within the United States or its possessions
or "United States persons" as defined in the Internal Revenue
Code except as provided in U.S. Treasury Regulation Section
1.163-5 (c) (2) (i) (D). In compliance with United States tax
laws and regulations, Bearer Securities may not be offered or
sold during the 40-day period beginning on the Closing Date, or
at any time if part of a Manager's unsold allotment, to a person
PAGE
<PAGE>
who is within the United States or to a United States person
other than (a) foreign branches of United States financial
institutions if such institutions agree in writing to comply with
the requirements of Section 165(j)(3)(A), (B), or (C) of the
Internal Revenue Code of 1986, as amended, and the regulations
thereunder, (b) United States offices of exempt distributors, or
(c) United States offices of international organizations or
foreign central banks. United States tax laws and regulations
also require that Bearer Securities not be delivered within the
United States.
(j) The Company will use its reasonable best efforts
to have the Securities approved for listing on the Luxembourg
Stock Exchange or such other exchange as shall be agreed upon by
the Managers and the Company, as soon as practicable after the
date hereof.
PAGE
<PAGE>
2. Appointment of Agents and Security Registrar.
(a) The Company hereby appoints Chemical Bank, at
present having its principal corporate trust office at 450 West
33rd Street, New York, New York 10001, and having its main office
in London at Chemical Bank House, 125 London Wall, London EC2
Y54J, England, as its fiscal agent in respect of the Securities
upon the terms and subject to the conditions herein set forth.
(Chemical Bank and its successor or successors as such fiscal
agent qualified and appointed in accordance with Section 12
hereof are herein called the "Fiscal Agent.") The Fiscal Agent
shall have the powers and authority granted to and conferred upon
it herein and in the Securities, and such further powers and
authority, acceptable to it, to act on behalf of the Company as
the Company may hereafter grant to or confer upon it.
(b) The Company hereby appoints Chemical Bank, at
present located at 450 West 33rd Street, New York, New York
10001, and having its main office in London at Chemical Bank
House, 125 London Wall, London EC2 Y54J, England, as its paying
agent in respect of the Securities upon the terms and subject to
the conditions herein set forth. (Chemical Bank and its successor
or successors as such paying agent qualified and appointed in
accordance with Section 12 hereof are herein called the _Paying
Agent.") The Paying Agent shall have the powers and authority
granted to and conferred upon it herein and in the Securities,
and such further powers and authority, acceptable to it, to act
on behalf of the Company as the Company may hereafter grant to or
confer upon it. As used herein, "paying agencies" shall mean
paying agencies maintained by the Company as provided in Section
12(f) hereof.
(c) The Company hereby appoints Chemical Bank, at
present located at 450 West 33rd Street, New York, New York
10001, and having its main office in London at Chemical Bank
House, 125 London Wall, London EC2 Y54J, England, as its
conversion agent in respect of the Securities upon the terms and
subject to the conditions herein set forth. (Chemical Bank and
its successor or successors as such conversion agent qualified
and appointed in accordance with Section 12 hereof are herein
called the "Conversion Agent," and the Paying Agent, the
Conversion Agent, the Transfer Agents (as herein defined) and the
Fiscal Agent are sometimes herein referred to severally as an
"Agent" and, collectively, as the "Agents."). The Conversion
Agent shall have the powers and authority granted to and
conferred upon it herein and in the Securities, and such further
powers and authority, acceptable to it, to act on behalf of the
Company as the Company may hereafter grant to or confer upon it.
As used herein, "conversion agencies" shall mean conversion
agencies maintained by the Company as provided in Section 12(f)
hereof.
(d) The Company shall cause to be kept at the
principal corporate trust office of the Fiscal Agent a register
PAGE
<PAGE>
(the registers maintained in such office and in any other office
or agency designated for such purpose (which office shall be
located outside of the United Kingdom) being herein sometimes
collectively referred to as the "Security Register") in which,
subject to such reasonable regulations as the Fiscal Agent may
prescribe, the Company shall provide for the registration of
Registered Securities and of transfers of Registered Securities.
The Fiscal Agent is hereby appointed "Security Registrar" for the
purpose of registering Registered Securities and transfers of
Registered Securities as herein provided.
(e) With respect to the Securities issuable or issued
in whole or in part in the form of the Rule 144A Global Security,
the Company hereby appoints DTC, at present located at 55 Water
Street, New York, New York, 10041, as the depository for the Rule
144A Global Security upon the terms and conditions herein set
forth. DTC and its successor or successors as such depository
are herein called the "Depository."
3. Registration of Transfer and Exchange; Restrictions on
Transfer.
(a) Upon surrender for registration of transfer of any
Registered Security at any office or agency designated for such
purpose by the Company pursuant to Section 12(g) hereof, the
Company shall execute, and the Fiscal Agent shall authenticate,
register and deliver, in the name of the designated transferee or
transferees, one or more new Registered Securities of any
authorized denominations and of a like aggregate principal amount
and bearing such restrictive legends as may be required by this
Agreement; provided, however, that, with respect to any
Registered Security that is a Restricted Security, the Fiscal
Agent shall not register the transfer of such Security unless the
conditions in Sections 3(b) hereof shall have been satisfied.
The holder of each Restricted Security, by such holder's
acceptance thereof, agrees to be bound by the transfer
restrictions set forth herein and in the legend on such
Restricted Security.
(b) Whenever any Restricted Security is presented or
surrendered for registration of transfer or exchange for a
Registered Security registered in a name other than that of the
holder, no registration of transfer or exchange shall be made
unless:
(i) The registered holder presenting such Restricted
Security for transfer shall have certified to the Fiscal Agent in
writing that such registered holder is transferring such
Restricted Security to a QIB in compliance with the exemption
from registration under the Securities Act provided by Rule 144A
thereunder (or a successor provision);
(ii) The registered holder presenting such Restricted
Security for transfer shall have certified to the Fiscal Agent in
PAGE
<PAGE>
writing that the registered holder is transferring such
Restricted Security outside the United States in a transaction
meeting the requirements of Rule 904 of Regulation S under the
Securities Act;
(iii) (A) The registered holder presenting such
Restricted Security for transfer shall have certified to the
Fiscal Agent in writing that such registered holder is
transferring such Restricted Security to an _institutional
accredited investor" (within the meaning of Rule 501(a)(1), (2),
(3) or (7) under the Securities Act) in a transaction that is
exempt from the registration requirements of the Securities Act;
and (B) a broker or dealer registered under Section 15 of the
Securities Exchange Act of 1934, as amended, shall have certified
to the Fiscal Agent in writing that: (x) each person who will
become a beneficial owner of the Restricted Security upon
transfer is an institutional "accredited investor" (as such term
is defined in Rule 501(a)(1), (2), (3) or (7) under the
Securities Act); (y) no general solicitation or general
advertising was made or used by such broker or dealer in
connection with the offer and sale of such Restricted Security to
such person(s); and (z) such institutional accredited investor
has been informed that the Securities have not been registered
under the Securities Act and are subject to the restrictions on
transfer set forth in the Securities and this Agreement;
(iv) The registered holder presenting such Restricted
Security for transfer shall have certified to the Fiscal Agent in
writing that the registered holder is transferring the Registered
Security to the Company; or
(v) The Fiscal Agent has received transfer
documentation indicating, and a written opinion of U.S. counsel
acceptable in form and substance to the Company and the Fiscal
Agent, that the transfer is being made pursuant to an exemption
from, or a transaction not otherwise subject to, the registration
requirements of the Securities Act.
For purposes of this Section 3(b), any such
certification to the Fiscal Agent in writing shall be in the form
of the Transfer Notice set forth on the reverse of such Security.
In the case of transfer pursuant to the foregoing clauses (ii),
(iii) or (v) above, the Company and the Fiscal Agent may require
that the registered holder deliver an opinion of counsel,
certifications or other information acceptable to them in form
and substance. The Fiscal Agent shall notify the Company upon
receipt of such Transfer Notice and the Company shall immediately
advise the Fiscal Agent as to whether an opinion of counsel,
certifications or other information as described herein shall be
required for such transfer. In addition, in the case of a
transfer pursuant to the foregoing clause (iii) above, the
transferor shall be required to deliver a letter from the
transferee substantially in the form of Exhibit G hereto.
PAGE
<PAGE>
(c) Bearer Securities may, at the option of the holder
thereof, (with all unmatured coupons appertaining thereto and
matured defaulted coupons appertaining thereto), be exchanged at,
subject to applicable laws and regulations, the offices of the
paying agencies in London and, if the Securities are listed on
the Luxembourg Stock Exchange and so long as listed thereon,
Luxembourg or as designated by the Company for such purposes
pursuant to Section 12(g), for an equal aggregate principal
amount of Registered Securities in denominations of $1,000 and
integral multiples thereof without coupons and/or Bearer
Securities of authorized denominations. If such holder is unable
to produce any such unmatured coupon or coupons or matured coupon
or coupons in default, such exchange may be effected if the
Bearer Securities are accompanied by payment in funds acceptable
to the Company in an amount equal to the face amount of such
missing coupon or coupons or the surrender of such missing coupon
or coupons may be waived by the Company if there be furnished to
it and the Fiscal Agent such security or indemnity as it may
require to save it, the Fiscal Agent, the Paying Agent and any
paying agency harmless. If thereafter the holder of such
Security shall surrender to any paying agency any such missing
coupon in respect of which such a payment shall have been made,
such holder shall be entitled to receive the amount of such
payment from the Company; provided, however, that, except as
otherwise provided in the form of Bearer Security set forth in
Exhibit A hereto, interest represented by coupons shall be
payable only upon presentation and surrender of those coupons
outside of the United States, its territories and its
possessions. Bearer Securities and coupons are transferable upon
delivery.
Registered Securities may, at the option of the holder
thereof, be exchanged at the Corporate Trust Office of the Fiscal
Agent in New York City, or subject to applicable laws and
regulations, the offices of the paying agencies in London and, if
the Securities are listed on the Luxembourg Stock Exchange and so
long as listed thereon, Luxembourg or as designated by the
Company for such purposes pursuant to Section 12(g), for an equal
aggregate principal amount of Registered Securities of different
denominations. Registered Securities shall not be exchangeable
for Bearer Securities. Whenever any Registered Securities are so
surrendered for exchange, the Company shall execute, and the
Fiscal Agent shall authenticate and deliver, the Registered
Securities which the holder making the exchange is entitled to
receive. If the Registered Security so surrendered for exchange
is a Registered Accredited Investor Security and the holder
thereof requests in writing that such Registered Accredited
Investor Security be exchanged for an interest in the Rule 144A
Global Security, such Registered Accredited Investor Security
will be exchangeable into an equal aggregate principal amount of
beneficial interest in the Rule 144A Global Security; provided,
however, that, if such Registered Accredited Investor Security is
a Restricted Security, such exchange may only be made if such
holder certifies to the Fiscal Agent in writing that such holder
PAGE
<PAGE>
is a QIB by completing the Transfer Notice on the reverse of such
Security. Upon any exchange as provided in the immediately
preceding sentence, the Fiscal Agent shall cancel such Registered
Accredited Investor Security and cause, or direct any custodian
for the Rule 144A Global Security to cause, in accordance with
the standing instructions and procedures existing between the
Depository and any such custodian, the aggregate principal amount
of Securities represented by the Rule 144A Global Security to be
increased accordingly. If no Rule 144A Global Securities are
then outstanding, the Company shall issue and the Fiscal Agent
shall authenticate a new Rule 144A Global Security in the
appropriate principal amount.
Any person having a beneficial interest in a Rule 144A
Global Security may upon request exchange such beneficial
interest for a Registered Security only as provided in this
paragraph. Upon receipt by the Company and the Fiscal Agent of
(i) written or electronic instructions from the Depository or its
nominee (or such other form of instructions as is customary) on
behalf of any person having a beneficial interest in a Rule 144A
Global Security and upon receipt by the Fiscal Agent of a written
order of such person containing registration instructions and
(ii) in the case of a Restricted Security, the following
additional information and documents (all of which may be
submitted by facsimile):
(A) if such beneficial interest is being
transferred to the person designated as being the beneficial
owner, a certification to that effect from such person; or
(B) if such beneficial interest is being
transferred to a person other than the person designated as being
the beneficial owner, the provisions of Section 3(b) hereof have
been satisfied;
in which case the Fiscal Agent or any custodian for the Rule 144A
Global Security, at the direction of the Fiscal Agent, shall, in
accordance with the standing instructions and procedures existing
between the Depository and such custodian, cause the aggregate
principal amount of the Rule 144A Global Security to be reduced
accordingly and, following such reduction, the Company shall
execute and the Fiscal Agent shall authenticate and deliver to
such person or the transferee, as the case may be, a Registered
Security in the appropriate principal amount and, if such
Registered Security is a Restricted Security, including the
appropriate legend. Registered Securities issued in exchange for
a beneficial interest in the Rule 144A Global Security pursuant
to this paragraph shall be registered in such names and such
authorized denominations as shall be instructed to the Fiscal
Agent. The Fiscal Agent shall deliver such Registered Securities
to the persons in whose names such Securities are so registered.
(d) Notwithstanding any other provision of this
Agreement (other than the provisions set forth in Section 3(e)
PAGE
<PAGE>
hereof), the Rule 144A Global Security may not be transferred as
a whole except by the Depository to a nominee of the Depository
or by a nominee of the Depository to the Depository or another
nominee of the Depository or by the Depository or any such
nominee to a successor Depository or a nominee of such successor
Depository.
(e) If at any time either (i) the Depository for the
Rule 144A Global Security notifies the Company that the
Depository is unwilling or unable to continue as Depository for
the Rule 144A Global Security and a successor Depository for the
Rule 144A Global Security is not appointed by the Company within
90 days after delivery of such notice, or (ii) the Company, at
its sole discretion, notifies the Fiscal Agent in writing that it
elects to cause the issuance of Registered Securities under this
Agreement, then the Company shall execute, and the Fiscal Agent
shall authenticate and deliver, Registered Securities in an
aggregate principal amount equal to the principal amount of the
Rule 144A Global Security in exchange for such Rule 144A Global
Security.
(f) Each certificate evidencing Restricted Securities
shall bear a legend in substantially the following form:
THIS SECURITY (OR ITS PREDECESSOR) HAS NOT BEEN REGISTERED
UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE
"SECURITIES ACT"), OR ANY STATE SECURITIES LAWS AND NEITHER THIS
SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED,
SOLD OR OTHERWISE TRANSFERRED WITHIN THE "UNITED STATES" OR TO
"U.S. PERSONS" (AS DEFINED IN REGULATION S UNDER THE SECURITIES
ACT) IN THE ABSENCE OF SUCH REGISTRATION OR AN APPLICABLE
EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY IS HEREBY
NOTIFIED THAT THE SELLER MAY BE RELYING ON THE EXEMPTION FROM THE
PROVISIONS OF SECTION 5 OF THE SECURITIES ACT PROVIDED BY RULE
144A THEREUNDER. THE HOLDER OF THIS SECURITY, BY ITS ACCEPTANCE
HEREOF, REPRESENTS, ACKNOWLEDGES AND AGREES FOR THE BENEFIT OF
THE COMPANY THAT: (I) IT HAS ACQUIRED A "RESTRICTED" SECURITY
WHICH HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT; (II) IT
WILL NOT OFFER, SELL OR OTHERWISE TRANSFER THIS SECURITY PRIOR TO
THE DATE WHICH IS THREE YEARS (OR THE THEN APPLICABLE HOLDING
PERIOD UNDER RULE 144(K) UNDER THE SECURITIES ACT (OR SUCCESSOR
PROVISION))AFTER THE DATE OF ORIGINAL ISSUANCE HEREOF AND THE
LAST DATE ON WHICH THE COMPANY OR ANY AFFILIATE OF THE COMPANY
WAS THE OWNER OF SUCH RESTRICTED SECURITIES (OR ANY PREDECESSOR),
EXCEPT (A) TO THE COMPANY, (B) PURSUANT TO A REGISTRATION
STATEMENT WHICH HAS BEEN DECLARED EFFECTIVE UNDER THE SECURITIES
ACT, (C) FOR SO LONG AS THIS SECURITY IS ELIGIBLE FOR RESALE
PURSUANT TO RULE 144A, TO A PERSON WHO THE SELLER REASONABLY
BELIEVES IS A _QUALIFIED INSTITUTIONAL BUYER" (AS DEFINED IN RULE
144A UNDER THE SECURITIES ACT) IN A TRANSACTION MEETING THE
REQUIREMENTS OF RULE 144A, (D) OUTSIDE THE UNITED STATES IN A
TRANSACTION MEETING THE REQUIREMENTS OF RULE 904 UNDER THE
SECURITIES ACT OR (E) PURSUANT TO ANOTHER AVAILABLE EXEMPTION
FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT AND, IN
PAGE
<PAGE>
EACH CASE, IN ACCORDANCE WITH THE APPLICABLE SECURITIES LAWS OF
ANY STATE OF THE UNITED STATES OR ANY OTHER APPLICABLE
JURISDICTION; AND (III) IT WILL, AND EACH SUBSEQUENT HOLDER IS
REQUIRED TO, NOTIFY ANY PURCHASER FROM IT OF THIS SECURITY OF THE
RESALE RESTRICTIONS SET FORTH IN (II) ABOVE. ANY OFFER, SALE OR
OTHER DISPOSITION PURSUANT TO THE FOREGOING CLAUSE (II)(D) AND
(E) IS SUBJECT TO THE RIGHT OF THE ISSUER OF THIS SECURITY AND
THE FISCAL AGENT FOR SUCH ISSUER TO REQUIRE THE DELIVERY OF AN
OPINION OF COUNSEL, CERTIFICATIONS OR OTHER INFORMATION
ACCEPTABLE TO THEM IN FORM AND SUBSTANCE.
(g) The restrictions imposed by Section 3(b) upon the
transferability of any particular Restricted Security shall cease
and terminate when such Restricted Security has been sold
pursuant to an effective registration statement under the
Securities Act or transferred pursuant to Rule 144 under the
Securities Act (or any successor provision thereto), unless the
holder is an affiliate of the Company within the meaning of said
Rule 144 (or such successor provision). Any Restricted Security
as to which such restrictions on transfer shall have expired in
accordance with their terms or shall have terminated may, upon
surrender of such Restricted Security for exchange to the Fiscal
Agent in accordance with the provisions of this Section 3(g)
(accompanied, in the event that such restrictions on transfer
have terminated by reason of a transfer pursuant to Rule 144 (or
any successor provision), by an opinion of counsel reasonably
acceptable to the Company, addressed to the Company and the
Fiscal Agent and in form and scope satisfactory to the Company,
to the effect that the transfer of such Restricted Security has
been made in compliance with Rule 144 (or such successor
provision)), be exchanged for a new Registered Security, of like
tenor and aggregate principal amount, which shall not bear the
restrictive legend required by Section 3(f) hereof. The Company
shall promptly inform the Fiscal Agent in writing of the
effective date of any registration statement registering the
Securities under the Securities Act.
(h) The transfer and exchange of the Rule 144A Global
Security or beneficial interests therein shall be effected
through the Depository, in accordance with this Agreement and the
procedures of the Depository therefor, which shall include
restrictions on transfer comparable to those set forth herein to
the extent required by the Securities Act.
(i) At such time as all beneficial interests in the
Rule 144A Global Security have either been exchanged for
Registered Securities, redeemed, repurchased or cancelled, the
Rule 144A Global Security shall be returned to or retained and
cancelled by the Fiscal Agent. At any time prior to such
cancellation, if any beneficial interest in the Rule 144A Global
Security is exchanged for Registered Securities, redeemed,
repurchased or cancelled, the principal amount of Securities
represented by the Rule 144A Global Security shall be reduced
accordingly and an endorsement shall be made on the Rule 144A
PAGE
<PAGE>
Global Security, by the Fiscal Agent or any custodian therefor,
at the direction of the Fiscal Agent, to reflect such reduction.
(j) All Securities issued upon any registration of
transfer or exchange of Securities shall be the valid obligations
of the Company, evidencing the same obligations, and entitled to
the same benefits under this Agreement, as the Securities
surrendered upon such registration of transfer or exchange.
(k) Every Registered Security presented for
registration of transfer or surrendered for exchange shall be
duly endorsed, or be accompanied by a written instrument of
transfer in form satisfactory to the Company, the Fiscal Agent
and the Transfer Agent to which such Security is presented or
surrendered and the Security Registrar, duly executed by the
holder thereof or his attorney duly authorized in writing. All
such instruments shall comply with the applicable provisions of
this Section 3. The registration of the transfer of a Registered
Security by the Security Registrar shall be deemed to be the
written acknowledgment of such transfer on behalf of the Company.
(1) No service charge shall be made for any
registration of transfer or exchange (other than the cost of
delivery), but the Company or the Transfer Agent may require
payment of a sum sufficient to cover any tax or other
governmental charge that may be imposed in connection with any
registration of transfer or exchange of Securities, other than
exchanges pursuant to Section 4 hereof or not involving any
registration of transfer.
(m) Neither the Company nor the Fiscal Agent nor any
of the offices or agencies designated for the purposes specified
in Section 12(f) nor any Transfer Agent shall be required (i) to
exchange Bearer Securities for Registered Securities during the
period between the close of business on any Record Date (as
defined in Section 5(c) hereof) and the opening of business on
the next succeeding interest payment date, (ii) to exchange any
Bearer Security (or portion thereof) for a Registered Security if
the Company shall determine and inform the Fiscal Agent in
writing that, as a result thereof, the Company would incur
adverse consequences under the United States Federal income tax
laws at the time of such exchange, or (iii) in the event of a
redemption in part, (A) to register the transfer of Registered
Securities or to exchange any Bearer Securities for Registered
Securities for a period of 15 days immediately preceding the date
notice is given pursuant to Section 3(f) of the Registered
Securities and the Bearer Securities identifying the serial
numbers of any Securities to be redeemed, or (B) to register the
transfer of or exchange of any Registered Security so selected
for redemption in whole or in part, except portions not being
redeemed of Securities being redeemed in part, or (C) to exchange
any Bearer Security called for redemption; provided, however,
that a Bearer Security called for redemption may be exchanged, on
the terms and conditions set forth above, for a Registered
PAGE
<PAGE>
Security that is simultaneously surrendered, with written
instruction for payment on the date fixed for redemption, unless
the redemption date is after a Record Date and on or before the
next succeeding interest payment date, in which case such
exchange may be made only prior to the Record Date immediately
preceding the redemption date.
4. Closing Date; Exchange of Regulation S Global Security.
(a) At any time and from time to time after the
execution and delivery of this Agreement, the Company may deliver
Securities executed by the Company in accordance with this
Agreement to the Fiscal Agent for authentication together with an
officer's certificate of the Company directing such
authentication, and the Fiscal Agent shall thereupon authenticate
and make such Securities available for delivery upon and in
accordance with the written order of the Company. No Security
shall be valid or enforceable for any purpose unless and until
the certificate of authentication thereon shall have been
manually signed by a duly authorized signatory of the Fiscal
Agent and such duly executed certificate of authentication on any
Security shall be conclusive evidence that the Security has been
duly authenticated and delivered hereunder. The Regulation S
Global Security, the Rule 144A Global Security and the Registered
Accredited Investor Securities will be issued upon payment to the
Company or its order in United States dollars in same-day funds
by check or wire transfer to a United States dollar account
designated by the Company, at 4:00 p.m., London time, on January
3, 1996, or at such other time on the same or such other date,
not later than 5:00 p.m., London time, on the fourth Business Day
(as such term is defined in Section 5(h) hereof) in London
thereafter, as the Managers and the Company may agree (the
"Closing Date"). Such payment will be made (1) upon
authorization from the Managers, (2) against delivery as provided
in Section 4(b) hereof of the amount, if any, of Rule 144A
Securities and Registered Accredited Investor Securities as the
Managers may request and as they shall direct, and (3) against
delivery of the Regulation S Global Security for the balance of
the Securities to The Chase Manhattan Bank, N.A., London office,
as depositary (the "Common Depositary") for Morgan Guaranty Trust
Company of New York, Brussels office, as operator of the
Euroclear System (the "Euroclear Operator"), and Cedel Bank
societe anonyme ("Cedel"). The Regulation S Global Security
shall be held on deposit with the Common Depositary for the
accounts of the Euroclear Operator and Cedel, for credit to the
Managers' respective Securities Clearance Accounts (or to such
other accounts as the Lead Manager may have specified) with the
Euroclear Operator or Cedel.
(b) On the Closing Date, the Company shall execute and
deliver to (i) the Managers, at the office of an affiliate of the
Lead Manager (as defined in the Subscription Agreement) in New
York, Registered Accredited Investor Securities (which shall have
been duly authenticated by the Fiscal Agent and which may be in
PAGE
<PAGE>
typewritten form) in respect of the Accredited Investor
Securities and (ii) the Depositary, at its office in New York,
the Rule 144A Global Security (which shall have been duly
authenticated by the Fiscal Agent and which may be in typewritten
form) in respect of the Rule 144A Securities.
(c) On or before the Exchange Date, the Company will
execute and deliver to the Fiscal Agent, at its office in London,
definitive Registered Regulation S Securities and Bearer
Securities in the aggregate principal amount outstanding in the
Regulation S Global Security and in such proportion of Registered
Regulation S Securities to Bearer Securities as the Fiscal Agent
may specify. "Exchange Date" means the date following the
expiration of the 40-day period commencing on the Closing Date.
On or after the Exchange Date, the Regulation S Global Security
may be surrendered to the Fiscal Agent to be exchanged, as a
whole or in part, for definitive Bearer Securities without
charge, and the Fiscal Agent shall authenticate and deliver, in
exchange for such Regulation S Global Security or the portions
thereof to be exchanged, an equal aggregate principal amount of
definitive Bearer Securities, but only upon presentation to the
Fiscal Agent at its office in London of a certificate of the
Euroclear Operator or Cedel with respect to the Regulation S
Global Security or portions thereof being exchanged,
substantially in the form of Exhibit C hereto, to the effect that
it has received a certificate or certificates in substantially
the form set forth in Exhibit D hereto dated no earlier than 15
days prior to the Exchange Date and signed by the person
appearing in its records as the owner of the Regulation S Global
Security or portions thereof being exchanged. Similarly, on or
after the Exchange Date, portions of the Regulation S Global
Security may be exchanged for an equal aggregate principal amount
of definitive Registered Regulation S Securities upon
presentation to the Fiscal Agent of a certificate substantially
in the form of Exhibit F hereto, to the effect that it has
received a certificate or certificates in substantially the form
set forth in Exhibit E hereto dated no earlier than 15 days prior
to the Exchange Date and signed by the person appearing in its
records as the owner of the Regulation S Global Security or
portions thereof being exchanged. In addition, on or after the
Exchange Date, (or if permitted by the Company and the Fiscal
Agent, before the Exchange Date), portions of the Regulation S
Global Security may be exchanged for a beneficial interest in an
equal aggregate principal amount of the Rule 144A Global Security
(which portion shall be a Restricted Security) upon
certifications acceptable to the Company and to the Fiscal Agent
to the effect that the person(s) beneficially owning such portion
of the Rule 144A Global Security are QIBs that acquired such
interest in transaction(s) that complied with the exemption from
registration under the Securities Act provided by Rule 144A
thereunder (or a successor provision).
(d) The definitive Securities and coupons shall be
printed, lithographed or engraved or produced by any combination
PAGE
<PAGE>
of these methods or may be produced in any other manner permitted
by the rules of any securities exchange on which the Securities
may be listed, all as determined by the officers executing such
Securities and coupons, as evidenced by such execution.
(e) Only Bearer Securities may be issued upon receipt
by the Euroclear Operator or Cedel of a certificate or
certificates in the form of Exhibit D hereto. Bearer Securities
will be delivered only outside the United States, its territories
or its possessions. Only Registered Securities may be issued
upon receipt by the Euroclear Operator or Cedel of a certificate
or certificates in the form of Exhibit E hereto.
(f) The delivery to the Fiscal Agent by the Euroclear
Operator or Cedel of any certificate referred to above may be
relied upon by the Company and the Fiscal Agent as conclusive
evidence that a corresponding certificate or certificates has or
have been delivered to the Euroclear Operator or Cedel pursuant
to the terms of this Agreement. The Fiscal Agent shall receive
such certificate on behalf of the Company and shall promptly
deliver the original certificate to the Company, retaining a copy
of such certificate for its records.
(g) Upon any such exchange of a portion of the
Regulation S Global Security for a definitive Bearer Security or
Securities or a definitive Registered Regulation S Security or
Securities or a beneficial interest in the Rule 144A Global
Security, the Regulation S Global Security shall be endorsed by
the Fiscal Agent to reflect the reduction of its principal amount
by an amount equal to the aggregate principal amount of such
definitive Security or Securities. Until so exchanged in full,
the Regulation S Global Security shall in all respects be
entitled to the same benefits under this Agreement as definitive
Securities authenticated and delivered hereunder.
5. Payment.
(a) The Company will pay or cause to be paid to the
Paying Agent the amounts, at the times and for the purposes, set
forth herein and in the text of the Securities, and the Company
hereby authorizes and directs the Paying Agent to make payment of
the principal of, premium, if any, and interest on and Additional
Amounts (as defined in Section 2 of the Registered Securities and
the Bearer Securities), if any, on the Securities from such
payments.
(b) At least 15 days prior to the date on which any
payment of Additional Amounts shall be required to be made
pursuant to Section 2 of the Registered Securities and the Bearer
Securities, the Company will furnish the Paying Agent, each other
paying agency of the Company and the Fiscal Agent with a
certificate of one of its duly authorized officers instructing
the Paying Agent and each other paying agency of the Company as
to the amounts required (i) to be deducted or withheld for or on
PAGE
<PAGE>
account of any taxes described in Section 2 of the Registered
Securities and the Bearer Securities from a payment to be made on
that date and (ii) to be paid to each holder of Securities or
coupons as Additional Amounts pursuant to that Section. If the
foregoing amounts are not uniform for all holders, then the
Company's certificate shall specify by country of residence or
other factor the amounts required to be deducted or withheld and
to be paid as Additional Amounts for each holder or class of
holders of the Securities or coupons. In the absence of its
receipt of any such certificate from the Company, the Paying
Agent may make payment without deduction or withholding. The
Company hereby agrees to indemnify the Paying Agent, each other
paying agency of the Company and the Fiscal Agent for, and to
hold them harmless against, any loss, liability or expense
reasonably incurred without gross negligence or bad faith on
their part, arising out of or in connection with actions taken or
omitted by any of them in reliance on any certificate furnished
pursuant to this Section.
(c) Interest on any Registered Security that is
payable, and is punctually paid or duly provided for, on any
interest payment date shall be paid to the person in whose name
that Security is registered at the close of business on the June
15 or December 15 immediately preceding such interest payment
date (each a "Record Date"), even if such Registered Security is
cancelled, upon redemption, conversion or otherwise, after such
Record Date. In case a Bearer Security is surrendered for
exchange for a Registered Security after the close of business on
any Record Date and before the opening of business on the next
succeeding interest payment date, the Fiscal Agent shall not be
required to perform such transfer or exchange of such Security.
(d) Interest on any Registered Security that is
payable upon conversion in accordance with Section 7(a) hereof
shall be paid to the person in whose name that Security is
registered immediately prior to the conversion, provided that if
a Registered Security is converted after the close of business on
a Record Date and before the opening of business on the next
succeeding interest payment date, accrued interest shall be paid
on the next succeeding interest payment date to the person in
whose name that Security is registered at the close of business
on that Record Date.
(e) Any interest on any Registered Security that is
payable, but is not punctually paid or duly provided for, on any
interest payment date shall forthwith cease to be payable to the
registered holder thereof on the relevant regular record date by
virtue of having been such holder, and such defaulted interest
may be paid by the Company to the registered holder of such
registered Security on a subsequent record date established by
the Company in any lawful manner if, after notice given by the
Company to the Fiscal Agent of the proposed payment pursuant to
this clause, such manner of payment shall be deemed practicable
by the Fiscal Agent.
PAGE
<PAGE>
(f) Subject to the foregoing provisions of this
Section 5, each Security delivered under this Agreement upon
registration of transfer of or in exchange for or in lieu of any
other Security shall carry all the rights to interest accrued and
unpaid, and to accrue, which were carried by such other Security.
(g) In order to provide for the payment of the
principal of, premium, if any, and interest on the Securities as
the same shall become due and payable, the Company shall pay to
the Paying Agent at its office in London, in such coin or
currency of the United States of America as at the time of
payment is legal tender for the payment of public and private
debts therein, and in same day funds, the following amounts (and
the Company shall give notice to the Fiscal Agent at least one
full Business Day prior to the date payment is due to the Paying
Agent as to the means of such payment), to be held and applied by
the Paying Agent as hereinafter set forth:
(i) The Company shall pay to the Paying Agent on the
Business Day immediately prior to each interest payment date in
same day funds an amount sufficient to pay the interest due (and
Additional Amounts, if any) on all the Securities outstanding on
such interest payment date and the Paying Agent shall apply the
amounts paid to it to the payment of such interest (and
Additional Amounts, if any) on such interest payment date.
(ii) Upon presentment for conversion of any Securities
pursuant to Section 7(a) hereof (except as described in the
proviso to Section 5(d)), the Paying Agent shall promptly notify
the Company of the amount of any accrued interest due and owing
thereon. Within four business days of such notification, the
Company shall pay to the Paying Agent an amount sufficient to pay
the accrued interest due on such Securities (and Additional
Amounts, if any, thereon), and the Paying Agent shall apply the
amounts so paid to it to the payment of such accrued interest
(and Additional Amounts, if any, thereon) in accordance with the
terms of the Securities.
(iii) If the Company shall elect, or shall be
required, to redeem the Securities in accordance with Section 6
hereof, the Company will pay to the Paying Agent on the Business
Day immediately prior to the date fixed for redemption thereof in
same day funds an amount sufficient (with any amount then held by
the Paying Agent and available for the purpose) to pay the
redemption price of the Securities called for redemption on the
redemption date or entitled to be redeemed, together with accrued
interest thereon (and Additional Amounts, if any, thereon) to the
date fixed for redemption and not paid pursuant to clause (g)(i)
of this Section 5, and the Paying Agent shall apply such amount
to the payment of the redemption price and accrued interest
thereon (and Additional Amounts, if any, thereon) in accordance
with the terms of the Securities.
PAGE
<PAGE>
(iv) On the Business Day immediately prior to the
maturity date of the Securities, the Company shall pay to the
Paying Agent in same day funds an amount which, together with any
amounts then held by the Paying Agent, and available for payment
thereof, shall be equal to the entire amount of principal and
interest (and Additional Amounts, if any) to be due on such
maturity date on all the Securities then outstanding, and the
Paying Agent shall apply such amount to each payment of the
principal of and interest on (and Additional Amounts, if any, on)
the Securities in accordance with the terms of the Securities.
(h) Notwithstanding anything in this Section to the
contrary, if any payment of interest or premium or principal (or
Additional Amounts, if any) is due on a day that is not a
Business Day, payment shall be made on the next succeeding
Business Day, with the same effect as if made on the day such
payment was due, and no interest shall accrue for the period
after such date. A "Business Day" is defined, with respect to
any act to be performed pursuant hereto or to the Securities, as
any day which is not a Saturday, Sunday or a day on which banking
institutions in the place where such act is to occur are
authorized or obligated by applicable law, regulation or
executive order to close.
6. Redemption.
(a) If, under the circumstances described in Section 3
of the Registered Securities and Bearer Securities, the Company
shall elect or be required to redeem outstanding Securities, the
following provisions shall be applicable:
(i) The Company shall, at least 35 days in the case of
a redemption in whole or 75 days in the case of a redemption in
part (or such shorter period as shall be reasonably acceptable to
the Fiscal Agent) before the date designated for such redemption,
give written notice to the Agents of its election to redeem the
Securities on the redemption date specified in such notice and
state in such notice that the conditions precedent to such
redemption have occurred and describe them, and in case of
redemptions pursuant to Section 3(b) of the Registered Securities
and the Bearer Securities, shall provide to the Fiscal Agent an
opinion of counsel satisfactory to the Fiscal Agent stating that
the legal conditions precedent to the right of the Company to
effect such redemption have occurred, and shall request the
Fiscal Agent to arrange for publication and mailing of the notice
specified in clause (a) (ii) below.
(ii) In case the Company shall give notice to the
Agents of its election to redeem the Securities, the Fiscal Agent
shall cause to be published on behalf of and at the expense of
the Company a notice of redemption in accordance with the
provisions of Section 3 of the Registered Securities and Bearer
Securities and shall mail by first-class mail a copy of the
notice to each holder of a Registered Security at the address of
PAGE
<PAGE>
such holder as it shall appear in the Security Register. The
Fiscal Agent shall send a copy of such notice of redemption to
the Company, the Paying Agent (if different from the Fiscal
Agent) and each other paying agency of the Company.
(iii) Such notice shall be published on behalf and
at the expense of the Company in an Authorized Newspaper (as
defined in Section 19 hereof) on a Business Day in New York City
and in London and, if the Securities are listed on the Luxembourg
Stock Exchange and so long as listed thereon, in an Authorized
Newspaper in Luxembourg, or, if publication in either London or
Luxembourg is not practical, in an Authorized Newspaper in any
country in Western Europe, as set forth in Section 19 of this
Agreement and Section 3 of the Registered Securities and Bearer
Securities. In the case of a redemption in whole, notice will be
given once not more than 60 nor less than 30 days prior to the
date fixed for redemption. In the case of partial redemption,
notice will be given twice, the first such notice to be given not
more than 75 nor less than 60 days prior to the date fixed for
redemption and the second such notice to be given not more than
60 and not less than 30 days prior to the date fixed for
redemption. The Fiscal Agent shall notify the Company promptly
of the portions of outstanding Securities to be called for
redemption as determined pursuant to Section 3(a) of the
Registered Securities and Bearer Securities.
(b) Under the circumstances described in Section 3(d)
of the Registered Securities and Bearer Securities concerning the
redemption of outstanding Securities at the option of the holders
thereof, the following provisions shall be applicable:
(i) The Company shall give notice to the Fiscal Agent
of the occurrence of a Redemption Event (as defined in Section
3(d) of the Registered Securities and Bearer Securities)
immediately upon the occurrence of such Redemption Event. Such
notice shall state:
(A) The nature of the Redemption Event;
(B) The Holder Redemption Date (as defined in
Section 3(d) of the Registered Securities and Bearer Securities)
in respect of such Redemption Event; and
(C) The redemption price as set forth in Section
3(d) of the Registered Securities and Bearer Securities.
(ii) The Fiscal Agent shall cause to be published on
behalf of the Company a notice of entitlement to redeem in
accordance with the provisions of Section 3 of the Registered
Securities and Bearer Securities and shall mail by first-class
mail a copy of such notice to each holder of a Registered
Security at the address of such holder as it shall appear in the
Security Register. The Fiscal Agent shall send a copy of such
notice of entitlement to redeem to the Company, the Paying Agent
PAGE
<PAGE>
(if different from the Fiscal Agent) and each other paying agency
of the Company hereunder. Such notice shall be published on
behalf and at the expense of the Company in Authorized Newspapers
on a Business Day in New York City and in London and, if the
Securities are listed on the Luxembourg Stock Exchange and so
long as listed thereon, in an Authorized Newspaper in Luxembourg,
or, if either publication in London or Luxembourg is not
practical, in an Authorized Newspaper in any country in Western
Europe, as set forth in Section 19 of this Agreement. Notice
shall be given not later than 10 days after the later of the
Exchange Date or the date of the occurrence of a Redemption
Event.
(iii) Upon the deposit of any of the Registered
Securities or Bearer Securities with the agency designated by the
Company as the place for payment of the Registered Securities and
Bearer Securities together with a duly signed and completed
redemption notice in the form set forth on the reverse of the
Bearer Securities and Registered Securities, all in accordance
with the provisions of Section 3 of the Registered Securities and
Bearer Securities, the holder of such Registered Security and
Bearer Security shall be entitled to receive a non-transferable
receipt evidencing such deposit.
(iv) The Fiscal Agent shall notify the Company on each
Business Day in the five Business Days prior to the Holder
Redemption Date for outstanding Securities to be redeemed under
this Section 6(b) of the amount required to redeem such
Securities.
(c) Under the circumstances described in Section 3(e)
of the Registered Securities and Bearer Securities concerning the
redemption of outstanding Securities at the option of the holders
thereof upon a Change in Control of the Company that is not
approved by a majority of the Continuing Directors prior to the
expiration of the Approval Period (all as defined and set forth
in Section 3(e) of the Registered Securities and Bearer
Securities), the following provisions shall be applicable:
(i) The Company shall give notice to the Fiscal
Agent of the occurrence of a Change in Control immediately upon
the expiration of the Approval Period if such Change in Control
has not been approved by a majority of the Continuing Directors
prior to the expiration of the Approval Period. Such notice
shall state:
(A) The nature of the Change in Control;
(B) The Repurchase Date (as that term is
defined in Section 3(e) of the Registered
Securities and Bearer Securities) in respect of such Change in
Control; and
PAGE
<PAGE>
(C) The redemption price as set forth in
Section 3(e) of the Registered Securities and
Bearer Securities.
(ii) The Fiscal Agent shall cause to be published
on behalf of the Company a notice of entitlement to redeem in
accordance with the provisions of Section 3 of the Registered
Securities and Bearer Securities and shall mail by first-class
mail a copy of such notice to each holder of a Registered
Security at the address of such holder as it shall appear in the
Security Register. The Fiscal Agent shall send a copy of such
notice of entitlement to redeem to the Company, the Paying Agent
(if different from the Fiscal Agent) and each other paying agency
of the Company hereunder. Such notice shall be published on
behalf and at the expense of the Company in Authorized Newspapers
on a Business Day in New York City and in London and, if the
Securities are listed on the Luxembourg Stock Exchange and so
long as listed thereon, in an Authorized Newspaper in Luxembourg,
or, if either publication in London or Luxembourg is not
practical, in an Authorized Newspaper in any country in Western
Europe, as set forth in Section 19 of this Agreement. Notice
shall be given not later than 10 days after the later of the
Exchange Date or the date of the expiration of the Approval
Period.
(iii) Upon the deposit of any of the
Registered Securities or Bearer Securities with the agency
designated by the Company as the place for payment of the
Registered Securities and Bearer Securities, together with a duly
signed and completed redemption notice in the form set forth on
the reverse of the Bearer Securities and Registered
Securities, all in accordance with the provisions of Section 3 of
the Registered Securities and Bearer Securities, the holder of
such Registered Security and Bearer Security shall be entitled to
receive a non-transferable receipt evidencing such deposit.
(iv) The Fiscal Agent shall notify the Company on
the second Business Day prior to the Repurchase Date for
outstanding Securities to be redeemed under this Section 6(c) of
the amount required to redeem such Securities.
7. Conversion of Securities.
(a) Subject to and upon compliance with the provisions
of this Section 7, at the option of the holder thereof, any
outstanding Registered Security or Bearer Security or, in the
case of any outstanding Registered Security or Bearer Security of
a denomination other than $1,000, any portion of the principal
amount thereof which is $1,000 or an integral multiple of $1,000,
may be converted into shares of the Company's common stock, par
value $1.00 per share ("Common Stock"), issuable upon conversion
of the Securities, at the principal amount thereof, or of such
portion thereof, into fully paid and nonassessable shares of
Common Stock ("Conversion Shares") as set forth in the Registered
PAGE
<PAGE>
Securities and Bearer Securities. Such Registered Securities or
Bearer Securities may be converted on or after the date which is
the latest of: (i) the Exchange Date, (ii) March 15, 1996 and
(iii) the date of the effectiveness of the Registration Statement
to be filed by the Company under the Securities Act relating to
the Common Stock issuable upon conversion of the Restricted
Securities (the _Registration Date_), and in any event prior to
redemption or maturity. The right to convert Securities called
for redemption will terminate at the close of business on the
fifteenth day next preceding the date fixed for redemption (or if
such date is not a Business Day, then the next succeeding
Business Day), and will be lost if not exercised prior to that
time. No payment or adjustment shall be made upon any conversion
on account of any dividends on the Common Stock issued upon
conversion. Accrued interest from the immediately preceding
interest payment date until the conversion date (and Additional
Amounts, if any, thereon) will be paid to the holder, through the
Paying Agent, in the same manner as payments of interest, within
five Business Days after the conversion date, provided that if a
Registered Security is converted after the close of business on a
Record Date and before the opening of business on the next
succeeding interest payment date, accrued interest shall be paid
on the next succeeding interest payment date to the person in
whose name that Security is registered at the close of business
on that Record Date. The price at which Conversion Shares shall
be delivered upon conversion (herein called the "Conversion
Price") shall be initially $56.70 per share of Common Stock. The
Conversion Price shall be adjusted in certain instances as
provided in paragraphs (c)(i), (ii), (iii), (iv), (vi) and (vii)
of Section 4 of the Registered Securities and Bearer Securities.
(b) In order to exercise the conversion privilege, the
holder of any Security to be converted shall surrender such
Security, or, if less than the entire principal amount of a
Registered Security or Bearer Security of a denomination other
than $1,000 is to be converted, the portion thereof to be
converted, together with all unmatured coupons and any matured
coupons in default appertaining thereto, at the office of the
Conversion Agent or any office or agency of the Company
maintained for that purpose pursuant to Section 12(f) hereof,
accompanied by a duly signed and completed Conversion Notice, in
substantially the form set forth in the Registered Securities and
Bearer Securities, to the Company, at such office or agency that
the holder elects to convert such Security (or specified portion
thereof).
(c) Securities shall be deemed to have been converted
immediately prior to the close of business on the day of
surrender of such Securities for conversion in accordance with
the foregoing provisions, and at such time the rights of the
holders of such Securities as holders shall cease, and the person
or persons entitled to receive the Common Stock issuable upon
conversion shall be treated for all purposes as the record holder
or holders of such Common Stock at such time. As promptly as
PAGE
<PAGE>
practicable on or after the conversion date, the Company shall
cause to be issued or delivered at such office or agency a
certificate or certificates for the number of full shares of
Common Stock issuable or deliverable upon conversion, together
with payment, in lieu of any fraction of a share, as provided
below. The Paying Agent shall, within five business days after
the conversion date, make a payment for the accrued interest
thereon (and Additional Amounts, if any, thereon), except as
otherwise provided in this Section 7.
(d) In the case of any Registered Security or Bearer
Security of a denomination other than $1,000 which is converted
in part only, upon such conversion the Company shall execute and
the Fiscal Agent shall authenticate and deliver to the holder
thereof, at the expense of the Company, a new Security or
Securities of any authorized kind or denomination as requested by
such holder, in aggregate principal amount equal to the
unconverted portion of the principal amount of such Security.
(e) No fractional shares of Common Stock shall be
issued or delivered upon conversion of Securities. If more than
one Security shall be surrendered for conversion at one time by
the same holder, the number of full shares of Common Stock which
shall be issuable or deliverable upon conversion thereof shall be
computed on the basis of the aggregate principal amount of the
Securities (or, in the case of Registered Securities or Bearer
Securities of a denomination other than $1,000, specified
portions thereof) so surrendered. Instead of any fractional
share of Common Stock which would otherwise be issuable or
deliverable upon conversion of any Security or Securities (or, in
the case of Registered Securities or Bearer Securities of a
denomination other than $1,000, specified portions thereof), the
Company shall pay a cash adjustment in respect of such fraction
in an amount equal to the same fraction of the Closing Price (as
defined in Section 4(c)(v) of the Registered Securities and
Bearer Securities) for a share of Common Stock at the close of
business on the day preceding the day of conversion.
(f) Whenever the Conversion Price is adjusted as
provided in the Registered Securities and Bearer Securities:
(i) the Company shall compute the adjusted
Conversion Price in accordance with the terms of the Registered
Securities and Bearer Securities and shall prepare a certificate
signed by the President, any Vice President or the Treasurer of
the Company setting forth the adjusted Conversion Price and
showing in reasonable detail the facts upon which such adjustment
is based, and such certificate shall forthwith be filed with the
Conversion Agent and at each office or agency maintained for the
purpose of conversion of Securities pursuant to Section 12(f)
hereof; and
(ii) a notice stating that the Conversion Price
has been adjusted and setting forth the adjusted Conversion Price
PAGE
<PAGE>
shall forthwith be prepared, and, as soon as practicable after it
is prepared, the Company shall promptly cause a notice setting
forth the adjusted Conversion Price to be given to the holders of
the Securities. Such notice shall be published on behalf and at
the expense of the Company in Authorized Newspapers on a Business
Day in New York City and in London and, if the Securities are
listed on the Luxembourg Stock Exchange and so long as listed
thereon, in an Authorized Newspaper in Luxembourg, or, if
publication in either London or Luxembourg is not practical, in
an Authorized Newspaper in any country in Western Europe, as set
forth in Section 19 of this Agreement and Section 4 of the
Registered Securities and Bearer Securities.
(g) In case:
(i) the Company shall declare a dividend (or any other
distribution) on its Common Stock payable otherwise than in cash
out of its retained earnings (excluding dividends payable in
stock for which adjustment is made pursuant to the terms of the
Registered Securities and Bearer Securities); or
(ii) the Company shall authorize the granting to the
holders of its Common Stock of rights or warrants to subscribe
for or purchase any shares of capital stock of any class or of
any other rights; or
(iii) of any reclassification of the Common Stock
of the Company (other than a subdivision or combination of its
outstanding shares of Common Stock), or of any consolidation
with, or merger of the Company into, any other corporation, or of
any merger of another corporation into the Company (other than a
merger which does not result in any reclassification, conversion,
exchange or cancellation of outstanding shares of Common Stock of
the Company), or of any sale or transfer of all or substantially
all of the assets of the Company (which shall not include the
sale or transfer of any portion of the assets of the Company to
any corporation which, immediately following such transfer is at
least 51% owned by the Company, provided that such sale or
transfer does not result in the reclassification, conversion,
exchange or cancellation of outstanding shares of Common Stock of
the Company); or
(iv) of the involuntary dissolution, liquidation or
winding up of the Company; or
(v) the Company proposes to take any other action
which would require an adjustment of the Conversion Price
pursuant to the Registered Securities and Bearer Securities;
then the Company shall cause to be filed with the Conversion
Agent and at each office or agency maintained for the purpose of
conversion of Securities a notice setting forth the adjusted
Conversion Price and shall cause notice to be given as provided
in Section 19 except that notice need be given once at least 20
PAGE
<PAGE>
days (or 10 days in any case specified in clause (i) or (iii)
above) prior to the applicable record date hereinafter specified,
stating (x) the date on which a record is to be taken for the
purpose of such dividend, distribution, rights or warrants or, if
a record is not to be taken, the date as of which the holders of
Common Stock of record to be entitled to such dividend,
distribution, rights or warrants is to be determined, or (y) the
date on which a reclassification, consolidation, merger, sale,
transfer, dissolution, liquidation or winding up is expected to
become effective, and the date as of which it is expected that
holders of Common Stock of record shall be entitled to exchange
their shares of Common Stock for the securities, cash or other
property deliverable upon such reclassification, consolidation,
merger, sale, transfer, dissolution, liquidation or winding up.
The failure to give notice required by this Section or any defect
therein shall not affect the legality or validity of any
dividend, distribution, rights, warrants, reclassification,
consolidation, merger, sale, transfer, dissolution, liquidation
or winding up, or the vote on any such action.
(h) The Company shall, at all times, have reserved and
available, free from preemptive rights, out of its authorized but
unissued shares of Common Stock, for the purpose of effecting the
conversion of Securities, the full number of Conversion Shares
then issuable upon the conversion of all Securities (based on the
aggregate principal amount of Securities outstanding).
(i) The Company shall file, as soon as practicable
following the Closing Date, a shelf registration statement with
the United States Securities and Exchange Commission covering the
resale of shares of Common Stock issuable upon conversion of the
Restricted Securities (_Registrable Securities_); provided that
any holder of any Restricted Securities shall not sell any shares
pursuant to such registration statement unless and until it
provides to the Company such information as the Company may
reasonably request for use in connection with the identification
of such holder as a selling stockholder in such registration
statement, or any prospectus included therein, and no such sale
shall be made by such holder pursuant to such registration
statement unless and until such information is included by the
Company in such registration statement or prospectus. The
Company shall in good faith use its best efforts and at its cost
to cause such registration statement to be declared effective as
promptly as practicable thereafter and to include in such
registration statement the information provided by a holder as a
selling stockholder and shall notify the Fiscal Agent of the
effectiveness thereof and agrees to use its best efforts to (i)
cause all registrations with, and to obtain any approvals by, any
governmental authority under any Federal or state law of the
United States that may be required in connection with the
conversion of the Securities into Common Stock and the resale
thereof, (ii) maintain the effectiveness of such registrations
until the earlier of (a) three years from the latest date of
original issuance of the Securities hereunder, or (b) the date
PAGE
<PAGE>
that Rule 144(k) under the Securities Act (or successor
provision) is available for the resale of the shares of Common
Stock issuable upon conversion of the Restricted Securities (or
other securities issuable upon conversion of the Securities) and
(iii) to list the shares of Common Stock required to be issued or
delivered upon conversion of Securities (or other securities
issuable upon conversion of the Securities) prior to such issue
or delivery on such national securities exchange or automated
over-the-counter trading market where such Common Stock is listed
or traded at the time of such delivery. The Company shall,
without limitation as to time, indemnify and hold harmless, to
the fullest extent permitted by law, each holder of Registrable
Securities, the officers, directors and agents and employees of
each of them, each person who controls such holder (within the
meaning of Section 15 of the Securities Act or Section 20 of the
Securities Exchange Act of 1934, as amended) and the officers,
directors, agents and employees of any such controlling person,
from and against all losses, claims, damages, liabilities, costs
(including, without limitation, the costs of preparation and
attorneys' fees) and expenses (collectively, _Losses_), as
incurred, arising out of or based upon any untrue or alleged
untrue statement of a material fact contained in any such
registration statement, or related prospectus or in any amendment
or supplement thereto, or arising out of or based upon any
omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are based
solely upon information, if any, furnished in writing to the
Company by such holder expressly for use therein; provided, that
the Company shall not be liable to any holder of Registrable
Securities to the extent that any such Losses arise out of or are
based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in any preliminary prospectus
if either (A)(i) such holder failed to send or deliver a copy of
the final prospectus with or prior to the delivery of written
confirmation of the sale by such holder of a Registrable Security
to the person asserting the claim from which such Losses arise
and (ii) the prospectus would have completely corrected such
untrue statement or alleged untrue statement or such omission or
alleged omission; or (B)(i) such untrue statement or alleged
untrue statement, omission or alleged omission is completely
corrected in an amendment or supplement to the prospectus and
(ii) having previously been furnished by or on behalf of the
Company with copies of the prospectus as so amended or
supplemented, such holder thereafter fails to deliver such
prospectus as so amended or supplemented, prior to or
concurrently with the sale of a Registrable Security to the
person asserting the claim from which such Losses arise.
Promptly after receipt by an indemnified party under this
Paragraph (i) of notice of any claim or the commencement of any
action, the indemnified party shall, if a claim in respect
thereof is to be made against the Company under this Paragraph
(i) notify the Company in writing of the claim or the
commencement of that action; provided, however, that the failure
PAGE
<PAGE>
to notify the Company shall not relieve it from any liability
which it may have to an indemnified party otherwise than under
this Paragraph (i). If any such claim or action shall be brought
against an indemnified party, and it shall notify the Company
thereof, the Company shall be entitled to participate therein
and, to the extent that it wishes, to assume the defense thereof
with counsel reasonably satisfactory to the indemnified party.
After notice from the Company to the indemnified party of its
election to assume the defense of such claim or action, the
Company shall not be liable to the indemnified party under this
Paragraph (i) for any legal or other expenses subsequently
incurred by the indemnified party in connection with the defense
thereof; provided, however, if the defendants in any such action
include both an indemnified party and the Company and the
indemnified party shall have reasonably concluded that there may
be legal defenses available to it and for other indemnified
parties that are different from or additional to those available
to the Company, the indemnified party or parties under this
Paragraph (i) shall have the right to employ not more than one
counsel to represent them and, in that event, the reasonable fees
and expenses of not more than one such separate counsel shall be
paid by the Company. The Company shall not be liable for any
settlement effected without its written consent of any claim or
action.
(j) The Company covenants that all shares of Common
Stock which may be issued or delivered upon conversion of
Securities (or other securities issuable upon conversion of the
Securities) will upon issuance be fully paid and nonassessable
and, except as provided in Section 13 hereof, the Company will
pay all stamp, excise or similar taxes or duties, liens and
charges with respect to the issue thereof.
(k) All converted Securities shall be held by the
Company, and may, at any time, be delivered to the Fiscal Agent
for cancellation, which shall hold or dispose of the same in
accordance with its policy for disposal of cancelled securities
or as otherwise directed by the Company. Converted Securities
shall not be transferred. The Conversion Agent shall give the
Company prompt notice of all Securities which have been
converted, and if the Fiscal Agent is not also the Conversion
Agent, the Company will promptly give, or cause to be given,
written notice to the Fiscal Agent of the serial numbers of all
Securities which have been converted.
(1) In case of any consolidation with, or merger of
the Company into, any other corporation, or in case of any merger
of another corporation into the Company (other than a merger
which does not result in any reclassification, conversion,
exchange or cancellation of outstanding shares of Common Stock of
the Company), or in case of any sale or transfer of all or
substantially all of the assets of the Company, the corporation
formed by such consolidation or resulting from such merger (which
shall not include the sale or transfer of any portion of the
PAGE
<PAGE>
assets of the Company to any corporation which, immediately
following such transfer is at least 51% owned by the Company,
provided that such sale or transfer does not result in the
reclassification, conversion, exchange or cancellation of
outstanding shares of Common Stock of the Company), or which
acquires such assets, as the case may be, shall execute and
deliver to the Fiscal Agent an amendment to the Fiscal Agency
Agreement providing that the holder of each Registered Security
and Bearer Security shall have the right during the period such
Security shall be convertible as specified in the Registered
Securities and Bearer Securities to convert such Security only
into the kind and amount of securities, cash and other property
receivable upon such consolidation, merger, sale or transfer by a
holder of the number of shares of Common Stock of the Company
into which such Security might have been converted immediately
prior to such consolidation, merger, sale or transfer, assuming,
if such consolidation, merger, sale or transfer is prior to the
period such Security shall be convertible as specified in the
Registered Securities and Bearer Securities, that the Securities
were convertible at such time at the initial Conversion Price as
adjusted pursuant to the terms of the Registered Securities and
Bearer Securities. Such amendment shall provide for adjustments
which, for events subsequent to the effective date of such
amendment, shall be as nearly equivalent as may be practicable to
the adjustments provided for in the Registered Securities and the
Bearer Securities. The above provisions of this Section shall
similarly apply to successive consolidations, mergers, sales or
transfers.
(m) Subject to Section 11(j) hereof, neither the
Fiscal Agent nor the Conversion Agent or conversion agency
appointed by the Company shall at any time be under any duty or
responsibility to any holder of Securities to determine whether
any facts exist which may require any adjustment of the
Conversion Price, or with respect to the nature or extent of any
such adjustment when made, or with respect to the method
employed, or herein or in the Registered Securities and Bearer
Securities provided to be employed, in making the same. Neither
the Fiscal Agent nor the Conversion Agent or conversion agency
appointed by the Company shall be accountable with respect to the
validity or value (or the kind or amount) of any shares of Common
Stock or of any securities or property which may at any time be
issued or delivered upon the conversion of any Security; and
neither the Fiscal Agent nor the Conversion Agent or conversion
agency appointed by the Company makes any representation with
respect thereto. Neither the Fiscal Agent nor the Conversion
Agent or conversion agency appointed by the Company shall be
responsible for any acts or omissions of the Company including
without limitation any failure of the Company to issue, transfer
or deliver any certificates representing shares of Common Stock
or other securities or property or to make any cash payment upon
the delivery of any Security for the purpose of conversion or to
comply with any of the covenants contained in this Section 7.
PAGE
<PAGE>
(n) Any Common Stock issued upon conversion of a
Restricted Security ("Restricted Common Stock") at any time prior
to the date which is three years (or the then applicable holding
period under Rule 144(k) under the Securities Act (or successor
provision)) after the date of original issuance of such
Restricted Security and the last date on which the Company or any
affiliate of the Company was the owner thereof (or any
predecessor), and when a registration statement in respect of
such Common Stock is not effective under the Securities Act,
shall be subject to the restrictions on transfer set forth in
Section 3 hereof to the same extent as such Restricted Securities
which were so converted. All shares of Restricted Common Stock
shall bear the legend and transfer requirements set forth in
Section 3(f) hereof, with such modifications thereto as the
Company shall deem appropriate.
8. Surrendered Securities.
All Securities, together with any coupons appertaining
thereto, surrendered for payment, redemption, retirement,
transfer or exchange and all coupons paid through the application
of interest installments and all Securities purchased by the
Company or any subsidiary shall be delivered to the Fiscal Agent.
In any such case the Fiscal Agent shall cancel all Securities and
coupons not previously cancelled and destroy all such Securities
and coupons so delivered and shall furnish to the Company a
certificate with respect to such destruction. Such certificate
shall state, in the case of destruction of the Regulation S
Global Security, that all certificates of the Euroclear Operator
or Cedel S.A. as to beneficial ownership required by Section 4
hereof have been duly presented by the Euroclear Operator or
Cedel S. A.
9. Mutilated, Destroyed, Stolen or Lost Securities.
The Fiscal Agent is hereby authorized, in accordance
with the provisions of the Securities and this Section, from time
to time to authenticate and deliver Securities in exchange for or
in lieu of Securities that become mutilated, destroyed, stolen or
lost, upon receipt of indemnity and such other documents or proof
as may be required in form and substance satisfactory to the
Fiscal Agent and the Company. Every Security authenticated and
delivered in exchange for or in lieu of any such Security shall
be considered obligations of the Company and shall carry all
rights to interest accrued and unpaid and to accrue which were
carried by such Security, and notwithstanding anything to the
contrary herein contained, any new Bearer Security shall have
attached thereto such coupons that neither gain nor loss in
interest shall result from such exchange or substitution.
10. Signatures.
Securities shall be executed on behalf of the Company
by its President, its Secretary, any Vice President or its
PAGE
<PAGE>
Treasurer, any of whose signatures may be manual or in facsimile,
and any coupons appertaining thereto shall be executed on behalf
of the Company by the facsimile signature of its President, its
Secretary, any Vice President or its Treasurer. Any signature in
facsimile may be imprinted or otherwise reproduced on the
Securities. The Company may adopt and use the signature or
facsimile signature of any person who shall be a President,
Secretary, Vice President or Treasurer at the time of the
execution of the Securities, notwithstanding the fact that at the
time the Securities shall be authenticated and delivered, or
disposed of, such person shall have ceased to have held such
office by virtue of which such person so executed such security.
11. Agreements Concerning Agents.
Each of the Agents accepts its obligations herein and
in the Securities, upon the terms and conditions hereof and
thereof, including the following, to all of which the Company
agrees and to all of which the rights hereunder of the holders
from time to time of the Securities and coupons shall be subject:
(a) Each of the Agents shall be entitled to reasonable
compensation for all services rendered by such Agent, as
separately agreed by the Company and the Agent, and the Company
agrees promptly to pay such compensation and to reimburse each of
the Agents for the reasonable out-of-pocket expenses (including,
but not limited to, counsel fees) incurred by such Agent in
connection with the services rendered by it hereunder. The
Company also agrees to indemnify each of the Agents and each
other paying agency and conversion agency of the Company for, and
to hold it harmless against, any loss, liability or expense
(including the costs and expenses of defending against any claim
of liability) incurred without negligence or bad faith on the
part of such Agent or other paying agency and conversion agency
of the Company hereunder. The obligations of the Company under
this clause (a) shall survive payment of the Securities or the
resignation or removal of any Agent or paying agency or
conversion agency.
(b) In acting under this Agreement and in connection
with the Securities, each of the Agents and each other paying
agency and conversion agency of the Company is acting solely as
agent of the Company, and does not assume any obligation, or
relationship of agency or trust, for or with any of the owners or
holders of the Securities or coupons, except that all funds held
by the Paying Agent or any other paying agency of the Company for
payment of principal, premium, if any, or interest on (or
Additional Amounts, if any, on) the Securities shall be held in
trust but need not be segregated from other funds except as
required by law and as set forth herein and in the Securities,
and shall be applied as set forth herein and in the Securities;
provided, however, that monies paid by the Company to the Paying
Agent or any other paying agency of the Company for the payment
of principal of or interest on (or Additional Amounts, if any,
PAGE
<PAGE>
on) Securities remaining unclaimed at the end of two years after
such principal or interest (or Additional Amounts, if any) shall
have become due and payable shall be repaid to the Company, as
provided and in the manner set forth in the Securities, whereupon
the aforesaid trust shall terminate and all liability of the
Paying Agent or such other paying agency or the Company with
respect thereto shall cease.
(c) Each of the Agents and each other paying agency
and conversion agency of the Company may consult with one or more
counsel satisfactory to it (including counsel to the Company),
and the written opinion of such counsel shall be full and
complete authorization and protection in respect of any action
taken, omitted or suffered by it hereunder in good faith and in
accordance with the opinion of such counsel.
(d) Each of the Agents and each other paying agency
and conversion agency of the Company shall be protected and shall
incur no liability for or in respect of any action taken, omitted
or suffered by it in reliance upon any Security or coupon,
notice, direction, consent, certificate, affidavit, statement or
other paper or document believed in good faith by such Agent or
such other paying agency and conversion agency of the Company to
be genuine and to have been signed by the property parties.
(e) Each of the Agents and each other paying agency
and conversion agency of the Company, its officers, directors and
employees may become the owner of, or acquire any interest in,
any Securities or coupons, with the same rights that it or they
would have if it were not an Agent or such other paying agency of
the Company hereunder, and may engage or be interested in any
financial or other transaction with the Company and its
affiliates and may act on, or as depositary, trustee or agent
for, any committee or body of holders of Securities or other
obligations of the Company, as freely as if it were not an Agent
or a paying agency or conversion agency of the Company hereunder.
(f) Neither the Paying Agent nor any other paying
agency of the Company shall be under any liability for interest
on any monies at any time received by it pursuant to any of the
provisions of this Agreement or of the Securities.
(g) The recitals contained herein and in the
Securities (except in the Fiscal Agent's certificates of
authentication), shall be taken as the statements of the Company,
and the Agents assume no responsibility for the correctness of
the same. None of the Agents makes any representation as to the
validity or sufficiency of this Agreement or the Securities or
the coupons, except for such Agent's due authorization to execute
this Agreement. Neither the Agents nor any other paying agency
or conversion agency of the Company shall be accountable for the
use or application by the Company of the proceeds of any
Securities authenticated and delivered by the Fiscal Agent in
conformity with the provisions of this Agreement.
PAGE
<PAGE>
(h) The Agents and each other paying agency and
conversion agency of the Company shall be obligated to perform
such duties and only such duties as are herein and in the
Securities specifically set forth and no implied duties or
obligations shall be read into this Agreement or the Securities
against the Agents or any other paying agency of the Company.
The Agents shall not be under any obligation to take any action
hereunder which may tend to involve them in any expense or
liability, the payment of which, within a reasonable time, is
not, in their reasonable opinion, assured to them.
(i) Unless herein or in the Securities otherwise
specifically provided, any order, certificate, notice, request,
direction, or other communication, from the Company made by or
given by it under any provision of this Agreement shall be
sufficient if signed by the President, the Secretary, any Vice
President or the Treasurer of the Company.
(j) Anything in this Agreement to the contrary
notwithstanding, none of the Agents shall incur any liability
hereunder, except as a result of negligence or bad faith
attributable to it or its officers or employees, and shall incur
no liability for the negligence or bad faith of its agents
appointed by it with due care; provided that the Agent shall
notify the Company of the appointment of any such agents.
(k) The Agents shall not be liable for any loss caused
by events beyond the reasonable control of the Agents, including
any malfunction, interruption of or error in the transmission of
information caused by any machines or systems or interruption of
communication facilities, abnormal operating conditions or acts
of God. The Agents shall have no liability whatsoever for any
consequential, special, indirect or speculative losses or
damages.
12. Offices, Resignation, Successors, Etc. of Agents,
Paying, Conversion and Transfer Agencies.
(a) The Company agrees that, until none of the
Securities and coupons are outstanding or until monies for the
payment of all principal, premium, if any, and interest on (and
Additional Amounts, if any, on) all outstanding Securities shall
have been made available at the office of the Paying Agent and
shall have been returned to the Company as provided in the
Securities, there shall at all times be a Fiscal Agent in the
Borough of Manhattan, New York City, which shall be a bank or
trust company organized and doing business under the laws of the
United States of America or of any State of the United States of
America, in good standing and authorized under such laws to
exercise corporate trust powers, a Paying Agent, a Conversion
Agent and a Transfer Agent having offices in a city in Western
Europe and in New York City, which shall be a bank or trust
company organized, in good standing and doing business under the
PAGE
<PAGE>
laws of the United States of America or of any State of the
United States of America, and a paying agency, a conversion
agency and a transfer agency in at least one city in Western
Europe, which shall be Luxembourg if the Securities are listed on
the Luxembourg Stock Exchange and so long as listed thereon.
(b) Each of the Agents may at any time resign as such
Agent by giving written notice to the Company of such intention
on its part, specifying the date on which its desired resignation
shall become effective; provided, however, that such date shall
not be less than 90 days after receipt of such notice by the
Company unless the Company agrees to accept less notice. Each of
the Agents hereunder may be removed at any time by the filing
with it of any instrument in writing signed on behalf of the
Company and specifying such removal and the date when it is
intended to become effective. Such resignation or removal shall
take effect upon the date of the appointment by the Company, as
hereinafter provided, of a successor Fiscal Agent, Conversion
Agent or Paying Agent, as the case may be, and the acceptance of
such appointment by such successor Agent. Upon its resignation
or removal, each of the Agents shall be entitled to the payment
by the Company of its compensation for the services rendered
hereunder and to the reimbursement of all reasonable
out-of-pocket expenses incurred in connection with the services
rendered hereunder by such Agent and shall promptly notify the
Company of such action.
(c) In case at any time any of the Agents shall
resign, or shall be removed, or shall be incapable of acting, or
shall file a voluntary petition as a debtor under Chapter 7 or 11
of Title 11 of the United States Code or have an order for relief
entered against it as a debtor under Chapter 7 or 11 of Title 11
of the United States Code or make an assignment for the benefit
of its creditors or consent to the appointment of a receiver of
all or any substantial part of its property, or shall admit in
writing its inability to pay or meet its debts as they mature, or
if an order of any court shall be entered approving any petition
filed by or against the Fiscal Agent under any legislation
similar to the provisions of Title 11 of the United States Code
or against any of the Agents under the provisions of any
legislation similar to the provisions of Title 11 of the United
States Code, or if a receiver of it or of all or any substantial
part of its property shall be appointed, or if any public officer
shall take charge or control of it or of its property or affairs,
for the purpose of rehabilitation, conservation or liquidation, a
successor Agent, qualified as aforesaid, shall be appointed by
the Company by an instrument in writing. Upon the appointment as
aforesaid of a successor Agent and acceptance by it of such
appointment, the Agent so superseded shall cease to be such Agent
hereunder. If no successor Agent shall have been so appointed by
the Company and shall have accepted appointment as hereinafter
provided, any holder of a Security, on behalf of itself and all
others similarly situated, or any Agent may petition any court of
PAGE
<PAGE>
competent jurisdiction for the appointment of a successor Agent
and shall promptly notify the Company of such action.
(d) Any successor Fiscal Agent, Conversion Agent,
Transfer Agent or Paying Agent appointed hereunder shall execute,
acknowledge and deliver to its predecessor and to the Company an
instrument accepting such appointment hereunder, and thereupon
such successor Agent, without any further act, deed or
conveyance, shall become vested with all the authority, rights,
powers, trusts, immunities, duties and obligations of such
predecessor with like effect as if originally named as such Agent
hereunder, and such predecessor, upon payment of its charges and
disbursements then unpaid, shall thereupon become obligated to
transfer, deliver and pay over, and such successor Agent shall be
entitled to receive, all monies, securities or other property on
deposit with or held by such predecessor, as such Agent
hereunder.
(e) Any corporation or bank into which any of the
Agents hereunder may be merged or converted, or any corporation
or bank with which such Agent may be consolidated, or any
corporation or bank resulting from any merger, conversion or
consolidation to which such Agent shall be a party, or any
corporation or bank to which such Agent shall sell or otherwise
transfer all or substantially all the assets and business of such
Agent, or any corporation to which the Fiscal Agent shall sell or
otherwise transfer all or substantially all of its corporate
trust business, provided that it shall be qualified as aforesaid,
shall be the successor to such Agent under this Agreement without
the execution or filing of any document or any further act on the
part of any of the parties hereto.
(f) So long as there shall be a Fiscal Agent and
Paying Agent hereunder, the Company shall maintain agencies (i)
where Registered Securities (but not Bearer Securities or
coupons) may be presented for surrender for payment (and for the
payment of Additional Amounts on the Registered Securities, if
any) and where Securities may be surrendered for conversion in
the Borough of Manhattan, New York City, and (ii) where Bearer
Securities and coupons may be surrendered for payment (and for
the payment of Additional Amounts (pursuant to Section 2 of the
Bearer Securities) on Bearer Securities, if any) and where Bearer
Securities may be surrendered for conversion in at least one city
in Western Europe, which shall be Luxembourg if the Securities
are listed on the Luxembourg Stock Exchange and so long as listed
thereon. The Company now intends to maintain additional agencies
(subject to applicable laws and regulations) where Bearer
Securities may be surrendered for payment (and for the payment of
Additional Amounts (pursuant to Section 2 of the Bearer
Securities) on Bearer Securities, if any), where Registered
Securities may be surrendered for payment and where Securities
may be surrendered for conversion in London, England and, if the
Securities are listed on the Luxembourg Stock Exchange and so
long as listed thereon, Luxembourg, and during such period to
PAGE
<PAGE>
keep the Agents advised of the names and locations of such
agencies. Unless the Company shall otherwise notify each of the
Agents in writing, the sole such paying agencies and conversion
agencies shall be the agencies specified in the Securities. The
Company authorizes the Paying Agent to pay to or to the order of
the aforesaid agencies, upon demand by such agencies, funds for
the payment of the principal, premium, if any, and interest on
(and Additional Amounts pursuant to Section 2 of the Registered
Securities and Bearer Securities, if any, on) the Securities.
Except as otherwise arranged by the Company, the Fiscal Agent
shall arrange for the payment of the compensation of such paying
agencies for their services as such, and the Company shall pay to
the Fiscal Agent from time to time sufficient funds to make such
payments.
(g) So long as there shall be a Fiscal Agent, Paying
Agent and Conversion Agent hereunder, the Company shall maintain
a Security Registrar and additional transfer agencies (the
"Transfer Agents") (i) where Registered Securities may be
surrendered for exchange for other Registered Securities in New
York City and (ii) in at least one city in Western Europe, which
shall be Luxembourg if the Securities are listed on the
Luxembourg Stock Exchange and so long as listed thereon, where
Bearer Securities may be delivered in exchange for Bearer
Securities or for Registered Securities. Consistent with
applicable laws and regulations, including the provisions of the
federal income tax laws of the United States, such agencies may
be the same agencies as or different agencies from those
maintained by the Company pursuant to Section 12(f).
The Company hereby appoints, subject to the listing of
the Securities on the Luxembourg Stock Exchange, Banque
Internationale a Luxembourg, 69, route d'Esch, L-1470 Luxembourg
Ville, Luxembourg, as Transfer Agent for such exchanges. The
transfer, exchange and registration of transfer or exchange of
Registered Securities shall be made by the Fiscal Agent in New
York City.
13. Taxes.
The Company will pay all stamp taxes and other similar
duties, if any, that may be imposed by the United States of
America or the United Kingdom, or any state or political
subdivision thereof or taxing authority therein, with respect to
the execution or delivery of this Agreement, or the issuance of
the Regulation S Global Security, or the exchange from time to
time of the Regulation S Global Security for Registered
Securities and Bearer Securities, or with respect to the issue or
delivery of shares of Common Stock on conversion of Securities;
provided, however, that the Company shall not be required to pay
any tax or duty which may be payable in respect of any transfer
involved in the issue or delivery of shares of Common Stock in a
name other than that of the holder of the Security or Securities
to be converted, and no such issue or delivery shall be made
PAGE
<PAGE>
unless and until the person requesting such issue has paid to the
Company the amount of any such tax or duty or has established to
the satisfaction of the Company that such tax or duty has been
paid; and further provided that the Company shall not be required
to pay any tax or duty that may be payable in respect of any
accrued interest paid in connection with the conversion of the
Securities.
14. Meetings and Votes of Holders.
(a) A meeting of holders of Securities may be called
at any time and from time to time pursuant to this Section for
any of the following purposes: (i) to give any notice to the
Company or to the Fiscal Agent, or to give any directions to the
Fiscal Agent, or to consent to the waiving of any default
hereunder or under the Registered Securities and Bearer
Securities and its consequences, or to take any other action
authorized to be taken by holders of Securities pursuant to
Section 9 of the Registered Securities and Bearer Securities; or
(ii) to take any other action authorized to be taken by or on
behalf of the holders of any specified aggregate principal amount
of the Securities under any other provision of this Agreement,
the Registered Securities and Bearer Securities or under
applicable law.
(b) Meetings of holders of Securities may be held at
such place or places in New York City or London as the Fiscal
Agent or, in case of its failure to act, the Company or the
holders calling the meeting shall from time to time determine.
(c) The Fiscal Agent may at any time call a meeting of
holders of Securities to be held at such time and at such place
in any of the locations designated in Section 14(b) hereof as the
Fiscal Agent shall determine. Notice of every meeting of holders
shall be made as specified in Section 19 hereof, except that such
notice shall set forth the time and the place of such meeting, in
general terms the action proposed to be taken at such meeting and
a general description of regulations applicable to such meeting,
and shall be published at least three times in the publications
specified in such Section 19, the first publication to be not
less than 21 nor more than 180 days prior to the date fixed for
the meeting.
(d) In case at any time the Company or the holders of
at least 25% in aggregate principal amount of the Securities
shall have requested the Fiscal Agent to call a meeting of the
holders, by written request setting forth in reasonable detail
the action proposed to be taken at the meeting, and the Fiscal
Agent shall not have given the first notice of such meeting
within 21 days after receipt of such request or shall not
thereafter proceed to cause the meeting to be held as provided
herein, then the Company or the holders of Securities in the
amount above specified may determine the time and the place in
either of the locations designated in Section 14(b) hereof for
PAGE
<PAGE>
such meeting and may call such meeting to take any action
authorized in Section 14(a) hereof by giving notice thereof as
provided in Section 14(c) hereof.
(e) To be entitled to vote at any meeting of holders
of Securities, a person shall be (i) a holder of one or more
Securities, or (ii) a person appointed by an instrument in
writing as proxy for a holder or holders of Securities by such
holder or holders, which proxy need not be a holder of
Securities. The only persons who shall be entitled to be present
or to speak at any meeting of holders shall be the persons
entitled to vote at such meeting and their counsel and any
representatives of the Fiscal Agent and its counsel and any
representatives of the Company and its counsel.
(f) The persons entitled to vote a majority in
principal amount of the outstanding Securities shall constitute a
quorum for the transaction of all business specified in Section
14(a) hereof. No business shall be transacted in the absence of a
quorum unless a quorum is represented when the meeting is called
to order. In the absence of a quorum within 30 minutes of the
time appointed for any such meeting, the meeting shall, if
convened at the request of the holders of Securities (as provided
in Section 14(d) hereof), be dissolved. In any other case the
meeting shall be adjourned for a period of not less than 10 days
as determined by the chairman of the meeting prior to the
adjournment of such adjourned meeting. Notice of the reconvening
of any adjourned meeting shall be given as provided in Section
14(c) hereof except that such notice need be published only once
but must be given not less than five days prior to the date on
which the meeting is scheduled to be reconvened. Subject to the
foregoing, at the reconvening of any meeting adjourned for a lack
of a quorum the persons entitled to vote 25% in principal amount
of the Securities outstanding shall constitute a quorum for the
taking of any action set forth in the notice of the original
meeting. Notice of the reconvening of an adjourned meeting shall
state expressly the percentage of the aggregate principal amount
of the Securities that shall constitute a quorum. At a meeting
or an adjourned meeting duly reconvened and at which a quorum is
present as aforesaid, any resolution and all matters (except as
limited by Section 9 of the Registered Securities and Bearer
Securities) shall be effectively passed and decided if passed or
decided by the persons entitled to vote a majority in principal
amount of the Securities represented and voting at such meeting,
provided that such amount shall be not less than 25% in principal
amount of the Securities outstanding. Any holder of a Security
who has executed an instrument in writing appointing a person as
his proxy shall be deemed to be present for the purposes of
determining a quorum and be deemed to have voted; provided,
however, that such holder shall be considered as present or
voting only with respect to the matters covered by such
instrument in writing. Any resolution passed or decision taken
at any meeting of the holders of Securities duly held in
accordance with this Section 14 shall be binding on all the
PAGE
<PAGE>
holders of Securities whether or not present or represented at
the meeting.
(g) Notwithstanding any other provision of this
Agreement, the Fiscal Agent may make such reasonable regulations
as it may deem advisable for any meeting of holders of Securities
in regard to proof of the holding of Securities and of the
appointment of proxies and in regard to the appointment and
duties of inspectors of votes, the submission and examination of
proxies, certificates and other evidence of the right to vote,
and such other matters concerning the conduct of the meeting as
it shall deem appropriate. Except as otherwise permitted or
required by any such regulations, the holding of Bearer
Securities shall be proved by the production of the Bearer
Securities or by a certificate executed, as depositary, by, and
the appointment of any proxy shall be proved by having the
signature of the person executing the proxy witnessed or
guaranteed by, in each case, any trust company, bank or banker
satisfactory to the Fiscal Agent. Such regulations may provide
that written instruments appointing proxies, regular on their
face, may be presumed valid and genuine without the proof
specified herein or other proof. The holding of Registered
Securities shall be proved by the registry books maintained in
accordance with Section 2(d) hereof or by a certificate or
certificates of the Fiscal Agent in its capacity as Company's
agent for the maintenance of such books.
(h) The Fiscal Agent shall, by an instrument in
writing, appoint a temporary chairperson and a temporary
secretary of the meeting, unless the meeting shall have been
called by the Company or by the holders of Securities or the
Fiscal Agent at the request of the Company or the holders of
Securities as provided in Section 14(d) hereof and in the
Securities, in which case the Company or the holders calling the
meeting, as the case may be, shall in like manner appoint a
temporary chairperson and a temporary secretary. A permanent
chairperson and a permanent secretary of the meeting shall be
elected by vote of the holders of a majority in principal amount
of the Securities represented at the meeting and entitled to
vote.
(i) At any meeting each holder or proxy shall be
entitled to one vote for each U.S.$1,000 principal amount of
Securities held or represented by him; provided, however, that no
vote shall be cast or counted at any meeting in respect of any
Securities challenged as not outstanding and ruled by the
chairperson of the meeting to be not outstanding. The
chairperson of the meeting shall have no right to vote, except as
a holder or proxy.
(j) Any meeting of holders of Securities duly called
pursuant to Section 14(c) or 14(d) hereof at which a quorum is
present may be adjourned from time to time by vote of the holders
(or proxies for the holders) of a majority in principal amount of
PAGE
<PAGE>
the Securities represented at the meeting and entitled to vote;
and the meeting may be held as so adjourned without further
notice.
(k) The vote upon any resolution submitted to any
meeting of holders of Securities shall be by written ballots on
which shall be subscribed the signatures of the holders of
Securities or of their representatives by proxy and the serial
number or numbers of the Securities held or represented by them.
The permanent chairperson of the meeting shall appoint two
inspectors of votes who shall count all votes cast at the meeting
for or against any resolution and who shall make and file with
the secretary of the meeting their verified written reports in
triplicate of all votes cast at the meeting. A record, at least
in triplicate, of the proceedings of each meeting of holders of
Securities shall be prepared by the secretary of the meeting and
there shall be attached to said record the original reports of
the inspectors of votes on any vote by ballot taken thereat and
affidavits by one or more persons having knowledge of the facts
setting forth a copy of the notice of the meeting and showing
that said notice was published as provided in Section 14(c) or
14(d) hereof and, if applicable, Section 14(f) hereof. Each copy
shall be signed and verified by the affidavits of the permanent
chairperson and secretary of the meeting, and one such copy shall
be delivered to the Company and another to the Fiscal Agent to be
preserved by the Fiscal Agent, the copy delivered to the Fiscal
Agent to have attached thereto the ballots voted at the meeting.
Any record so signed and verified shall be conclusive evidence of
the matters therein stated.
15. Merger, Consolidation or Sale of Assets.
(a) If at any time there shall be a merger,
consolidation, sale or conveyance of assets or assumption of
obligations to which any of the covenants contained in Section 6
of the Registered Securities and Bearer Securities is applicable,
then in any such event the successor or assuming corporation
referred to therein will promptly deliver to the Fiscal Agent:
(i) a certificate signed by an executive officer of
such successor or assuming corporation stating that as of the
time immediately after the effective date of any such
transaction, the covenants of the Company contained in the
Registered Securities and Bearer Securities have been complied
with and the successor or assuming corporation is not in default
under the provisions of this Agreement or the Securities, as
applicable; and
(ii) a written opinion of legal counsel (who may be an
employee of or counsel to the successor or assuming corporation)
stating that, in such counsel's opinion, such covenants have been
complied with and that any instrument or instruments executed in
the performance of such covenants comply with the requirements
thereof.
PAGE
<PAGE>
In case of any such merger, consolidation, sale,
conveyance or assumption, such successor or assuming corporation
shall succeed to and be substituted for the Company with the same
effect, subject to (in the case of a merger to which the Company
is a party) Section 6(b) of the Registered Securities and Bearer
Securities, as if such successor or assuming corporation had been
named herein and in the Registered Securities and Bearer
Securities as the Company; the Company shall thereupon be
relieved of any further obligation or liability hereunder or upon
the Securities, provided that any successor or assuming
corporation shall have the right to redeem the Securities,
pursuant to Section 3(b) of the Registered Securities and Bearer
Securities, only as a result of circumstances which occur
subsequent to such merger, consolidation, sale, conveyance or
assumption and as a result of which the Company would have had
such right if the Company had remained the obligor on the
Securities. The Company, as the predecessor corporation may
thereupon or at any time thereafter be dissolved, wound up or
liquidated. If applicable, such successor or assuming
corporation thereupon may cause to be signed, and may issue
either in its own name or in the name of the Company any or all
of the Securities issuable hereunder which theretofore shall not
have been executed on behalf of the Company and delivered to the
Fiscal Agent; and, upon the order of such successor or assuming
corporation, instead of the Company, and subject to all the
terms, conditions and limitations in this Agreement prescribed,
the Fiscal Agent shall authenticate and shall deliver any
Securities which previously shall have been signed and delivered
by the officers of the Company to the Fiscal Agent for
authentication, and any Securities which such successor or
assuming corporation thereafter shall cause to be signed and
delivered to the Fiscal Agent for that purpose. All the
Securities so issued shall in all respects have the same legal
rank and benefit under this Agreement as the Securities
theretofore or thereafter issued in accordance with the terms of
this Agreement as though all of such Securities had been issued
at the date of the execution hereof.
In case of any merger, consolidation, sale, conveyance
or assumption, such changes in phraseology and form (but not in
substance) may be made in the Securities thereafter to be issued
as may be appropriate.
(b) The Fiscal Agent may rely on the documents
delivered pursuant to this Agreement by any successor or assuming
corporation pursuant to this Section 15 as conclusive evidence
that any such merger, consolidation, sale, conveyance or
assumption complies with the provisions of this Section and the
Securities.
16. Governing Law.
PAGE
<PAGE>
THIS AGREEMENT, THE SECURITIES AND ANY COUPONS
APPERTAINING THERETO SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS,
UNITED STATES OF AMERICA, WITHOUT GIVING EFFECT TO ITS CONFLICTS
OF LAW RULES.
17. Amendments.
This Agreement may be amended by the parties hereto,
and certain provisions hereof may be waived, in the manner
provided in Section 9 of the Registered Securities and Bearer
Securities. This Agreement may also be amended by the parties
hereto, without the consent of the holder of any Security, for
the purposes set forth in Section 9 of the Registered Securities
and Bearer Securities and for the purpose of curing any
ambiguity, or of curing, correcting or supplementing any
defective provision contained herein or in any manner that the
parties may mutually deem necessary or desirable, and that shall
not materially adversely affect the interests of the holders of
the Securities.
18. Agent for Service of Process.
As long as any of the Securities or coupons
appertaining thereto remain outstanding, the Company will at all
times have an authorized agent in the City of New York, upon whom
process may be served in any legal action or proceeding arising
out of or relating to this Agreement or any Security or any
coupons appertaining thereto. Service of process upon such agent
and written notice of such service mailed or delivered to the
Company shall to the extent permitted by law be deemed in every
respect effective service of process upon the Company in any such
legal action or proceeding. The Company hereby appoints the
Fiscal Agent as its agent for such purpose, and covenants and
agrees that service of process in any legal action or proceeding
may be made upon it at the office of such agent located at 450
West 33rd Street, 15th Floor, New York, New York 10001 (or such
other address in the City of New York, as may be the principal
corporate trust office of such agent), unless and until the
Company shall designate another agent for such purpose by written
notice to the Fiscal Agent. If the Fiscal Agent receives any
such service of process, it shall promptly notify the Company of
such service.
19. Notices.
All notices hereunder shall be deemed to have been given
when deposited in the mail as first-class mail, registered or
certified, return receipt requested, postage prepaid, addressed
to any party hereto as follows:
The Company: 81 Wyman Street
P.O. Box 9046
Waltham, MA 02254-9046
PAGE
<PAGE>
Attn: Secretary,
with a copy to the General Counsel
The Fiscal Agent: 450 West 33rd Street
15th Floor
New York, New York 10001
Attn: Corporate Trust Department
Chemical Bank House
125 London Wall
London EC2 Y54J
England
Attn: Corporate Agency
The Paying Agent: 450 W. 33rd Street
15th Floor
New York, New York 10001
Attn: Corporate Trust Department
Chemical Bank House
125 London Wall
London EC2 Y54J
England
Attn: Corporate Agency
The Transfer Agent: Banque Internationale a Luxembourg, S.A.
69, Route d'Esch
L-1470 Luxembourg Ville, Luxembourg
or at any other address of which any of the foregoing shall have
notified the others in writing.
Notices to holders of the Securities shall be given by
publication on a Business Day in an Authorized Newspaper. For
purposes of this Agreement, the term "Authorized Newspaper" means
an English language newspaper, customarily published on each
business day in morning editions, whether or not it shall be
published in Saturday, Sunday or holiday editions, such as The
Wall Street Journal (Eastern edition) in New York City, the
Financial Times in London and the Luxemburger Wort in Luxembourg.
If by reason of the temporary or permanent suspension of
publication of any newspaper or by reason of any other cause it
shall be impossible to make publication of such notice in an
Authorized Newspaper as herein provided, then such publication or
other notice in lieu thereof as shall be made by the Fiscal Agent
shall constitute sufficient publication of such notice, if such
publication or other notice shall, so far as may be possible,
approximate the terms and conditions of the publication in lieu
of which it is given. Notices will be mailed by the Fiscal
Agent, on behalf of and at the expense of the Company, by
1 Subject to the listing of the Securities on the Luxembourg
Stock Exchange.
PAGE
<PAGE>
first-class mail to registered holders of Registered Securities
at their registered address as the same shall appear on the books
of the Fiscal Agent on the day 15 days prior to such mailing.
The Fiscal Agent shall promptly furnish to the Company and to
each other paying agency of the Company a copy of each notice so
published or mailed.
20. Counterparts.
This Agreement may be executed in separate
counterparts, and by each party separately in a separate
counterpart, each such counterpart, when so executed and
delivered, to be an original. Such counterparts shall together
constitute but one and the same instrument.
[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]
PAGE
<PAGE>
IN WITNESS WHEREOF, the parties hereto have executed
this Fiscal Agency Agreement as of the date first above written.
THERMO ELECTRON CORPORATION
By: _________________________________
Name:
Title:
CHEMICAL BANK,
as Fiscal Agent
By: _________________________________
Name:
Title:
PAGE
<PAGE>
EXHIBIT A
(FORM OF FACE OF REGISTERED SECURITY)
Unless and until it is exchanged in whole or in part
for Securities in definitive form, this Security may not be
transferred except as a whole by the Depository to a nominee of
the Depository or by a nominee of the Depository to the
Depository or another nominee of the Depository or by the
Depository or any such nominee to a successor depository or a
nominee of such successor Depository. Unless this certificate is
presented by an authorized representative of The Depository Trust
Company, a New York corporation (55 Water Street, New York, New
York) ("DTC"), to the issuer or its agent for registration of
transfer, exchange or payment, and any certificate issued is
registered in the name of Cede & Co. or such other name as may be
requested by an authorized representative of DTC (and any payment
is made to Cede & Co. or such other entity as may be requested by
an authorized representative of DTC), ANY TRANSFER, PLEDGE OR
OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS
WRONGFUL inasmuch as the registered owner hereof, Cede & Co., has
an interest herein.
THIS SECURITY (OR ITS PREDECESSOR) HAS NOT BEEN
REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS
AMENDED (THE "SECURITIES ACT"), OR ANY STATE SECURITIES LAWS AND
NEITHER THIS SECURITY NOR ANY INTEREST OR PARTICIPATION HEREIN
MAY BE OFFERED, SOLD OR OTHERWISE TRANSFERRED WITHIN THE "UNITED
STATES" OR TO "U.S. PERSONS" (AS DEFINED IN REGULATION S UNDER
THE SECURITIES ACT) IN THE ABSENCE OF SUCH REGISTRATION OR AN
APPLICABLE EXEMPTION THEREFROM. EACH PURCHASER OF THIS SECURITY
IS HEREBY NOTIFIED THAT THE SELLER MAY BE RELYING ON THE
EXEMPTION FROM THE PROVISIONS OF SECTION 5 OF THE SECURITIES ACT
PROVIDED BY RULE 144A THEREUNDER. THE HOLDER OF THIS SECURITY,
BY ITS ACCEPTANCE HEREOF, REPRESENTS, ACKNOWLEDGES AND AGREES FOR
THE BENEFIT OF THE COMPANY THAT: (I) IT HAS ACQUIRED A
"RESTRICTED" SECURITY WHICH HAS NOT BEEN REGISTERED UNDER THE
SECURITIES ACT; (II) IT WILL NOT OFFER, SELL OR OTHERWISE
TRANSFER THIS SECURITY PRIOR TO THE DATE WHICH IS THREE YEARS (OR
THE THEN APPLICABLE HOLDING PERIOD UNDER RULE 144(K) UNDER THE
SECURITIES ACT (OR SUCCESSOR PROVISION)) AFTER THE DATE OF
ORIGINAL ISSUANCE HEREOF AND THE LAST DATE ON WHICH THE COMPANY
OR ANY AFFILIATE OF THE COMPANY WAS THE OWNER OF SUCH RESTRICTED
SECURITIES (OR ANY PREDECESSOR), EXCEPT (A) TO THE COMPANY, (B)
PURSUANT TO A REGISTRATION STATEMENT WHICH HAS BEEN DECLARED
EFFECTIVE UNDER THE SECURITIES ACT, (C) FOR SO LONG AS THIS
SECURITY IS ELIGIBLE FOR RESALE PURSUANT TO RULE 144A, TO A
PERSON WHO THE SELLER REASONABLY BELIEVES IS A "QUALIFIED
INSTITUTIONAL BUYER" (AS DEFINED IN RULE 144A UNDER THE
SECURITIES ACT) IN A TRANSACTION MEETING THE REQUIREMENTS OF RULE
2 This paragraph should be included only if the Security is
issued in global form.
PAGE
<PAGE>
144A, (D) OUTSIDE THE UNITED STATES IN A TRANSACTION MEETING THE
REQUIREMENTS OF RULE 904 UNDER THE SECURITIES ACT, OR (E)
PURSUANT TO ANOTHER AVAILABLE EXEMPTION FROM THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT AND, IN EACH CASE, IN
ACCORDANCE WITH THE APPLICABLE SECURITIES LAWS OF ANY STATE OF
THE UNITED STATES OR ANY OTHER APPLICABLE JURISDICTION; AND (III)
IT WILL, AND EACH SUBSEQUENT HOLDER IS REQUIRED TO, NOTIFY ANY
PURCHASER FROM IT OF THIS SECURITY OF THE RESALE RESTRICTIONS SET
FORTH IN (II) ABOVE. ANY OFFER, SALE OR OTHER DISPOSITION
PURSUANT TO THE FOREGOING CLAUSES II(D) AND (E) IS SUBJECT TO THE
RIGHT OF THE ISSUER OF THIS SECURITY AND THE FISCAL AGENT FOR
SUCH ISSUER TO REQUIRE THE DELIVERY OF AN OPINION OF COUNSEL,
CERTIFICATIONS OR OTHER INFORMATION ACCEPTABLE TO THEM IN FORM
AND SUBSTANCE.
3 This paragraph to be included if the Security is a Restricted
Security.
PAGE
<PAGE>
THERMO ELECTRON CORPORATION
(Incorporated in the State of Delaware)
4 1/4% CONVERTIBLE SUBORDINATED DEBENTURE DUE 2003
No. R-________________ U.S.$_______
Thermo Electron Corporation, a corporation duly
incorporated and existing under the laws of the State of Delaware
(the "Company"), for value received, hereby promises to pay to
________________, or registered assigns, the principal sum of
__________________ United States Dollars on January 1, 2003 upon
presentation and surrender hereof and to pay interest thereon,
from January 3, 1996 or from the most recent Interest Payment
Date (as defined below) to which interest has been paid or duly
provided for, semiannually in arrears on January 1 and July 1 in
each year (each an "Interest Payment Date"), commencing July 1,
1996, at the rate of 4q% per annum, until the principal hereof is
paid or made available for payment. Interest hereon shall be
calculated on the basis of a 360-day year comprised of twelve
30-day months. The interest so payable, and punctually paid or
duly provided for, on any Interest Payment Date will, as provided
in the Fiscal Agency Agreement (as defined on the reverse
hereof), be paid to the person in whose name this Security is
registered at the close of business on the Record Date for such
interest payment, which shall be the December 15 or June 15
(whether or not a Business Day (as defined on the reverse
hereof)) next preceding such Interest Payment Date. Except as
otherwise provided in the Fiscal Agency Agreement (as defined on
the reverse hereof), any such interest not so punctually paid or
duly provided for will forthwith cease to be payable to the
holder on such Record Date and may be paid at any time in any
lawful manner, all as more fully provided in the Fiscal Agency
Agreement. Payment of interest on this Security shall be made by
United States dollar check drawn on a bank in the City of New
York and mailed to the person entitled thereto at his address as
it shall appear in the Security Register, or (if arrangements
satisfactory to the Company and the Fiscal Agent are made) by
wire transfer to a United States dollar account maintained by the
payee with a bank in the City of New York; provided, however,
that if such mailing is not possible and no such application
shall have been made, payment of interest shall be made at the
principal corporate trust office of the Fiscal Agent, or such
other office or agency of the Company as may be designated for
such purpose in the City of New York, in United States currency.
Reference is hereby made to the further provisions of
this Security set forth under Terms and Conditions of the
Securities on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this
place.
PAGE
<PAGE>
This Security shall not become valid or enforceable for
any purpose unless and until the certificate of authentication
hereon shall have been manually signed by a duly authorized
signatory of the Fiscal Agent.
IN WITNESS WHEREOF, the Company has caused this
Security to be duly executed in its corporate name by the manual
or facsimile signature of a duly authorized officer and coupons
bearing the facsimile signature of a duly authorized signatory to
be annexed hereto.
Dated:
THERMO ELECTRON CORPORATION
By: ____________________________
Name:
Title:
Attest:
_______________________________
CERTIFICATE OF AUTHENTICATION
This is one of the Securities described in the
within-mentioned Fiscal Agency Agreement.
CHEMICAL BANK,
as Fiscal Agent
By__________________________
Authorized Signatory
PAGE
<PAGE>
(FORM OF FACE OF BEARER SECURITY)
THIS SECURITY HAS NOT BEEN AND WILL NOT BE REGISTERED UNDER THE
UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES
ACT"), AND MAY NOT BE OFFERED OR SOLD WITHIN THE UNITED STATES OR
TO U.S. PERSONS EXCEPT TO QUALIFIED INSTITUTIONAL BUYERS (AS
DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN ACCORDANCE WITH
RULE 144A (IF AVAILABLE) OR OTHERWISE PURSUANT TO AN EXEMPTION
FROM, OR IN A TRANSACTION NOT SUBJECT TO, THE REGISTRATION
REQUIREMENTS OF THE SECURITIES ACT.
ANY UNITED STATES PERSON WHO HOLDS THIS OBLIGATION WILL BE
SUBJECT TO LIMITATIONS UNDER THE UNITED STATES INCOME TAX LAWS,
INCLUDING THE LIMITATIONS PROVIDED IN SECTIONS 165(j) AND 1287(a)
OF THE UNITED STATES INTERNAL REVENUE CODE.
THERMO ELECTRON CORPORATION
(Incorporated in the State of Delaware)
4 1/4% CONVERTIBLE SUBORDINATED DEBENTURE DUE 2003
No. B-______________ U.S.$______
Thermo Electron Corporation, a corporation duly
incorporated and existing under the laws of the State of Delaware
(the "Company"), for value received, hereby promises to pay to
bearer upon presentation and surrender of this Security the
principal sum of __________United States Dollars on January 1,
2003, and to pay interest thereon from January 3, 1996,
semiannually in arrears on January 1 and July 1 in each year
(each an "Interest Payment Date"), commencing July 1, 1996, at
the rate of 4q% per annum, until the principal hereof is paid or
made available for payment. Interest hereon shall be calculated
on the basis of a 360-day year comprised of twelve 30-day months.
Such payments (including premium, if any) shall be made in such
coin or currency of the United States of America as at the time
of payment shall be legal tender for the payment of public and
private debts, subject to any laws or regulations applicable
thereto and to the right of the Company (limited as provided in
the Fiscal Agency Agreement (as defined on the reverse hereof))
to terminate the appointment of any paying agency, at the London
office of Chemical Bank located at Chemical Bank House, 125
London Wall, London EC2Y 5A4J, England, or, if the Securities are
listed on the Luxembourg Stock Exchange and so long as listed
thereon, Banque Internationale a Luxembourg S.A., 69, Route
d'Esch, L-1470 Luxembourg or at such other offices or agencies
outside the United States of America, its territories or its
possessions as the Company may designate, by United States dollar
check drawn on a bank in the City of New York, or (if
arrangements satisfactory to the Company and the Fiscal Agent (as
defined on the reverse hereof) are made) by wire transfer to a
United States dollar account maintained by the holder at a bank
outside the United States, its territories and its possessions.
Interest on this Security shall be paid only at an office or
PAGE
<PAGE>
agency located outside the United States, its territories or its
possessions and, in the case of interest due on or before
maturity, only upon presentation and surrender at such an office
or agency of the interest coupons hereto attached as they
severally mature. No payment on this Security or any coupon will
be made at the corporate trust office of the Fiscal Agent or any
other paying agency maintained by the Company in the United
States its territories and possessions, nor will any payment be
made by transfer to an account in, or by mail to an address in,
the United States, its territories or possessions, except as may
be permitted by United States tax laws and regulations in effect
at the time of such payment without detriment to the Company.
Notwithstanding the foregoing, payment of this Security and
coupons may be made at the office of the Fiscal Agent in the City
of New York if full payment at all paying agencies outside the
United States is illegal or effectively precluded by exchange
controls or other similar restrictions.
References is hereby made to the further provisions of
this Security set forth under Terms and Conditions of the
Securities on the reverse hereof, which further provisions shall
for all purposes have the same effect as if set forth at this
place.
Neither this Security nor any of the coupons attached
hereto shall become valid or enforceable for any purpose unless
and until the certificate of authentication hereon shall have
been manually signed by a duly authorized signatory of the Fiscal
Agent.
IN WITNESS WHEREOF, the Company has caused this
Security to be duly executed in its corporate name by the manual
or facsimile signature of a duly authorized signatory.
Dated: THERMO ELECTRON CORPORATION
By: ____________________________
Name:
Title:
Attest:
_______________________________
CERTIFICATE OF AUTHENTICATION
This is one of the Securities described in the
within-mentioned Fiscal Agency Agreement.
CHEMICAL BANK,
as Fiscal Agent
By: ____________________________
Authorized Signatory
PAGE
<PAGE>
(FORM OF FACE OF COUPON ON BEARER SECURITIES)
ANY UNITED STATES PERSON WHO HOLDS THIS OBLIGATION WILL BE
SUBJECT TO LIMITATIONS UNDER THE UNITED STATES INCOME TAX LAWS,
INCLUDING THE LIMITATIONS PROVIDED IN SECTIONS 165(j) AND 1287(a)
OF THE UNITED STATES INTERNAL REVENUE CODE.
THERMO ELECTRON CORPORATION
(Incorporated in the State of Delaware)
4 1/4% CONVERTIBLE SUBORDINATED DEBENTURE. DUE 2003
No: _____________
U.S.$____________
Due:
Unless the Security to which this coupon appertains
shall have been called for redemption prior to the due date
hereof and payment thereof duly provided for or shall have been
converted, THERMO ELECTRON CORPORATION (herein called the
"Company") shall, subject to and in accordance with the terms and
conditions of the Bearer Security and the Fiscal Agency Agreement
dated as of January 3, 1996 between the Company and Chemical
Bank, as Fiscal Agent, pay to the bearer, on the date set forth
herein upon surrender hereof, the amount shown hereon (together
with any Additional Amount in respect thereof which the Company
may be required to pay according to the terms of said Bearer
Security) at the paying agencies set out on the reverse hereof or
at such other places outside the United States of America, its
territories and its possessions as the Company may determine from
time to time, by United States dollar check drawn on a bank in
the City of New York, or (if arrangements satisfactory to the
Company and the Fiscal Agent are made) wire transfer to a United
States dollar account maintained by the bearer at a bank outside
the United States of America, its territories and its
possessions, being one-half year's interest then payable on said
Security.
THERMO ELECTRON CORPORATION
By: ____________________________
Name:
Title:
Attest:
--------------------------
PAGE
<PAGE>
[Reverse of Coupon]
Chemical Bank Banque Internatioanle a Luxembourg S.A.
Chemical Bank House 69, Route d'Esch
125 London Wall L-1470 Luxembourg
London EC2 Y54J
England
PAGE
<PAGE>
(FORM OF REVERSE OF REGISTERED AND BEARER SECURITIES)
Terms and Conditions of the Securities
1. General.
(a) This Security is one of a duly authorized issue of
Securities of the Company designated as its 4q% Convertible
Subordinated Debentures Due 2003 (herein called the
"Securities"). The Company, for the benefit of the holders from
time to time of the Securities, has entered into a Fiscal Agency
Agreement dated as of January 3, 1996 (the "Fiscal Agency
Agreement") between the Company and Chemical Bank, as Fiscal
Agent, Paying Agent, Security Registrar and Conversion Agent (the
"Fiscal Agent"), to which Fiscal Agency Agreement reference is
hereby made for a statement of the respective rights, limitations
of rights, duties and immunities thereunder of the Company, the
Fiscal Agent, and the holders of Securities and any coupons
appertaining thereto and of the terms upon which the Securities
are, and are to be, authenticated and delivered. The holders of
the Securities will be entitled to the benefits of, be bound by,
and be deemed to have notice of, all of the provisions of the
Fiscal Agency Agreement. A copy of the Fiscal Agency Agreement
is on file and may be inspected at the office of paying agencies
appointed by the Company.
(b) The Securities are issuable as bearer securities (the
"Bearer Securities"), with interest coupons attached, in the
denominations of U.S. $1,000 and U.S. $10,000, and as registered
securities (the "Registered Securities"), without coupons, in
denominations of U.S. $1,000 and integral multiples thereof. The
Registered Securities, and transfers thereof, shall be registered
as provided in Section 8 hereof and in the Fiscal Agency
Agreement. The holder of any Bearer Security or any coupon and
the registered holder of a Registered Security shall (to the
fullest extent permitted by applicable law) be treated at all
times, by all persons and for all purposes as the absolute owner
of such Security or coupon, as the case may be, regardless of any
notice of ownership, theft or loss or of any writing thereon.
(c) The Securities are direct and unsecured obligations of
the Company, subordinated as set forth in Section 7 hereof.
There are no restrictions herein on other indebtedness or
securities which may be incurred or issued by the Company.
2. Additional Amounts. The Company will pay to the holder
of this Security or of any coupon appertaining hereto who is a
United States Alien (as defined below) such additional amounts
(_Additional Amounts") as may be necessary in order that every
net payment of the principal of, premium, if any, and interest on
this Security, after withholding for or on account of any
present or future tax, assessment or governmental charge imposed
upon or as a result of such payment by the United States or any
PAGE
<PAGE>
political subdivision or taxing authority thereof or therein,
will not be less than the amount provided herein or in any coupon
appertaining hereto to be then due and payable; provided,
however, that the foregoing obligation to pay Additional Amounts
shall not apply to any one or more of the following:
(a) any tax, assessment or other governmental charge
which would not have been so imposed but for (i) the existence of
any present or former connection between such holder (or between
a fiduciary, settlor, beneficiary, member or stockholder of, or a
person holding a power over, such holder, if such holder is an
estate, trust, partnership or corporation) and the United States,
including, without limitation, such holder (or such fiduciary,
settlor, beneficiary, member, stockholder or person holding a
power) being or having been a citizen or resident or treated as a
resident thereof or being or having been engaged in a trade or
business therein or being or having been present therein or
having or having had a permanent establishment therein, or (ii)
such holder's present or former status as a personal holding
company, foreign personal holding company, passive foreign
investment company, foreign private foundation or other foreign
tax-exempt entity or controlled foreign corporation for United
States tax purposes or a corporation which accumulates earnings
to avoid United States Federal income tax, or (iii) such holder's
status as a bank extending credit pursuant to a loan agreement
entered into in the ordinary course of business;
(b) any tax, assessment or other governmental charge
which would not have been so imposed but for the presentation by
the holder of this Security or any coupon appertaining hereto for
payment on a date more than 10 days after the date on which such
payment became due and payable or on the date on which payment
thereof is duly provided, whichever occurs later;
(c) any estate, inheritance, gift, sales, transfer or
personal property tax or any similar tax, assessment or other
governmental charge;
(d) any tax, assessment or other governmental charge
which would not have been imposed but for the failure to comply
with certification, information, documentation or other reporting
requirements concerning the nationality, residence, identity or
present or former connection with the United States of the holder
or beneficial owner of such Security or any related coupon if
such compliance is required by statute, regulation or ruling of
the United States or any political subdivision or taxing
authority thereof as a precondition to relief or exemption from
such tax, assessment or other governmental charge;
(e) any tax, assessment or other governmental charge
which is payable otherwise than by deduction or withholding from
payments of principal of and premium, if any, or interest on this
Security;
PAGE
<PAGE>
(f) any tax, assessment or other governmental charge
imposed on interest received by a person holding, actually or
constructively, 10% or more of the total combined voting power of
all classes of stock of the Company entitled to vote; or
(g) any tax, assessment or other governmental charge
required to be withheld by any paying agent from any payment of
principal, or premium, if any, or interest on any Security or
interest on any coupon appertaining thereto if such payment can
be made without such withholding by any other paying agent; nor
will Additional Amounts be paid with respect to any payment of
the principal of, premium, if any, or interest on this Security
(or cash in lieu of issuance of shares of Common Stock upon
conversion) to a person other than the sole beneficial owner of
such payment, or that is a partnership or fiduciary to the extent
such beneficial owner, member of such partnership or beneficiary
or settlor with respect to such fiduciary would not have been
entitled to the payment of Additional Amounts had such beneficial
owner, member, beneficiary or settlor been the holder of this
Security or any coupon appertaining hereto.
The term "United States Alien" means any person who,
for United States Federal income tax purposes, is a foreign
corporation, a non-resident alien individual, a foreign
partnership, or an estate or trust subject to United States
Federal income tax on net income basis, and the term "United
States" means the United States of America (including the several
States and the District of Columbia), its territories, its
possessions and other areas subject to its jurisdiction.
Except as specifically provided herein and in the
Fiscal Agency Agreement, the Company shall not be required to
make any payment with respect to any tax, assessment or other
governmental charge imposed by any government or any political
subdivision or taxing authority thereof or therein.
Whenever any Additional Amounts are to be paid on the
Securities, the Company will give notice to the Fiscal Agent, the
Paying Agent and any paying agency of the Company, all as
provided in the Fiscal Agency Agreement.
3. Redemption.
(a) The Company, at its option, may redeem the
Securities, in whole or in part, at any time on or after January
1, 1999, upon notice as hereinafter prescribed, at a redemption
price equal to 100% of the principal amount thereof, together
with accrued interest to the redemption date; provided, however,
that in the event that the Company shall have elected to redeem
all or any part of the Securities pursuant to this clause after
the date on which a Change in Control (as defined in Section 3(e)
hereof) shall have been determined to occur by the Continuing
Directors (as defined in Section 3(e) hereof), which Change in
Control shall not have been approved by the Continuing Directors,
PAGE
<PAGE>
the date on which such redemption may occur shall be not sooner
than the first business day immediately following the Repurchase
Date (as defined in Section 3(e) hereof). In the event of a
partial redemption, the Securities to be redeemed will be
selected by the Fiscal Agent not more than 75 days before the
date fixed for redemption by such method as the Fiscal Agent
shall deem fair and appropriate. Provisions of this Security that
apply to Securities called for redemption also apply to portions
of Securities called for redemption. The Fiscal Agent shall
notify the Company promptly of the Securities or portions of
Securities to be called for redemption.
(b) If, at any time, the Company shall determine that
as a result of any change in or amendment to the laws or any
regulations or rulings of the United States or any political
subdivision or taxing authority thereof or therein affecting
taxation, or any amendment to, or change in, an official
application or interpretation of such laws, regulations or
rulings, which amendment or change is announced or becomes
effective on or after November 28, 1995, the Company has or will
become obligated to pay to the holder of any Security (other than
the Restricted Securities) or coupon Additional Amounts and such
obligation cannot be avoided by the Company taking reasonable
measures available to it, then the Company may, at its election
exercised at any time when such conditions continue to exist,
redeem such Securities as a whole but not in part, upon notice as
hereinafter prescribed, at a redemption price equal to 100% of
the principal amount, together with accrued interest, if any, to
the date fixed for redemption; provided that no such notice of
redemption shall be given earlier than 90 days prior to the
earliest date on which the Company would be obligated to pay such
Additional Amounts were a payment in respect of such Securities
then due; and provided further that, at the time such notice is
given, such obligations to pay such Additional Amounts remains in
effect.
Prior to any redemption of the Securities pursuant to
the preceding paragraph, the Company shall provide the Fiscal
Agent with one or more certificates (signed by the President or
any Vice President and the Treasurer or the Secretary) of the
Company on which the Fiscal Agent may conclusively rely to the
effect that the Company is entitled to redeem such Securities
pursuant to such paragraph and that the conditions precedent to
the right of the Company to redeem such Securities pursuant to
such paragraph have occurred and a written opinion of counsel
(who may be an employee of the Company) stating that all legal
conditions precedent to the right of the Company to redeem such
Securities pursuant to such paragraph have occurred.
(c) Except as set forth in the next succeeding
paragraph, the Company shall redeem the Bearer Securities as a
whole but not in part, upon notice as hereinafter prescribed, at
100% of their principal amount, together with interest accrued to
the date fixed for redemption, less applicable withholding taxes,
PAGE
<PAGE>
if any, plus any applicable Additional Amounts payable, in the
event that the Company determines that payment of principal of,
premium, if any, or interest on a Bearer Security or a coupon
appertaining thereto made outside the United States by the
Company or a paying agent, based on a written opinion of counsel,
would under any present or future laws or regulations of the
United States be subject to any certification, identification or
information reporting requirement with regard to the nationality,
residence or identity of a beneficial owner of a Bearer Security
or a coupon appertaining thereto who is a United States Alien
(other than a requirement (a) that would not be applicable to a
payment made by the Company or any one of its paying agents (i)
directly to the beneficial owner or (ii) to a custodian, nominee
or other agent of the beneficial owner, or (b) that can be
satisfied by the custodian, nominee or other agent certifying
that the beneficial owner is a United States Alien, provided,
however, in each case referred to in clauses (a)(ii) and (b),
payment by such custodian, nominee or other agent of the
beneficial owner is not otherwise subject to any such
requirement). The Company shall make such determination on the
basis of a written opinion of counsel and will notify the Fiscal
Agent thereof in writing as soon as practicable, stating in the
notice the effective date of such certification, identification,
or information reporting requirement and the dates within which
the redemption shall occur, and the Fiscal Agent shall give
prompt notice thereof to the holders of the Securities in
accordance with the Fiscal Agency Agreement. The Company shall
determine the redemption date by notice to the Fiscal Agent at
least 75 days before the redemption date, unless shorter notice
is acceptable to the Fiscal Agent. Such redemption of the Bearer
Securities must take place on such date, not later than one year
after the publication of the initial notice of the Company's
determination of the existence of such certification,
identification or information reporting requirement. The Company
shall not so redeem the Bearer Securities, however, if the
Company, based on a written opinion of counsel, determines not
less than 30 days prior to the date fixed for redemption, that no
such payment would be subject to any requirement described above,
in which case the Company shall notify the Fiscal Agent, which
shall give prompt notice of that determination in accordance with
the Fiscal Agency Agreement and any earlier redemption notice
shall thereupon be revoked and of no further effect.
Notwithstanding the next preceding paragraph, if and so
long as the certification, identification or information
reporting requirement referred to in the next preceding paragraph
would be fully satisfied by payment of United States withholding,
backup withholding or similar taxes, the Company may elect, prior
to publication of the notice of redemption and in lieu of
redemption of the Bearer Securities, to have the provisions of
this paragraph apply in lieu of the provisions of the next
preceding paragraph. In that event, the Company will pay such
Additional Amounts (without regard to Section 2 hereof) as are
necessary in order that, following the effective date of such
PAGE
<PAGE>
requirements, every net payment made outside the United States by
the Company or a paying agent of the principal of, premium, if
any, and interest on a Bearer Security or a coupon appertaining
thereto to a holder who is a United States Alien (without regard
to a certification, identification or information reporting
requirement as to the nationality, residence or identity of such
holder), after deduction for United States withholding, backup
withholding or similar taxes (other than a tax (i) that would not
be applicable in the circumstances referred to in the
parenthetical clause of the first sentence of the next preceding
paragraph or (ii) are imposed as a result of presentation of such
Bearer Security or coupon for payment more than 10 days after the
date on which such payment becomes due and payable or on which
payment thereof is duly provided for, whichever occurs later),
will not be less than the amount provided in the Bearer Security
or the related coupon to be then due and payable. If the Company
elects to pay such Additional Amounts and as long as it is
obligated to pay such Additional Amounts, the Company may
subsequently redeem the Bearer Securities, at any time, in whole
but not in part, upon not more than 60 days nor less than 30 days
notice, given as hereinafter prescribed, at 100% of their
principal amount, plus accrued interest to date fixed for
redemption and Additional Amounts, if any.
(d) Each Security is subject to redemption in whole or
in part (which shall be in a principal amount hereof which is
U.S. $1,000 or an integral multiple thereof) at the option of the
holder thereof on any Holder Redemption Date (as defined below)
at a redemption price equal to 100% of the principal amount
thereof, together with accrued interest, if a Redemption Event
shall occur or have occurred. For purposes hereof a "Redemption
Event" shall have occurred if the Company's Common Stock (or
other equity securities into which the Securities are then
convertible) is neither listed for trading on a United States
national securities exchange nor approved for trading on an
established automated over-the-counter trading market in the
United States. The "Holder Redemption Date" with respect to any
Redemption Event shall be the ninetieth day after the later of
the Exchange Date or the date a Redemption Event has occurred.
Notwithstanding the fact that a Security or a portion
thereof is called for redemption by the Company, each holder of a
Security desiring to exercise the option for redemption set forth
in this Section 3(d) shall, as a condition to such redemption, on
or before the close of business on the fifth day prior to the
Holder Redemption Date, surrender the Security to be redeemed in
whole or in part together with the redemption notice hereon duly
executed at the place or places specified in the notice required
by Section 3(f) and otherwise comply with the provisions of
Section 3(g). A holder of a Security who has tendered a
redemption notice (i) will be entitled to revoke its election by
delivering a written notice of such revocation together with the
holder's non-transferable receipt for such Security to the office
or agency of the Company designated as the place for the payment
PAGE
<PAGE>
of the Securities to be so redeemed on or before the Holder
Redemption Date and (ii) will retain the right to convert its
Securities into shares of Common Stock of the Company to the
extent set forth in Section 4.
(e) Each Security is subject to redemption in whole or
in part (which shall be in a principal amount hereof which is
U.S. $1,000 or an integral multiple thereof) at the option of the
holder thereof on the Repurchase Date (as defined below) at a
redemption price equal to 100% of the principal amount thereof,
together with accrued interest to the Repurchase Date, if a
Change in Control (as defined below) shall have been determined
to occur by the Continuing Directors (as defined below), which
Change in Control shall not have been approved by a majority of
the Continuing Directors prior to the expiration of the Approval
Period (as defined below).
A Change in Control shall be deemed to have occurred at
such time or times when (1) any person that acquired any Common
Stock pursuant to a tender offer becomes the beneficial owner,
directly or indirectly, of more than 50% of the outstanding
Common Stock, (2) any person that is the beneficial owner,
directly or indirectly, of more than 50% of the outstanding
Common Stock becomes the beneficial owner, directly or
indirectly, of any additional shares of Common Stock pursuant to
a tender offer, (3) individuals who constitute the Continuing
Directors cease for any reason to constitute at least a majority
of the Board of Directors of the Company, or (4) the Continuing
Directors shall determine that any other event constitutes an
effective change in control of the Company. The Continuing
Directors shall mean any member of the Board of Directors of the
Company who was a member of the Board of Directors of the Company
on January 3, 1996 and any future director of the Company who has
been nominated or elected by a majority of Continuing Directors
who are then members of the Board of Directors of the Company.
The Approval Period shall mean an initial period of 60 days after
the date on which a Change of Control shall have occurred, plus
one or more 60 day extensions of such initial or successive
period which extension shall take effect by vote of a majority of
the Continuing Directors taken prior to the expiration of the
applicable 60 day initial or successive period. The Repurchase
Date shall be the date that is 50 days after the expiration of
the Approval Period.
The Company will make the determination whether or not
a Change in Control has occurred, and if one has occurred and it
shall not have been approved by a majority of the Continuing
Directors prior to the expiration of the Approval Period, the
Company shall immediately upon expiration of the Approval Period
give notice to the Fiscal Agent, stating in the notice the nature
of the Change in Control, the Repurchase Date and the redemption
price.
PAGE
<PAGE>
Notwithstanding the fact that a Security or a portion
thereof is called for redemption by the Company, each holder of a
Security desiring to exercise the option for redemption set forth
in this Section 3(e) shall, as a condition to such redemption, on
or before the close of business on the fifth day prior to the
Repurchase Date, surrender the Security to be redeemed in whole
or in part together with the redemption notice thereon duly
executed at the place or places specified in the notice required
by Section 3(f) and otherwise comply with the provisions of
Section 3(g). A holder of a Security who has tendered a
redemption notice will not be entitled to revoke its election and
will lose the right to convert its Securities into shares of
Common Stock of the Company on or before the Repurchase Date.
(f) Notice of redemption will be given by publication
in Authorized Newspapers (as defined in the Fiscal Agency
Agreement) on a Business Day (as defined in the Fiscal Agency
Agreement) in New York City and in London and, if the Securities
are listed on the Luxembourg Stock Exchange and so long as listed
thereon, in an Authorized Newspaper in Luxembourg, or, if either
publication in London or Luxembourg is not practical, in an
Authorized Newspaper in any country in Western Europe, and by
mail to holders of Registered Securities, all as provided in the
Fiscal Agency Agreement. In the case of a redemption in whole at
the option of the Company, notice will be given once not more
than 60 nor less than 30 days prior to the date fixed for
redemption. In the case of a partial redemption at the option of
the Company, notice will be given twice, the first such notice to
be given not more than 75 nor less than 60 days prior to the date
fixed for redemption and the second such notice to be given not
more than 60 nor less than 30 days prior to the date fixed for
redemption. In the case of a redemption by the Company at the
option of a holder of a Security pursuant to Section 3(d) hereof,
notice will be given by the Fiscal Agent setting forth the
information described below not later than 10 days after the
later of the Exchange Date or the occurrence of a Redemption
Event. In the case of a redemption by the Company at the option
of a holder of a Security pursuant to Section 3(e) resulting from
a Change in Control that shall not have been approved by a
majority of the Continuing Directors prior to the expiration of
the Approval Period, notice will be given by the Fiscal Agent
setting forth the information described below not later than 10
days after the later of the Exchange Date or the expiration of
the Approval Period. Neither the failure to give notice nor any
defect in any notice given to any particular holder of a Security
shall affect the sufficiency of any notice with respect to other
Securities.
Notices relating to the redemption of Securities
whether at the option of the Company or the holder hereof shall
specify: the date fixed for redemption or the Holder Redemption
Date or the Repurchase Date, as the case may be; the redemption
price; the date the conversion privilege expires; the place or
places of payment; and that payment will be made upon
PAGE
<PAGE>
presentation and surrender of the Securities to be redeemed,
together, in the case of a Bearer Security, with all appurtenant
coupons, if any, maturing subsequent to the date fixed for
redemption; and that interest accrued to the date fixed for
redemption (unless the redemption date is an interest payment
date) will be paid as specified in such notice; and that, on and
after said date, interest thereon will cease to accrue. In the
case of a redemption by the Company at the option of the holder
of a Security pursuant to Section 3(d), the notices given by the
Fiscal Agent informing a holder of such holder's entitlement to
redeem shall also specify that a holder electing redemption will
be entitled to revoke its election by delivering a written notice
of such revocation, together with the holder's non-transferable
receipt for such Security, to the agency designated by the
Company as the place for the payment of the Securities to be so
redeemed not later than the fifth day prior to the Holder
Redemption Date. In the case of a redemption in part at the
option of the Company, notices shall specify the aggregate
principal amount of Securities to be redeemed and the aggregate
principal amount of Securities outstanding after such partial
redemption. The first notice shall specify the last date on
which exchanges or transfers of Securities may be made, and the
second notice shall specify the serial numbers of the Securities
and the portions thereof called for redemption. In the case of a
redemption in whole or in part by the Company, notices shall
specify the date the conversion privilege expires in accordance
with Section 4(a) hereof. Such notices shall also state that the
conditions precedent, if any, to such redemption have occurred.
(g) If (i) notice of redemption has been given in the
manner set forth in Section 3(f) hereof with respect to
Securities to be redeemed at the option of the Company, or (ii)
notice of redemption has been given by the holder of a Security
to be redeemed pursuant to Section 3(d) or Section 3(e) hereof,
the Securities so to be redeemed shall become due and payable on
the applicable redemption date specified in such notice and upon
presentation and surrender of the Securities at the place or
places specified in the notices given by the Company with respect
to such redemption, together in the case of Bearer Securities
with all appurtenant coupons, if any, maturing subsequent to the
redemption date and any related mature defaulted coupons, the
Securities shall be paid and redeemed by the Company, at the
places and in the manner and currency herein specified and at the
redemption price together with accrued interest, if any, to the
redemption date; provided, however, that interest due in respect
of coupons maturing on or prior to the redemption date shall be
payable only upon the presentation and surrender of such coupons
(at an office or agency located outside of the United States of
America). If any Bearer Security surrendered for redemption
shall not be accompanied by all appurtenant coupons maturing
after the redemption date and any related mature defaulted
coupons, such Security may be paid after deducting from the
amount otherwise payable an amount equal to the face amount of
all such missing coupons, or the surrender of such missing coupon
PAGE
<PAGE>
or coupons may be waived by the Company and the Fiscal Agent if
they are furnished with such security or indemnity as they may
require to save each of them and each other paying agency of the
Company harmless. From and after the redemption date, if monies
for the redemption of Securities shall have been available at the
principal corporate trust office of the Fiscal Agent for
redemption on the redemption date, the Securities shall cease to
bear interest, the coupons for interest appertaining to Bearer
Securities maturing subsequent to the redemption date shall be
void, the only right of the holders of such Securities shall be
to receive payment of the redemption price together with accrued
interest to the redemption date. If monies for the redemption of
the Securities are not made available by the Company for payment
until after the redemption date, the Securities shall not cease
to bear interest until such monies have been so made available.
(h) Accrued interest payable on any Registered
Security that is redeemed will be payable against surrender of
such Registered Security in the manner described in this Section
with respect to payments of principal on Registered Securities,
except that interest on any Registered Security that is redeemed
on a date after the close of business on any interest Record Date
and on or before the next succeeding Interest Payment Date, shall
be paid to the holder of record of such Registered Security on
the interest Record Date.
4. Conversion.
(a) Subject to and upon compliance with the provisions
of the Fiscal Agency Agreement, a holder of Securities is
entitled, at its option, at any time on or after the date that is
the latest of (i) the Exchange Date, (ii) March 15, 1996 and
(iii) the date of the effectiveness of the Registration Statement
to be filed by the Company under the Securities Act relating to
the Common Stock issuable upon conversion of the Restricted
Securities (the _Registration Date_) and on or before the close
of business on January 1, 2003, or in the case of a Security or
portion thereof that is called for redemption by the Company, or
the holder thereof elects to have such Security or portion
thereof redeemed by the Company pursuant to Section 3(d) hereof,
then in respect of such Security or such portion thereof until
and including, but (unless the Company defaults in making the
payment due upon redemption) not after, the close of business on
the 15th day next preceding the date fixed for redemption (or if
such date is not a business day, as described in Section 11
hereof in New York City, then the next succeeding business day),
or in the case of a Security or portion thereof that the holder
elects to have redeemed by the Company pursuant to Section 3(e)
hereof, then in respect of such Security or portion thereof until
and including, but (unless the Company defaults in making the
payment due upon redemption) not after, the close of business on
the date the holder makes such election, to convert such
Security (or any portion of the principal amount thereof which is
U.S. $1,000 or an integral multiple thereof), at the principal
PAGE
<PAGE>
amount thereof, or of such portion, into fully paid and
nonassessable shares ("Conversion Shares") (calculated as to
each conversion to the nearest 1/1000 of a share) of common
stock, par value $1.00 per share of the Company ("Common Stock_),
at a Conversion Price equal to U.S. $56.70 aggregate principal
amount of Securities for each Conversion Share (the "Conversion
Price") (or at the current adjusted Conversion Price if an
adjustment has been made as provided herein) by surrender of the
Security, or in the case of a Security submitted for redemption
pursuant to Section 3(d) or Section 3(e) hereof, satisfactory
evidence of such submission, together with (i) if a Bearer
Security, all unmatured coupons and any matured coupons in
default appertaining thereto, and if a Registered Security (if so
required by the Company or the Fiscal Agent), instruments of
transfer in form satisfactory to the Company and the Fiscal
Agent, duly executed by the registered holder or by his duly
authorized attorney, and (ii) the conversion notice hereon duly
executed (x) at the principal corporate trust office of the
Fiscal Agent, or at such other office or agency of the Company as
may be designated by it for such purpose in New York City, or (y)
subject to any laws or regulations applicable thereto and subject
to the right of the Company to terminate the appointment of any
such conversion agency, at Chemical Bank, Chemical Bank House,
125 London Wall, London EC2Y 5AJ, England, and if the Securities
are listed on the Luxembourg Stock Exchange and so long as listed
thereon, Banque Internationale a Luxembourg, S.A., 69, Route
d'Esch, L-1470 Luxembourg, or at such other offices or agencies
as the Company may designate.
(b) In the case of a conversion after the close of
business on a Record Date next preceding any interest payment
date and before the opening of business on such interest payment
date, the holder of record of a Registered Security at such
Record Date is to receive an installment of interest on the
interest payment date. No payment or adjustment shall be made
upon any conversion for dividends on the Common Stock delivered
on conversion. Except as set forth in the first sentence of this
subsection (b), accrued interest from the immediately preceding
interest payment date until the date of conversion (together with
any Additional Amounts, if any, thereon) will be paid to the
holder within five business days after presentment for conversion
on account of any interest accrued on the Securities surrendered
for conversion, except that interest on Registered Securities
surrendered for conversion after the close of business on a
Record Date and before the opening of business on the next
succeeding interest payment date shall be paid in an amount equal
to the interest payable on such interest payment date on the
principal amount being surrendered for conversion. No fractions
of shares or scrip representing fractions of shares will be
issued or delivered on conversion, but instead of any fractional
interest the Company shall pay a cash adjustment as provided in
the Fiscal Agency Agreement. Such conversion shall be so
affected by the Company, except payment of accrued interest
PAGE
<PAGE>
(together with Additional Amounts, if any, thereon) which will be
paid by the Paying Agent.
(c) (i) In case at any time the Company shall pay or make a
dividend or other distribution on any class of capital stock of
the Company in shares of Common Stock, the Conversion Price in
effect at the opening of business on the day following the date
fixed for the determination of stockholders entitled to receive
such dividend or other distribution shall be reduced so that the
same shall equal the price determined by multiplying such
Conversion Price by a fraction of which the numerator shall be
the number of shares of Common Stock outstanding at the close of
business on the date fixed for such determination and the
denominator shall be the sum of such number of shares and the
total number of shares of Common Stock constituting such dividend
or other distribution, such adjustment to become effective
immediately after the opening of business on the day following
the date fixed for such determination.
(ii) In the case at any time the Company shall (A) subdivide
its outstanding shares of Common Stock, (B) combine its
outstanding shares of Common Stock into a smaller number of
shares, or (C) issue by reclassification of its shares of Common
Stock (including any such reclassification in connection with a
consolidation or merger in which the Company is the continuing
corporation) any shares of capital stock, the Conversion Price in
effect at the effective date of such subdivision, combination or
reclassification shall be proportionately adjusted so that the
holder of any Security surrendered for conversion after such time
shall be entitled to receive the aggregate number and kind of
shares which, if such Security had been converted immediately
prior to such time, the holder would have owned upon such
conversion and been entitled to receive upon such subdivision,
combination or reclassification. Such adjustment shall become
effective immediately after the effectiveness of such
subdivision, combination or reclassification. Such adjustment
shall be made successively whenever any event listed above shall
occur.
(iii) In case at any time the Company shall fix a record
date for the issuance of rights or warrants to all holders of its
Common Stock entitling them to subscribe for or purchase Common
Stock at a price per share less than the current market price per
share of Common Stock (determined as provided in paragraph (v) of
this subsection (c)) on such record date, the Conversion Price in
effect at the opening of business on the day following such
record date shall be reduced so that the same shall equal the
price determined by multiplying such Conversion Price by a
fraction of which the numerator shall be the number of shares of
Common Stock outstanding at the close of business on such record
date plus the number of shares of Common Stock which the
aggregate of the offering price of the total number of shares so
offered for subscription or purchase would purchase at such
current market price per share of Common Stock and the
PAGE
<PAGE>
denominator shall be the number of shares of Common Stock
outstanding at the close of business on such record date plus the
number of shares so offered for subscription or purchase, such
reduction to become effective immediately after the opening of
business on the day following such record date. Such reduction
shall be made successively whenever such a record date is fixed;
and in the event that such rights or warrants are not so issued,
the Conversion Price shall again be adjusted to be the Conversion
Price which would then be in effect if such record date had not
been fixed.
(iv) In case at any time the Company shall fix a record
date for the making of a distribution, by dividend or otherwise,
to all holders of its shares if Common Stock, of evidences of its
indebtedness or assets (including securities, but excluding any
dividend or distribution referred to in paragraph (i) of this
subsection (c), any rights or warrants referred to in paragraph
(iii) of this subsection (c), and any dividend or distribution
paid in cash out of the retained earnings of the Company), then
in each such case the Conversion Price in effect after such
record date shall be determined by multiplying the Conversion
Price in effect immediately prior to such record date by a
fraction, of which numerator shall be the total number of
outstanding shares of Common Stock multiplied by the current
market price per share of Common Stock (determined as provided in
paragraph (v) of this subsection (c)) on such record date, less
the fair market value (as determined by the Board of Directors of
the Company, whose determination shall be conclusive and
described in a statement filed with the Fiscal Agent) of the
portion of the assets or evidences of indebtedness so to be
distributed, and of which denominator shall be the total number
of outstanding shares of Common Stock multiplied by such current
market price per share of Common Stock. Such adjustment shall be
made successively whenever such a record date is fixed; and in
the event that such distribution is not so made, the Conversion
Price shall again be adjusted to be the Conversion Price which
would then be in effect if such record date has not been fixed.
(v) For the purpose of any computation under
paragraphs (iii) and (iv) of this subsection (c), the current
market price per share of Common Stock on any date shall be
deemed to be the average of the Closing Prices (as defined below)
for the 15 consecutive trading days upon which the principal
trading market for the Common Stock is open and selected by the
Company commencing not less than 20 nor more than 30 days before
the day in question. The "Closing Price" for any day shall be
the last reported sales prices regular way or, in case no such
reported sale takes place on such day, the average of the
reported closing bid and asked prices regular way, in either case
on the New York Stock Exchange or, if the Common Stock is not or
admitted to trading on such exchange, on the principal national
securities exchange on which the Common Stock is listed or
admitted to trading or, if not listed or admitted to trading on
any national securities exchange, the closing sale price quoted
PAGE
<PAGE>
on the Nasdaq National Market, or if not so quoted, as determined
by the Company.
(vi) The Company may make such adjustments in the
Conversion Price, in addition to those required by paragraphs
(i), (ii) and, (iii) selected by the Company of this section, as
it considers to be advisable in order that any event treated for
United States Federal income tax purposes as a dividend of stock
or stock rights shall not be taxable to the recipients.
(vii) No adjustment in the Conversion Price shall
be required unless such adjustment would require an increase or
decrease of at least U.S. $.25 in such Conversion Price;
provided, however, that any adjustment which by reason of this
paragraph (vii) is not required to be made shall be carried
forward and taken into account in any subsequent adjustment. All
calculations under this subsection (c) shall be made to the
nearest cent or to the nearest 1/1000 of a share, as the case may
be.
(viii) In the event that the Company shall
distribute rights pro rata to holders of Common Stock pursuant to
the Rights Agreement, dated as of May 4, 1988, between the
Company and the First National Bank of Boston, as Rights Agent,
or any similar plan (_Rights_) the Company shall make proper
provision so that each holder of a Security who converts such
Security (or any portion thereof) after the record date for such
distribution and prior to the expiration or redemption of the
Rights shall be entitled to receive upon such conversion, in
addition to the Conversion Shares, a number of Rights to be
determined as follows: (i) if such conversion occurs on or prior
to the date for the distribution to the holders of Rights of
separate certificates evidencing such Rights (the _Distribution
Date_), the same number of Rights to which a holder of a number
of shares of Common Stock equal to the number of Conversion
Shares is entitled at the time of such conversion in accordance
with the terms and provisions of and applicable to the Rights;
and (ii) if such conversion occurs after the Distribution Date,
the same number of Rights to which a holder of the number of
shares of Common Stock into which the principal amount of the
Security so converted was convertible immediately prior to the
Distribution Date would have been entitled on the Distribution
Date in accordance with the terms and provisions of and
applicable to the Rights; provided, however, that if after the
Distribution Date with respect to such Rights converting Holders
of Securities are not entitled to receive the Rights that would
otherwise be attributable (but for the date of conversion) to
their respective Conversion Shares or such Rights are not issued
to them upon conversion for any reason, then adjustment of the
Conversion Price shall be made under paragraph (iii) and this
subsection (c), except the Distribution Date with respect to such
Rights shall be substituted as _the record date for the issuance
of rights_; provided, further, that if such an adjustment is made
and such Rights are later redeemed, invalidated or terminated,
PAGE
<PAGE>
then a corresponding reversing adjustment of the Conversion Price
shall be made to the Conversion Price, on an equitable basis, to
take account of such event.
(d) Whenever the Conversion Price is adjusted and in
the event of certain other corporate actions, as herein provided,
the Company shall give notice, all as provided in the Fiscal
Agency Agreement.
(e) The Company shall file, as soon as practicable
following the Closing Date, a shelf registration statement with
the United States Securities and Exchange Commission covering the
resale of the shares of Common Stock issuable upon conversion of
the Restricted Securities (_Registrable Securities_); provided
that any holder of any Restricted Securities or Registrable
Securities shall not sell any shares pursuant to such
registration statement unless and until it provides to the
Company such information as the Company may reasonably request
for use in connection with the identification of such holder as a
selling stockholder in such registration statement, or any
prospectus included therein, and no such sale shall be made by
such holder pursuant to such registration statement unless and
until such information is included by the Company in such
registration statement or prospectus. The Company shall in good
faith use its best efforts and at its cost to cause such
registration statement to be declared effective as promptly as
practicable thereafter and to include in such registration
statement the information provided by a holder as a selling
stockholder and shall notify the Fiscal Agent of the
effectiveness thereof and agrees to use its best efforts to (i)
cause all registrations with, and to obtain any approvals by, any
governmental authority under any Federal or state law of the
United States that may be required in connection with the
conversion of the Securities into Common Stock and the resale
thereof, (ii) maintain the effectiveness of such registrations
until the earlier of (a) three years from the date of the Fiscal
Agency Agreement, or (b) the date that Rule 144(k) under the
Securities Act is available for the resale of the shares of
Common Stock issuable upon conversion of the Restricted
Securities (or other securities issuable upon conversion of the
Securities) and (iii) to list the shares of Common Stock required
to be issued or delivered upon conversion of Securities (or other
securities issuable upon conversion of the Securities) prior to
such issue or delivery on such national securities exchange or
automated over-the-counter trading market where such Common Stock
is listed or traded at the time of such delivery. The Company
shall, without limitation as to time, indemnify and hold
harmless, to the fullest extent permitted by law, each holder of
Registrable Securities, the officers, directors and agents and
employees of each of them, each person who controls such holder
(within the meaning of Section 15 of the Securities Act or
Section 20 of the Securities Exchange Act of 1934, as amended)
and the officers, directors, agents and employees of any such
controlling person, from and against all losses, claims, damages,
PAGE
<PAGE>
liabilities, costs (including, without limitation, the costs of
preparation and attorneys' fees) and expenses (collectively,
_Losses_), as incurred, arising out of or based upon any untrue
or alleged untrue statement of a material fact contained in any
such registration statement, or related prospectus or in any
amendment or supplement thereto, or arising out of or based upon
any omission or alleged omission to state therein a material fact
required to be stated therein or necessary to make the statements
therein not misleading, except insofar as the same are based
solely upon information, if any, furnished in writing to the
Company by such holder expressly for use therein; provided, that
the Company shall not be liable to any holder of Registrable
Securities to the extent that any such Losses arise out of or are
based upon an untrue statement or alleged untrue statement or
omission or alleged omission made in any preliminary prospectus
if either (a)(i) such holder failed to send or deliver as
required a copy of the final prospectus with or prior to the
delivery of written confirmation of the sale by such holder of a
Registrable Security to the person asserting the claim from which
such Losses arise and (ii) the prospectus would have completely
corrected such untrue statement or alleged untrue statement or
such omission or alleged omission; or (b)(i) such untrue
statement or alleged untrue statement, omission or alleged
omission is completely corrected in an amendment or supplement to
the prospectus and (ii) having previously been furnished by or on
behalf of the Company with copies of the prospectus as so amended
or supplemented, such holder thereafter fails to deliver as
required such prospectus as so amended or supplemented, prior to
or concurrently with the sale of a Registrable Security to the
person asserting the claim from which such Losses arise. Promptly
after receipt by an indemnified party under this Paragraph (e) of
notice of any claim or the commencement of any action, the
indemnified party shall, if a claim in respect thereof is to be
made against the Company under this Paragraph (e) notify the
Company in writing of the claim or the commencement of that
action; provided, however, that the failure to notify the Company
shall not relieve it from any liability which it may have to an
indemnified party otherwise than under this Paragraph (e). If
any such claim or action shall be brought against an indemnified
party, and it shall notify the Company thereof, the Company shall
be entitled to participate therein and, to the extent that it
wishes, to assume the defense thereof with counsel reasonably
satisfactory to the indemnified party. After notice from the
Company to the indemnified party of its election to assume the
defense of such claim or action, the Company shall not be liable
to the indemnified party under this Paragraph (e) for any legal
or other expenses subsequently incurred by the indemnified party
in connection with the defense thereof; provided, however, if the
defendants in any such action include both an indemnified party
and the Company and the indemnified party shall have reasonably
concluded that there may be legal defenses available to it and
for other indemnified parties that are different from or
additional to those available to the Company, the indemnified
party or parties under this Paragraph (e) shall have the right to
PAGE
<PAGE>
employ not more than one counsel to represent them and, in that
event, the reasonable fees and expenses of not more than one such
separate counsel shall be paid by the Company. The Company shall
not be liable for any settlement effected without its written
consent of any claim or action.
(f) The Company shall, at all times, have reserved and
available, free from preemptive rights, out of its authorized but
unissued shares of Common Stock, for the purpose of effecting the
conversion of Securities, the full number of shares of Common
Stock then issuable upon the conversion of all Securities (based
on the aggregate principal amount of Securities outstanding).
The Company covenants that all shares of Common Stock which may
be issued or delivered upon conversion of Securities will upon
issuance be fully paid and nonassessable.
(g) Subject to the rights of the holders pursuant to
Section 3(e) hereof, in case of any consolidation with, or merger
of the Company into, any other corporation, or in case of any
merger of another corporation into the Company (other than a
merger which does not result in any reclassification, conversion,
exchange or cancellation of outstanding shares of Common Stock of
the Company), or in case of any sale or transfer of all or
substantially all of the assets of the Company (which shall not
include the sale or transfer of any portion of the assets of the
Company to any corporation which, immediately following such
transfer is at least 51% owned by the Company, provided that such
sale or transfer does not result in the reclassification,
conversion, exchange or cancellation of outstanding shares of
Common Stock of the Company), the corporation formed by such
consolidation or resulting from such merger or which acquires
such assets, as the case may be, shall execute and deliver to the
Fiscal Agent an amendment to the Fiscal Agency Agreement
providing that the holder of each Security shall have the right
during the period such Security shall be convertible as specified
in section (a) hereof to convert such Security only into the kind
and amount of securities, cash and other property receivable upon
such consolidation, merger, sale or transfer by a holder of the
number of shares of Common Stock of the Company into which such
Security might have been converted immediately prior to such
consolidation, merger, sale or transfer assuming, if such
consolidation, merger, sale or transfer is prior to the period
such Security shall be convertible as specified in subsection (a)
hereof, that the Securities were convertible at such time at the
initial Conversion Price as adjusted from November 28, 1995 to
such time pursuant to paragraphs (i), (ii), (iii), (iv) and (vi)
of subsection (c) hereof. Such amendment shall provide for
adjustments which, for events subsequent to the effective date of
such amendment, shall be as nearly equivalent as may be
practicable to the adjustments provided for herein. The above
provisions of this subsection shall similarly apply to successive
consolidations, mergers, sales or transfers.
PAGE
<PAGE>
5. Events of Default. In the event that any of the
following ("Events of Default_) shall occur and be continuing:
(a) the Company shall fail to pay when due the
principal of, or premium, if any, on any of the Securities
whether at maturity or upon redemption or otherwise; or
(b) the Company shall fail to pay any installment of
interest or any required payment of any Additional Amounts (as
described in Section 2 hereof) on any of the Securities for a
period of 10 days after the date when due; or
(c) the Company shall fail duly to perform or observe
any other term, covenant or agreement contained in any of the
Securities or in the Fiscal Agency Agreement for a period of 60
days after the date on which written notice of such failure,
requiring the Company to remedy the same, shall first have been
given to the Company and the Fiscal Agent by the holders of at
least 25% in aggregate principal amount of the Securities at the
time outstanding; provided, however, that in the event the
Company shall within the aforesaid period of 60 days commence
legal action in a court of competent jurisdiction seeking a
determination that the Company had not failed duly to perform or
observe the term or terms, covenant or covenants or agreement or
agreements specified in the aforesaid notice, such failure shall
not be an Event of Default unless the same continues for a period
of 10 days after the date of any final determination to the
effect that the Company had failed to duly perform or observe one
or more of such terms, covenants or agreements; or
(d) a court having jurisdiction in the premises shall
enter a decree or order for relief in respect of the Company in
an involuntary case or proceeding under any applicable
bankruptcy, insolvency, reorganization or other similar law now
or hereafter in effect, or appointing a receiver, liquidator,
assignee, custodian, trustee, sequestrator (or similar official)
of the Company or for any substantial part of the property of it
or ordering the winding-up or liquidation of the affairs of it
and such decree or order shall remain unstayed and in effect for
a period of 20 consecutive days; or
(e) the Company shall commence a voluntary case or
proceeding under any applicable bankruptcy, insolvency,
reorganization or other similar law now or hereafter in effect,
or shall consent to the entry of an order for relief in an
involuntary case under any such law, or shall consent to the
appointment of or taking possession by a receiver, liquidator,
assignee, trustee, custodian, sequestrator (or similar official)
of the Company or for any substantial part of its property, or
shall make any general assignment for the benefit of creditors,
or shall admit in writing its inability to pay its debts as they
become due or shall take any corporate action in furtherance of
any of the foregoing; or
PAGE
<PAGE>
(f) an event of default, as defined in any indenture
or instrument evidencing or under which the Company shall have at
least $25,000,000 outstanding (or its equivalent in another
currency), in aggregate principal amount of indebtedness for
borrowed money, shall happen and be continuing and such default
shall involve the failure to pay the principal of such
indebtedness (or any part thereof), when due and payable after
the expiration of any applicable grace period with respect
thereto, or such indebtedness shall have been accelerated so the
same shall be or become due and payable prior to the date on
which the same would otherwise have become due and payable, and
failure to pay shall not have been cured by the Company within 20
days after such failure or such acceleration shall not be
rescinded or annulled within 20 days after notice thereof shall
have first been given to the Company; provided that if such event
of default under such indenture or instrument shall be remedied
or cured by the Company or waived by the holders of such
indebtedness, then the Event of Default hereunder by reason
thereof shall be deemed likewise to have been thereupon remedied,
cured or waived without further action upon the part of any of
the holders of Securities; then the holder of this Security may,
at such holder's option, declare the principal of this Security
and the interest accrued hereon (and Additional Amounts under
Section 2 hereof, if any, thereon) to be due and payable
immediately by written notice to the Company and the Fiscal
Agent, and if any such Event of Default shall continue at the
time of receipt of such written notice, the principal of this
Security and the interest accrued hereon (and Additional Amounts,
if any, hereon) shall become immediately due and payable, subject
to the proviso of subsection (c) of this Section 5. Upon payment
of such amount of principal, premium, if any, and interest (and
Additional Amounts pursuant to Section 2 hereof, if any), all of
the Company's obligations in respect of payment of principal of,
premium, if any, and interest on (and Additional Amounts, if any,
on) this Security shall terminate. Interest on overdue
principal, premium, if any, and interest (and Additional Amounts,
if any) shall accrue from the date on which such principal,
premium, if any, and interest (and Additional Amounts, if any)
were due and payable to the date such principal, premium, if any,
and interest (and Additional Amounts, if any) are paid or duly
provided for, at the rate borne by the Securities (to the extent
payment of such interest shall be legally enforceable). Any
acceleration of this Security pursuant to this Section 5 shall
not affect the subordination provisions of Section 7 hereof.
If an Event of Default, as defined in this Section 5,
with respect to the Securities, or an event which would, with the
passing of time or the giving of notice, or both, be an Event of
Default, shall occur and be continuing, the Company shall within
five Business Days of becoming aware thereof notify the Fiscal
Agent in writing of such Event of Default, and the Fiscal Agent
shall thereupon promptly notify all of the holders of the
Securities of such Event of Default.
PAGE
<PAGE>
6. Merger, Consolidation, Sale, Conveyance or Assumption.
(a) Subject to the rights of the holder pursuant to
Section 3(e) hereof, the Company will not merge or consolidate
with, or sell or convey all or substantially all of its assets
to, any other corporation, unless (i) either (A) the Company
shall be the surviving corporation in the case of a merger, (B)
the assets sold or conveyed shall be owned by a corporation
which, immediately following such sale or conveyance, is at least
51% owned by the Company, provided that such sale or conveyance
does not result in the reclassification, conversion, exchange or
cancellation of outstanding shares of Common Stock of the
Company, or (C) (I) the surviving, resulting or transferee
corporation shall expressly assume the due and punctual payment
(including Additional Amounts pursuant to Section 2 hereof, if
any) of all the Securities, according to their tenor, and the due
and punctual performance of all of the covenants and obligations
of the Company under the Securities, the coupons and the Fiscal
Agency Agreement, by supplemental agreement reasonably
satisfactory to the Fiscal Agent and (II) the Fiscal Agent shall
have received the documentation required in the context by the
Fiscal Agency Agreement, (ii) the surviving, resulting or
transferee corporation, if not organized and validly existing
under the laws of the United States, shall expressly agree to
make payments under the Securities free of any deduction or
withholding for any and all then existing or future withholding
taxes, levies, imposts and charges whatsoever imposed by or for
the account of the jurisdiction where such successor corporation
is generally subject to taxation (or any political subdivision or
taxing authority thereof or therein) in a manner equivalent to
that set forth herein, subject to the exceptions contained in
such forms of the Securities, and (iii) the Company or such
successor corporation, as the case may be, shall not, immediately
after such merger, consolidation, sale or conveyance, be in
default in the performance of any covenants or obligations of the
Company under the Securities or the Fiscal Agency Agreement.
(b) Upon any merger, consolidation, sale, conveyance
or assumption as provided in Section 6(a), the successor or
assuming corporation shall succeed to and be substituted for, and
may exercise every right and power of and be subject to all the
obligations of, the Company under the Securities and Fiscal
Agency Agreement, with the same effect as if such successor or
assuming corporation had been named as the Company therein and
herein and the Company shall be released from its liability as
obligor under the Securities and Fiscal Agency Agreement;
provided that any successor or assuming corporation shall have
the right to redeem the Securities pursuant to Section 3(b)
hereof only as a result of circumstances which occur subsequent
to such merger, consolidation, sale, conveyance or assumption and
as a result of which the Company would have had such right if the
Company had remained the obligor on the Securities.
7. Agreement of Subordination of Securities.
PAGE
<PAGE>
(a) The Company, for itself, its successors and
assigns, covenants and agrees, and each holder of Securities and
coupons by his acceptance thereof, likewise covenants and agrees,
that the payment of the principal of, premium, if any, and
interest and Additional Amounts (pursuant to Section 2 hereof) on
each and all of the Securities and coupons is hereby expressly
subordinated, to the extent and in the manner hereinafter set
forth, in right of payment to the prior payment in full of all
Senior Indebtedness of the Company (as defined below).
"Senior Indebtedness of the Company_ or _Senior
Indebtedness_ shall mean the principal of, premium, if any, and
interest on and all other amounts due on or with respect to the
following whether outstanding at the date of execution of the
Fiscal Agency Agreement or thereafter incurred or created:
(i) indebtedness of the Company for money borrowed by
the Company (excluding the Securities, but including, without
limitation, purchase money obligations), whether or not evidenced
by debentures, bonds, notes or other corporate debt securities or
similar instruments issued by the Company (including the
Company's obligations with respect to its 5% Senior Convertible
Debentures due 2001 and its 4-5/8% Senior Convertible Debentures
due 1997); provided, however, that Senior Indebtedness shall not
include (a) the Company's 4-7/8% Convertible Subordinated
Debentures due 1997, the obligations represented by which shall
rank pari passu with the obligations represented hereby in right
of payment, (b) the Company's subordinated guarantee of the
principal, premium, if any, and interest on the 6-5/8%
Convertible Subordinated Debentures due 2001 of Thermo Instrument
Systems Inc., on the 6-1/2% Convertible Subordinated Debentures
due 1997 of Thermo Process Systems Inc., on the Non-Interest
Bearing Convertible Subordinated Debentures due 1997 and the
5-1/2% Convertible Subordinated Note due 2002 of Thermo
Cardiosystems Inc., on the 6-1/2% Convertible Subordinated
Debentures due 1998 of Thermedics Inc., on the 3-3/4% Convertible
Subordinated Debentures due 2000 of Thermo Voltek Corp., on the
4-7/8% Convertible Subordinated Debentures due 2000 of Thermo
Remediation Inc., on the 5% Convertible Subordinated Debentures
due 2000 of ThermoQuest Corporation, and on the 5% Convertible
Subordinated Debentures due 2000 of Thermo Optek Corporation, the
obligations represented by which shall rank pari passu with the
obligations represented hereby in right of payment and (c) the
Company's subordinated guarantee of the obligations to redeem the
common stock of ThermoLyte Corporation, the obligations
represented by which shall rank pari passu with the obligations
represented hereby in right of payment;
(ii) obligations to reimburse any bank or other person
in respect of amounts paid under letters of credit;
(iii) leases of real property, equipment or other
assets, which leases are capitalized in the Company's financial
PAGE
<PAGE>
statements in accordance with generally accepted accounting
principles;
(iv) commitment, standby and other fees due and payable
to financial institutions with respect to credit facilities
available to the Company;
(v) obligations of the Company under interest rate and
currency swaps, floors, caps or other similar arrangements
intended to hedge interest rates or currency exposure;
(vi) indebtedness secured by any mortgage, pledge, lien
or other encumbrance on property which is owned or held by the
Company subject to such mortgage, pledge, lien or other
encumbrance, whether or not the indebtedness secured thereby
shall have been assumed by the Company;
(vii) obligations of the Company constituting
guarantees of indebtedness of or joint obligation with another or
others which would be included in the preceding clauses (i),
(ii), (iii), (iv), (v) or (vi) (including the Company's guarantee
of the principal, premium, if any, and interest on the 3-3/4%
Senior Convertible Debentures due 2000 of Thermo Instrument
Systems Inc.); and
(viii) modifications, renewals, extensions or
refundings of any of the indebtedness, leases, fees or
obligations referred to in the preceding clauses (i), (ii),
(iii), (iv), (v), (vi) or (vii), or debentures, notes or other
evidences of indebtedness issued in exchange therefor;
provided that Senior Indebtedness shall not include any
particular indebtedness, lease, fee, obligation, modification,
renewal, extension, refunding or exchanged securities if, under
the express provisions of the instrument creating or evidencing
the same, or pursuant to which the same is outstanding, such
indebtedness, lease, fee or obligation or such renewal, extension
or refunding thereof is stated to be not superior in right to
payment to the Securities.
(b) (i) In the event of any insolvency or bankruptcy
proceedings, or any receivership, liquidation, reorganization or
other similar proceedings in connection therewith, relative to
the Company or to its creditors, in their capacity as such
creditors, or to its property, or in the event of any proceedings
for voluntary liquidation, dissolution or other winding up of the
Company, whether or not involving insolvency or bankruptcy, or in
the event of any assignment for the benefit of creditors of the
Company or any marshalling of assets of the Company, then the
holders of Senior Indebtedness of the Company shall first be
entitled to receive payment in full of the principal of (and
premium, if any, on) and interest, including interest thereon
accruing after the commencement of any such proceeding, and other
amounts due on or with respect to, all Senior Indebtedness of the
PAGE
<PAGE>
Company before the holders of any of the Securities shall be
entitled to receive any payment on account of the principal of,
premium, if any, or interest and Additional Amounts (pursuant to
Section 2 hereof) on the Securities, and to that end the holders
of Senior Indebtedness of the Company shall be entitled to
receive for application in payment thereof any payment or
distribution of any kind or character, whether in cash, property
or securities, which may be payable or deliverable in any such
proceedings in respect of the Securities, other than securities
of the Company as reorganized or readjusted or securities of the
Company or any other corporation provided for by a plan of
reorganization or readjustment, the payment of which is
subordinate, at least to the extent provided in this Section 7
with respect to the Securities, to the payment of all Senior
Indebtedness of the Company, provided that the rights of the
holders of Senior Indebtedness of the Company are not altered by
such reorganization or readjustment. For the purposes of this
Section 7, no consolidation, merger, conveyance or transfer made
pursuant to the provisions of Section 6 shall be deemed to be a
liquidation, reorganization, dissolution or other winding up of
the Company.
(ii) If under the circumstances set forth in paragraph
(i) of this subsection, and notwithstanding the provisions
thereof, any payment or distribution of assets of the Company of
any kind, whether in cash, property or securities (other than
securities of the Company as reorganized or readjusted or
securities of the Company or any other corporation provided for
by a plan of reorganization or readjustment the payment of which
is subordinated, at least to the extent provided in this Section
7 with respect to the Securities, to the payment of all Senior
Indebtedness of the Company, provided that the rights of the
holders of Senior Indebtedness of the Company are not altered by
such reorganization or readjustment), shall be received by the
holders of the Securities before all Senior Indebtedness of the
Company is paid in full, such payment or distribution shall be
paid over to the holders of Senior Indebtedness of the Company,
ratably, for application to the payment of all Senior
Indebtedness of the Company remaining unpaid until all Senior
Indebtedness of the Company shall have been paid in full, after
giving effect to any concurrent payment or distribution to the
holders of such Senior Indebtedness of the Company.
(iii) Upon any distribution of assets of the
Company referred to in this Section, the holders of Securities
shall be entitled to rely upon any final order or decree of a
court of competent jurisdiction in which such dissolution,
winding up, liquidation or reorganization proceedings are
pending, and the holders of Securities shall be entitled to rely
upon a certificate of the liquidating trustee or agent or other
person making any distribution to the holders of Securities for
the purpose of ascertaining the persons entitled to participate
in such distribution, the holders of the Senior Indebtedness of
the Company and other indebtedness of the Company, the amount
PAGE
<PAGE>
thereof or payable thereon, the amount or amounts paid or
distributed thereon and all other facts pertinent thereto or to
this Section.
(c) (i) Upon the maturity of any Senior Indebtedness
of the Company by lapse of time, acceleration or otherwise, all
principal thereof (and premium, if any) and interest due thereon,
including interest thereon accruing after the commencement of any
proceeding of the type referred to in paragraph (i) of Section
7(b) above, and all other amounts due on or with respect thereto,
shall first be paid in full, or such payment duly provided for in
cash, before any payment, directly or indirectly, is made on
account of the principal of, premium, if any, or interest and
Additional Amounts (pursuant to Section 2 hereof) on the
Securities or coupons.
(ii) Upon the happening of an event of default with
respect to any Senior Indebtedness of the Company, as defined
therein or in the instrument under which it is outstanding
permitting the holders to accelerate the maturity thereof, then,
unless and until such event of default shall have been cured or
waived or shall have ceased to exist, no payment shall be made by
the Company, directly or indirectly, on account of the principal
of, premium, if any, or interest and Additional Amounts (pursuant
to Section 2 hereof) on the Securities or coupons.
(d) In case cash, securities or other property
otherwise payable or deliverable to the holders of the Securities
shall have been applied, pursuant to Section 7(b) or 7(c), to the
payment of Senior Indebtedness of the Company, then, upon the
payment in full of all Senior Indebtedness of the Company, the
holders of the Securities shall be subrogated to any rights of
any holders of Senior Indebtedness of the Company to receive any
further payment or distributions applicable to Senior
Indebtedness of the Company until the principal of, premium, if
any, and interest and Additional Amounts (pursuant to Section 2
hereof) on the Securities shall have been paid in full, and such
payments or distributions received by the holders of the
Securities and coupons, by reason of such subrogation, of cash,
securities or other property which otherwise would be paid or
distributed to the holders of Senior Indebtedness of the Company
shall, as between the Company and its creditors other than the
holders of Senior Indebtedness of the Company, on the one hand,
and the holders of the Securities, on the other hand, be deemed
to be a payment by the Company on account of Senior Indebtedness
of the Company and not on account of the Securities.
(e) No present or future holder of any Senior
Indebtedness of the Company shall be prejudiced in any way in the
right to enforce the subordination of the Securities by any act
or failure to act on the part of the Company. The provisions of
this Section are solely for the purpose of defining the relative
rights of the holders of Senior Indebtedness of the Company, on
the one hand, and the holders of the Securities, on the other
PAGE
<PAGE>
hand, against the Company and its assets, and nothing contained
in this Section shall impair, as between the Company and the
holder of any Security, the obligation of the Company, which is
unconditional and absolute, to pay to the holder thereof, the
principal thereof, premium, if any, and interest and Additional
Amounts (pursuant to Section 2 hereof) thereon as and when the
same shall become due and payable in accordance with the terms
thereof, or prevent the holder of any Security, upon default
hereunder or under such Security, from exercising all rights,
powers and remedies otherwise provided herein or therein or by
applicable law, all subject to the rights of the holders of
Senior Indebtedness of the Company under this Section to receive
cash, property or securities otherwise payable or deliverable to
the holders of the Securities and coupons.
(f) Nothing contained in this Section or in any of the
Securities shall prevent at any time, except under the conditions
described in Sections 7(b) and (c) hereof or during the pendency
of any dissolution, winding up, liquidation or reorganization
proceedings therein referred to, the Company from making payments
at any time of principal of, premium of, if any, or interest or
Additional Amounts (pursuant to Section 2 hereof) on the
Securities. Nothing contained in this Section shall prevent
conversions of Securities.
8. Replacement, Transfer and Exchange of Securities.
(a) In case any Security (including any coupons
appertaining thereto) shall at any time become mutilated,
destroyed, stolen or lost and such Security or evidence of the
loss, theft or destruction thereof (together with the indemnity
hereinafter referred to and such other documents or proof as may
be required) shall be delivered to the Fiscal Agent, a new
Security of like tenor and date with appropriate interest
coupons, if any, will be issued by the Company in exchange for
the Security so mutilated, or in lieu of the Security so
destroyed, stolen or lost, but, in the case of a destroyed,
stolen or lost Security only upon receipt of evidence
satisfactory to the Fiscal Agent and the Company that such
Security was destroyed, stolen or lost, and if required by the
Fiscal Agent or the Company, upon receipt also of indemnity
satisfactory to the Fiscal Agent and the Company. All expenses
and reasonable charges associated with procuring such indemnity
and with the preparation, authentication and delivery of a new
Security shall be borne by the owner of the Security so
mutilated, destroyed, stolen or lost.
(b) As provided in the Fiscal Agency Agreement and
subject to certain limitations therein set forth, Bearer
Securities (with all unmatured and matured defaulted coupons
appertaining thereto) are exchangeable at, subject to applicable
laws and regulations, the offices of the paying agencies in
London and, if the Securities are listed on the Luxembourg Stock
PAGE
<PAGE>
Exchange and so long as listed thereon, Luxembourg or as
designated by the Company for such purpose pursuant to the Fiscal
Agency Agreement, for an equal aggregate principal amount of
Registered Securities in the denominations of $1,000 and integral
multiples thereof without coupons and/or Bearer Securities of
authorized denominations, and Registered Securities are
exchangeable at the Corporate Trust Office of the Fiscal Agent in
New York City or, subject to applicable laws and regulations, the
offices of the paying agencies in London and, if the Securities
are listed on the Luxembourg Stock Exchange and so long as listed
thereon, Luxembourg or as designated by the Company for such
purpose pursuant to the Fiscal Agency Agreement, for an equal
aggregate principal amount of Registered Securities of authorized
denominations as requested by the holder surrendering the same.
Registered Securities will not be exchangeable for Bearer
Securities. The Company shall not be required (a) to exchange
Bearer Securities for Registered Securities during the period
between the close of business on each June 15 and December 15 and
the opening of business on the next succeeding interest payment
date or (b) to exchange Bearer Securities for Registered
Securities, if as a result, the Company would incur adverse
consequences under United States Federal income tax laws in
effect of the time of exchange, or (c) in the event of a
redemption in part, (i) to register the transfer of Registered
Securities or to exchange Bearer Securities for Registered
Securities for a period of 15 days immediately preceding the date
notice is given identifying the serial numbers of the Securities
called for such redemption; (ii) to register the transfer or
exchange of any such Registered Securities, or portion thereof,
called for redemption; or (iii) to exchange any such Bearer
Securities called for redemption; provided, however, that a
Bearer Security called for redemption may be exchanged for a
Registered Security that is simultaneously surrendered, with
written instruction for payment on the date fixed for redemption,
unless the date fixed for redemption is during the period between
the close of business on each June 15 and December 15 and the
close of business on the next succeeding interest payment date,
in which case such exchange may only be made prior to the close
of business on each June 15 and December 15 immediately preceding
the date fixed for redemption. In the event of redemption or
conversion of a Security in part only, a new Security or
Securities for the unredeemed or unconverted portion hereof will
be issued in the name of the holder thereof.
(c) The costs and expenses of effecting any exchange
or registration of transfer pursuant to the foregoing provisions,
except for the expenses of delivery by other than regular mail
(if any) and except, if the Company shall so require, the payment
of a sum sufficient to cover any tax or other governmental charge
or insurance charges that may be imposed in relation thereto,
will be borne by the Company.
(d) The Company has initially appointed as registrar
and transfer agent the Fiscal Agent acting through the Corporate
PAGE
<PAGE>
Trust Office in New York. The Company has also initially
appointed Banque Internationale a Luxembourg as a transfer agent,
subject to the listing of the Securities on the Luxembourg Stock
Exchange. The Company may at any time terminate the appointment
of the registrar and transfer agent and appoint additional or
other registrars and transfer agents or approve any change in an
office through which the registrar and transfer agent acts;
provided that, until all of the Securities have been delivered to
the Fiscal Agent for cancellation, or monies sufficient to pay
the Securities have been made available for payment and either
paid or returned to the Company as provided in the Securities,
the Company will maintain a registrar and transfer agent in the
City of New York in the United States.
(e) For purposes of the provisions of this Security
and the Fiscal Agency Agreement, any Security authenticated and
delivered pursuant to the Fiscal Agency Agreement shall, as of
any date of determination, be deemed to be "outstanding", except
for:
(i) Securities previously canceled by the Fiscal
Agent or delivered to the Fiscal Agent for cancellation;
(ii) Securities which have been called for
redemption by the Company in accordance with Section 3 hereof or
which have become due and payable at maturity or otherwise and
with respect to which monies sufficient to pay the principal
thereof and interest thereon (including Additional Amounts, if
any) shall have been made available to the Fiscal Agent; or
(iii) Securities in lieu of or in substitution
for which other Securities have been authenticated and delivered
pursuant to the Fiscal Agency Agreement;
provided, however, that in determining whether the holders of the
requisite principal amount of outstanding Securities are present
at a meeting of holders of Securities for quorum purposes or have
given any request, demand, authorization, direction, notice,
consent or waiver hereunder, Securities owned by the Company or
any subsidiary thereof shall be disregarded and deemed not to be
outstanding.
9. Modifications and Amendments.
(a) Without the consent of any holders of Securities
or coupons, modifications of or amendments to the Fiscal Agency
Agreement or the Terms and Conditions of the Securities may be
made for any of the following purposes:
(i) to evidence the succession of another
corporation to the Company and the assumption by any such
successor of the covenants of the Company in the Fiscal Agency
Agreement or the Securities;
PAGE
<PAGE>
(ii) to add to the covenants of the Company for
the benefit of the holders of Securities or related coupons, or
to surrender any right or power herein conferred upon the
Company;
(iii) to permit payment of principal of,
premium, if any, and interest
on Bearer Securities in the United States, provided that such
payment is permitted by
United States tax laws and regulations then in effect;
(iv) to make provision with respect to the
conversion rights and redemption rights of holders of Securities
or coupons in the event of a consolidation, merger or sale of
substantially all of the assets of the Company;
(v) to cure any ambiguity, to correct or
supplement any defective provision in the Fiscal Agency Agreement
which may be inconsistent with any other provision therein, or to
make any other provisions with respect to matters or questions
arising under this Security or the Fiscal Agency Agreement,
provided such action pursuant to this clause (v) will not
materially adversely affect the interests of the holders of
Securities or related coupons; or
(vi) to increase the principal amount of
Securities that may be issued pursuant to the Fiscal Agency
Agreement; or
(vii) to delete the agreement of subordination
contained in Section 7 hereof and any other references thereto.
(b) Modifications and amendments to the Fiscal Agency
Agreement or to the Terms and Conditions of the Securities may be
made, and future compliance with or past default by the Company
under any of the provisions thereof may be waived, with the
written consent of the holders of not less than a majority in
aggregate principal amount of the Securities at the time
outstanding (excluding for purposes of this calculation the
aggregate principal amount of Securities held by the Company or
any of its subsidiaries), or of such lesser percentage as may act
at a meeting of holders of Securities held in accordance with the
provisions set forth herein; provided that no such modification,
amendment or waiver may, without the consent of the holder of
each such Security affected thereby:
(i) waive a default in the payment of the
principal of, premium, if any, or any installment of interest on
any Security;
(ii) change the stated maturity of the principal
of, premium, if any, or any installment of interest on, any
Security, or reduce the principal amount thereof or any premium,
if any, or any installment of interest, or change the obligation
PAGE
<PAGE>
of the Company to pay Additional Amounts pursuant to Section 2
hereof (except as permitted by subsection (a) of Section 9 or by
the Fiscal Agency Agreement), or change the coin or currency in
which any Security or any premium or interest thereon is payable,
or, except as otherwise permitted or contemplated by the
provisions concerning corporate reorganizations, adversely affect
the right to redeem (pursuant to Section 3(d) or Section 3(e)
hereof) or convert any Securities as provided in Sections 3 and
4, respectively;
(iii) reduce the requirements of Section 10
hereof for the adoption of a resolution of the quorum required at
any meeting of holders of Securities at which a resolution is
adopted, or reduce the percentage in principal amount of the
outstanding Securities the consent of whose holders is required
for any amendment or modification of the Fiscal Agency Agreement
or the Terms and Conditions of the Securities or the consent of
whose holders is required for any waiver (of compliance with
certain provisions of the Fiscal Agency Agreement or the
Securities or certain defaults hereunder and thereunder and their
consequences) provided for in the Terms and Conditions of the
Securities;
(iv) modify the obligation of the Company to
maintain an office or agency in the City of New York and outside
the United States; or
(v) modify any of the provisions of this section
except to increase any such percentage or to provide that certain
other provisions of the Fiscal Agency Agreement or the Securities
cannot be modified or waived without the consent of the holder of
each outstanding Security affected thereby.
It shall not be necessary for any act of holders of Securities
under this Section to approve the particular form of any proposed
amendment, modification or waiver, but it shall be sufficient if
such act shall approve the substance thereof. Any modifications,
amendments or waivers to the Fiscal Agency Agreement or to these
Terms and Conditions will be conclusive and binding on all
holders of the Securities and any coupons appertaining thereto,
whether or not they have given such consent or were present at
such meeting and whether or not notation of such modifications,
amendments or waivers is made upon the Securities or coupons, and
on all future holders of Securities and coupons. Any instrument
given by or on behalf of any holder of a Security in connection
with any consent to any such modification, amendment or waiver
will be irrevocable once given and will be conclusive and binding
on all subsequent holders of such Security and coupons
appertaining thereto.
PAGE
<PAGE>
10. Meetings and Votes of Holders.
(a) A meeting of holders of Securities may be called
at any time and from time to time pursuant to this Section for
any of the following purposes: (i) to give any notice to the
Company or to the Fiscal Agent, or to give any directions to the
Fiscal Agent, or to consent to the waiving of any default
hereunder and its consequences, or to take any other action
authorized to be taken by holders of Securities pursuant to these
Terms and Conditions; or (ii) to take any other action authorized
to be taken by or on behalf of the holders of any specified
aggregate principal amount of the Securities under any other
provision of the Fiscal Agency Agreement, under applicable law or
under these Terms and Conditions.
(b) Meetings of holders of Securities may be held at
such place or places in New York City or London as the Fiscal
Agent or, in case of its failure to act, the Company or the
holders calling the meeting shall from time to time determine.
The Fiscal Agent may at any time call a meeting of
holders of the Securities to be held at such time and at such
place in any of such designated locations as the Fiscal Agent
shall determine. Notice of every meeting of holders shall be
made as specified in the Fiscal Agency Agreement.
In case at any time the Company or the holders of at
least 25% in aggregate principal amount of the Securities shall
have requested the Fiscal Agent to call a meeting of the holders,
by written request setting forth in reasonable detail the action
proposed to be taken at the meeting, and the Fiscal Agent shall
not have given the first notice of such meeting within 21 days
after receipt of such request or shall not thereafter proceed to
cause the meeting to be held as provided herein, then the Company
or the holders of Securities in the amount above specified may
determine the time and the place in such designated locations for
such meeting and may call such meeting to take any action
authorized herein by giving notice thereof as provided in the
Fiscal Agency Agreement.
(c) To be entitled to vote at any meeting of holders
of Securities, a person shall be (i) a holder of one or more
Securities, or (ii) a person appointed by an instrument in
writing as proxy for a holder or holders of Securities by such
holder or holders, which proxy need not be a holder of
Securities. The only persons who shall be entitled to be present
or to speak at any meeting of holders shall be the persons
entitled to vote at such meeting and their counsel and any
representatives of the Fiscal Agent and its counsel and any
representatives of the Company and its counsel. The persons
entitled to vote a majority in principal amount of outstanding
Securities shall constitute a quorum for the transaction of all
business specified in subsection (a) hereof. No business shall
be transacted in the absence of a quorum unless a quorum is
PAGE
<PAGE>
represented when the meeting is called to order. In the absence
of a quorum within 30 minutes of the time appointed for any such
meeting, the meeting shall, if convened at the request of the
holders of Securities, be dissolved. In any other case the
meeting shall be adjourned for a period of not less than 10 days
as determined by the chairman of the meeting prior to the
adjournment of such adjourned meeting. Notice of the reconvening
of any adjourned meeting shall be given as provided in the Fiscal
Agency Agreement. Subject to the foregoing, at the reconvening
of any meeting adjourned for a lack of a quorum the persons
entitled to vote 25% in principal amount of the Securities
outstanding shall constitute a quorum for the taking of any
action set forth in the notice of the original meeting. Notice
of the reconvening of an adjourned meeting shall state expressly
the percentage of the aggregate principal amount of the
Securities that shall constitute a quorum. At a meeting or an
adjourned meeting duly reconvened and at which a quorum is
present as aforesaid, any resolution and all matters (except as
limited by Section 9 of these Terms and Conditions) shall be
effectively passed and decided if passed or decided by the
persons entitled to vote a majority in principal amount of the
Securities represented and voting at such meeting, provided that
such amount shall not be less than 25 % in principal amount of
the Securities outstanding. Any holder of a Security who has
executed an instrument in writing appointing a person as his
proxy shall be deemed to be present for the purposes of
determining a quorum and be deemed to have voted; provided,
however, that such holder shall be considered as present or
voting only with respect to the matters covered by such
instrument in writing. Any resolution effectively passed or
decision taken at any meeting of the holders of Securities duly
held in accordance with this Section 10 shall be binding on all
the holders of Securities whether or not present or represented
at the meeting.
(d) The Fiscal Agent may make such reasonable
regulations as it may deem advisable for any meeting of holders
of Securities in regard to proof of the holding of Securities and
of the appointment of proxies and in regard to the appointment
and duties of inspectors of votes, the submission and examination
of proxies, certificates and other evidence of the right to vote,
and such other matters concerning the conduct of the meeting as
it shall deem appropriate. Except as otherwise permitted or
required by any such regulations, the holding of Bearer
Securities shall be proved by the production of the Bearer
Securities or by a certificate executed, as depositary, by, and
the appointment of any proxy shall be proved by having the
signature of the person executing the proxy witnessed or
guaranteed by, in each case, any trust company, bank or banker
satisfactory to the Fiscal Agent. Such regulations may provide
that written instruments appointing proxies, regular on their
face, may be presumed valid and genuine without the proof
specified herein or other proof. The holding of Registered
Securities shall be proved by the registry books maintained in
PAGE
<PAGE>
accordance with the Fiscal Agency Agreement or by a certificate
or certificates of the Fiscal Agent in its capacity as the
Company's agent for the maintenance of such books.
(e) The Fiscal Agent shall, by an instrument in
writing, appoint a temporary chairperson and a temporary
secretary of the meeting, unless the meeting shall have been
called by the Company or by the holders of Securities as provided
herein and in the Fiscal Agency Agreement, in which case the
Company or the holders calling the meeting, as the case may be,
shall in like manner appoint a temporary chairperson and a
temporary secretary. A permanent chairperson and a permanent
secretary of the meeting shall be elected by vote of the holders
of a majority in principal amount of the Securities represented
at the meeting and entitled to vote. At any meeting each holder
or proxy shall be entitled to one vote for each U.S. $1,000
principal amount of Securities held or represented by him;
provided, however, that no vote shall be cast or counted at any
meeting in respect of the Securities challenged as not
outstanding and ruled by the chairperson of the meeting to be not
outstanding. The chairperson of the meeting shall have no right
to vote, except as a holder or proxy. Any meeting of holders of
Securities duly called at which a quorum is present may be
adjourned from time to time by vote of the holders (or proxies
for the holders) of a majority in principal amount of the
Securities represented at the meeting and entitled to vote; and
the meeting may be held as so adjourned without further notice.
(f) The vote upon any resolution submitted to any
meeting of holders of Securities shall be written ballots on
which shall be subscribed the signatures of the holders of
Securities or of their representatives by proxy and the serial
number or numbers of the Securities held or represented by them.
The permanent chairperson of the meeting shall appoint two
inspectors of votes who shall count all votes cast at the meeting
for or against any resolution and who shall make and file with
the secretary of the meeting their verified written reports in
triplicate of all votes cast at the meeting. A record, at least
in triplicate, of the proceedings of each meeting of holders of
Securities shall be prepared by the secretary of the meeting and
there shall be attached to said record the original reports of
the inspectors of votes on any vote by ballot taken thereat and
affidavits by one or more persons having knowledge of the facts
setting forth a copy of the notice of the meeting and showing
that said notice was published as provided in the Fiscal Agency
Agreement. Each copy shall be signed and verified by the
affidavits of the permanent chairperson and secretary of the
meeting, and one of such copy of the notice of the meeting and
showing that said notice was published as provided in the Fiscal
Agency Agreement. Each copy shall be signed and verified by the
affidavits of the permanent chairperson and secretary of the
meeting, and one of such copy shall be delivered to the Company
and another to the Fiscal Agent to be preserved by the Fiscal
Agent, the copy delivered to the Fiscal Agent to have attached
PAGE
<PAGE>
thereto by ballots voted at the meeting. Any record so signed
and verified shall be conclusive evidence of the matters therein
stated.
11. Business Days. Notwithstanding anything herein or in
the Fiscal Agency Agreement to the contrary, if any payment of
interest or premium or principal (or Additional Amounts, if any)
is due on a day that is not a Business Day, payment shall be made
on the next succeeding Business Day, with the same effect as if
made on the day such payment was due, and no interest shall
accrue for the period after such date. A "Business Day" is
defined, with respect to any act to be performed pursuant hereto
or to the Fiscal Agency Agreement, as any day which is not a
Saturday, Sunday or a day on which banking institutions in the
place where such act is to occur are authorized or obligated by
applicable law, regulation or executive order to close.
12. Fiscal and Paying Agent.
(a) In acting under the Fiscal Agency Agreement and in
connection with the Securities, the Fiscal Agent is acting solely
as agent of the Company and does not assume any obligation, or
relationship of agency or trust, for or with the owner or holder
of this Security or any interest coupon appertaining hereto,
except that funds held by the Fiscal Agent for payment on this
Security shall be held in trust by it and applied as set forth
herein, but need not be segregated from other funds held by it,
except as required by law. For a description of the duties and
the immunities and rights of the Fiscal Agent under the Fiscal
Agency Agreement, reference is made to the Fiscal Agency
Agreement, and the obligations of the Fiscal Agent to the holder
hereof are subject to such immunities and rights.
(b) Any monies paid by the Company to any paying
agency for payment of principal of, premium, if any, or interest
on any Security (including Additional Amounts, if any, in respect
thereof) and remaining unclaimed for two years after such payment
has been made shall be repaid to the Company and to the extent
permitted by law the holder of any Security shall thereafter look
only to the Company for any payment thereof as a general
unsecured obligation thereof and all liability of the Fiscal
Agent with respect thereto shall cease.
(c) No reference herein to the Fiscal Agency Agreement
and no provision of this Security or of the Fiscal Agency
Agreement shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of,
premium, if any, and interest (and Additional Amounts, as
described above) on this Security at the times, places and rate,
and in the coin or currency, herein prescribed or to convert or
redeem (at the request of a holder) this Security as provided
herein or in the Fiscal Agency Agreement.
PAGE
<PAGE>
Title to Bearer Securities and coupons shall pass by
delivery. As provided in the Fiscal Agency Agreement and subject
to certain limitations therein set forth, the transfer of
Registered Securities is registrable on the Security Register
upon surrender of a Registered Security for registration of
transfer at the office or agency of the Company in the City of
New York, duly endorsed by, or accompanied by a written
instrument of transfer in form satisfactory to the Company and
the Security Registrar duly executed by, the holder thereof or
his attorney duly authorized in writing, and thereupon one or
more new Registered Securities, of authorized denominations and
for the same aggregate principal amount, will be issued to the
designated transferee or transferees.
13. Notices. All notices to the holders of Securities will
be published on a Business Day in an Authorized Newspaper (as
defined in the Fiscal Agency Agreement) in New York City and in
London, and, as long as the Securities are listed on the
Luxembourg Stock Exchange, in Luxembourg or, if either
publication in London or Luxembourg is not practical, in an
Authorized Newspaper in any country in Western Europe. It is
expected that publication in New York City will be made in The
Wall Street Journal (Eastern edition), in London in the Financial
Times and in Luxembourg in the Luxemburger Wort. Notices shall
be deemed to have been given on the date of publication as
aforesaid or, if published on different dates, on the date of the
first such publication. A copy of each such notice will be
mailed by the Fiscal Agent, on behalf of and at the expense of
the Company, by first-class mail to each holder of a Registered
Security at the registered address of such holder as the same
shall appear in the Security Register (as defined in the Fiscal
Agency Agreement) on the day fifteen days prior to such mailing.
14. Governing Law.
(a) THE FISCAL AGENCY AGREEMENT, THE SECURITIES AND
ANY COUPONS APPERTAINING THERETO SHALL BE GOVERNED BY AND
CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF
MASSACHUSETTS, UNITED STATES OF AMERICA WITHOUT GIVING EFFECT TO
ITS CONFLICTS OF LAWS RULES.
(b) The Company has appointed the Fiscal Agent as its
agent upon whom process may be served in any suit, action or
proceeding initially at its office located at 450 West 33rd
Street, 15th Floor, New York, New York 10001, with a copy to the
Company at 81 Wyman Street, Waltham, Massachusetts 02254-9046,
Attention: General Counsel.
15. Authentication. This Security and any coupons
appertaining thereto shall not become valid or obligatory for any
purpose until the certificate or authentication hereon shall have
been duly signed by the Fiscal Agent acting under the Fiscal
Agency Agreement.
PAGE
<PAGE>
16. Warranty of the Issuer. Subject to Section 15 hereof,
the Company hereby certifies and warrants that all acts,
conditions and things required to be done and performed and to
have happened precedent to the creation and issuance of this
Security and any coupons appertaining thereto, and to constitute
the same legal, valid and binding obligations of the Company
enforceable in accordance with their terms, have been done and
performed and have happened in due and strict compliance with all
applicable laws.
17. Delivery of Certain Information. At any time when the
Company is not subject to Section 13 or 15(d) of the Securities
Exchange Act of 1934, as amended, upon the request of a holder
or beneficial owner of a Restricted Security, the Company will
promptly furnish or cause to be furnished such information as is
specified in Rule 144A(d)(4) under the Securities Act (or any
successor thereto) to such holder, to a prospective purchaser of
such Restricted Security designated by such holder, to such
beneficial owner or to a prospective purchaser of such Restricted
Security designated by such beneficial owner, as the case may be,
in order to permit compliance by such holder or beneficial owner
with Rule 144A under the Securities Act in connection with the
resale of such Security by such holder or beneficial owner,
provided, however, that the Company shall not be required to
furnish such information in connection with any request made on
or after the date which is three years (or the then applicable
holding period under Rule 144(k) under the Securities Act (or
successor provision)) from the later of (i) the date such
Security (or any predecessor security) was originally acquired
from the Company and (ii) the date such Security (or any
predecessor security) was last acquired from the Company or an
"affiliate" of the Company within the meaning of Rule 144 under
the Securities Act.
18. Accounting Terms. All accounting terms not otherwise
defined herein shall have the meanings assigned to them in
accordance with generally accepted accounting principles as
applied in the United States.
19. Descriptive Headings. The descriptive headings
appearing in these Terms and Conditions are for convenience of
reference only and shall not alter, limit or define the
provisions hereof.
TRANSFER NOTICE
Only if a Registered Security is transferred:
FOR VALUE RECEIVED, the undersigned Holder hereby sell(s),
assign(s) and transfer(s)
unto ___________________________________________________________
________________________________________________________________
______________________________________________ whose taxpayer
identification number is and whose address
------------------
PAGE
<PAGE>
including postal/zip code is
____________________________________the within Security and all
rights thereunder, hereby irrevocably constituting and appointing
_________________________ attorney-in-fact to transfer said
Security on the books of the Fiscal Agent with full power of
substitution in the premises.
In connection with the transfer of this Security, the undersigned
Holder certifies that:
(Check one)
(a) This Security is being transferred to a "qualified
institutional buyer" (as defined in Rule 144A under the
Securities Act of 1933) in compliance with the exemption from
registration under the Securities Act of 1933 provided by Rule
144A.
(b) This Security is being transferred in an Offshore
Transaction (as defined in Regulation S under the Securities Act
of 1933) in compliance with the exemption from registration under
the Securities Act of 1933 provided by Regulation S and in
connection with which transfer the Company has received, if so
requested, an opinion of counsel (satisfactory to it in form and
substance) to the effect that the transfer is being made pursuant
to an exemption from the registration requirements of Securities
Act of 1933.
(c) This Security is being transferred to an
institutional investor which is an "accredited investor" (within
the meaning of Rule 501(a)(1), (2), (3) or (7) under the
Securities Act of 1933) in a transaction that is exempt from the
registration requirements of the Securities Act of 1933 and in
connection with which transfer the Company has received, if so
requested, an opinion of counsel (satisfactory to it in form and
substance) to the effect that the transfer is being made pursuant
to an exemption from the registration requirements of Securities
Act of 1933.
(d) This Security is being transferred to Thermo
Electron Corporation.
(e) Transfer other than those above in connection with
which the Company has received an opinion of counsel
(satisfactory to it in form and substance) to the effect that the
transfer is being made pursuant to an exemption from, or in a
transaction not subject to, the registration requirements of the
Securities Act of 1933.
(f) This Security is being exchanged for a beneficial
interest in the Rule 144A Global Security and the undersigned is
a "qualified institutional buyer" (as defined in Rule 144A under
the Securities Act of 1933).
PAGE
<PAGE>
Dated: Name:
By:
Title:
NOTICE: The signature of the Holder
to this assignment must correspond with the name as written upon
the face of the within instrument in every particular, without
enlargement or any change whatsoever.
SIGNATURE GUARANTEED
TO BE COMPLETED BY A BROKER OR DEALER IF (c) ABOVE IS CHECKED:
The undersigned represents and warrants that (i) it is a broker
or dealer registered under Section 15 of the Securities Exchange
Act of 1934, (ii) each person which will become a beneficial
owner of this Security upon transfer is an institutional investor
which is an "accredited investor" (within the meaning of Rule
501(a)(1), (2), (3) or (7) under the Securities Act of 1933);
(iii) no general solicitation or advertising was made or used by
it in connection with the offer and sale of this Security to such
person(s); and (iv) each such person has been notified that this
Security has not been registered under the Securities Act of 1933
and is subject to the restrictions on transfer of the Security
set forth herein and in the Fiscal Agency Agreement.
Dated:
By:
IF NONE OF THE FOREGOING BOXES IS CHECKED, THE FISCAL AGENT SHALL
NOT BE OBLIGATED TO REGISTER THE TRANSFER OF THIS SECURITY UNLESS
AND UNTIL THE CONDITIONS TO ANY SUCH TRANSFER OF REGISTRATION SET
FORTH HEREIN, ON THE FACE HEREOF AND IN THE FISCAL AGENCY
AGREEMENT SHALL HAVE BEEN SATISFIED.
PAGE
<PAGE>
CONVERSION NOTICE
If (i) Registered Security of denomination U.S. $1,000 or (ii)
Bearer Security of denomination U.S. $1,000:
The undersigned holder of this Security hereby (i)
irrevocably exercises the option to convert this Security into
shares of Common Stock of Thermo Electron Corporation (the
"Company") in accordance with the terms of this Security, and
(ii) directs that such shares be registered in the name of and
delivered, together with a check in payment for any fractional
share, to the undersigned unless a different name has been
indicated below. If shares are to be registered in the name of a
person other than the undersigned, the undersigned will pay all
transfer taxes payable with respect thereto.
Dated:
Signature
[MUST BE GUARANTEED IF STOCK IS TO BE ISSUED
IN A NAME OTHER THAN THE REGISTERED
HOLDER OF THE SECURITY]
If shares are to be registered in the name of and delivered to a
person other than the holder, please print such person's name and
address and, if this is a Restricted Security, complete the
Transfer Notice:
HOLDER
Please print name and address of holder:
PAGE
<PAGE>
CONVERSION NOTICE
If (i) Registered Security of denomination greater than U.S.
$1,000 or (ii) Bearer Security of denomination U.S. $10,000:
The undersigned holder of this Security hereby irrevocably
exercises the option to convert this Security, or portion hereof
(which is U.S. $1,000 or an integral multiple thereof) below
designated, into shares of Common Stock of Thermo Electron
Corporation (the "Company") in accordance with the terms of this
Security, and (ii) directs that such shares, together with a
check in payment for any fractional share and any Securities
representing any unconverted principal amount hereof, be
delivered to and be registered (if a Registered Security) in the
name of the undersigned unless a different name has been
indicated below. If shares or Securities are to be registered in
the name of a person other than the undersigned, the undersigned
will pay all transfer taxes payable with respect thereto.
Signature
[MUST BE GUARANTEED IF STOCK IS TO
BE ISSUED IN A NAME OTHER THAN
THE REGISTERED HOLDER OF THE SECURITY]
Dated:
If shares or Securities are to be registered in the name of a
Person other than the registered holder, please print such
person's name and address and, if this is a Restricted Security,
complete Transfer Notice:
________________________
________________________
________________________
HOLDER
Please print name and address of holder:
_________________________________
_________________________________
_________________________________
If only a portion of the Securities is to be converted, please
indicate:
1 . Principal Amount to be converted: U.S.$
--------
PAGE
<PAGE>
2. Kind, amount and denomination of Securities
representing unconverted principal amount to be issued:
Bearer U.S. $_____________
(U.S. $1,000 or $10,000)
Registered U.S.$___________
Denominations: U.S.$__________
(U.S. $1,000 or an integral multiple thereof)
Registered Securities are not exchangeable for Bearer Securities.
PAGE
<PAGE>
REDEMPTION NOTICE UNDER SECTION 3(d)
If (i) Registered Security of denomination U.S. $1,000 or (ii)
Bearer Security of denomination
U.S. $ 1,000:
The undersigned holder of this Security hereby requests and
instructs the Company to redeem this Security in accordance with
the terms of Section 3(d) of this Security and directs that a
check in payment of the redemption amount be delivered to the
undersigned unless a different name has been indicated below.
The undersigned understands that this request can be revoked by
delivering written notice to the Paying Agent on or before the
Holder Redemption Date, together with the undersigned's
non-transferable receipt for such Security.
Dated:
_____________________________________
Signature
[MUST BE GUARANTEED IF CHECK IS TO
BE MADE PAYABLE TO A NAME OTHER
THAN THE REGISTERED HOLDER OF THE SECURITY]
If a check in payment of the redemption amount is to be delivered
to a person other than the holder, please print such person's
name and address:
_________________________________
_________________________________
_________________________________
HOLDER
Please print name and address of holder:
_________________________________
_________________________________
---------------------------------
PAGE
<PAGE>
REDEMPTION NOTICE UNDER SECTION 3(d)
If (i) Registered Security of denomination greater than U.S.
$1,000 or (ii) Bearer Security of denomination U.S. $10,000:
The undersigned holder of this Security hereby requests and
instructs the Company to redeem this Security or portion hereof
(which is U.S. $1,000 or an integral multiple thereof) in
accordance with the terms of Section 3(d) of this Security, and
directs that a check in payment of the redemption amount be
delivered to, and any Securities representing any unredeemed
principal amount hereof be delivered to and be registered in the
name of, the undersigned unless a different name has been
indicated below. If Securities are to be registered in the name
of a person other than the undersigned, the undersigned will pay
all transfer taxes payable with respect thereto. The undersigned
understands that this request can be revoked by delivering
written notice to the Paying Agent on or before the Holder
Redemption Date, together with the undersigned's non-transferable
receipt for such Security.
Dated:
_________________________________
Signature
[MUST BE GUARANTEED IF CHECK IS TO
BE MADE PAYABLE TO A NAME OTHER
THAN THE REGISTERED HOLDER OF THE
SECURITY]
If Securities are to be registered HOLDER
in the name of, or a check in Please print name
payment of the redemption and address of holder:
amount is to be delivered to,
a person other than the holder,
please print such person's name
and address, and if this is a
Restricted Security and any
Securities representing any
unredeemed principal amount
hereof are to be registered in the
name of a person other than the
undersigned, complete Transfer
Notice.
_____________________________
_____________________________
-----------------------------
PAGE
<PAGE>
1. Principal Amount to redeemed: U.S. $
2. Kind, amount and denomination of Securities
representing unredeemed principal amount to
be issued:
Bearer U.S. $_____________
Denominations: U.S. $__________
(U.S. $1,000 or $10,000)
Registered U.S.$___________
Denominations: U.S.$__________
(U.S. $1,000 or an integral multiple thereof)
Registered Securities are not
exchangeable for Bearer Securities.
PAGE
<PAGE>
REDEMPTION NOTICE UNDER SECTION 3(e)
If (i) Registered Security of denomination U.S. $1,000 or (ii)
Bearer Security of denomination
U.S. $ 1,000:
The undersigned holder of this Security hereby requests and
instructs the Company to redeem this Security in accordance with
the terms of Section 3(e) of this Security and directs that a
check in payment of the redemption amount be delivered to the
undersigned unless a different name has been indicated below.
The undersigned understands that this request can not be revoked
unless the Company fails to provide for payment of the redemption
amount on the Repurchase Date.
Dated:
_____________________________________
Signature
[MUST BE GUARANTEED IF CHECK IS TO
BE MADE PAYABLE TO A NAME OTHER THAN
THE REGISTERED HOLDER OF THE SECURITY]
If a check in payment of the redemption amount is to be delivered
to a person other than the holder, please print such person's
name and address:
_________________________________
_________________________________
_________________________________
HOLDER
Please print name and address of holder:
_________________________________
_________________________________
---------------------------------
PAGE
<PAGE>
REDEMPTION NOTICE UNDER SECTION 3(e)
If (i) Registered Security of denomination greater than U.S.
$1,000 or (ii) Bearer Security of denomination U.S. $10,000:
The undersigned holder of this Security hereby requests and
instructs the Company to redeem this Security or portion hereof
(which is U.S. $1,000 or an integral multiple thereof) in
accordance with the terms of Section 3(e) of this Security, and
directs that a check in payment of the redemption amount be
delivered to, and any Securities representing any unredeemed
principal amount hereof be delivered to and be registered in the
name of, the undersigned unless a different name has been
indicated below. If Securities are to be registered in the name
of a person other than the undersigned, the undersigned will pay
all transfer taxes payable with respect thereto. The undersigned
understands that this request can not be revoked unless the
Company fails to provide for payment of the redemption amount on
the Repurchase Date.
Dated:
___________________________________
Signature
[MUST BE GUARANTEED IF CHECK IS TO
BE MADE PAYABLE TO A NAME OTHER
THAN THE REGISTERED HOLDER OF THE
SECURITY]
If Securities are to be registered
in the name of, or a check in
payment of the redemption
amount is to be delivered to,
a person other than the holder,
please print such person's name
and address, and if this is a
Restricted Security and any
Securities representing any
unredeemed principal amount
hereof are to be registered in the
name of a person other than the
undersigned, complete Transfer
Notice.
_____________________________
_____________________________
_____________________________
1. Principal Amount to redeemed: U.S. $
2. Kind, amount and denomination of
Securities representing unredeemed principal amount to be issued:
Bearer U.S. $__________
Denominations: U.S. $__________
(U.S. $1,000 or $10,000)
Registered U.S.$___________
Denominations: U.S.$__________
(U.S. $1,000 or an integral multiple thereof)
Registered Securities are not exchangeable for Bearer Securities.
PAGE
<PAGE>
EXHIBIT B
(FORM OF REGULATION S GLOBAL SECURITY)
THIS SECURITY HAS NOT BEEN REGISTERED UNDER THE UNITED
STATES SECURITIES ACT OF 1933, AS AMENDED (THE "SECURITIES ACT_),
OR ANY STATE SECURITIES LAWS. NEITHER THIS SECURITY NOR ANY
INTEREST OR PARTICIPATION HEREIN MAY BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, DIRECTLY OR INDIRECTLY, IN THE UNITED
STATES OF AMERICA, ITS TERRITORIES, ITS POSSESSION AND OTHER
AREAS SUBJECT TO ITS JURISDICTION (THE _UNITED STATES_ ) OR TO
ANY CITIZEN, NATIONAL RESIDENT OF THE UNITED STATES OR TO ANY
CORPORATION, PARTNERSHIP OR OTHER ENTITY CREATED OR ORGANIZED IN
OR UNDER THE LAWS OF THE UNITED STATES OR ANY POLITICAL
SUBDIVISION THEREOF, OR TO ANY ESTATE OR TRUST THE INCOME OF
WHICH IS SUBJECT TO UNITED STATES FEDERAL INCOME TAXATION
REGARDLESS OF ITS SOURCE OR TO ANY OTHER PERSON OR ENTITY DEEMED
A U.S. PERSON UNDER REGULATIONS UNDER THE SECURITIES ACT (_UNITED
STATES PERSON_), EXCEPT TO CERTAIN INSTITUTIONAL INVESTORS IN THE
UNITED STATES IN TRANSACTIONS NOT REQUIRED TO BE REGISTERED UNDER
THE SECURITIES ACT.
ANY UNITED STATES PERSON WHO HOLDS THIS SECURITY WILL BE
SUBJECT TO LIMITATIONS UNDER THE UNITED STATES INCOME TAX LAWS,
INCLUDING THE LIMITATIONS PROVIDED IN SECTION 165(j) AND 1287(a)
OF THE UNITED STATES INTERNAL REVENUE CODE.
THIS SECURITY IS A TEMPORARY GLOBAL SECURITY, WITHOUT
COUPONS OR CONVERSION RIGHTS, EXCHANGEABLE FOR DEFINITIVE BEARER
SECURITIES WITH INTEREST COUPONS OR REGISTERED SECURITIES WITHOUT
INTEREST COUPONS. THE RIGHTS ATTACHING TO THIS GLOBAL SECURITY,
AND THE CONDITIONS AND PROCEDURES GOVERNING ITS EXCHANGE FOR
DEFINITIVE SECURITIES, ARE AS SPECIFIED IN THE FISCAL AGENCY
AGREEMENT (AS DEFINED HEREIN).
NEITHER THE HOLDER NOR THE BENEFICIAL OWNERS OF THIS GLOBAL
SECURITY SHALL BE ENTITLED TO RECEIVE PAYMENT OF INTEREST HEREON
EXCEPT PURSUANT TO THE PROVISIONS HEREOF.
PAGE
<PAGE>
THERMO ELECTRON CORPORATION
(Incorporated in the State of Delaware)
4 1/4% Convertible Subordinated Debenture Due 2003
TEMPORARY GLOBAL DEBENTURE
THERMO ELECTRON CORPORATION, a corporation duly incorporated
and existing under the laws of the State of Delaware (the
"Company"), for value received, hereby promises to pay to bearer
upon presentation and surrender of this Global Security the
principal sum of $_______ United States Dollars on January 1,
2003 and to pay interest thereon, from the date hereof,
semiannually in arrears on January 1 and July 1 in each year,
commencing July 1, 1996, at the rate of 4q% per annum, until the
principal hereof is paid or made available for payment; provided,
however, that interest on this Global Security shall be payable
only after the issuance of the definitive Securities for which
this Global Security is exchangeable and, in the case of
definitive Securities in bearer form, only upon presentation and
surrender (at an office or agency outside the United States, its
territories and its possessions, except as otherwise provided in
the Fiscal Agency Agreement referred to below) of the interest
coupons thereto attached as they severally mature.
This Global Security is one of a duly authorized issue of
Securities of the Company designated as specified in the title
hereof, issued and to be issued under the Fiscal Agency Agreement
dated as of January 3, 1996 (the "Fiscal Agency Agreement")
between the Company and Chemical Bank, as fiscal agent (the
"Fiscal Agent", which term includes any successor fiscal agent
under the Fiscal Agency Agreement). This Global Security is a
temporary security and is exchangeable in whole or from time to
time in part without charge upon request of the holder hereof for
definitive Securities in bearer form, with interest coupons
attached, or in registered form, without coupons, of authorized
denominations, (a) not earlier than the day following expiration
of the 40-day period that begins on the date hereof and (b) as
promptly as practicable following presentation of certification,
in the forms set forth as Exhibits C and F of the Fiscal Agency
Agreement for such purpose, that the beneficial owner or owners
of this Global Security (or, if such exchange is only for a part
of this Global Security, of such part) are not United States
Persons or other persons who have purchased such Debenture for
resale to United States Persons. Definitive Securities in bearer
form to be delivered in exchange for any part of this Global
Security shall be delivered only outside of the United States,
its territories and its possessions. Upon any exchange of a part
of this Global Security for definitive Securities, the portion of
the principal amount hereof so exchanged shall be endorsed by the
Fiscal Agent or its agents on the Schedule of Exchanges hereto,
and the principal amount hereof shall be reduced for all purposes
by the amount so exchanged.
PAGE
<PAGE>
Until exchanged in full for definitive Securities, this
Global Security shall in all respects be entitled to the same
benefits under, and subject to the same terms and conditions of,
the Fiscal Agency Agreement as definitive Securities
authenticated and delivered thereunder, except that neither the
holder hereof nor the beneficial owners of this Global Security
shall be entitled to receive payment of interest hereon, except
as provided above, or to convert this Global Security into shares
of Common Stock of the Company or any other security, cash or
other property.
THIS GLOBAL SECURITY SHALL BE GOVERNED BY AND CONSTRUED IN
ACCORDANCE WITH THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS,
UNITED STATES OF AMERICA, WITHOUT GIVING EFFECT TO ITS CONFLICTS
OF LAW RULES.
All terms used in this Global Security which are defined in
the Fiscal Agency Agreement shall have the meanings assigned to
them in the Fiscal Agency Agreement.
Unless the certificate of authentication hereon has been
manually executed by an authorized signatory of the Fiscal Agent,
this Global Security shall not be entitled to any benefit under
the Fiscal Agency Agreement or valid or obligatory for any
purpose.
IN WITNESS WHEREOF, the Company has caused this Global
Security to be duly executed in its corporate name by its duly
authorized signatory under its corporate seal.
Dated: January 3, 1996
THERMO ELECTRON CORPORATION
By:
Name:
Title:
Attest:
_________________________
CERTIFICATE OF AUTHENTICATION
This is one of the Securities described in the
within-mentioned Fiscal Agency Agreement.
CHEMICAL BANK
as Fiscal Agent
By:
Authorized Officer
PAGE
<PAGE>
SCHEDULE OF EXCHANGES
Principal Remaining
amount principal Notation
exchanged amount made on
Date for following behalf of
made definitive such the
Securities exchange Fiscal
Agent
PAGE
<PAGE>
EXHIBIT C
Form of Certificate to be Given by
The Euroclear Operator and Cedel Bank, societe anonyme
CERTIFICATION
U.S. $
THERMO ELECTRON CORPORATION
4 1/4% Convertible Subordinated Debentures
due January 1, 2003
(the "Securities")
This is to certify that, based solely on certifications we
have received in writing, by tested telex or electronic
transmission from member organizations appearing in our records
as persons being entitled to a portion of the principal amount
set forth below or to interest payable on an interest payment
date (our _Member Organizations"), substantially to the effect
set forth in the Fiscal Agency Agreement relating to the
above-captioned Securities, as of the date hereof, U.S.
$_______________ aggregate principal amount of the
above-captioned Securities is owned by persons that are not
citizens or residents of the United States, domestic
partnerships, domestic corporations or any estate or trust the
income of which is subject to United States Federal income
taxation regardless of its source or any other person deemed a
_United States person_ or a "U.S. person" under the Internal
Revenue Code of 1986, as amended, or Regulation S under the U.S.
Securities Act of 1933, as amended ("United States persons").
The following denominations of Bearer Securities are
requested:
No. of Amount
Certificates
$1,000 ______________ = $________________
Denomination
$10,000 ______________ = $________________
Denomination
Total Requested ______________ = $________________
We further certify (i) that we are not making available
herewith for exchange any portion of the Regulation S Global
Security excepted in such certifications and (ii) that as of the
date hereof we have not received any notification from any of our
Member Organizations to the effect that the statements made by
such Member Organization with respect to any portion of the part
submitted herewith for exchange are no longer true and cannot be
relied upon as of the date hereof. We further certify that
interest payable on the interest payment dates on January 1 and
PAGE
<PAGE>
July 1 will be paid with respect to U.S. $_____________ principal
amount of the Securities with respect to which we have received
from Member Organizations certificates substantially in the form
set out in Exhibit D to the Fiscal Agency Agreement relating to
the Securities that the Securities (a) are owned by a person
(other than a financial institution for purposes of resale during
the restricted period) who is not a United States person; (b) are
owned by a United States person (other than a financial
institution for purposes of resale during the restricted period)
who is (i) a foreign branch of a United States financial
institution or (ii) a United States person who acquired such
Securities through the foreign branch of a United States
financial institution and who for purposes of this certification
holds such Securities through such financial institution on the
date hereof and, in either case, such United States financial
institution has agreed, for the benefit of the Company, to comply
with the requirements of Section 165(j)(3)(A), (B) or (C) of the
United States Internal Revenue Code of 1986, as from time to time
amended, and the regulations thereunder; or (c) are owned by a
financial institution for purposes of resale during the
restricted period and such financial institution has certified
that it has not acquired such Securities for purposes of resale
directly or indirectly to a United States person or to a person
within the United States or its possessions.
To the extent that we have knowledge that any of such
certificates from a Member Organization is false and to the
extent that we have not received with respect to any Securities
such certificates from Member Organization, we are not requesting
that payment be made for interest with respect thereto.
We further certify that as of the date hereof we have not
received any notification from any of our Member Organizations to
the effect that the statements made by such Member Organization
with respect to any interest payment on any portion of the
principal amount of the Securities are no longer true and cannot
be relied upon as of the date hereof. We further certify that
under the rules of the undersigned organization, each Member
Organization has agreed that any electronic certification shall
have the effect of a signed certification and that all
certifications shall be retained for at least four years in
compliance with the rules set forth under Treas. Reg. _1. 163-5
(c) (2) (i) (D) (3) (ii).
We undertake that any interest received by us and not paid
as provided above shall be returned to the Fiscal Agent for the
above-captioned Securities immediately prior to the expiration of
two years after such interest payment date in order to be repaid
by such Fiscal Agent to the above issuer at the end of two years
after such interest payment date.
We understand that this certification is required in
connection with certain tax laws and, if applicable, certain
securities laws of the United States. In connection therewith,
if administrative or legal proceedings are commenced or
threatened in connection with which this certification is or
would be relevant, we irrevocably authorize you to produce this
certification to any interested party in such proceedings.
PAGE
<PAGE>
As used herein, "United States" means the United States of
America (including the States and the District of Columbia); and
its territories and possessions, including Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa, Wake Island and the
Northern Mariana Islands. As used herein, "restricted period"
means the period described in Section 1. 163-5(c)(2)(i)(D)(7) of
the Treasury Regulations and "financial institution" means the
persons described in Section 1. 165-12(c)(1)(v) of the Treasury
Regulations.
Dated: ____________________, 1996
Yours faithfully,
[MORGAN GUARANTY TRUST COMPANY OF NEW
YORK, BRUSSELS OFFICE, AS OPERATOR OF
THE EUROCLEAR SYSTEM]
[CEDEL BANK, SOCIETE ANONYME 4**
By:_____________________________
4 ** Delete as appropriate.
PAGE
<PAGE>
EXHIBIT D
Form of Certificate of Beneficial Ownership for
Bearer Securities to be Provided to the
Euroclear Operator or to Cedel Bank, societe anonyme
CERTIFICATION
U.S. $____________
THERMO ELECTRON CORPORATION
4 1/4% Convertible Subordinated Debentures
due January 1, 2003
(the "Securities")
This is to certify that as of the date hereof and except as
set forth below, $___________ aggregate principal amount of the
above-mentioned Securities held by you for our account are owned
or, if this certificate is being delivered in connection with a
payment of interest, were owned, by or on behalf of, (a) a person
(other than a financial institution for purposes of resale during
the restricted period) who is not a United States person; or (b)
a United States person (other than a financial institution for
purposes of resale during the restricted period) who is (i) a
foreign branch of a United States financial institution or (ii) a
United States person acquiring such Securities through the
foreign branch of a United States financial institution and who
for purposes of this certification holds such Securities through
such financial institution on the date hereof, and, in the case
of either (i) or (ii), such United States financial institution
has agreed, for the benefit of the Company, to comply with the
requirements of Section 165(j)(3)(A), (B) or (C) of the United
States Internal Revenue Code of 1986, as from time to time
amended, and the regulations thereunder; or (c) a financial
institution for purposes of resale during the restricted period
and such financial institution has not acquired such Securities
for purposes of resale directly or indirectly to a United States
person or to a person within the United States or its
possessions; and the undersigned has obtained a similar
certificate from its member organizations on which this
certificate is based; provided, however, that if the undersigned
has actual knowledge that the information contained in such a
certificate is false (and, absent documentary evidence that the
beneficial owner of such Security is not a United states person,
it will be deemed to have actual knowledge that such certificate
is false if it has a United States address for such beneficial
owner, other than a financial institution described above), the
undersigned will not deliver a Security in temporary or
definitive bearer form to the person who signed such certificate
notwithstanding the delivery of such certificate to the
undersigned.
PAGE
<PAGE>
No. of Amount
Certificates
$1,000 = $
-------------- ----------------
Denomination __
$10,000 = $
-------------- ----------------
Denomination __
Total Requested = $
-------------- ----------------
__
As used herein, (i) "United States person" means a citizen
or resident of the United States, a corporation, partnership or
other entity created or organized in or under the laws of the
United States and an estate or trust the income of which is
subject to United States Federal income taxation regardless of
its source or any other person deemed a _United States person_ or
a "U.S. person" under the Internal Revenue Code of 1986, as
amended, or Regulation S under the U.S. Securities Act of 1933,
as amended, (ii) "United States" means the United States of
America (including the States and the District of Columbia) and
its territories and possessions, including Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa, Wake Island and the
Northern Mariana Islands, (iii) _restricted period" means the
period described in Section 1.163-5(c)(2)(i)(D)(7) of the
Treasury Regulations, and (iv) "financial institution" means the
persons described in Section 1. 165-12(c)(1)(v) of the United
States Treasury Regulations.
We undertake to advise you promptly by tested telex on or
prior to the date on which you intend to submit your
certification relating to the Securities held by you for our
account in accordance with your operating procedures if any
applicable statement herein is not correct on such date, and in
the absence of any such notification it may be assumed that this
certification applies as of such date.
This certification excepts and does not relate to
U.S.$_______________ of such interest in the above Securities in
respect of which we are not able to certify and as to which we
understand exchange and delivery of definitive Securities cannot
be made until we do so certify.
We understand that this certification is required in
connection with certain tax laws and, if applicable, certain
securities laws of the United States. In connection therewith,
if administrative or legal proceedings are commenced or
threatened in connection with which this certification is or
would be relevant, we irrevocably authorize you to produce this
certification or a copy hereof to any interested party in such
proceedings.
PAGE
<PAGE>
Dated: ___________________, 1996*
[Name]
By:_________________________
Signature
As, or as agent for,
the beneficial
owner[s] of the
Securities to which
this certificate
relates.
PAGE
<PAGE>
EXHIBIT E
Form of Certificate of Beneficial Ownership
for Registered Securities to be Provided to the
Euroclear Operator or to Cedel Bank, societe anonyme
CERTIFICATION
U.S. $____________
THERMO ELECTRON CORPORATION
4 1/4% Convertible Subordinated Debentures
due January 1, 2003
(the "Securities")
Please issue U. S. $_______ of the U.S. $________ aggregate
principal amount of the Securities held by you for our account in
registered form. We hereby certify to you that we are not a
"U.S. Person" as defined in Regulation S under the United States
Securities Act of 1933, as amended. The exact name of the
beneficial holder that the Securities are to be registered in is
as follows:
The following denomination(s) of Registered Securities are
requested (integral multiples of $1,000):
No. of Amount
------ ------
Denominations Certificates
------------- ------------
$ = $
--------------- -------------- ----------------
__ __
= $
---------------- -------------- ----------------
__ __
= $
---------------- -------------- ----------------
__ __
= $
---------------- -------------- ----------------
__ __
= $
-------------- ----------------
Total Requested __
This certificate does not constitute such certification [or
We hereby certify that we have provided such certification] on
Form W-8 or its equivalent as may be necessary to avoid
imposition of withholding and/or back-up withholding under U.S.
PAGE
<PAGE>
federal tax law with respect to any payments of interest on the
Securities .
We irrevocably authorize you to produce this certificate or
a copy hereof to any interested party in any administrative or
proceedings with respect to the matters covered by this
certificate.
Dated: __________________, 1996 78*
Yours faithfully,
[NAME]
By:
Signature
To be completed by the account
holder as, or as agent for, the
beneficial owner(s) of the
Securities to which this
certificate relates.
7
8 * To be dated not earlier than the date which is 40 days
after January 3, 1996.
PAGE
<PAGE>
EXHIBIT F
Form of Certificate to be Given by
The Euroclear Operator and Cedel Bank, societe anonyme
CERTIFICATION
U.S. $_____________
THERMO ELECTRON CORPORATION
4 1/4% Convertible Subordinated Debentures
due December 1, 2003
(the "Securities")
This is to certify that, based solely on certifications we
have received in writing, by tested telex or electronic
transmission from member organizations appearing in our records
as persons being entitled to a portion of the principal amount
set forth below (our "Member Organizations"), substantially to
the effect set forth in the Fiscal Agency Agreement, as of the
date hereof, U.S. $___________ aggregate principal amount of the
above-captioned Securities is owned by persons that are not
citizens or residents of the United States, domestic
partnerships, domestic corporations or any estate or trust the
income of which is subject to United States Federal income
taxation regardless of its source or any other person deemed a
_U.S. person_ under Regulation S under the U.S. Securities Act of
1933, as amended.
The following denomination(s) of Registered Securities are
requested (integral multiples of $1,000):
No. of Amount
------ ------
Certificates
------------
$1,000 = $
-------------- ----------------
Denomination __
$10,000 = $
-------------- ----------------
Denomination __
Total Requested ______________ = $________________
__
We further certify (i) that we are not making available
herewith for exchange (or, if relevant, exercise of any rights or
collection of any interest) any portion of the Regulation S
Global Security excepted in such certifications and (ii) that as
of the date hereof we have not received any notification from any
of our Member Organizations to the effect that the statements
made by such Member Organization with respect to any portion of
PAGE
<PAGE>
the part submitted herewith for exchange (or, if relevant,
exercise of any rights or collection of any interest) are no
longer true and cannot be relied upon as of the date hereof.
We understand that this certification is required in
connection with certain tax laws and, if applicable, certain
securities laws of the United States. In connection therewith,
if administrative or legal proceedings are commenced or
threatened in connection with which this certification is or
would be relevant, we irrevocably authorize you to produce this
certification to any interested party in such proceedings.
As used herein, "United States" means the United States of
America (including the States and the District of Columbia); and
its territories and possessions, including Puerto Rico, the U.S.
Virgin Islands, Guam, American Samoa, Wake Island and the
Northern Mariana Islands.
Dated: __________________, 19969 10*
Yours faithfully,
[MORGAN GUARANTY TRUST COMPANY OF
NEW YORK, BRUSSELS OFFICE, AS OPERATOR OF THE EUROCLEAR SYSTEM]
[CEDEL BANK, SOCIETE ANONYME]
By:____________________________
9
10 * To be dated no earlier than the date which is 40 days
after January 3, 1996.
PAGE
<PAGE>
EXHIBIT G
FORM OF TRANSFEREE LETTER
Thermo Electron Corporation
81 Wyman St.
P.O. Box 9046
Waltham, MA 02254-9046
and
Chemical Bank
Attention: Corporate Trust Department
450 West 33rd Street, 15th floor
New York, New York 10001
and
Chemical Bank House
Attention: Corporate Agency
125 London Wall
London EC2Y 5AJ
England
Ladies and Gentlemen:
We are delivering this letter in connection with the
purchase of 4 1/4% Convertible Subordinated Debentures due 2003 (the
_Debentures_) of Thermo Electron Corporation, a Delaware
corporation (the _Company_), which are convertible into shares of
Common Stock of the Company (the _Underlying Shares_ and together
with the Debentures, the "Restricted Securities"), all as
described in the Company's Offering Circular dated November 28,
1995 (the "Offering Circular").
We represent, warrant and agree as follows:
1. We understand and hereby acknowledge that the
Debentures and, prior to the effectiveness of a registration
statement filed with the Securities and Exchange Commission
relating to the resale of the Underlying Shares, the Underlying
Shares have not been registered under the Securities Act of 1933,
as amended (the "Securities Act"), and may not be sold except as
permitted in the following sentence. We agree on our own behalf
and on behalf of any investor account (as hereinafter defined)
for which we are purchasing the Debentures to offer, sell or
otherwise transfer such Restricted Securities prior to the date
which is three years (or the then applicable holding period under
Rule 144(k) under the Securities Act (or successor provision))
after the later of the date of original issue and the last date
on which the Company or any affiliate of the Company was the
owner of such Restricted Securities (or any predecessor thereto)
(the "Resale Restriction Termination Date") only (a) to the
Company, (b) pursuant to a registration statement which has been
declared effective under the Securities Act, (c) for so long as
the Debentures are eligible for resale pursuant to Rule 144A
under the Securities Act, to a person we reasonably believe is a
qualified institutional buyer under Rule 144A (a _QIB_) that
purchases for its own account or for the account of a QIB to whom
PAGE
<PAGE>
notice is given that the transfer is being made in reliance on
Rule 144A (d) outside the United States in a transaction meeting
the requirements of Rule 904 of Regulation S under the Securities
Act, (e) in a transaction arranged by a broker or dealer
registered under the Securities Exchange Act of 1934, as amended,
to an institutional "accredited investor" within the meaning of
subparagraph (a)(1), (2), (3), or (7) of Rule 501 under the
Securities Act (an "Institutional Accredited Investor") that is
purchasing Restricted Securities for its own account or for the
account of such Institutional Accredited Investor, for investment
purposes and not with a view to, or for offer or sale in
connection with, any distribution in violation of the Securities
Act or (f) pursuant to any other available exemption from the
registration requirements of the Securities Act as confirmed in
an opinion of counsel, acceptable in from and substance to the
Company, and, in each case, in accordance with the applicable
securities laws of any state of the United States or any other
applicable jurisdiction and subject to any requirement of law
that the disposition of our property or the property of such
investor account or accounts be at all times within our or their
control and in compliance with any applicable state securities
laws. The foregoing restrictions on resale will not apply
subsequent to the Resale Restriction Termination Date. If any
resale or other transfer of the Restricted Securities is proposed
to be made pursuant to clause (e) above prior to the Resale
Restriction Termination Date, the transferor shall deliver a
letter from the transferee containing representations and
agreements substantially the same as those contained herein. We
acknowledge that the Company and the Fiscal Agent reserve the
right prior to any offer, sale or other transfer prior to the
Resale Restriction Termination Date of the Debentures and Common
Stock pursuant to clause (d), (e) or (f) above to require the
delivery of an opinion of counsel, certifications or other
information acceptable to the Company and the Fiscal Agent in
form and substance.
2. We are an Institutional Accredited Investor within
the meaning of subparagraph (a)(1), (2), (3) or (7) of Rule 501
under the Securities Act.
3. Any purchase of Restricted Securities by us will
be for our own account or for the account of one or more other
Institutional Accredited Investors (an "investor account") as to
which we exercise sole investment discretion.
4. We are not acquiring the Restricted Securities
with a view to, or for offer or sale in connection with, any
distribution in violation of the Securities Act.
5. We have such knowledge and experience in financial
and business matters as to be capable of evaluating the merits
and risks of purchasing the Restricted Securities, and we and any
investor account for which we are acting are each able to bear
the economic risk of our or its investment.
6. We have received a copy of the Offering Circular
and acknowledge that we have had access to such financial and
other information, and have been afforded the opportunity to ask
such questions of representatives of the Company and receive
PAGE
<PAGE>
answers thereto, as we deem necessary in connection with our
decision to purchase Restricted Securities.
We understand that the registrar and transfer agent will not
be required to accept for registration of transfer any Restricted
Securities, except upon presentation of evidence satisfactory to
the Company and the Fiscal Agent that the foregoing restrictions
on transfer have been complied with. We further understand that
the Restricted Securities will be in the form of definitive
physical certificates and that such certificates will bear a
legend reflecting the substance of paragraph 1 above.
We shall provide to any person purchasing any Restricted
Securities from us a notice advising such purchaser that
transfers of the Debentures and the Underlying Shares are
restricted as set forth herein.
We understand that prior to any proposed offer of Debentures
occurring before the Resale Restriction Termination Date, we must
check the appropriate box set forth on the reverse of the
certificate evidencing such Debentures relating to the manner of
such transfer and submit the certificates to the Fiscal Agent.
In addition, we understand that prior to any proposed transfer of
Debentures or any proposed offer of Underlying Shares acquired
upon conversion of Debentures when there is not effective
registration statement covering such Underlying Shares to an
institutional accredited investor occurring before the Resale
Restriction Termination Date, we may be required to furnish to
the Company and the Fiscal Agent such certifications, legal
opinion or other information as they may reasonably require to
confirm that the proposed transfer is being made pursuant to an
exemption from, or in a transaction not subject to, the
registration requirements of the Securities Act, and that
transfers occurring before the Resale Restriction Termination
Date to any other person pursuant to another available exemption
under the Securities act will require an opinion of counsel
satisfactory to the Company.
We acknowledge that you and others will rely upon our
confirmations, acknowledgments and agreements set forth herein,
and we agree to notify you promptly in writing of any of our
representations or warranties herein ceases to be accurate and
complete. You are irrevocably authorized to produce this letter
or a copy hereof to any interested party in any administrative or
legal proceeding or official inquiry with respect to the matters
covered hereby.
THIS LETTER SHALL BE GOVERNED BY, AND CONSTRUED IN
ACCORDANCE WITH, THE LAWS OF THE COMMONWEALTH OF MASSACHUSETTS.
Very truly yours,
_____________________________
(Name of Purchaser)
By:___________________________
Name:
Title:
Address:
Exhibit 11
Thermo Electron Corporation
Computation of Earnings per Share
1995 1994 1993
------------ ----------- -----------
Computation of Fully Diluted
Earnings per Share:
Income:
Income per primary
computation $140,080,000 $104,711,000 $ 76,868,000
Add: Convertible debt
interest, net of tax 15,561,000 15,934,000 10,273,000
------------ ------------ ------------
Income applicable to common
stock assuming full
dilution (a) $155,641,000 $120,645,000 $ 87,141,000
------------ ------------ ------------
Shares:
Weighted average shares
outstanding 83,655,644 77,666,970 69,468,495
Add: Shares issuable from
assumed conversion of
convertible debentures 20,015,397 22,368,855 16,884,552
Shares issuable from
assumed exercise of
options (as determined
by the application of the
treasury stock method) 1,730,838 783,546 725,577
------------ ------------ ------------
Weighted average shares
outstanding, as
adjusted (b) 105,401,879 100,819,371 87,078,624
------------ ------------ ------------
Fully Diluted Earnings Per
Share (a) / (b) $ 1.48 $ 1.20 $ 1.00
============ ============ ============
Exhibit 13
THERMO ELECTRON CORPORATION
Consolidated Financial Statements
as of December 30, 1995
PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Income
(In thousands except per share amounts) 1995 1994 1993
--------------------------------------------------------------------------
Revenues:
Product revenues $1,802,371 $1,418,306 $1,103,558
Service revenues 210,503 141,438 121,987
Research and development contract
revenues 194,543 169,447 128,963
---------- ---------- ----------
2,207,417 1,729,191 1,354,508
---------- ---------- ----------
Costs and Expenses:
Cost of products 1,064,775 824,845 664,201
Cost of services 144,864 103,800 91,292
Expenses for research and development
and new lines of business (a) 269,584 233,099 183,965
Selling, general and administrative
expenses 480,774 384,715 289,282
Restructuring and other nonrecurring
costs (Note 12) 21,938 650 6,616
---------- ---------- ----------
1,981,935 1,547,109 1,235,356
---------- ---------- ----------
Operating Income 225,482 182,082 119,152
Gain on Issuance of Stock by
Subsidiaries (Note 10) 80,815 25,283 39,863
Other Expense, Net (Note 11) (6,802) (989) (27,548)
---------- ---------- ----------
Income Before Income Taxes and
Minority Interest 299,495 206,376 131,467
Provision for Income Taxes (Note 9) 98,900 70,703 33,513
Minority Interest Expense 60,515 30,962 21,086
---------- ---------- ----------
Net Income $ 140,080 $ 104,711 $ 76,868
========== ========== ==========
Earnings per Share:
Primary $ 1.67 $ 1.35 $ 1.11
========== ========== ==========
Fully diluted $ 1.48 $ 1.20 $ 1.00
========== ========== ==========
Weighted Average Shares:
Primary 83,656 77,667 69,468
========== ========== ==========
Fully diluted 105,402 100,819 87,079
========== ========== ==========
2PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Income (continued)
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
(a) Includes costs of:
Research and development
contracts $ 167,120 $ 149,645 $ 116,733
Internally funded research
and development 98,984 79,555 59,583
Other expenses for new lines
of business 3,480 3,899 7,649
---------- ---------- ----------
$ 269,584 $ 233,099 $ 183,965
========== ========== ==========
The accompanying notes are an integral part of these consolidated financial
statements.
3PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Balance Sheet
(In thousands) 1995 1994
------------------------------------------------------------------------
Assets
Current Assets:
Cash and cash equivalents $ 461,983 $ 383,005
Short-term available-for-sale investments,
at quoted market value (amortized cost of
$588,471 and $617,837) (Note 2) 593,802 614,915
Accounts receivable, less allowances
of $28,021 and $21,664 476,479 347,444
Unbilled contract costs and fees 74,941 59,906
Inventories 318,182 233,382
Prepaid income taxes (Note 9) 72,993 57,824
Prepaid expenses 22,846 15,148
---------- ----------
2,021,226 1,711,624
---------- ----------
Property, Plant and Equipment, at Cost, Net 712,845 624,888
---------- ----------
Long-term Available-for-sale Investments, at
Quoted Market Value (amortized cost of $60,780
and $65,218) (Note 2) 61,845 62,451
---------- ----------
Long-term Held-to-Maturity Investments
(quoted market value of $24,942) (Note 2) 23,819 -
---------- ----------
Other Assets 98,102 85,338
---------- ----------
Cost in Excess of Net Assets of Acquired
Companies (Notes 3 and 9) 827,071 577,634
---------- ----------
$3,744,908 $3,061,935
========== ==========
4PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Balance Sheet (continued)
(In thousands except share amounts) 1995 1994
------------------------------------------------------------------------
Liabilities and Shareholders' Investment
Current Liabilities:
Notes payable and current maturities of
long-term obligations (Note 6) $ 106,248 $ 94,003
Accounts payable 164,605 116,768
Accrued payroll and employee benefits 91,393 79,849
Accrued income taxes 51,807 35,845
Accrued installation and warranty costs 40,699 33,442
Other accrued expenses (Note 3) 260,084 200,985
---------- ----------
714,836 560,892
---------- ----------
Deferred Income Taxes (Note 9) 59,188 58,250
---------- ----------
Other Deferred Items 65,878 57,723
---------- ----------
Long-term Obligations (Note 6):
Senior convertible obligations 458,925 620,000
Subordinated convertible obligations 343,076 186,661
Tax-exempt obligations 128,567 130,985
Nonrecourse tax-exempt obligations 94,700 95,300
Other 90,743 16,904
---------- ----------
1,116,011 1,049,850
---------- ----------
Minority Interest 471,648 327,734
---------- ----------
Commitments and Contingencies (Note 7)
Common Stock of Subsidiary Subject to
Redemption ($18,450 redemption value) 17,513 -
---------- ----------
Shareholders' Investment (Notes 4 and 5):
Preferred stock, $100 par value, 50,000
shares authorized; none issued
Common stock, $1 par value, 175,000,000
shares authorized; 87,863,315 and 53,558,248
shares issued 87,863 53,558
Capital in excess of par value 597,678 493,058
Retained earnings 612,476 472,396
Treasury stock at cost, 11,574 and 38,318
shares (536) (1,631)
Cumulative translation adjustment 561 (3,557)
Deferred compensation (Note 8) (2,271) (2,657)
Net unrealized gain (loss) on available-for-sale
investments (Note 2) 4,063 (3,681)
---------- ----------
1,299,834 1,007,486
---------- ----------
$3,744,908 $3,061,935
========== ==========
The accompanying notes are an integral part of these consolidated financial
statements.
5PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Cash Flows
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
Operating Activities:
Net income $ 140,080 $ 104,711 $ 76,868
Adjustments to reconcile net income
to net cash provided by operating
activities:
Depreciation and amortization 84,979 65,028 44,192
Restructuring and other nonrecurring
costs (Note 12) 21,938 650 6,616
Equity in losses of unconsolidated
subsidiaries 203 4,019 22,721
Provision for losses on accounts
receivable 5,473 4,225 2,720
Increase in deferred income taxes 4,562 9,403 14,134
Gain on sale of property, plant
and equipment (547) (15,025) (198)
Gain on sale of investments (9,305) (4,851) (2,469)
Gain on issuance of stock by
subsidiaries (Note 10) (80,815) (25,283) (39,863)
Minority interest expense 60,515 30,962 21,086
Other noncash expenses 15,642 9,809 7,850
Changes in current accounts,
excluding the effects of
acquisitions:
Accounts receivable (49,442) (8,526) (45,034)
Inventories (31,805) 10,017 (6,525)
Other current assets (8,868) (9,713) (8,319)
Accounts payable 16,341 804 13,865
Other current liabilities 25,613 16,295 (6,319)
--------- --------- ---------
Net cash provided by operating
activities 194,564 192,525 101,325
--------- --------- ---------
Investing Activities:
Acquisitions, net of cash acquired
(Note 3) (330,698) (173,764) (142,962)
Purchases of available-for-sale
investments (570,064) (748,879) -
Purchases of long-term held-to-
maturity investments (22,300) - -
Proceeds from sale and maturities of
available-for-sale investments 617,145 495,361 -
Purchases of property, plant and
equipment (62,907) (65,525) (62,704)
Proceeds from sale of property,
plant and equipment 5,643 21,391 5,224
Purchases of long-term investments - - (20,573)
Proceeds from sale of long-term
investments - - 16,651
Increase in short-term investments - - (193,894)
6PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Cash Flows (continued)
(In thousands) 1995 1994 1993
-------------------------------------------------------------------------
Decrease in net restricted funds $ - $ 23,420 $ -
Other (18,858) (7,662) (7,297)
--------- --------- ---------
Net cash used in investing
activities (382,039) (455,658) (405,555)
--------- --------- ---------
Financing Activities:
Proceeds from issuance of long-term
obligations 201,891 368,620 102,282
Repayment and repurchase of long-term
obligations (16,826) (27,176) (11,732)
Proceeds from issuance of Company
and subsidiary common stock 173,326 60,601 378,790
Purchases of Company and subsidiary
common stock (97,789) (101,481) (57,198)
Increase in short-term notes
payable, net 1,588 16,683 27,343
Other 962 987 3,096
--------- --------- ---------
Net cash provided by financing
activities 263,152 318,234 442,581
--------- --------- ---------
Exchange Rate Effect on Cash 3,301 1,915 (3,374)
--------- --------- ---------
Increase in Cash and Cash Equivalents 78,978 57,016 134,977
Cash and Cash Equivalents at
Beginning of Year 383,005 325,989 191,012
--------- --------- ---------
Cash and Cash Equivalents at End
of Year $ 461,983 $ 383,005 $ 325,989
========= ========= =========
See Note 13 for supplemental cash flow information.
The accompanying notes are an integral part of these consolidated financial
statements.
7PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Shareholders' Investment
Common Capital
Stock, in Excess
$1 Par of Par Retained
(In thousands) Value Value Earnings
-------------------------------------------------------------------------
Balance January 2, 1993 $ 29,633 $260,185 $290,817
Net income - - 76,868
Public offering of Company
common stock 4,500 241,505 -
Issuance of stock under
employees' and directors'
stock plans 216 763 -
Conversion of convertible
obligations 285 6,619 -
Effect of majority-owned
subsidiaries' equity
transactions - (19,029) -
Effect of three-for-two stock
split 15,850 (15,850) -
Translation adjustment - - -
Amortization of deferred
compensation - - -
-------- -------- --------
Balance January 1, 1994 50,484 474,193 367,685
Net income - - 104,711
Issuance of stock under
employees' and directors'
stock plans 153 2,429 -
Conversion of convertible
obligations 2,921 63,013 -
Effect of majority-owned
subsidiaries' equity
transactions - (46,577) -
Translation adjustment - - -
Amortization of deferred
compensation - - -
Effect of change in accounting
principle (Note 2) - - -
Change in net unrealized gain
(loss) on available-for-sale
investments (Note 2) - - -
-------- -------- --------
8PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Shareholders' Investment (continued)
Common Capital
Stock, in Excess
$1 Par of Par Retained
(In thousands) Value Value Earnings
-------------------------------------------------------------------------
Balance December 31, 1994 $ 53,558 $493,058 $472,396
Net income - - 140,080
Issuance of stock under
employees' and directors'
stock plans 571 5,293 -
Tax benefit related to directors'
and employees' stock plans - 9,666 -
Conversion of convertible
obligations 6,047 150,787 -
Effect of majority-owned
subsidiaries' equity
transactions - (33,439) -
Effect of three-for-two stock
split 27,687 (27,687) -
Translation adjustment - - -
Amortization of deferred
compensation - - -
Change in net unrealized gain
(loss) on available-for-sale
investments (Note 2) - - -
-------- -------- --------
Balance December 30, 1995 $ 87,863 $597,678 $612,476
======== ======== ========
The accompanying notes are an integral part of these consolidated financial
statements.
9PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Shareholders' Investment (continued)
Net
Unrealized
Cumulative Gain (Loss)
Transla- on Avail-
tion Deferred able-for-
Treasury Adjust- Compensa- sale
(In thousands) Stock ment tion Investments
---------------------------------------------------------------------------
Balance January 2, 1993 $ (3,810) $ (7,949) $ (5,050) $ -
Net income - - - -
Public offering of Company
common stock - - - -
Issuance of stock under
employees' and directors'
stock plans 2,598 - - -
Conversion of convertible
obligations - - - -
Effect of majority-owned
subsidiaries' equity
transactions - - - -
Effect of three-for-two stock
split - - - -
Translation adjustment - (5,642) - -
Amortization of deferred
compensation - - 1,211 -
-------- -------- -------- --------
Balance January 1, 1994 (1,212) (13,591) (3,839) -
Net income - - - -
Issuance of stock under
employees' and directors'
stock plans (419) - - -
Conversion of convertible
obligations - - - -
Effect of majority-owned
subsidiaries' equity
transactions - - - -
Translation adjustment - 10,034 - -
Amortization of deferred
compensation - - 1,182 -
Effect of change in accounting
principle (Note 2) - - - 2,868
Change in net unrealized gain
(loss) on available-for-sale
investments (Note 2) - - - (6,549)
-------- -------- -------- --------
10PAGE
<PAGE>
Thermo Electron Corporation
Consolidated Statement of Shareholders' Investment (continued)
Net
Unrealized
Cumulative Gain (Loss)
Transla- on Avail-
tion Deferred able-for-
Treasury Adjust- Compensa- sale
(In thousands) Stock ment tion Investments
---------------------------------------------------------------------------
Balance December 31, 1994 $ (1,631) $ (3,557) $ (2,657) $ (3,681)
Net income - - - -
Issuance of stock under
employees' and directors'
stock plans 1,095 - - -
Tax benefit related to directors'
and employees' stock plans - - - -
Conversion of convertible
obligations - - - -
Effect of majority-owned
subsidiaries' equity
transactions - - - -
Effect of three-for-two stock
split - - -
Translation adjustment - 4,118 - -
Amortization of deferred
compensation - - 386 -
Change in net unrealized gain
(loss) on available-for-sale
investments (Note 2) - - - 7,744
-------- -------- -------- --------
Balance December 30, 1995 $ (536) $ 561 $ (2,271) $ 4,063
======== ======== ======== ========
The accompanying notes are an integral part of these consolidated financial
statements.
11PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
1. Nature of Operations and Significant Accounting Policies
Nature of Operations
Thermo Electron Corporation and its subsidiaries develop, manufacture, and
market environmental monitoring and analysis instruments; biomedical
products including heart-assist devices, respiratory care equipment, and
mammography systems; paper-recycling and papermaking equipment;
alternative-energy systems; industrial process equipment; and other
specialized products. The Company also provides environmental, laboratory,
and metallurgical services and conducts advanced-technology research and
development.
Principles of Consolidation
The accompanying consolidated financial statements include the accounts of
Thermo Electron Corporation and its majority- and wholly owned subsidiaries
(the Company). All material intercompany accounts and transactions have
been eliminated. Majority-owned public subsidiaries include Thermedics
Inc., Thermo Instrument Systems Inc., Thermo TerraTech Inc. (formerly
Thermo Process Systems Inc.), Thermo Power Corporation, ThermoTrex
Corporation, Thermo Fibertek Inc., and Thermo Ecotek Corporation. Thermo
Cardiosystems Inc. and Thermo Voltek Corp. are majority-owned, public
subsidiaries of Thermedics. Thermo Remediation Inc. is a majority-owned
public subsidiary of Thermo TerraTech. ThermoLase Corporation is a
majority-owned, public subsidiary of ThermoTrex. ThermoSpectra Corporation
is a majority-owned, public subsidiary of Thermo Instrument. Thermo
BioAnalysis Corporation is a majority-owned, privately held subsidiary of
Thermo Instrument. ThermoQuest Corporation and Thermo Optek Corporation are
wholly owned subsidiaries of Thermo Instrument, which have privately sold
debentures that will be convertible into shares of common stock of these
subsidiaries upon completion of their initial public offerings. Thermo
EuroTech N.V. is a majority-owned, privately held subsidiary of Thermo
TerraTech. ThermoLyte Corporation is a majority-owned, privately held
subsidiary of Thermo Power. Trex Medical Corporation is a majority-owned,
privately held subsidiary of ThermoTrex. The Company accounts for
investments in businesses in which it owns between 20% and 50% using the
equity method.
Fiscal Year
The Company has adopted a fiscal year ending the Saturday nearest December
31. References to 1995, 1994, and 1993 are for the fiscal years ended
December 30, 1995, December 31, 1994, and January 1, 1994, respectively.
Revenue Recognition
For the majority of its operations, the Company recognizes revenues upon
shipment of its products or upon completion of services it renders. The
Company provides a reserve for its estimate of warranty and installation
costs at the time of shipment. Revenues and profits on substantially all
contracts are recognized using the percentage-of-completion method.
Revenues recorded under the percentage-of-completion method were $472.0
million in 1995, $319.8 million in 1994, and $281.4 million in 1993. The
percentage of completion is determined by relating either the actual costs
or actual labor incurred to date to management's estimate of total costs or
total labor, respectively, to be incurred on each contract. If a loss is
indicated on any contract in process, a provision is made currently for the
entire loss. The Company's contracts generally provide for billing of
customers upon the attainment of certain milestones specified in each
12PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
1. Nature of Operations and Significant Accounting Policies (continued)
contract. Revenues earned on contracts in process in excess of billings are
classified as unbilled contract costs and fees in the accompanying balance
sheet. There are no significant amounts included in the accompanying
balance sheet that are not expected to be recovered from existing contracts
at current contract values, or that are not expected to be collected within
one year, including amounts that are billed but not paid under retainage
provisions.
In August 1993, the Company agreed, in exchange for a cash settlement,
to terminate a power sales agreement between a subsidiary of the Company
and a utility. The power sales agreement required the utility to purchase
output of a cogeneration facility that had been under development. Under
the termination agreement, the Company received $15.3 million through 1995,
with subsequent payments of $2.7 million to be made through 1997. The
Company will be obligated to return $8.2 million of this settlement if the
Company elects to proceed with the facility and it achieves commercial
operation before January 1, 2000. Accordingly, the Company has deferred
recognition of $8.2 million of revenues, pending final determination of the
project's status. During 1993, the Company recorded revenues of $9.8
million and operating income of $5.4 million from the termination of the
power sales agreement.
Gain on Issuance of Stock by Subsidiaries
At the time a subsidiary sells its stock to unrelated parties at a price in
excess of its book value, the Company's net investment in that subsidiary
increases. If at that time the subsidiary is an operating entity and not
engaged principally in research and development, the Company records the
increase as a gain.
If gains have been recognized on issuances of a subsidiary's stock and
shares of the subsidiary are subsequently repurchased by the subsidiary or
by the Company, gain recognition does not occur on issuances subsequent to
the date of a repurchase until such time as shares have been issued in an
amount equivalent to the number of repurchased shares. Such transactions
are reflected as equity transactions, and the net effect of these
transactions is reflected in the accompanying statement of shareholders'
investment as the effect of majority-owned subsidiaries' equity
transactions.
Income Taxes
In accordance with Statement of Financial Accounting Standards (SFAS) No.
109, "Accounting for Income Taxes," the Company recognizes deferred income
taxes based on the expected future tax consequences of differences between
the financial statement basis and the tax basis of assets and liabilities,
calculated using enacted tax rates in effect for the year in which the
differences are expected to be reflected in the tax return.
Earnings per Share
Primary earnings per share have been computed based on the weighted average
number of common shares outstanding during the year. Because the effect of
common stock equivalents was not material, they have been excluded from the
primary earnings per share calculation. Fully diluted earnings per share
assumes the exercise of stock options and the conversion of the Company's
dilutive convertible obligations and elimination of the related interest
expense.
13PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
1. Nature of Operations and Significant Accounting Policies (continued)
Stock Split
All share and per share information has been restated to reflect a
three-for-two stock split, effected in the form of a 50% stock dividend,
which was distributed in May 1995.
Cash and Cash Equivalents
Cash equivalents consist principally of U.S. government agency securities,
corporate notes, commercial paper, money market funds, and other marketable
securities purchased with an original maturity of three months or less.
These investments are carried at cost, which approximates market value.
Available-for-sale and Held-to-maturity Investments
Pursuant to SFAS No. 115, "Accounting for Certain Investments in Debt and
Equity Securities," short- and long-term debt and marketable equity
securities that the Company considers available-for-sale are accounted for
at market value. Debt securities that the Company intends to hold to
maturity are accounted for at amortized cost (Note 2). Prior to 1994,
short- and long-term marketable equity securities were carried at the lower
of cost or market value.
Inventories
Inventories are stated at the lower of cost (on a first-in, first-out or
weighted average basis) or market value and include materials, labor, and
manufacturing overhead. The components of inventories are as follows:
(In thousands) 1995 1994
----------------------------------------------------------------------
Raw materials and supplies $172,742 $128,876
Work in process 72,087 44,711
Finished goods 73,353 59,795
-------- --------
$318,182 $233,382
======== ========
Property, Plant and Equipment
The costs of additions and improvements are capitalized, while maintenance
and repairs are charged to expense as incurred. The Company provides for
depreciation and amortization using the straight-line method over the
estimated useful lives of the property as follows: buildings and
improvements -- 5 to 40 years, alternative-energy and waste-recycling
14PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
1. Nature of Operations and Significant Accounting Policies (continued)
facilities -- 5 to 25 years, machinery and equipment -- 3 to 20 years, and
leasehold improvements -- the shorter of the term of the lease or the life
of the asset. Property, plant and equipment consist of the following:
(In thousands) 1995 1994
-----------------------------------------------------------------------
Land $ 47,848 $ 43,990
Buildings 175,165 143,727
Alternative-energy and waste-recycling
facilities 382,257 335,064
Machinery, equipment and leasehold
improvements 361,799 288,544
-------- --------
967,069 811,325
Less: Accumulated depreciation and
amortization 254,224 186,437
-------- --------
$712,845 $624,888
======== ========
Other Assets
Other assets in the accompanying balance sheet include the costs of
acquired trademarks, patents, and other specifically identifiable
intangible assets, as well as capitalized costs associated with the
Company's operation of certain alternative-energy facilities. These assets
are being amortized using the straight-line method over their estimated
useful lives, which range from 5 to 20 years. These assets were $44.5
million and $39.7 million, net of accumulated amortization of $27.4 million
and $21.7 million, at year-end 1995 and 1994, respectively.
Cost in Excess of Net Assets of Acquired Companies
The excess of cost over the fair value of net assets of acquired companies
is amortized using the straight-line method principally over 40 years.
Accumulated amortization was $65.3 million and $47.3 million at year-end
1995 and 1994, respectively. The Company assesses the future useful life of
this asset whenever events or changes in circumstances indicate that the
current useful life has diminished. The Company considers the future
undiscounted cash flows of the acquired companies in assessing the
recoverability of this asset.
Common Stock of Subsidiary Subject to Redemption
In March 1995, ThermoLyte sold 1,845,000 units, each unit consisting of one
share of ThermoLyte common stock and one redemption right, at $10.00 per
unit, for net proceeds of $17.3 million. Holders of the common stock
purchased in the offering will have the option to require ThermoLyte to
redeem in December 1998 or 1999 any or all of their shares at $10.00 per
share. The difference between the redemption value and the original
carrying amount of common stock of subsidiary subject to redemption is
accreted over the period ending December 1998, which corresponds to the
first redemption period. The accretion is charged to minority interest
expense in the accompanying statement of income.
15PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
1. Nature of Operations and Significant Accounting Policies (continued)
Foreign Currency
All assets and liabilities of the Company's foreign subsidiaries are
translated at year-end exchange rates, and revenues and expenses are
translated at average exchange rates for the year in accordance with SFAS
No. 52, "Foreign Currency Translation." Resulting translation adjustments
are reflected as a separate component of shareholders' investment titled
"Cumulative translation adjustment." Foreign currency transaction gains and
losses are included in the accompanying statement of income and are not
material for the three years presented.
Use of Estimates
The preparation of financial statements in conformity with generally
accepted accounting principles requires management to make estimates and
assumptions that affect the reported amounts of assets and liabilities and
disclosure of contingent assets and liabilities at the date of the
financial statements and the reported amounts of revenues and expenses
during the reporting period. Actual results could differ from those
estimates.
Presentation
The historical financial information presented has been restated to reflect
the March 1995 acquisition of Coleman Research Corporation, which has been
accounted for under the pooling-of-interests method (Note 3).
2. Available-for-sale and Held-to-maturity Investments
Effective January 2, 1994, the Company adopted SFAS No. 115, "Accounting
for Certain Investments in Debt and Equity Securities." In accordance with
SFAS No. 115, certain of the Company's debt and marketable equity
securities are considered available-for-sale investments in the
accompanying balance sheet and are carried at market value, with the
difference between cost and market value, net of related tax effects,
recorded currently as a component of shareholders' investment titled "Net
unrealized gain (loss) on available-for-sale investments." Effect of change
in accounting principle in the accompanying 1994 statement of shareholders'
investment represents the unrealized gain, net of related tax effects,
pertaining to available-for-sale investments held by the Company on January
2, 1994.
16PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
2. Available-for-sale and Held-to-maturity Investments (continued)
The aggregate market value, cost basis, and gross unrealized gains and
losses of short- and long-term available-for-sale investments by major
security type, at year-end 1995 and 1994, are as follows:
1995 Gross Gross
Market Cost Unrealized Unrealized
(In thousands) Value Basis Gains Losses
---------------------------------------------------------------------------
Government agency securities $367,208 $366,659 $ 574 $ (25)
Corporate bonds 194,628 192,422 2,223 (17)
Tax-exempt securities 16,275 16,247 28 -
Other 77,536 73,923 3,885 (272)
-------- -------- -------- --------
$655,647 $649,251 $ 6,710 $ (314)
======== ======== ======== ========
1994 Gross Gross
Market Cost Unrealized Unrealized
(In thousands) Value Basis Gains Losses
---------------------------------------------------------------------------
Government agency securities $287,418 $291,342 $ - $ (3,924)
Corporate bonds 298,799 301,103 74 (2,378)
Tax-exempt securities 33,588 33,882 - (294)
Other 57,561 56,728 2,783 (1,950)
-------- -------- -------- --------
$677,366 $683,055 $ 2,857 $ (8,546)
======== ======== ======== ========
Short- and long-term available-for-sale investments in the
accompanying 1995 balance sheet include equity securities of $22.9 million,
debt securities of $280.9 million with contractual maturities of one year
or less, debt securities of $321.0 million with contractual maturities of
more than one year through five years, and debt securities of $30.8 million
with contractual maturities of more than five years. Actual maturities may
differ from contractual maturities as a result of the Company's intent to
sell these securities prior to maturity and as a result of put and call
options that enable either the Company and/or the issuer to redeem these
securities at an earlier date.
The cost of available-for-sale investments that were sold was based on
specific identification in determining realized gains and losses recorded
in the accompanying statement of income. Gain on sale of investments in
1995 resulted from gross realized gains of $9.8 million and gross realized
losses of $0.5 million relating to the sale of available-for-sale
investments. Gain on sale of investments in 1994 resulted from gross
realized gains of $6.7 million and gross realized losses of $1.8 million
relating to the sale of available-for-sale investments.
Held-to-maturity investments in the accompanying 1995 balance sheet
represent investments in U.S. treasury bonds that mature in February and
May 1998. It is the Company's intent to hold these securities to maturity.
17PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
3. Acquisitions
In March 1995, the Company acquired Coleman Research Corporation in
exchange for 4,002,224 shares of the Company's common stock, including
202,861 shares reserved for issuance upon exercise of stock options assumed
upon the acquisition of Coleman Research. Coleman Research provides systems
integration, systems engineering, and analytical services to government and
commercial customers in fields of information technology, energy and the
environment, software engineering, launch systems, advanced radar imaging,
and health systems. The acquisition has been accounted for under the
pooling-of-interests method.
Accordingly, all historical financial information presented has been
restated to include the acquisition of Coleman Research. Revenues and net
income for 1994 and 1993, as previously reported by the separate entities
prior to the acquisition and as restated for the combined Company, are as
follows:
(In thousands) 1994 1993
------------------------------------------------------------------
Revenues:
Previously reported $1,585,348 $1,249,718
Coleman Research 143,843 104,790
---------- ----------
$1,729,191 $1,354,508
========== ==========
Net Income:
Previously reported $ 103,410 $ 76,633
Coleman Research 1,301 235
---------- ----------
$ 104,711 $ 76,868
========== ==========
In addition, in 1995, the Company and its majority-owned subsidiaries
made several acquisitions for an aggregate of $339.1 million in cash, the
issuance of common stock and stock options of the Company's majority-owned
subsidiaries valued at $19.0 million, and the issuance of $22.3 million in
debt. In 1994, the Company and its majority-owned subsidiaries made several
acquisitions for an aggregate of $174.3 million in cash.
These acquisitions have been accounted for using the purchase method
of accounting, and the acquired companies' results of operations have been
included in the accompanying financial statements from their respective
dates of acquisition. The aggregate cost of the acquisitions in 1994 and
1995 exceeded the estimated fair value of the acquired net assets by $385.6
million, which is being amortized principally over 40 years. Allocation of
the purchase price for these acquisitions was based on estimates of the
fair value of the net assets acquired and, for acquisitions completed in
1995, is subject to adjustment upon finalization of the purchase price
allocation. Pro forma data is not presented since the acquisitions were not
material to the Company's results of operations.
Other accrued expenses in the accompanying balance sheet includes
approximately $33 million and $26 million at year-end 1995 and 1994,
respectively, for estimated severance, relocation, and other reserves
associated with acquisitions.
18PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
4. Common Stock
At December 30, 1995, the Company had reserved 30,229,901 unissued shares
of its common stock for possible issuance under stock-based compensation
plans, for possible conversion of the Company's convertible debentures, and
for possible exchange of subsidiaries' convertible obligations into common
stock of the Company. Substantially all of the subsidiaries' obligations
are exchangeable into common stock of the Company in the event of a change
in control (as defined in the related fiscal agency agreement) that has not
been approved by the continuing members of Company's Board of Directors
(Note 6). The exchange price would be equal to 50% of the average price of
the Company's common stock for the 30 trading days preceding the change in
control.
In January 1996, the Company redeemed the share purchase rights
outstanding under its previously existing shareholder rights plan for $.02
per right, or $.009 per share of the Company's common stock outstanding.
Simultaneous with this redemption, the Company distributed rights under a
new shareholder rights plan adopted by the Company's Board of Directors to
holders of outstanding shares of the Company's common stock. Each right
entitles the holder to purchase one ten-thousandth of a share of Series B
Junior Participating Preferred Stock, $100 par value, at a purchase price
of $250 per share, subject to adjustment. The rights will not be
exercisable until the earlier of (i) 10 days following a public
announcement that a person or group of affiliated or associated persons (an
Acquiring Person) has acquired, or obtained the right to acquire,
beneficial ownership of 15% or more of the outstanding shares of common
stock (the Stock Acquisition Date), or (ii) 10 business days following the
commencement of a tender offer or exchange offer for 15% or more of the
outstanding shares of common stock.
In the event that a person becomes the beneficial owner of 15% or more
of the outstanding shares of common stock, except pursuant to an offer for
all outstanding shares of common stock approved by the outside Directors,
each holder of a right (except for the Acquiring Person) will thereafter
have the right to receive, upon exercise, that number of shares of common
stock that equals the exercise price of the right divided by one half of
the current market price of the common stock. In the event that, at any
time after any person has become an Acquiring Person, (i) the Company is
acquired in a merger or other business combination transaction in which the
Company is not the surviving corporation or its common stock is changed or
exchanged (other than a merger that follows an offer approved by the
outside Directors), or (ii) 50% or more of the Company's assets or earning
power is sold or transferred, each holder of a right (except for the
Acquiring Person) shall thereafter have the right to receive, upon
exercise, the number of shares of common stock of the acquiring company
that equals the exercise price of the right divided by one half of the
current market price of such common stock.
At any time until 10 days following the Stock Acquisition Date, the
Company may redeem the rights in whole, but not in part, at a price of $.01
per right (payable in cash or stock). The rights expire on January 29,
2006, unless earlier redeemed or exchanged.
19PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
5. Stock-based Compensation Plans
The Company has several stock-based compensation plans for its key
employees, directors, and others, which permit the award of stock-based
incentives in the stock of the Company and its majority-owned subsidiaries.
The Company has a nonqualified stock option plan, adopted in 1974, and an
incentive stock option plan, adopted in 1981, which permit the award of
stock options to key employees. The incentive stock option plan expired in
1991, and no grants were made after that date. An equity incentive plan,
adopted in 1989, permits the grant of a variety of stock and stock-based
awards as determined by the human resources committee of the Company's
Board of Directors (the Board Committee), including restricted stock, stock
options, stock bonus shares or performance-based shares. To date, only
nonqualified stock options have been awarded under this plan. The option
recipients and the terms of options granted under these plans are
determined by the Board Committee. Generally, options presently outstanding
under these plans are exercisable immediately, but are subject to certain
transfer restrictions and the right of the Company to repurchase shares
issued upon exercise of the options at the exercise price, upon certain
events. The restrictions and repurchase rights generally lapse ratably over
periods ranging from two to ten years after the first anniversary of the
grant date, depending on the term of the option, which may range from three
to twelve years. In addition, under certain options, shares acquired upon
exercise are restricted from resale until retirement or other events.
Nonqualified options may be granted at any price determined by the Board
Committee, while incentive stock options must be granted at not less than
the fair market value of the Company's stock on the date of grant.
Generally, stock options have been granted at fair market value. The
Company also has a directors' stock option plan, adopted in 1993, that
provides for the annual grant of stock options of the Company and its
majority-owned subsidiaries to outside directors pursuant to a formula
approved by the Company's shareholders. Options awarded under this plan are
exercisable six months after the date of grant and expire three to seven
years after the date of grant. In addition to the Company's stock-based
compensation plans, certain officers and key employees may also participate
in stock-based compensation plans of the Company's majority-owned
subsidiaries.
In connection with the acquisition of Coleman Research in 1995, the
Company assumed certain outstanding options granted under Coleman
Research's nonqualified stock option plan. Such options were converted into
options to purchase shares of the Company's common stock, in accordance
with the original terms of the options. On the date of acquisition, 25% of
the nonvested options being converted became exercisable immediately. The
remaining options become exercisable commencing two or three years after
the date of grant, and expire three or four years from the date of grant.
No accounting recognition is given to options granted at fair market
value until they are exercised. Upon exercise, net proceeds, including tax
benefits realized, are credited to equity.
20PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
5. Stock-based Compensation Plans (continued)
A summary of the Company's stock option information is as follows:
1995 1994 1993
---------------- ---------------- ----------------
Range Range Range
of of of
Option Option Option
Number Prices Number Prices Number Prices
(In thousands except of per of per of per
per share amounts) Shares Share Shares Share Shares Share
--------------------------------------------------------------------------
Options outstanding, $ 4.85- $ 4.85- $ 4.85-
beginning of year 5,252 $30.07 4,442 $28.21 3,111 $20.87
Assumed upon
acquisition of 5.21-
Coleman 203 10.45 -- -- -- --
32.17- 25.79- 26.15-
Granted 887 48.90 1,094 30.07 1,838 28.21
4.85- 6.15- 4.85-
Exercised (733) 27.59 (210) 20.87 (476) 19.35
8.33- 7.69- 7.15-
Lapsed or canceled (74) 37.27 (74) 27.59 (31) 24.71
----- ----- -----
Options outstanding, $ 6.36- $ 4.85- $ 4.85-
end of year 5,535 $48.90 5,252 $30.07 4,442 $28.21
===== ===== =====
$ 6.36- $ 4.85- $ 4.85-
Options exercisable 5,508 $48.90 5,252 $30.07 4,442 $28.21
===== ===== =====
Options available
for grant 1,598 2,418 438
===== ===== =====
21PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
6. Long-term Obligations and Other Financing Arrangements
Long-term obligations of the Company are as follows:
(In thousands except per share amounts) 1995 1994
- -------------------------------------------------------------------------------
5% Senior convertible debentures,
due 2001, convertible at $31.50 per share $ 309,000 $ 345,000
4 5/8% Senior convertible debentures,
due 1997, convertible at $21.50 per share 82,325 205,000
4 7/8% Subordinated convertible debentures,
due 1997, convertible at $21.50 per share 55,000 55,000
3 3/4% Senior convertible debentures,
due 2000, convertible into shares of
Thermo Instrument at $16.93 per share 67,600 70,000
6 5/8% Subordinated convertible debentures,
due 2001, convertible into shares of
Thermo Instrument at $9.38 per share 22,275 36,862
5% Subordinated convertible debentures,
due 2000, convertible into shares of ThermoQuest 86,250 -
5% Subordinated convertible debentures,
due 2000, convertible into shares of Thermo Optek 86,250 -
4 7/8% Subordinated convertible debentures,
due 2000, convertible into shares of
Thermo Remediation at $17.92 per share 34,950 -
6 1/2% Subordinated convertible debentures,
due 1998, convertible into shares of
Thermedics at $10.42 per share 8,037 10,252
6 1/2% Subordinated convertible debentures,
due 1997, convertible into shares of
Thermo TerraTech at $10.33 per share 13,432 16,597
Noninterest-bearing subordinated convertible
debentures, due 1997, convertible into shares
of Thermo Cardiosystems at $21.74 per share 11,642 33,000
5 1/2% Subordinated convertible notes,
due 2002, convertible into shares of
Thermo Cardiosystems at $9.88 per share - 450
3 3/4% Subordinated convertible debentures,
due 2000, convertible into shares of Thermo
Voltek at $11.75 per share 25,240 34,500
8.1% Nonrecourse tax-exempt obligation, payable
in semiannual installments, with final
payment in 2000 59,100 62,500
6.0% Nonrecourse tax-exempt obligation, payable
in semiannual installments, with final
payment in 2000 49,700 49,700
Tax-exempt obligations, payable in semiannual
installments, with final payment in 2017 132,047 133,670
Other 101,228 19,353
---------- ----------
1,144,076 1,071,884
Less: Current maturities of long-term
obligations 28,065 22,034
---------- ----------
$1,116,011 $1,049,850
========== ==========
22PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
6. Long-term Obligations and Other Financing Arrangements (continued)
The debentures that are convertible into subsidiary common stock have
been issued by the respective subsidiaries and are guaranteed by the
Company.
In the event of a change in control of the Company (as defined in the
related fiscal agency agreement) that has not been approved by the
continuing members of the Company's Board of Directors, each holder of the
5%, 4 5/8%, and 4 7/8% convertible debentures issued by the Company will
have the right to require the Company to buy all or part of the holder's
debentures, at par value plus accrued interest, within 50 calendar days
after the date of expiration of a specified approval period. In addition,
substantially all of the obligations convertible into subsidiary common
stock become exchangeable for common stock of the Company at an exchange
price equal to 50% of the average price of the Company's common stock for
the 30 trading days preceding the change in control.
Nonrecourse tax-exempt obligations represent obligations issued by the
California Pollution Control Financing Authority (CPCFA), the proceeds of
which were used to finance two alternative-energy facilities (Delano I and
Delano II) located in Delano, California. The obligations are payable only
by a subsidiary of Thermo Ecotek and are not guaranteed by the Company,
except under limited circumstances. As required by the financing bank
group, Thermo Ecotek entered into interest rate swap agreements that
effectively convert these obligations from floating rates to the fixed
rates described above. These swaps have terms expiring in 2000,
commensurate with the final maturity of the debt. During 1995 and 1994, the
average variable rate received under the interest rate swap agreements was
3.8% and 4.9%, respectively.
Tax-exempt obligations represent obligations issued by the CPCFA in
January 1992, the proceeds of which were used to finance the construction
of a waste-recycling facility in San Diego County, California. Construction
of this facility was completed in 1994. Of these tax-exempt obligations,
$93 million carry fixed rates of interest ranging from 7.2% to 8.5%, and
$39 million carry a floating rate of interest that varies weekly based on
short-term, tax-exempt markets. The interest rate ranged from 4.3% to 7.5%
in 1995 and 3.1% to 7.2% in 1994.
During 1994, the Company capitalized $2.1 million of interest expense,
net of interest income, incurred in connection with the construction of the
waste-recycling facility discussed above.
The annual requirements for long-term obligations are as follows:
(In thousands)
--------------------------------------------------------
1996 $ 28,065
1997 214,181
1998 67,650
1999 37,084
2000 333,316
2001 and thereafter 463,780
----------
$1,144,076
==========
23PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
6. Long-term Obligations and Other Financing Arrangements (continued)
Certain of the Company's obligations include requirements to maintain
predetermined financial ratios. At December 30, 1995, the Company was in
compliance with these requirements.
See Note 14 for fair value information pertaining to the Company's
long-term obligations.
Notes payable and current maturities of long-term obligations in the
accompanying balance sheet include $78.1 million and $71.9 million in 1995
and 1994, respectively, of short-term bank borrowings by several of the
Company's subsidiaries. The weighted average interest rates for these
borrowings were 5.1% and 6.2% at year-end 1995 and 1994, respectively.
7. Commitments and Contingencies
Litigation
Cogeneration Joint Venture
The Company has participated in the operation of the Dade County Downtown
Government Center cogeneration facility in Miami, Florida, through a 50/50
joint venture of the Company and Rolls-Royce, Inc. Because the demand for
power and chilled water at the Dade County Downtown Government Center
complex has been substantially less than anticipated since the plant's
startup in 1987, and because the plant has had difficulty disposing of the
remainder of its output, the joint venture has experienced continuing
losses. In September 1994, the plant's operations were suspended in
connection with the resolution of litigation that the joint venture brought
against Dade County related to the plant.
The joint venture has a pending antitrust lawsuit against another
purchaser of part of the plant's output, Florida Power and Light (FPL). FPL
has continued to pursue petitions it has filed with the Florida Public
Service Commission (FPSC) and the Federal Energy Regulatory Commission
(FERC). The petition at FPSC seeks a determination that the joint venture
has been engaging in illegal retail sales of electricity. FPL's actions at
FERC seek to take advantage of a 1993 FERC order finding that, from 1987
through 1991, the plant did not meet required operating efficiencies. If
either FPSC or FERC were to take the action requested by FPL, the joint
venture could be subject to potentially significant refund and other
liabilities, including any deficiency between (a) in the event the lessor
of the plant's generating equipment declared a default under the lease and
sold the equipment, approximately $44 million and the amount realized from
the sale, or (b) in the case of a re-lease by the lessor in lieu of a sale,
the present value of future rentals and prepayment penalty under the lease
(approximately $33 million) and the present value of a fair rental to be
collected from a new tenant. The joint venture's revenues for the
cumulative period from 1987 through 1991 were $26.3 million.
In 1996, the joint venture and FPL entered into an agreement to settle
their disputes. Before the settlement can become effective, it must be
approved by FPSC. There can be no assurance as to whether or when FPSC will
approve the settlement agreement. The settlement would include (i) the
continued closure of the plant but the availability of its capacity for
24PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
7. Commitments and Contingencies (continued)
potential dispatch by FPL, (ii) payments by FPL of the plant's lease
payments and operation and maintenance costs, and (iii) termination of the
antitrust litigation and withdrawal of FPL's motions in the FPSC and FERC
proceedings.
Other Litigation and Related Contingencies
The Company's wholly owned Napco, Inc. subsidiary is challenging a jury
verdict rendered against it during the third quarter of 1994 for
approximately $11.0 million in a contract dispute arising out of an
allegedly defective waste-treatment system installed by Napco in 1984. The
Company believes that the verdict is in error and has appealed the decision
to the U.S. Court of Appeals for the First Circuit. Because this verdict
exceeds Napco's financial ability to pay, Napco has filed a petition for
bankruptcy.
In a lawsuit relating to the Company's waste-recycling facility in
southern California, a third party, from which the Company acquired certain
development rights, alleges that fees totaling $7.9 million plus interest
and legal costs are due and payable by the Company in connection with
construction of the facility. The Company contends that no additional fees
are payable because the facility actually built was substantially different
from the one contemplated in the agreement with the third-party developer.
The Company has been sued by third-party developers of an alternative-
energy facility, constructed by the Company and its subcontractors in 1988
and 1989 and leased and operated by a partnership including Thermo Ecotek.
The third-party developers seek $25 million in damages for alleged
misrepresentation, breach of contract, and other causes of action. The
dispute arises out of the development, construction, and subsequent
operating performance of the plant. The Company believes that the
allegations are without merit and intends to vigorously defend this matter.
The Company's ThermoTrex subsidiary is a defendant in a lawsuit brought
by Fischer Imaging Corporation (Fischer), which alleges that the
StereoGuide(R) prone breast-biopsy system of ThermoTrex's Lorad division
infringes on a Fischer patent on a precision mammographic needle-biopsy
system. The Company believes it has meritorious legal defenses and intends
to vigorously defend the matter. Lorad's cumulative revenues from this
product totaled approximately $39 million through December 30, 1995.
In the opinion of management, the ultimate liability for all such
matters, together with the liability for all other pending legal
proceedings, asserted legal claims, and known potential legal claims that
are probable of assertion, will not be material to the Company's financial
position, but could materially affect the results of operations or cash
flows for a particular quarter or annual period.
25PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
7. Commitments and Contingencies (continued)
Operating Leases
The Company leases portions of its office and operating facilities under
various noncancelable operating lease arrangements. The accompanying
statement of income includes expenses from operating leases of $30.3
million, $24.3 million, and $17.2 million in 1995, 1994, and 1993,
respectively. Minimum rental commitments under noncancelable operating
leases at December 30, 1995, are as follows:
(In thousands)
------------------------------------------------------
1996 $ 30,591
1997 23,955
1998 18,228
1999 13,717
2000 11,994
2001 and thereafter 49,346
--------
$147,831
========
8. Employee Benefit Plans
401(k) Savings Plan
The Company's 401(k) savings plan covers the majority of the Company's
eligible full-time U.S. employees. Contributions to the plan are made by
both the employee and the Company. Company contributions are based on the
level of employee contributions. For this plan, the Company contributed and
charged to expense $7.6 million, $6.5 million, and $4.5 million in 1995,
1994, and 1993, respectively.
Other Retirement Plans
Certain of the Company's subsidiaries offer retirement plans, separate from
the Company's 401(k) savings plan. These retirement plans cover
approximately a third of the Company's U.S. employees. The majority of
these subsidiaries offer 401(k) savings plans; however, one subsidiary
offers a money purchase plan, and two subsidiaries offer profit-sharing
plans. Company contributions to the 401(k) savings plans are based on the
level of employee contributions. Company contributions to the money
purchase plan and profit-sharing plans are based on formulas determined by
the Company. For these plans, the Company contributed and charged to
expense $7.7 million, $5.8 million, and $4.8 million in 1995, 1994, and
1993, respectively.
26PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
8. Employee Benefit Plans (continued)
Employee Stock Ownership Plan
The Company's Employee Stock Ownership Plan (ESOP) covers eligible
full-time U.S. employees. The Company borrowed funds from a financial
institution and then loaned these funds to the ESOP to purchase shares of
common stock of the Company and its majority-owned subsidiaries. The loan
balance between the Company and the financial institution was paid in 1992.
The loan between the Company and the ESOP remains outstanding. The shares
purchased are reported as deferred compensation in the accompanying balance
sheet. The Company makes annual contributions to the ESOP, and shares are
allocated to plan participants based on employee compensation. Effective
December 31, 1994, the ESOP was split into two plans: ESOP I, covering
employees of the Company's corporate office and its wholly owned
subsidiaries and ESOP II, covering employees of certain of the Company's
majority-owned subsidiaries. Also, effective December 31, 1994, ESOP II was
terminated, and as a result, employees of certain of the Company's
majority-owned subsidiaries are no longer eligible to participate in an
ESOP. For this plan, the Company charged to expense $0.3 million, $1.1
million, and $1.1 million in 1995, 1994, and 1993, respectively.
Employee Stock Purchase Plan
Substantially all of the Company's full-time U.S. employees are eligible to
participate in employee stock purchase plans sponsored by the Company or by
the Company's majority-owned public subsidiaries. Prior to the November
1995 plan year, shares of the Company's common stock could be purchased at
the end of a 12-month plan year at 85% of the fair market value at the
beginning of the plan year, and the shares purchased were subject to a
one-year resale restriction. Effective November 1, 1995, shares of the
Company's common stock may be purchased at 95% of the fair market value at
the beginning of the plan year, and the shares purchased are subject to a
six-month resale restriction. Shares are purchased through payroll
deductions of up to 10% of each participating employee's gross wages.
Participants of employee stock purchase plans sponsored by the Company's
majority-owned public subsidiaries may also elect to purchase shares of the
common stock of the subsidiary by which they are employed under the same
general terms described above. During 1995, 1994, and 1993, the Company
issued 220,296 shares, 145,836 shares, and 187,902 shares of its common
stock, respectively, under these plans.
27PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
9. Income Taxes
The components of income before income taxes and minority interest are as
follows:
(In thousands) 1995 1994 1993
-------------------------------------------------------------------------
Domestic $257,214 $165,761 $113,500
Foreign 42,281 40,615 17,967
-------- -------- --------
$299,495 $206,376 $131,467
======== ======== ========
The components of the provision for income taxes are as follows:
(In thousands) 1995 1994 1993
-------------------------------------------------------------------------
Currently payable:
Federal $ 72,496 $ 30,089 $ 10,270
Foreign 17,751 16,343 8,643
State 19,733 9,672 5,320
-------- -------- --------
109,980 56,104 24,233
-------- -------- --------
Deferred (prepaid), net:
Federal (9,050) 11,355 6,922
Foreign 232 (243) 931
State (2,262) 3,487 1,427
-------- -------- --------
(11,080) 14,599 9,280
-------- -------- --------
$ 98,900 $ 70,703 $ 33,513
======== ======== ========
The provision for income taxes that are currently payable does not
reflect $20.5 million, $3.5 million, and $3.4 million of tax benefits of
the Company and its majority-owned subsidiaries allocated to capital in
excess of par value, directly or through the effect of majority-owned
subsidiaries' equity transactions, or $3.0 million, $0.1 million, and $2.3
million of tax benefits used to reduce cost in excess of net assets of
acquired companies in 1995, 1994, and 1993, respectively. The deferred
provision for income taxes does not reflect $5.8 million of tax benefits
used to reduce cost in excess of net assets of acquired companies in 1995.
28PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
9. Income Taxes (continued)
The provision for income taxes in the accompanying statement of income
differs from the provision calculated by applying the statutory federal
income tax rate of 35% to income before income taxes and minority interest
due to the following:
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
Provision for income taxes at
statutory rate $104,823 $ 72,232 $ 46,013
Increases (decreases) resulting from:
Gain on issuance of stock by
subsidiaries (28,285) (8,849) (13,770)
State income taxes, net of federal tax 11,356 8,317 4,307
Investment and research and development
tax credits - (2,786) (6,625)
Foreign tax rate and tax law differential 3,785 1,422 3,969
Amortization and write-off of cost in
excess of net assets of acquired companies 7,484 3,450 3,400
Reduction in valuation allowance (2,104) - -
Other, net 1,841 (3,083) (3,781)
-------- -------- --------
$ 98,900 $ 70,703 $ 33,513
======== ======== ========
Prepaid income taxes and deferred income taxes in the accompanying
balance sheet consist of the following:
(In thousands) 1995 1994
----------------------------------------------------------------
Prepaid income taxes:
Reserves and accruals $ 31,659 $ 31,369
Inventory basis difference 19,782 16,756
Capitalized costs and joint venture equity 4,821 3,727
Accrued compensation 12,551 8,599
Allowance for doubtful accounts 5,592 5,470
Net operating loss carryforwards 28,692 17,022
Federal tax credit carryforwards 6,770 7,869
Available-for-sale investments (2,383) 1,025
Other, net 4,723 6,185
-------- --------
112,207 98,022
Less: Valuation allowance 39,214 40,198
-------- --------
$ 72,993 $ 57,824
======== ========
Deferred income taxes:
Depreciation $ 55,418 $ 49,313
Intangible assets 2,806 7,373
Other 964 1,564
-------- --------
$ 59,188 $ 58,250
======== ========
29PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
9. Income Taxes (continued)
The valuation allowance relates to the uncertainty surrounding the
realization of tax loss and credit carryforwards and the realization of tax
benefits attributable to purchase accounting reserves and certain other tax
assets of the Company and certain subsidiaries. Of the year-end 1995
valuation allowance, $24.6 million will be used to reduce cost in excess of
net assets of acquired companies when any portion of the related deferred
tax asset is recognized, and $2.1 million will increase capital in excess
of par value when previously unrealized stock option benefits are
recognized.
During 1995, the valuation allowance was reduced as it became more
likely than not that certain tax benefits will be realized, offset in part
by the establishment of valuation allowances for tax loss and credit
carryforwards of businesses acquired in 1995.
The Company has not recognized a deferred tax liability for the
difference between the book basis and tax basis of the common stock of its
domestic subsidiaries (such difference relates primarily to unremitted
earnings and gains on issuance of stock by subsidiaries) because the
Company does not expect this basis difference to become subject to tax at
the parent level. The Company believes it can implement certain tax
strategies to recover its investment in its domestic subsidiaries tax-free.
A provision has not been made for U.S. or additional foreign taxes on
$101 million of undistributed earnings of foreign subsidiaries that could
be subject to taxation if remitted to the U.S. because the Company
currently plans to keep these amounts permanently reinvested overseas. The
Company believes that any additional U.S. tax liability due upon remittance
of such earnings would be immaterial due to available U.S. foreign tax
credits.
10. Transactions in Stock of Subsidiaries
Gain on issuance of stock by subsidiaries in the accompanying statement of
income results primarily from the following transactions:
1995
Initial public offering of 2,333,556 shares of Thermo Ecotek common
stock at $12.75 per share for net proceeds of $27.5 million resulted in a
gain of $7.9 million.
Private placement of 1,601,500 shares of Thermo BioAnalysis common
stock at $10.00 per share for net proceeds of $14.9 million resulted in a
gain of $9.5 million that was recorded by Thermo Instrument.
Private placement of 500,000 shares of Thermo Remediation common stock
at $13.25 per share for net proceeds of $6.6 million resulted in a gain of
$1.6 million that was recorded by Thermo TerraTech.
Private placements of 150,000 and 50,000 shares of ThermoLase common
stock at $13.75 and $12.825 per share, respectively, and a public offering
of 2,250,000 shares at $25.25 per share, for aggregate net proceeds of
$55.3 million resulted in an aggregate gain of $34.7 million that was
recorded by ThermoTrex.
Initial public offering of 1,725,000 shares of ThermoSpectra common
stock at $14.00 per share and a private placement of 202,000 shares at
30PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
10. Transactions in Stock of Subsidiaries (continued)
$15.72 per share, for aggregate net proceeds of $24.9 million resulted in
an aggregate gain of $10.6 million that was recorded by Thermo Instrument.
Conversion of $9.1 million of Thermo Voltek 3 3/4% subordinated
convertible debentures convertible at $11.75 per share into 775,399 shares
of Thermo Voltek common stock resulted in a gain of $3.5 million that was
recorded by Thermedics.
Private placement of 1,862,000 shares of Trex Medical common stock at
$10.25 per share for net proceeds of $17.6 million resulted in a gain of
$12.8 million that was recorded by ThermoTrex.
1994
Public offering of 1,610,000 shares of ThermoTrex common stock at
$15.375 per share for net proceeds of $23.0 million resulted in a gain of
$7.9 million.
Initial public offering of 5,349,572 shares of ThermoLase common stock
at $3.00 per share for net proceeds of $14.8 million resulted in a gain of
$8.6 million that was recorded by ThermoTrex.
Private placements of 1,505,000 shares of ThermoSpectra common stock
at $10.00 per share for net proceeds of $14.0 million resulted in a gain of
$6.5 million that was recorded by Thermo Instrument.
Conversion of $3.7 million of Thermedics 6 1/2% subordinated
convertible debentures convertible at $10.42 per share into 357,597 shares
of Thermedics common stock resulted in a gain of $1.0 million.
1993
Public offering of 3,225,000 shares of Thermedics common stock at
$10.00 per share for net proceeds of $30.0 million resulted in a gain of
$10.7 million.
Public offering of 4,312,500 shares of Thermo Power common stock at
$9.00 per share for net proceeds of $36.0 million resulted in a gain of
$10.6 million.
Private placements of 2,062,500 shares of ThermoTrex common stock at
$11.17 and $14.50 per share for net proceeds of $27.5 million resulted in a
gain of $11.4 million.
Private placement of 300,000 shares and initial public offering of
1,650,000 shares of Thermo Remediation common stock at $6.59 and $8.33 per
share, respectively, for aggregate net proceeds of $14.6 million resulted
in an aggregate gain of $4.2 million that was recorded by Thermo TerraTech.
Conversion of $7.3 million of Thermedics 6 1/2% subordinated
convertible debentures convertible at $10.42 per share into 697,919 shares
of Thermedics common stock resulted in a gain of $2.5 million.
The Company's ownership percentage in these subsidiaries changed
primarily as a result of the transactions listed above, as well as the
Company's purchases of shares of its majority-owned subsidiaries' stock,
the subsidiaries' purchases of their own stock, the issuance of
subsidiaries' stock by the Company or by the subsidiaries under stock-based
compensation plans or in other transactions, and the conversion of
convertible obligations held by the Company, its subsidiaries, or by third
parties.
31PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
10. Transactions in Stock of Subsidiaries (continued)
The Company's ownership percentages at year-end were as follows:
1995 1994 1993
---- ---- ----
Thermedics 51% 51% 52%
Thermo Instrument 86% 83% 81%
Thermo TerraTech 81% 80% 72%
Thermo Power 63% 60% 52%
ThermoTrex 51% 50% 55%
Thermo Fibertek 81% 81% 80%
Thermo Ecotek 83% 97% 88%
Thermo Cardiosystems (a) 55% 58% 57%
Thermo Voltek (a) 59% 71% 67%
Thermo Remediation (b) 69% 65% 67%
ThermoLase (c) 65% 69% 81%
ThermoSpectra (d) 72% 86% 100%
Thermo EuroTech (e) 62% 64% 72%
ThermoLyte (f) 78% 100% 100%
Thermo BioAnalysis (d) 80% 100% 100%
ThermoQuest (d) 100% 100% 100%
Thermo Optek (d) 100% 100% 100%
Trex Medical (c) 91% 100% 100%
(a) Reflects combined ownership by Thermedics and Thermo Electron.
(b) Reflects combined ownership by Thermo TerraTech and Thermo Electron.
(c) Reflects ownership by ThermoTrex.
(d) Reflects ownership by Thermo Instrument.
(e) Reflects ownership by Thermo TerraTech.
(f) Reflects ownership by Thermo Power.
11. Other Expense, Net
The components of other expense, net, in the accompanying statement of
income are as follows:
(In thousands) 1995 1994 1993
-------------------------------------------------------------------------
Interest income $ 62,146 $ 43,280 $ 23,905
Interest expense (76,961) (59,844) (31,736)
Equity in losses of unconsolidated
subsidiaries (203) (4,019) (22,721)
Gain on sale of investments 9,305 4,851 2,469
Gain on sale of land - 14,698 -
Other income (expense), net (1,089) 45 535
-------- -------- --------
$ (6,802) $ (989) $(27,548)
======== ======== ========
32PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
12. Restructuring and Other Nonrecurring Costs
Restructuring and other nonrecurring costs in the accompanying 1995 statement
of income includes $11.5 million to write off the Company's net investment in a
waste-recycling facility in southern California due to contractual defaults by
the facility's sole customer, which have caused operations to be substantially
curtailed; $5.0 million to write off the cost in excess of net assets of
acquired companies at Thermo TerraTech's thermal-processing equipment business
due to this asset no longer being recoverable based on discontinuing investment
in this business; $2.5 million to write off the cost in excess of net assets of
acquired companies at the Company's Napco subsidiary, which is a defendant in
litigation described in Note 7; and $2.9 million of other nonrecurring costs.
The 1994 amount represents severance costs and, to a lesser extent, the
costs to write off leasehold improvements at ThermoTrex's East Coast division.
The 1993 amount primarily represents a $1.9 million reserve for the
write-off of machinery and equipment and costs to phase out a product line in
the Company's metal-fabrication services business, a $1.2 million reserve for
restructuring at the Company's steam turbines and compressors business, and
$2.7 million for the write-off of mobile soil-remediation assets and other
related expenses.
13. Supplemental Cash Flow Information
Supplemental cash flow information is as follows:
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
Cash Paid For:
Interest $ 71,816 $ 47,745 $ 29,529
Income taxes $ 50,788 $ 27,456 $ 9,909
Noncash Activities:
Conversions of the Company's and
subsidiaries' convertible obligations $ 212,979 $ 89,625 $ 50,403
Acquisition of asset under capital
lease $ 47,020 $ - $ -
Purchase of alternative-energy
facility through assumption of
debt $ - $ - $ 66,900
Fair value of assets of acquired
companies $ 521,558 $ 250,404 $ 208,193
Cash paid for acquired companies (339,075) (174,330) (143,790)
Issuance of subsidiaries' common stock
and stock options for acquired
companies (18,990) - -
Issuance of long-term obligations for
acquired company (22,300) - -
--------- -------- --------
Liabilities assumed of acquired
companies $ 141,193 $ 76,074 $ 64,403
========= ========= =========
33PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
14. Fair Value of Financial Instruments
The Company's financial instruments consist mainly of cash and cash
equivalents, available-for-sale and held-to-maturity investments, accounts
receivable, notes payable and current maturities of long-term obligations,
accounts payable, long-term obligations, forward exchange contracts, and
interest rate swaps. The carrying amount of these financial instruments, with
the exception of available-for-sale investments, long-term obligations, forward
exchange contracts, and interest rate swaps, approximates fair value due to
their short-term nature.
Available-for-sale investments are carried at fair value in the
accompanying balance sheet. The fair values were determined based on quoted
market prices. See Note 2 for fair value information pertaining to these
financial instruments. Held-to-maturity investments in the accompanying balance
sheet are carried at amortized cost. The fair values are disclosed on the
accompanying balance sheet and were determined based on quoted market prices.
The Company enters into forward exchange contracts to hedge certain firm
purchase and sale commitments denominated in currencies other than its
subsidiaries' local currencies, principally U.S. dollars, British pounds
sterling, French francs, and Japanese yen. The purpose of the Company's foreign
currency hedging activities is to protect the Company's local currency cash
flows related to these commitments from fluctuations in foreign exchange rates.
The amounts of such forward exchange contracts at year-end 1995 and 1994 were
$34.2 million and $19.9 million, respectively.
The Company's Thermo Ecotek subsidiary has interest rate swap agreements
relating to its nonrecourse tax-exempt obligations. The interest rate swap
agreements are with a different counterparty than the holders of the underlying
debt. The Company believes, however, that the credit risks associated with
these swaps are minimal because the agreements are with a large, reputable
bank. The notional amount of the swap agreement is $110.0 million at December
30, 1995 and December 31, 1994.
The carrying amount and fair value of the Company's long-term obligations
and off-balance-sheet financial instruments are as follows:
1995 1994
----------------------- ------------------------
Carrying Fair Carrying Fair
(In thousands) Amount Value Amount Value
--------------------------------------------------------------------------
Long-term obligations:
Convertible obligations$ 802,001 $1,354,682 $ 806,661 $ 973,659
Other long-term
obligations 314,010 334,004 243,189 245,045
---------- ---------- ---------- ----------
$1,116,011 $1,688,686 $1,049,850 $1,218,704
========== ========== ========== ==========
Off-balance-sheet
financial instruments:
Forward exchange
contracts receivable $ (1,015) $ (579)
Interest rate swaps
(receivable) payable $ 3,467 $ (2,113)
34PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
14. Fair Value of Financial Instruments (continued)
The fair value of long-term obligations was determined based on quoted
market prices and on borrowing rates available to the Company at the respective
year-ends. The fair value of convertible obligations exceeds the carrying
amount primarily due to the market price of the Company's or subsidiaries'
common stock at the respective year-ends exceeding the conversion price of the
convertible obligations.
The fair value of forward exchange contracts and interest rate swap
agreements (used for hedging purposes) is the estimated amount that the Company
would pay or receive upon termination of the contract, taking into account the
change in foreign exchange rates on forward exchange contracts, and market
interest rates and the creditworthiness of the counterparties on interest rate
swap agreements.
15. Business Segment and Geographical Information
The Company's business segments include the following:
Instruments: environmental-monitoring, analytical, test and measurement, and
process-control instruments
Alternative-energy Systems: biomass power plants, waste-recycling facility,
industrial refrigeration systems, natural gas engines, cooling and
cogeneration units, turbines and compressors
Process Equipment: paper-recycling equipment, papermaking systems and
accessories, metallurgical-processing systems, electroplating equipment
Biomedical Products: biomedical materials, mammography and needle-biopsy
systems, general-purpose X-ray systems, respiratory-care equipment,
skin-incision devices, blood coagulation-monitoring equipment, left
ventricular-assist systems, neurophysiology monitoring instruments,
personal-care products
Environmental Services: thermal soil-remediation, industrial-fluids
recycling, nuclear monitoring and cleanup, on-site industrial remediation,
laboratory analysis, environmental sciences, metallurgical heat treating and
fabrication
Advanced Technologies: process detection systems, explosives-detection
instruments, precision weighing and inspection equipment, electronic test
equipment, power-conversion instruments, laser-based hair-removal system,
systems integration and engineering, development of avionics products and
medical equipment
35PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
15. Business Segment and Geographical Information (continued)
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
Business Segment Information
Revenues:
Instruments $ 782,662 $ 650,114 $ 516,712
Alternative-energy Systems 325,912 285,410 242,662
Process Equipment 317,951 190,217 167,524
Biomedical Products 255,752 180,318 127,533
Environmental Services 210,503 141,438 121,987
Advanced Technologies 321,563 286,523 181,094
Intersegment Sales Elimination (a) (6,926) (4,829) (3,004)
---------- ---------- ----------
$2,207,417 $1,729,191 $1,354,508
========== ========== ==========
Income Before Income Taxes and
Minority Interest:
Instruments $ 113,651 $ 105,440 $ 91,412
Alternative-energy Systems 32,952 34,451 12,859
Process Equipment 29,071 20,730 13,444
Biomedical Products 32,343 17,601 5,758
Environmental Services 21,215 14,853 4,702
Advanced Technologies 18,930 12,563 8,260
---------- ---------- ----------
Total Segment Income (b) 248,162 205,638 136,435
Equity in Losses of Unconsolidated
Subsidiaries (203) (4,019) (22,721)
Corporate (c) 51,536 4,757 17,753
---------- ---------- ----------
$ 299,495 $ 206,376 $ 131,467
========== ========== ==========
Identifiable Assets:
Instruments $1,372,814 $1,011,916 $ 850,688
Alternative-energy Systems 695,849 577,781 593,247
Process Equipment 238,537 191,846 179,251
Biomedical Products 552,825 348,199 285,715
Environmental Services 335,726 192,523 146,658
Advanced Technologies 303,270 236,543 203,375
Corporate (d) 245,887 503,127 248,663
---------- ---------- ----------
$3,744,908 $3,061,935 $2,507,597
========== ========== ==========
Depreciation and Amortization:
Instruments $ 25,257 $ 22,070 $ 18,059
Alternative-energy Systems 25,186 16,078 4,982
Process Equipment 5,228 4,780 4,277
Biomedical Products 8,597 6,292 5,328
Environmental Services 11,197 8,382 6,641
Advanced Technologies 8,243 6,193 3,679
Corporate 1,271 1,233 1,226
---------- ---------- ----------
$ 84,979 $ 65,028 $ 44,192
========== ========== ==========
36PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
15. Business Segment and Geographical Information (continued)
(In thousands) 1995 1994 1993
--------------------------------------------------------------------------
Capital Expenditures:
Instruments $ 10,313 $ 7,574 $ 6,347
Alternative-energy Systems (e) 14,024 31,717 92,862
Process Equipment 3,686 3,231 2,631
Biomedical Products 7,168 7,284 9,042
Environmental Services 19,499 7,559 7,583
Advanced Technologies 7,757 8,019 8,898
Corporate 460 141 2,241
---------- ---------- ----------
$ 62,907 $ 65,525 $ 129,604
========== ========== ==========
Geographical Information
Revenues:
United States $1,739,910 $1,386,455 $1,103,133
Europe 504,439 374,192 298,562
Other 117,425 91,161 65,165
Transfers among geographical
areas (a) (154,357) (122,617) (112,352)
---------- ----------- ----------
$2,207,417 $1,729,191 $1,354,508
========== ========== ==========
Income Before Income Taxes and
Minority Interest:
United States $ 201,464 $ 182,177 $ 116,863
Europe 33,059 13,315 12,175
Other 13,639 10,146 7,397
---------- ---------- ----------
Total Segment Income (b) 248,162 205,638 136,435
Equity in Losses of Unconsolidated
Subsidiaries (203) (4,019) (22,721)
Corporate (c) 51,536 4,757 17,753
---------- ---------- ----------
$ 299,495 $ 206,376 $ 131,467
========== ========== ==========
Identifiable Assets:
United States $2,907,585 $2,110,843 $1,905,825
Europe 501,997 387,268 300,302
Other 89,439 60,697 52,807
Corporate (d) 245,887 503,127 248,663
---------- ---------- ----------
$3,744,908 $3,061,935 $2,507,597
========== ========== ==========
Export Sales Included in United
States Revenues Above (f) $ 336,702 $ 265,298 $ 219,914
========== ========== ==========
37PAGE
<PAGE>
Thermo Electron Corporation
Notes to Consolidated Financial Statements
15. Business Segment and Geographical Information (continued)
(a) Intersegment sales and transfers among geographical areas are accounted
for at prices that are representative of transactions with unaffiliated
parties.
(b) Segment income is income before corporate general and administrative
expenses, other income and expense, minority interest expense, and income
taxes.
(c) Includes corporate general and administrative expenses, other income and
expense, and gain on issuance of stock by subsidiaries.
(d) Primarily cash and cash equivalents, short- and long-term investments, and
property and equipment at the Company's Waltham, Massachusetts,
headquarters.
(e) Includes $88.4 million in 1993 for the purchase of an alternative-energy
facility in Delano, California.
(f) In general, export revenues are denominated in U.S. dollars.
16. Subsequent Events
Issuance of Subordinated Convertible Debentures
On January 3, 1996, the Company issued and sold $585 million principal amount
of 4 1/4% subordinated convertible debentures due 2003. The debentures will be
convertible into shares of the Company's common stock at a price of $56.70 per
share.
Pending Acquisition
On March 1, 1995, Thermo Instrument entered into an agreement with Fisons plc
(Fisons) to acquire the Scientific Instruments Division of Fisons for
approximately 202 million British pounds sterling. On April 13, 1995, Thermo
Instrument announced that it had received a "second request" for information
regarding the transaction from the U.S. Federal Trade Commission (FTC). After
extensive discussions with Fisons and the FTC, in January 1996 Thermo
Instrument withdrew its original pre-merger notification filing under the
Hart-Scott-Rodino Antitrust Improvements Act (the HSR Act), and submitted a new
filing with respect to a modified form of the acquisition. On February 15,
1996, Thermo Instrument announced that the FTC had granted early termination of
the waiting period under the HSR Act with respect to the modified acquisition
and on March 1, 1996, Thermo Instrument announced that it had received
clearance from U.K. antitrust regulatory authorities. The form of the
acquisition cleared by the FTC and the U.K. authorities excludes from the
businesses to be acquired by Thermo Instrument substantially all of the mass
spectrometer businesses of Fisons and a high-resolution mass
spectrometer/inductively-coupled plasma product. These businesses accounted for
slightly less than 20% of the 1995 revenues of Fisons' Scientific Instruments
Division. The new purchase price is expected to be slightly less than 150
million British pounds sterling and will be subject to a post-closing
adjustment based on the net asset value of the acquired businesses as of the
closing date. The modified acquisition is still subject to the consent of
certain third parties and the satisfaction of other closing conditions.
38PAGE
<PAGE>
Report of Independent Public Accountants
To the Shareholders and Board of Directors
of Thermo Electron Corporation:
We have audited the accompanying consolidated balance sheet of Thermo
Electron Corporation (a Delaware corporation) and subsidiaries as of
December 30, 1995 and December 31, 1994, and the related consolidated
statements of income, shareholders' investment, and cash flows for each of
the three years in the period ended December 30, 1995. These consolidated
financial statements are the responsibility of the Company's management.
Our responsibility is to express an opinion on these consolidated financial
statements based on our audits.
We conducted our audits in accordance with generally accepted auditing
standards. Those standards require that we plan and perform the audit to
obtain reasonable assurance about whether the financial statements are free
of material misstatement. An audit includes examining, on a test basis,
evidence supporting the amounts and disclosures in the financial
statements. An audit also includes assessing the accounting principles used
and significant estimates made by management, as well as evaluating the
overall financial statement presentation. We believe that our audits
provide a reasonable basis for our opinion.
In our opinion, the consolidated financial statements referred to
above present fairly, in all material respects, the financial position of
Thermo Electron Corporation and subsidiaries as of December 30, 1995 and
December 31, 1994, and the results of their operations and their cash flows
for each of the three years in the period ended December 30, 1995, in
conformity with generally accepted accounting principles.
As discussed in Note 2 to the consolidated financial statements,
effective January 2, 1994, the Company changed its method of accounting for
investments in debt and marketable equity securities.
Arthur Andersen LLP
Boston, Massachusetts
February 15, 1996 (except with
respect to the matters discussed
in Note 16 as to which the date
is March 1, 1996)
39PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Overview
The Company develops and manufactures a broad range of products that are
sold worldwide. The Company expands the product lines and services it
offers by developing and commercializing its own core technologies and by
making strategic acquisitions of complementary businesses. The majority of
the Company's businesses fall into four broad markets: environmental,
energy, process control, and selected health and safety instrumentation.
An important component of the Company's strategy is to establish
leading positions in its markets through the application of proprietary
technology, whether developed internally or acquired. A key contribution to
the growth of the Company's segment income (as defined in the results of
operations below), particularly over the last three years, has been the
ability to identify attractive acquisition opportunities, complete those
acquisitions, and derive a growing income contribution from the newly
acquired businesses as they are integrated into the Company's business
segments.
The Company seeks to minimize its dependence on any specific product
or market by maintaining and diversifying its portfolio of businesses and
technologies. Similarly, the Company's goal is to maintain a balance in its
businesses between those affected by various regulatory cycles and those
more dependent on the general level of economic activity. Although the
Company is diversified in terms of technology, product offerings, and
geographic markets served, the future financial performance of the Company
as a whole is largely affected by the strength of worldwide economies and
the continued adoption and diligent enforcement of environmental, health,
and safety regulations, among other factors.
The Company believes that maintaining an entrepreneurial atmosphere is
essential to its continued growth and development. In order to preserve
this atmosphere, the Company has adopted a strategy of spinning out certain
of its businesses into separate subsidiaries and having these subsidiaries
sell a minority interest to outside investors. The Company believes that
this strategy provides additional motivation and incentives for the
management of the subsidiaries through the establishment of subsidiary-
level stock option incentive programs, as well as capital to support the
subsidiaries' growth. As a result of the sale of stock by subsidiaries, the
issuance of stock by subsidiaries upon conversion of convertible
debentures, and similar transactions, the Company records gains that
represent the increase in the Company's net investment in the subsidiaries
and are classified as "Gain on issuance of stock by subsidiaries" in the
accompanying statement of income. These gains have represented a
substantial portion of the net income reported by the Company in recent
years. The size and timing of these transactions are dependent on market
and other conditions that are beyond the Company's control. Accordingly,
there can be no assurance that the Company will be able to generate gains
from such transactions in the future.
Proposed Accounting Pronouncement
In October 1995, the Financial Accounting Standards Board (FASB)
issued an exposure draft of a Proposed Statement of Financial Accounting
Standards, "Consolidated Financial Statements: Policy and Procedures"
(Proposed Statement). The Proposed Statement would establish new rules for
determining when entities should be consolidated and how consolidated
financial statements should be prepared. Under the Proposed Statement, it
is possible that companies would be required to consolidate entities in
40PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Proposed Accounting Pronouncement (continued)
which their legal ownership is as low as 40%. Companies involved with
special purpose entities could be required to include these entities in
their consolidated financial statements in such instances as when a company
is the only general partner, although the company may own only a very small
percentage of the entity (e.g. 1%). This portion of the Proposed Statement
is expected to have little effect on the Company's consolidated financial
statements. The portion of the Proposed Statement referred to as the
Procedures portion, which describes how consolidated financial statements
should be prepared, could result in significant changes in the way the
Company records certain transactions once control, as newly defined, has
been reached. Under the Proposed Statement, the following accounting will
result:
Decreases in a parent's ownership interest in a subsidiary -- Under
the Proposed Statement, any sale of the stock of a subsidiary that does not
result in loss of control would be accounted for as a transaction in the
equity of the consolidated entity with no gain or loss being recognized.
This would occur even when the sale is made by the parent, and even though
such a sale would result in a gain for corporate tax purposes. Under this
provision, any sale of a non-controlling interest, e.g. 49% of a wholly
owned entity, whether the sale results in an economic gain or loss, would
be recorded only in the equity section of the balance sheet.
Recording gains from the purchase of additional shares -- Under
current practice, a company that owns marketable equity securities of other
issuers may account for them as "available-for-sale" under Statement of
Financial Accounting Standards (SFAS) No. 115, with the fair value
adjustment being recorded in equity. Upon obtaining "significant influence"
(current practice being twenty percent or greater ownership), under the
Proposed Statement the unrealized holding gains and losses previously
recorded in equity would be recorded in the income statement. The same
accounting would result if an entity increased its ownership from an SFAS
No. 115 investment directly to control and consolidation. Under this
accounting, the more the acquirer pays for the additional shares, the
greater the gain recorded.
Changes in a parent's ownership interest in a subsidiary and step
acquisitions -- Under the FASB's proposed economic unit model, once control
is obtained, any transactions in a subsidiary's stock between the
controlling and noncontrolling shareholders are considered equity
transactions and, therefore, only the equity accounts of the reporting
entity are impacted. Under the Proposed Statement, after control is
obtained, the cost of any subsequent purchase is recorded as a reduction of
equity. As a result, no additional goodwill is recorded on these subsequent
purchases, but the charge to equity would reduce the book value of the
acquirer. This charge to equity would not become part of the "cost" of
acquiring the entity and, therefore, it would be possible to sell the
entity at a later date and record a "gain" on the transaction, even though
the seller actually sold it for less than what the seller paid to acquire
it.
41PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Proposed Accounting Pronouncement (continued)
The FASB conducted a hearing concerning the Proposed Statement in
February 1996, at which the Company, along with other major companies and
many of the major accounting firms and accounting associations, expressed
their disagreement with various parts of the Proposed Statement. The FASB
expects to issue a final Statement by June 30, 1996, which could become
effective for fiscal years beginning after December 15, 1996.
Results of Operations
1995 Compared With 1994
Sales in 1995 were $2,207.4 million, an increase of $478.2 million, or
28%, over 1994. Segment income, excluding restructuring and other
nonrecurring costs described below of $21.9 million in 1995 and $0.7
million in 1994, was $270.1 million, compared with $206.3 million in 1994,
an increase of 31%. (Segment income is income before corporate general and
administrative expenses, other income and expense, minority interest
expense, and income taxes.) Operating income, which includes restructuring
and other nonrecurring costs, was $225.5 million, an increase of $43.4
million, or 24%, over 1994. Financial results for 1994 have been restated
to include Coleman Research, which was acquired in a pooling-of-interests
transaction in March 1995 (Note 3).
Sales from the Instruments segment were $782.7 million in 1995, an
increase of $132.5 million, or 20% over 1994. Sales increased primarily due
to acquisitions made by Thermo Instrument, which added $104 million to
sales in 1995. The remaining sales increase was substantially due to the
favorable effects of currency translation due to a weaker U.S. dollar in
1995. Segment income margin (segment income margin is segment income as a
percentage of sales) was 14.5% in 1995, compared with 16.2% in 1994.
Segment income margin declined due to lower margins at acquired businesses
and reduced shipments at Thermo Instrument's air-monitoring instruments
subsidiary.
Sales from the Alternative-energy Systems segment were $325.9 million
in 1995, an increase of $40.5 million, or 14%, over 1994. Within this
segment, revenues from Thermo Ecotek, which consist of revenues from
biomass power plant operations, were $141.4 million in 1995, compared with
$134.3 million in 1994. This increase results from a full year of revenues
from the Whitefield, New Hampshire, plant which did not operate for most of
the first half of 1994 due to major damage to the turbine-generator, as
well as higher contractual energy rates in 1995 at all of Thermo Ecotek's
facilities, excluding the facility in Hemphill, New Hampshire. These
increases were offset largely by utility-imposed curtailment of power at
the Woodland and Mendota plants in California. The utility that purchases
the electrical output of these California plants has the right to curtail
the plants' power output up to 1,000 hours per year during periods of low
demand. The utility commonly experiences low demand following periods of
heavy rain or snow, when hydroelectric power is available. During 1995,
these plants were each curtailed for 1,000 hours. During January and
February 1996, these plants each experienced approximately 200 hours of
curtailment and are likely to receive the contractual maximum during 1996.
Revenues from the Company's waste-recycling facility in southern California
declined by $0.8 million due to a reduction in the amounts paid by the
facility's customer. The facility ceased processing waste during 1995 and
the Company wrote off its net investment in this facility in the third
42PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1995 Compared With 1994 (continued)
quarter of 1995, as described below. Sales at Peter Brotherhood Ltd.
increased $18.1 million to $56.2 million as a result of increased demand
for steam turbines and, to a lesser extent, increased demand for special
purpose machinery over depressed 1994 levels. Sales from Thermo Power
increased $16.5 million to $108.4 million, due primarily to increased
demand for refrigeration packages and marine engine-related products and,
to a lesser extent, the acquisition of NuTemp, Inc. in May 1994.
Segment income from the Alternative-energy Systems segment, excluding
restructuring and other nonrecurring costs of $11.5 million in 1995, was
$44.5 million in 1995, compared with $34.5 million in 1994. Thermo Ecotek
had segment income of $34.6 million in 1995, compared with $26.9 million in
1994. This improvement results from lower fuel costs at two of the
California plants and higher contractual energy rates in 1995, offset in
part by utility-imposed curtailment of power at the Woodland and Mendota
facilities. Segment income at Thermo Power declined to $5.1 million in 1995
from $5.3 million in 1994, reflecting an increase in expenditures for
research and development. Peter Brotherhood incurred a segment loss of $1.1
million in 1995, compared with a loss of $0.8 million in 1994, as a result
of increased costs to complete jobs in process and competitive pricing
pressures.
In 1995, the Company recorded restructuring and other nonrecurring
costs of $11.5 million for this segment. This amount represents the
Company's net investment in a waste-recycling facility in southern
California that contracted to process waste for San Diego County (the
County). The County had previously advised the Company that it was
attempting to raise funds to purchase the facility and had entered into
discussions with the Company regarding termination of the Company's
long-term service agreement. Termination of the service agreement would
have required the County to pay the Company a termination fee and reimburse
the Company for certain other items connected with the facility. To date,
the County has been unable to raise the necessary funds on terms acceptable
to the County. During the third quarter of 1995, the County paid the
Company less than the amount due under the service agreement. In October
1995, the Company notified the County that the County was in default of the
service agreement and that, pursuant to that agreement, the County had 45
days to cure the default. To date, the County has not cured this default.
The Company's financing on this facility consists of tax-exempt obligations
(Note 6), which are nonrecourse to the Company for events of County
default. The County is a party to these financing arrangements. The County
is in default of certain terms of its agreements with the bank group that
provided the financing and if the County does not cure these defaults, it
could be declared in default under the financing agreements. Based upon
County assertions, its financial obligation to the Company in a default
situation would be limited to the funds it has available from the
day-to-day operation of the County's solid waste-disposal system, which
would be insufficient for the Company to recover any of its investment.
In a lawsuit relating to the waste-recycling facility discussed above,
a third party, from which the Company's subsidiary acquired certain
development rights, alleges that fees totaling $7.9 million plus interest
and legal costs are due and payable in connection with construction of the
facility. The Company contends that no additional fees are payable because
the facility actually built was substantially different from the one
contemplated in the agreement with the third-party developer. There can be
43PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1995 Compared With 1994 (continued)
no assurance as to the outcome of this matter.
Certain of Thermo Ecotek's plants have power sales agreements with
utilities under which the rates paid for power will convert from fixed
rates to "avoided-cost" rates in the year 2000. Avoided-cost rates are
currently substantially less than the fixed rates. One of these plants,
located in Woodland, California, has conditions in its nonrecourse lease
agreement that require funding of a "power reserve" in years prior to 2000,
based on projections of operating cash flow shortfalls in the year 2000 and
thereafter. The power reserve represents funds available to make lease
payments in the event that revenues are not sufficient after the Woodland
plant converts to avoided-cost rates. Without sufficient increases in
avoided-cost rates or reductions in fuel costs and other operating expenses
by the year 2000, Thermo Ecotek expects to either renegotiate its
nonrecourse lease agreement or forfeit its interest in the Woodland plant.
Beginning in the third quarter of 1996, Thermo Ecotek will expense the
funding of reserves required under the nonrecourse lease agreement. As a
result, the Company expects that the results of the plant will be reduced
to approximately breakeven at that time. During 1995, the plant contributed
$6.3 million of operating income.
Sales in the Process Equipment segment were $318.0 million in 1995,
compared with $190.2 million in 1994. Sales from Thermo Fibertek increased
$44.1 million to $206.7 million, due to an increase of $23.3 million in
sales of paper-recycling equipment, which included $14.7 million of sales
under an approximately $16 million subcontract with Thermo Electron to
supply equipment and services for an office wastepaper de-inking facility
in Menominee, Michigan, and due to increased demand at Thermo Fibertek's
paper-recycling business in France. Sales at Thermo Fibertek also increased
$17.3 million due to greater demand at its North American accessories
business, and increased by $2.7 million due to the favorable effects of
currency translation. In addition to sales recorded by Thermo Fibertek
under the Michigan project, a wholly owned subsidiary of the Company
recorded revenues from the project of $77.0 million. This facility is
expected to be completed by the end of 1996. Sales of Thermo TerraTech's
(formerly Thermo Process Systems) thermal-processing equipment and Napco's
automated electroplating equipment increased $2.6 million and $4.2 million,
respectively, from depressed 1994 levels. Segment income margin, excluding
restructuring and other nonrecurring costs of $7.5 million in 1995, was
11.5% in 1995, compared with 10.9% in 1994. Thermo Fibertek's segment
income margin improved to 16.2% from 12.9% in 1994, primarily due to
increased sales and an improved sales mix. During 1995, the Process
Equipment segment recorded restructuring and other nonrecurring costs of
$7.5 million to write off cost in excess of net assets of acquired
companies, of which $5.0 million was recorded by Thermo TerraTech, and $2.5
million was recorded by the Company's Napco subsidiary. Thermo TerraTech
has decided to focus its resources on growing the environmental
infrastructure services part of its business and, therefore, no longer
expects to reinvest in its thermal-processing equipment business to the
extent necessary to recover this investment. Napco is appealing a jury
verdict rendered against it for approximately $11.0 million in a contract
dispute arising out of an allegedly defective waste-treatment system
installed by Napco in 1984. Because this verdict exceeds Napco's financial
44PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1995 Compared With 1994 (continued)
ability to pay, Napco has filed a petition for bankruptcy. The Company
believes that it will be unable to recover its investment in Napco. Napco's
sales and income are not significant to the Company's consolidated results
of operations.
Sales in the Biomedical Products segment were $255.8 million in 1995,
an increase of $75.4 million, or 42%, over 1994 due primarily to increased
demand for a number of the Company's biomedical products and the inclusion
of $31.6 million in sales from Bird Medical Technologies, Inc. and Bennett
X-Ray Corporation, which were acquired in the third quarter of 1995. Sales
of ThermoTrex's mammography and needle-biopsy systems increased 38% to
$74.9 million; Thermo Cardiosystems' implantable left ventricular-assist
system (LVAS) increased 98% to $20.6 million; ThermoLase's skin-care
products increased 33% to $24.9 million; neurodiagnostic monitoring
equipment sold by the Company's wholly owned Nicolet Biomedical Inc.
subsidiary increased 12% to $53.1 million; and sales of blood
coagulation-monitoring products and skin-incision devices sold by the
Company's wholly owned International Technidyne Corporation subsidiary
increased 13% to $32.3 million. Segment income margin improved to 12.6%
from 9.8% in 1994 as a result of increased sales and, to a lesser extent,
price increases for Thermo Cardiosystems' air-driven LVAS.
Sales in the Environmental Services segment were $210.5 million in
1995, an increase of $69.1 million, or 49%, over 1994. Within this segment,
sales from Thermo Remediation were $57.5 million in 1995, compared with
$50.4 million in 1994. Sales from Thermo Remediation's soil-remediation and
fluids-recycling services increased due to acquisitions, offset in part by
lower sales at existing sites resulting from ongoing regulatory
uncertainties, primarily at two sites, as well as severe weather conditions
at one site, and competitive pricing pressures. Thermo Remediation's
nuclear services sales from existing sites increased primarily due to a
long-term environmental restoration contract for the U.S. Department of
Energy's (DOE's) Hanford site, offset in part by a decrease in
radiochemistry laboratory work, reflecting a reduction in spending at the
DOE. Sales of analytical laboratory and environmental consulting services
increased $60.2 million, to $100.6 million, due to the inclusion of sales
from acquired businesses. Sales of metallurgical services declined $2.0
million to $42.8 million, due to the effect of closing a small plant in
1995. Segment income margin, excluding restructuring and other nonrecurring
costs of $1.9 million in 1995, improved to 11.0% from 10.5% in 1994, due
primarily to higher sales, offset in part by higher legal expenses incurred
within the environmental consulting services operations. The restructuring
and other nonrecurring costs included $1.5 million as a result of the
decision to close a metallurgical services division located in Albuquerque,
New Mexico. The costs primarily represent severance costs and the write-off
of cost in excess of net assets of acquired companies and leasehold
improvements. The facility was closed in the second quarter of 1995.
Sales from the Advanced Technologies segment were $321.6 million in
1995, compared with $286.5 million in 1994. Sales increased $22.3 million
due to the inclusion of a full year of sales from Thermo Sentron Inc.
(formerly Ramsey Technology Inc.), which was acquired in March 1994, and
sales from the Orion laboratory products division of Analytical Technology,
Inc., which was acquired in December 1995. Sales at Thermo Voltek increased
45PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1995 Compared With 1994 (continued)
$12.7 million to $36.3 million, due to the inclusion of $7.2 million in
sales from acquired businesses and, to a lesser extent, the introduction of
a new product line and an increase in demand. Sales at Coleman Research
increased $20.7 million to $164.6 million due to increased contract
funding. Coleman Research has experienced a decline in backlog, which could
result in lower revenues in 1996. Sales of Thermedics Detection's
process-detection instruments declined $21.8 million to $16.2 million
primarily due to lower demand from its principal customer, which has
substantially completed its deployment of these systems, and sales of
EGIS(R) explosives-detection systems declined $2.1 million to $8.0 million,
due primarily to lower demand as a result of the shipment of several large
orders in 1994. Segment income, excluding restructuring and other
nonrecurring costs of $1.0 million in 1995 and $0.7 million in 1994,
increased $6.7 million to $19.9 million as a result of improved margins at
Coleman Research and Thermo Sentron, due primarily to efforts to control
costs. These improvements were offset in part by a decline in segment
income from Thermedics Detection, primarily as a result of lower sales and,
to a lesser extent, increased expenses incurred by ThermoLase to develop
and commercialize its laser-based hair-removal process. Restructuring and
other nonrecurring costs of $1.0 million in 1995 were recorded by
ThermoTrex as a result of the decision to close its East Coast division.
The costs included $0.6 million for the write-off of intangible assets.
As a result of the sale of stock by subsidiaries, the issuance of
stock by subsidiaries upon conversion of indebtedness, and similar
transactions, the Company recorded gains of $80.8 million in 1995 and $25.3
million in 1994. Such gains represent the increase in the Company's
proportionate share of the subsidiaries' equity and are classified as gain
on issuance of stock by subsidiaries in the accompanying statement of
income. See Notes 1 and 10 for a more complete description of these
transactions. Minority interest expense increased to $60.5 million in 1995
from $31.0 million in 1994. Minority interest expense includes $28.6
million in 1995 and $5.7 million in 1994 related to gains recorded by the
Company's majority-owned subsidiaries as a result of the sale of stock and
the issuance of stock upon conversion of indebtedness, by their
subsidiaries.
Other expense, net, in the accompanying statement of income includes a
gain of $14.7 million in 1994 resulting from the sale of the Peter
Brotherhood facility in the United Kingdom. Also included is equity in
losses of unconsolidated subsidiaries, which represents the Company's
portion of results from entities in which the Company's ownership is 50% or
less, including the operation of the Dade County cogeneration facility. The
loss associated with the Dade County facility was $1.6 million in 1995 and
$5.7 million in 1994. Because the demand for power and chilled water at the
Dade County Downtown Government Center complex has been substantially less
than anticipated since the plant's startup in 1987, and because the plant
has had difficulty disposing of the remainder of its output, the joint
venture has experienced continuing losses. In September 1994, the joint
venture suspended operation of this plant for an indefinite period of time,
although it will continue to be responsible for lease and fixed costs. In
1993, the Company established a reserve representing management's estimate,
discounted to present value, of the Company's share of estimated negative
cash flows of the joint venture. The Company is involved in regulatory
46PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1995 Compared With 1994 (continued)
proceedings that could require additional reserves if the outcome of one or
more matters is adverse to the Company. See Note 7 for a description of
these and other legal proceedings involving the Company.
1994 Compared With 1993
Sales in 1994 were $1,729.2 million, an increase of $374.7 million, or
28%, over 1993. Segment income, excluding restructuring and other
nonrecurring costs described below, of $0.7 million in 1994 and $6.6
million in 1993, was $206.3 million, compared with $143.1 million in 1993,
an increase of 44%. Operating income was $182.1 million, compared with
$119.2 million in 1993, an increase of 53%.
Sales from the Instruments segment were $650.1 million in 1994, an
increase of $133.4 million, or 26%, over 1993. Sales increased due to
acquisitions made by Thermo Instrument during 1993 and its acquisition of
several businesses within the EnviroTech Measurements & Controls group of
Baker Hughes Incorporated in March 1994. Segment income margin was 16.2%,
compared with 17.7% in 1993. Segment income margin declined principally due
to lower margins at the acquired businesses within the EnviroTech
Measurements & Controls group.
Sales from the Alternative-energy Systems segment were $285.4 million,
an increase of $42.7 million, or 18%, over 1993. Within this segment,
revenues from Thermo Ecotek, which consist of revenues from biomass power
plant operations, were $134.3 million, compared with $117.7 million in
1993. This increase results from an additional plant in operation in 1994
and, to a lesser extent, the absence of utility-imposed curtailments of
power output as well as improved performance at two California plants and
annual contractual energy rate increases under certain power sales
contracts. The 1993 period included $9.8 million of revenues recorded as a
result of the termination of a power sales contract and $3.1 million from
the one-time sale of gas pipeline rights. Sales from the Company's wholly
owned Energy Systems division increased $10.7 million as a result of a
waste-recycling facility in San Diego County that commenced operation in
the first quarter of 1994. Sales from Thermo Power increased 19%, to $91.9
million, as a result of the inclusion of $8.4 million in sales from NuTemp,
which was acquired in May 1994, and due to increased demand for
refrigeration packages at its FES division.
Segment income from the Alternative-energy Systems segment, excluding
restructuring and other nonrecurring costs of $1.5 million in 1993, was
$34.5 million, compared with $14.4 million in 1993. Thermo Ecotek had
segment income of $26.9 million, compared with $13.2 million in 1993. This
improvement results from an additional power plant in operation during
1994, the absence of utility-imposed curtailments of power output and
improved performance at two California plants, and annual contractual
energy rate increases under certain power sales contracts. Thermo Ecotek's
segment income also improved as a result of lower lease expense, offset in
part by depreciation expense, resulting from the December 1993 purchase of
the Delano I facility in California. The 1993 period included $8.6 million
of income from the termination of a power sales contract and the one-time
sale of gas pipeline rights. Segment income from the Company's Energy
47PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1994 Compared With 1993 (continued)
Systems division, excluding restructuring and other nonrecurring costs of
$0.3 million in 1993, increased $3.4 million as a result of the
waste-recycling facility that commenced operation in the first quarter of
1994. Segment income increased at Thermo Power by $2.6 million as a result
of increased sales, as well as lower expenses at its Crusader Engines
division. During 1993, the Company recorded restructuring and other
nonrecurring costs of $1.5 million for this segment, which primarily
represents a $1.2 million reserve for restructuring at the Company's steam
turbines and compressors business.
Sales in the Process Equipment segment were $189.9 million, compared
with $167.5 million in 1993. Within this segment, sales from Thermo
Fibertek increased to $162.6 million from $137.1 million in 1993 due to an
increase of $17.6 million in sales as a result of the acquisition of AES
Engineered Systems in June 1993, an increase of $7.9 million in sales from
the Company's paper-recycling equipment business as a result of three large
contracts received earlier in the year, and an increase of $4.1 million in
sales from the Company's U.S. accessories business due to greater demand.
These increases were offset in part by a decline of $4.4 million in sales
of environmental-process systems sold by the Company's U.K. subsidiary, to
$1.3 million in 1994, as a result of changes in U.K. environmental
regulations that required modifications to that subsidiary's equipment.
Sales of Thermo TerraTech's thermal-processing equipment, which remain
depressed, declined $1.5 million in 1994, and sales of automated
electroplating equipment from Napco declined $1.5 million due to weak
demand. Segment income margin in the Process Equipment segment, excluding
restructuring and other nonrecurring costs of $0.5 million in 1993, was
10.9%, compared with 8.3% in 1993. Thermo Fibertek's segment income margin,
excluding restructuring and other nonrecurring costs of $0.5 million in
1993, improved to 12.9% from 11.6% in 1993, primarily due to increased
sales and an improved sales mix. Thermal-processing equipment operations
were just above the breakeven level, while Napco operations resulted in a
segment loss of $0.3 million due to lower sales levels.
Sales in the Biomedical Products segment were $180.3 million, an
increase of $52.8 million, or 41%, over 1993. Sales increased $18.1 million
due to the inclusion for a full year of sales from CBI Laboratories, Inc.,
which was acquired by ThermoLase in December 1993. Sales of a number of the
Company's biomedical products also contributed to the increase, including
ThermoTrex's mammography and needle-biopsy systems, which increased 45% to
$54.4 million; Thermo Cardiosystems' implantable LVAS, which increased $6.9
million; blood coagulation-monitoring products and skin-incision devices
sold by the Company's wholly owned International Technidyne Corporation
subsidiary, which increased 18% to $28.6 million; and Thermedics' Scent
Seal fragrance samplers, which increased $3.0 million, due primarily to
increased demand. Segment income margin improved to 9.8% from 4.5% in 1993
as a result of increased sales and efforts to reduce costs.
48PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1994 Compared With 1993 (continued)
Sales in the Environmental Services segment were $141.8 million,
compared with $122.0 million in 1993. Within this segment, sales from
Thermo Remediation increased $8.6 million, to $29.7 million, primarily due
to an increase in the volume of soil processed at its soil-remediation
centers and, to a lesser extent, the inclusion of revenues from businesses
acquired during 1994 and late 1993. Sales of analytical laboratory and
environmental consulting services increased 10.9% to $61.2 million, due to
the inclusion of sales from businesses acquired during 1994 and, to a
lesser extent, the addition of a long-term environmental restoration
contract for the DOE's Hanford site. Sales of metallurgical services
increased 9.1%, to $44.8 million, due to increased demand. Segment income
margin, excluding restructuring and other nonrecurring costs of $4.6
million in 1993, improved to 10.5% from 7.6% in 1993, due to increased
sales and efforts to reduce costs. During 1993, the Company recorded
restructuring and other nonrecurring costs of $4.6 million for this
segment, which represents a $1.9 million reserve for the write-off of
machinery and equipment and costs to phase out a product line in the
Company's metal-fabrication services business and $2.7 million for the
write-off of mobile soil-remediation assets and related expenses.
Sales from the Advanced Technologies segment were $286.5 million,
compared with $181.1 million in 1993. Sales increased $54.7 million due to
the inclusion of sales from Thermo Sentron, which was acquired by
Thermedics in March 1994, and Comtest, which was acquired by Thermo Voltek
in August 1993. Revenues from Coleman Research's government-sponsored
research and development contracts increased $39.1 million, while revenues
from ThermoTrex's government-sponsored research and development contracts
increased $1.8 million. Sales of Thermedics Detection's EGIS explosives-
detection systems increased $4.1 million, and sales of Thermedics
Detection's process-detection instruments, principally to one customer,
increased $3.6 million. Segment income margin, excluding restructuring and
other nonrecurring costs of $0.7 million in 1994, was 4.6% in both 1994 and
1993. Improved segment income margin at Coleman Research resulting from
increased revenues was offset by lower margins at ThermoTrex due to
increased research and development expenses to develop and commercialize
new products and, to a lesser extent, lower margins at newly acquired
businesses. During 1994, the Company recorded restructuring and other
nonrecurring costs of $0.7 million for severance costs and, to a lesser
extent, the costs to write off leasehold improvements at ThermoTrex's East
Coast division.
The Company's Napco subsidiary is challenging a jury verdict rendered
against it during the third quarter of 1994 (Note 7). In the third quarter
of 1994, the Company increased its reserve for potential losses from
pending litigation by approximately $4.0 million, which is reflected in
corporate general and administrative expenses.
49PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
1994 Compared With 1993 (continued)
As a result of the sale of stock by subsidiaries, the issuance of
stock by subsidiaries upon conversion of indebtedness, and similar
transactions, the Company recorded gains of $25.3 million in 1994 and $39.9
million in 1993. See Notes 1 and 10 for a more complete description of
these transactions. Minority interest expense increased to $31.0 million in
1994 from $21.1 million in 1993. Minority interest expense includes $5.7
million in 1994 and $1.3 million in 1993 relating to gains recorded by the
Company's majority-owned subsidiaries as a result of the sale of stock by
their subsidiaries.
Other expense, net, in the accompanying statement of income includes a
gain of $14.7 million resulting from the sale of the Peter Brotherhood
facility in the United Kingdom. Also included is equity in losses of
unconsolidated subsidiaries, which represents the Company's portion of
results from entities in which the Company's ownership is 50% or less,
primarily the operation of the Dade County cogeneration facility, and
beginning in 1994, the Company's share of the profit from a 50%-owned joint
venture that is responsible for the operation and maintenance of the
Company's waste-recycling facility in San Diego. The loss associated with
the Dade County facility was $5.7 million in 1994 and 1993, excluding a
$15.0 million provision recorded in 1993 as management's estimate,
discounted to present value, of the Company's share of estimated future
negative cash flows of the venture.
Liquidity and Capital Resources
Consolidated working capital was $1,306.4 million at December 30, 1995,
compared with $1,150.7 million at December 31, 1994. Included in working
capital were cash, cash equivalents, and short-term available-for-sale
investments of $1,055.8 million at December 30, 1995, compared with $997.9
million at December 31, 1994. In addition, at December 30, 1995, the
Company had $61.8 million of long-term available-for-sale investments and
$23.8 million of long-term held-to-maturity investments, compared with
$62.5 million of long-term available-for-sale investments at December 31,
1994. During 1995, certain of the Company's majority-owned subsidiaries
issued long-term obligations of $201.9 million. During 1995, an aggregate
principal amount of $213.0 million of the Company's and subsidiaries'
convertible obligations were converted into shares of the Company's or
subsidiaries' common stock. Net proceeds from the issuance of Company and
subsidiary common stock totaled $173.3 million in 1995. In January 1996,
the Company issued and sold $585 million principal amount of 4 1/4%
subordinated convertible debentures due 2003.
On February 15, 1996, the Company announced that the Federal Trade
Commission had granted early termination of the waiting period under the
Hart-Scott-Rodino Antitrust Improvements Act with respect to the previously
announced modified acquisition of the Scientific Instruments Division of
Fisons plc and on March 1, 1996, the Company announced that it had received
clearance of the transaction from U.K. antitrust regulatory authorities
(see Note 16 for information regarding this pending acquisition).
50PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Liquidity and Capital Resources (continued)
In 1995, the Company expended $330.7 million for acquisitions and
$62.9 million for purchases of property, plant and equipment. Including the
Fisons transaction discussed above, as of March 11, 1996, the Company had
agreements or letters of intent to expend approximately $245 million on the
acquisition of new businesses. These transactions are subject to various
conditions to closing, and there can be no assurance that these
transactions will be consummated. The Company has no material commitments
for purchases of property, plant and equipment and expects that, for 1996,
such expenditures will approximate the 1995 level.
A substantial percentage of the Company's consolidated cash and
investments is held by subsidiaries that are not wholly owned by the
Company. This percentage may vary significantly over time. Pursuant to the
Thermo Electron Corporate Charter (the Charter), to which each of the
majority-owned subsidiaries of the Company is a party, the combined
financial resources of Thermo Electron and its subsidiaries allow the
Company to provide banking, credit, and other financial services to its
subsidiaries so that each member of the Thermo Electron group of companies
may benefit from the financial strength of the entire organization. Toward
that end, the Charter states that each member of the group may be required
to provide certain credit support to the consolidated entity. Nonetheless,
the Company's ability to access assets held by its majority-owned
subsidiaries through dividends, loans, or other transactions is subject in
each instance to a fiduciary duty owed to the minority shareholders of the
relevant subsidiary. In addition, dividends received by Thermo Electron
from a subsidiary that does not consolidate with Thermo Electron for tax
purposes are subject to tax. Therefore, under certain circumstances, a
portion of the Company's consolidated cash and short-term investments may
not be readily available to Thermo Electron or certain of its subsidiaries.
The Company intends for the foreseeable future to maintain at least
80% ownership of its Thermo Instrument, Thermo Fibertek, and Thermo Ecotek
subsidiaries, which is required in order to continue to file a consolidated
federal income tax return with these subsidiaries. In addition, the Company
intends to maintain greater than 50% ownership of its other majority-owned
subsidiaries so that the Company may continue to consolidate these
subsidiaries for financial reporting purposes. This may require the
purchase by the Company of additional shares or convertible debentures of
these companies from time to time as the number of outstanding shares
issued by these companies increases, either in the open market or directly
from the subsidiaries. See Note 6 for a description of outstanding
convertible debentures issued by Thermo Instrument. In addition, at
December 30, 1995, Thermo Instrument, Thermo Fibertek, and Thermo Ecotek
had outstanding stock options for 3,221,000 shares, 2,522,000 shares, and
1,113,000 shares, respectively, exercisable at various prices and subject
to certain vesting schedules. The Company's other majority-owned
subsidiaries also have outstanding stock options and/or convertible
debentures.
51PAGE
<PAGE>
Thermo Electron Corporation
Management's Discussion and Analysis of Financial Condition and Results of
Operations
Liquidity and Capital Resources (continued)
During 1995, the Company expended $97.8 million to purchase common
stock of certain of the Company's subsidiaries. The Company expects that
these purchases will continue although the amount of purchases in a given
reporting period may vary significantly. In addition, the Company repaid
and repurchased long-term obligations of $16.8 million in 1995.
52PAGE
<PAGE>
Thermo Electron Corporation
Information as to Publicly Owned Businesses (Unaudited)
(In thousands) 1995 1994 1993
-------------------------------------------------------------------------
Revenues:
Thermedics Inc. (a) $ 175,754 $ 155,111 $ 80,220
Thermo Instrument Systems Inc. (b) 782,662 649,992 529,278
Thermo TerraTech Inc. (c) 197,769 123,463 108,737
Thermo Power Corporation 108,393 91,873 77,360
ThermoTrex Corporation (d) 129,626 91,052 54,329
Thermo Fibertek Inc. 206,743 162,625 137,088
Thermo Ecotek Corporation 141,435 134,261 117,691
Wholly Owned Nonpublic Companies 487,576 323,816 251,892
Intercompany Sales Elimination (22,541) (3,002) (2,087)
---------- ---------- ----------
$2,207,417 $1,729,191 $1,354,508
========== ========== ==========
Income Before Income Taxes and
Minority Interest:
Thermedics Inc. (a) $ 21,662 $ 16,909 $ 8,292
Thermo Instrument Systems Inc. (b) 113,652 106,241 96,786
Thermo TerraTech Inc. (c) 11,918 9,219 (1,803)
Thermo Power Corporation 5,078 5,263 2,707
ThermoTrex Corporation (d) 3,024 817 485
Thermo Fibertek Inc. 33,408 20,948 15,902
Thermo Ecotek Corporation 34,564 26,928 13,184
Wholly Owned Nonpublic Companies 24,856 19,313 882
---------- ---------- ----------
Total Segment Income (e) 248,162 205,638 136,435
Equity in Losses of Unconsolidated
Subsidiaries (203) (4,019) (22,721)
Corporate 51,536 4,757 17,753
---------- ---------- ----------
$ 299,495 $ 206,376 $ 131,467
========== ========== ==========
(a) Includes Thermo Cardiosystems Inc. and Thermo Voltek Corp.
(b) Includes ThermoSpectra Corporation.
(c) Includes Thermo Remediation Inc.
(d) Includes ThermoLase Corporation.
(e) Segment income is income before corporate general and administrative
expenses, other income and expense, minority interest expense, and
income taxes.
53PAGE
<PAGE>
Thermo Electron Corporation
Quarterly Information (Unaudited)
(In thousands except per share amounts)
1995(a) First Second Third Fourth
-------------------------------------------------------------------------
Revenues $478,545 $528,721 $570,373 $629,778
Gross profit 179,295 198,818 214,938 237,607
Net income 29,548 32,584 38,133 39,815
Earnings per share:
Primary .37 .39 .45 .46
Fully diluted .32 .35 .40 .41
1994(b) First Second Third Fourth
-------------------------------------------------------------------------
Revenues $383,724 $428,547 $445,516 $471,404
Gross profit 140,020 159,736 171,114 180,031
Net income 22,925 24,418 27,827 29,541
Earnings per share:
Primary .30 .32 .35 .37
Fully diluted .27 .28 .31 .33
(a) Results include nontaxable gains of $12.9 million, $9.7 million, $43.0
million, and $15.2 million in the first, second, third, and fourth
quarters, respectively, from the issuance of stock by subsidiaries.
(b) Results include nontaxable gains of $8.5 million, $0.2 million, $12.6
million, and $4.0 million in the first, second, third, and fourth
quarters, respectively, from the issuance of stock by subsidiaries.
Common Stock Market Information
--------------------------------------------------------------------------
The following table shows the market range for the Company's common stock
based on reported sales prices on the New York Stock Exchange (symbol TMO)
for 1995 and 1994. Prices have been restated to reflect a three-for-two
stock split, effected in the form of a 50% stock dividend, which was
distributed in May 1995.
1995 1994
---------------- ----------------
Quarter High Low High Low
-----------------------------------------------------------------------
First $34 1/4 $29 1/4 $29 3/5 $25 1/3
Second 41 32 2/3 27 3/5 24
Third 46 5/8 40 30 3/5 25 1/4
Fourth 52 42 3/8 31 11/12 27 1/6
The closing market price on the New York Stock Exchange for the
Company's common stock on January 26, 1996, was $53 7/8 per share.
As of January 26, 1996, the Company had 7,787 holders of record of its
common stock. This does not include holdings in street or nominee names.
54PAGE
<PAGE>
Thermo Electron Corporation
Common stock of the Company's majority-owned public subsidiaries is
traded on the American Stock Exchange: Thermedics Inc. (TMD), Thermo
Instrument Systems Inc. (THI), Thermo TerraTech Inc. (TTT), Thermo Power
Corporation (THP), ThermoTrex Corporation (TKN), Thermo Fibertek Inc.
(TFT), Thermo Ecotek Corporation (TCK), Thermo Cardiosystems Inc. (TCA),
Thermo Voltek Corp. (TVL), Thermo Remediation Inc. (THN), ThermoLase
Corporation (TLZ), and ThermoSpectra Corporation (THS).
Stock Transfer Agent
The Bank of Boston is the stock transfer agent and maintains shareholder
activity records. The agent will respond to questions on issuances of stock
certificates, changes of ownership, lost stock certificates, and changes of
address. For these and similar matters, please direct inquiries to:
The Bank of Boston
Post Office Box 644
Mail Stop: 45-02-09
Boston, Massachusetts 02102-0644
(617) 575-3120
Shareholder Services
Shareholders of Thermo Electron Corporation who desire information about
the Company are invited to contact John N. Hatsopoulos, Chief Financial
Officer, Thermo Electron Corporation, 81 Wyman Street, P.O. Box 9046,
Waltham, Massachusetts 02254-9046, (617) 622-1111. A mailing list is
maintained to enable shareholders whose stock is held in street name, and
other interested individuals, to receive quarterly reports, annual reports,
and press releases as quickly as possible. Quarterly reports and press
releases are also available through the Internet at Thermo Electron's home
page on the World Wide Web (http://www.thermo.com).
Dividend Policy
The Company has never paid cash dividends and does not expect to pay cash
dividends in the foreseeable future because its policy has been to use
earnings to finance expansion and growth. Payment of dividends will rest
within the discretion of the Board of Directors and will depend upon, among
other factors, the Company's earnings, capital requirements, and financial
condition.
Annual Meeting
The annual meeting of shareholders will be held on Tuesday, May 21, 1996,
at 5:00 p.m. at the Turnberry Isle Resort & Club, Aventura, Florida.
Form 10-K Report
A copy of the Annual Report on Form 10-K for the fiscal year ended December
30, 1995, as filed with the Securities and Exchange Commission, may be
obtained at no charge by writing to John N. Hatsopoulos, Chief Financial
Officer, Thermo Electron Corporation, 81 Wyman Street, P.O. Box 9046,
Waltham, Massachusetts 02254-9046.
55PAGE
<PAGE>
<TABLE>
Thermo Electron Corporation
Ten Year Financial Summary
(In millions except per share amounts)
<CAPTION>
1995 1994(a) 1993(b) 1992(c) 1991(d) 1990(e) 1989 1988 1987 1986
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
<S> <C> <C> <C> <C> <C> <C> <C> <C> <C> <C>
Revenues $2,207.4 $1,729.2 $1,354.5 $999.2 $842.5 $744.5 $640.3 $553.7 $430.8 $368.0
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
Costs and Expenses:
Cost of revenues 1,209.6 928.6 755.5 609.0 532.9 465.1 424.2 359.6 280.3 244.8
Expenses for R&D
and new lines of
business 269.6 233.1 183.9 106.5 84.6 74.5 60.7 54.3 40.9 33.9
Selling, general
and administrative
expenses 480.8 384.7 289.3 213.2 177.7 163.0 129.6 113.1 90.4 71.7
Restructuring and
other nonrecurring
costs 21.9 .7 6.6 - 3.7 1.0 2.2 0.9 3.4 7.1
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
1,981.9 1,547.1 1,235.3 928.7 798.9 703.6 616.7 527.9 415.0 357.5
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
Operating Income 225.5 182.1 119.2 70.5 43.6 40.9 23.6 25.8 15.8 10.5
Gain on Issuance
of Stock by
Subsidiaries 80.8 25.3 39.8 30.2 27.4 20.3 16.8 6.0 16.1 15.9
Other Income
(Expense), Net (6.8) (1.0) (27.5) 1.8 10.6 (0.5) 1.1 2.8 (2.5) (5.1)
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
Income Before
Income Taxes,
Minority Interest,
and Cumulative
Effect of Change
in Accounting
Principle 299.5 206.4 131.5 102.5 81.6 60.7 41.5 34.6 29.4 21.3
Provision for
Income Taxes 98.9 70.7 33.5 27.7 25.8 18.1 10.9 9.2 6.3 4.4
Minority Interest
Expense 60.5 31.0 21.1 13.9 7.3 7.1 3.3 2.1 1.9 0.5
-------- -------- -------- ------ ------ ------ ------ ------ ------ ------
56PAGE
<PAGE>
Thermo Electron Corporation
Ten Year Financial Summary (continued)
(In millions except per share amounts)
1995 1994(a) 1993(b) 1992(c) 1991(d) 1990(e) 1989 1988 1987 1986
----- ------ ------ ------ ------ ------ ------ ------ ------ ------
Income Before
Cumulative Effect
of Change in
Accounting
Principle 140.1 104.7 76.9 60.9 48.5 35.5 27.3 23.3 21.2 16.4
Cumulative Effect
of Change in
Accounting Prin-
ciple, Net of
Tax (f) - - - 1.4 - - - - - -
------ ------ ------ ------ ------ ------ ------ ------ ------ ------
Net Income $140.1 $104.7 $ 76.9 $ 59.5 $ 48.5 $ 35.5 $ 27.3 $ 23.3 $ 21.2 $ 16.4
====== ====== ====== ====== ====== ====== ====== ====== ====== ======
Earnings per
Share Before
Cumulative Effect
of Change in
Accounting
Principle:
Primary $ 1.67 $ 1.35 $ 1.11 $ .95 $ .84 $ .68 $ .55 $ .48 $ .43 $ .34
Fully diluted $ 1.48 $ 1.20 $ 1.00 $ .90 $ .79 $ .65 $ .53 $ .48 $ .43 $ .34
Earnings per Share:
Primary $ 1.67 $ 1.35 $ 1.11 $ .93 $ .84 $ .68 $ .55 $ .48 $ .43 $ .34
Fully diluted $ 1.48 $ 1.20 $ 1.00 $ .88 $ .79 $ .65 $ .53 $ .48 $ .43 $ .34
57PAGE
<PAGE>
Thermo Electron Corporation
Ten Year Financial Summary (continued)
(In millions except per share amounts)
1995 1994(a) 1993(b) 1992(c) 1991(d) 1990(e) 1989 1988 1987 1986
-------- -------- ------- ------- ------- ------- ------ ------ ------ ------
Balance Sheet
Data:
Working
capital $1,306.4 $1,150.7 $ 833.8 $ 508.7 $ 468.4 $ 244.1 $277.6 $220.1 $211.8 $124.5
Total
assets 3,744.9 3,061.9 2,507.6 1,838.0 1,212.5 912.0 669.9 528.5 465.0 336.0
Long-term
obliga-
tions 1,116.0 1,049.9 647.6 494.2 255.1 210.5 177.0 152.9 136.1 61.4
Minority
interest 471.6 327.7 277.7 164.3 122.5 83.9 51.8 22.6 25.8 20.1
Common stock
of subsid-
iaries
subject to
redemption 17.5 - 14.5 5.5 5.5 8.7 13.1 - - -
Shareholders'
investment 1,299.8 1,007.5 873.7 563.8 489.5 314.1 229.2 196.4 175.3 154.5
(a) Reflects the issuance of $345.0 million principal amount of convertible debentures
(b) Reflects the Company's 1993 public offering of common stock for net proceeds of $246.0 million.
(c) Reflects the August 1992 acquisition of Nicolet Instrument Corporation and the issuance of $260.0
million principal amount of convertible debentures.
(d) Reflects the issuance of $164.0 million principal amount of convertible debentures.
(e) Reflects the May 1990 acquisition of Finnigan Corporation.
(f) Reflects the adoption in fiscal 1992 of Statement of Financial Accounting Standards No. 106,
"Accounting for Post-retirement Benefits Other Than Pensions".
58PAGE
<PAGE>
</TABLE>
EXHIBIT 21
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Coleman Research Corporation Florida 100
Coleman Information Services Corporation Delaware 100
Nicolet Biomedical Inc. California 100
Eden Medical Electronics, Inc. Delaware 100
Eden Medizinische Elektronik GmbH Germany 100
Neuroscience Limited United Kingdom 100
Nicolet Biomedical Ltd. United Kingdom 100
Nicolet Biomedical S.A.R.L. France 100
Peter Brotherhood Holdings Ltd. United Kingdom 100
Peter Brotherhood Limited United Kingdom 100
D.S.T. Pattern & Engineering Co. Ltd. United Kingdom 100
FES International Limited United Kingdom 100
Link Control Technology Ltd. United Kingdom 100
Machtech Ltd. United Kingdom 100
Peter Brotherhood Pension Fund Trustees Ltd. United Kingdom 100
Sensonics Ltd. United Kingdom 100
Thermo Electron Realty Limited United Kingdom 100
Turboflex Limited United Kingdom 100
T & A Nash (Penn) Limited United Kingdom 100
Torsiflex Limited United Kingdom 100
(50% of which shares are owned directly
by Peter Brotherhood Limited)
Vikram Brotherhood Turbines Ltd. United Kingdom 51*
Thermo Holdings Limited United Kingdom 100
Termo Electron, S.A. de C.V. Mexico 100
The Thermo Electron Companies Inc. Wisconsin 100
Bird Medical Technologies, Inc. California 100
Bird International, Inc. U. S. Virgin 100
Islands
Bird Products Corporation California 100
Bird Life Design Corporation California 100
Stackhouse, Inc. California 100
Gulf Precision, Inc. Arizona 100
Seeley Enterprises, Inc. New Mexico 100
International Technidyne Corporation Delaware 100
International Technidyne Corporation Limited United Kingdom 100
Loftus Furnace Company Pennsylvania 100
Metal Treating Inc. Wisconsin 100
Met-Therm, Inc. Ohio 100
NAPCO, Inc. Connecticut 100
Nicolet Biomedical of California Inc. California 100
North Carbondale Minerals, Inc. California 100
North County Recycling, Inc. California 100
Overly, Inc. Wisconsin 100
Perfection Heat Treating Company Michigan 100
San Marcos Resource Recovery, Inc. California 100
Southern Ocean County Resource Recovery, Inc. New Jersey 100
Page 1PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Staten Island Cogeneration Corporation New York 100
TE Great Lakes Inc. Michigan 100
TEC Cogeneration Inc. Florida 100
South Florida Cogeneration Associates Florida 50*
TEC Energy Corporation California 100
North County Resource Recovery Associates California 100*
(50% of which is owned directly by
San Marcos Resource Recovery, Inc.)
Tecomet Inc. Massachusetts 100
Thermedics Inc. Massachusetts 50.95**
Analytical Technology, Inc. Delaware 100
Orion Foreign Sales Corp. U.S. Virgin 100
Islands
Orion Research Limited United Kingdom 100
Orion Research Puerto Rico, Inc. Puerto Rico 100
Corpak Inc. Massachusetts 100
Walpak Company Illinois 100
Orion Research, Inc. Massachusetts 100
Russell pH Limited Scotland 100
Thermedics Detection Inc. Massachusetts 100
Rutter & Co. Netherlands 100
Rutter Instrumentation S.A.R.L. France 90
Systech B.V. Netherlands 50
ThermedeTec Corporation Delaware 100
Thermedics Detection de Argentina S.A. Argentina 100
(1% of which shares are owned
directly by Thermedics Detection Inc.)
Thermedics Detection de Mexico, S.A. de Mexico 100
C.V.
Thermedics Detection GmbH Germany 100
Thermedics Detection Limited United Kingdom 100
Thermedics Detection Scandinavia AS Norway 100
Thermedics F. S. C. Inc. U. S. Virgin 100
Islands
Thermo Sentron Inc. Delaware 100
Ramsey France S.A.R.L. France 100
Ramsey Ingenieros S.A. Spain 100
Ramsey Italia S.R.L. Italy 100
Tecno Europa Elettromeccanica S.R.L. Italy 100
Ramsey Technology Inc. Massachusetts 100
Xuzhou Ramsey Technology Co., Limited China 50*
Thermedics Australia Pty. Ltd. Australia 100
Thermo Sentron B.V. Netherlands 100
Thermo Sentron Canada Inc. Canada 100
Thermo Sentron GmbH Germany 100
Thermo Sentron Limited United Kingdom 100
Hitech Electrocontrols Limited United Kingdom 100
Page 2PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Hitech Licenses Ltd. United Kingdom 100
Hitech Metal Detectors Ltd. United Kingdom 100
Thermo Sentron SEC Corporation Massachusetts l00
Thermo Sentron (South Africa) Pty. Ltd. South Africa 100
TMD Securities Corporation Massachusetts 100
Thermo Cardiosystems Inc. Massachusetts 51.95**
(additionally, 2.74% of the shares are
owned directly by The Thermo Electron
Companies Inc.)
TCA Securities Corporation Massachusetts 100
Thermo Voltek Corp. Delaware 50.07**
(additionally, 8.66% of the shares are
owned directly by The Thermo Electron
Companies Inc.)
Comtest Europe B.V. Netherlands 100
Comtest Instrumentation, B.V. Netherlands 100
Comtest Limited United Kingdom 100
KeyTek FSC, Ltd. U.S. Virgin 100
Islands
TVL Securities Corporation Delaware 100
UVC Realty Corp. New York 100
Thermo Administrative Services Corporation Delaware 100
Thermo Ecotek Corporation Delaware 82.73**
Caribbean Cogeneration Company, Inc. Massachusetts 100
Delano Energy Company Inc. Delaware 100
Delano Operations Company, Inc. California 100
Eco Fuels Inc. Wyoming 100
Gatepeak Corporation Delaware 100
Independent Power Services Corporation Nevada 100
SFS Corporation New Hampshire 100
TCK Fuels Inc. Delaware 100
KFx Fuel Partners, L.P. Delaware 95*
(2% of which is owned
directly by Eco Fuels Inc.)
Tenpeak Corporation Nevada 100
TES Securities Corporation Delaware 100
Thermendota, Inc. California 100
Mendota Biomass Power, Ltd. California 60*
MBPL Agriwaste Corporation California 100
Thermo Ecotek International Holdings Inc. Cayman Islands 100
Thermo Ecotek International Inc. Cayman Islands 100
TCK Cogeneration Dominicana Inc. Cayman Islands 100
(1% of which shares are owned directly by
Thermo Ecotek International Holdings Inc.)
TCK Dominicana Holdings Inc. Cayman Islands 100
(1% of which shares are owned directly by
Thermo Ecotek International Holdings Inc.)
Thermo Electron of Maine, Inc. Maine 100
Page 3PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Gorbell/Thermo Electron Power Company Maine 80*
Thermo Electron of New Hampshire, Inc. New Hampshire 100
Hemphill Power and Light Company New Hampshire 66*
Thermo Electron of Whitefield, Inc. New Hampshire 100
Whitefield Power and Light Company New Hampshire 100*
(39% of which is owned
directly by SFS Corporation)
Thermo Fuels Company, Inc. California 100
Thermo Trilogy Corporation Delaware 100
Woodland Biomass Power, Inc. California 100
Woodland Biomass Power, Ltd. California 100*
(.1% of which is owned directly
by Thermo Ecotek Corporation)
Thermo Electron Foundation, Inc. Massachusetts 100
Thermo Electron Metallurgical Services, Inc. Texas 100
Thermo Fibertek Inc. Delaware 80.74**
AES Equipos y Sistemas S.A. de C.V. Mexico 100
Thermo AES Canada Inc. Canada 100
Thermo Electron Web Systems, Inc. Massachusetts 100
Fiberprep Inc. Delaware 95
(31.05% of which shares are owned
directly by E. & M. Lamort, S.A.)
Fiberprep Securities Corporation Delaware 100
Thermo Electron Wisconsin, Inc. Wisconsin 100
Thermo Fibergen Inc. Delaware 100
Thermo Fibertek U.K. Limited United Kingdom 100
Vickerys Holdings Limited United Kingdom 100
Vickerys Limited United Kingdom 100
Paperliners Limited New Zealand 100
Vickerys Projects Limited United Kingdom 100
Winterburn Limited United Kingdom 100
TMO Lamort Holdings Inc. Delaware 100
E. & M. Lamort, S.A. France 100
Lamort GmbH Germany 100
Lamort Italia S.R.L. Italy 100
Lamort Paper Services Ltd. United Kingdom 100
Nordiska Lamort Lodding A.B. Sweden 100
Thermo Instrument Systems Inc. Delaware 85.61**
Analytical Instrument Development, Inc. Pennsylvania 100
ATI Acquisition Corp. Wisconsin 100
Mattson Instruments Limited United Kingdom 100
Unicam Analytical Inc. Canada 100
Unicam Analytical Technology Netherlands Netherlands 100
B.V.
Unicam Analytische System GmbH Germany 100
Unicam France S.A. France 100
Unicam Italia SpA Italy 100
Page 4PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Unicam S.A. Belgium 100
Unicam Technology Limited United Kingdom 100
Unicam Limited United Kingdom 100
Unicam Export Limited United Kingdom 100
Eberline Instrument Company Limited United Kingdom 100
Eberline Instrument Corporation New Mexico 100
Epsilon Industrial Inc. Texas 100
Gamma-Metrics California 100
Gamma-Metrics International F.S.C. Inc. Guam 100
Gas Tech Inc. California 100
Gas Tech Australia, Pty. Ltd. Australia 50
Gas Tech Partnership California 50*
Gastech Instruments Canada Ltd. Canada 100
Houston Atlas Inc. Texas 100
National Nuclear Corporation California 100
Optek-Nicolet Holdings Inc. Wisconsin 100
Thermo Optek Corporation Delaware 100
Nicolet Instrument Corporation Wisconsin 100
Nicolet Japan K.K. Japan 100
Spectra-Tech, Europe Limited United Kingdom 100
Spectra-Tech, Inc. Wisconsin 100
Nicolet Instrument GmbH Germany 100
Nicolet Instrument S.A.R.L. France 100
Thermo Instrument Systems Japan Holdings, Delaware 100
Inc.
Nippon Jarrell-Ash Company, Ltd. Japan 100
Thermo Jarrell Ash Corporation Massachusetts 100
Baird Do Brazil Representacoes Ltda. Brazil 100
Beijing Baird Analytical Instrument China 100
Technology Co. Limited
Thermo Instrument Systems (F.E.) China 100
Limited
Thermo Instruments (Canada) Inc. Canada 100
Eberline Instruments (Canada) Ltd. Canada 100
Thermo Optek Ltd. United Kingdom 100
Nicolet Instrument Limited United Kingdom 100
Planweld Limited United Kingdom 100
Hilger Analytical Limited United Kingdom 100
Thermo Electron Limited United Kingdom 100
Thermo Vision Corporation Delaware 100
CID Technologies Inc. New York 100
Oriel Corporation Delaware 100
Andor Technology Limited United Kingdom 51.25
Oriel Foreign Sales Corp. U. S. Virgin 100
Islands
Scientific Measurement Systems Inc. Colorado 100
ThermoSpectra Corporation Delaware 72.39**
Page 5PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Beleggingsmaatschappij Zeis B.V. Netherlands 100
Bakker Electronics Dongen B.V. Netherlands 100
Bakker Electronics Limited United Kingdom 100
Diametrix Detectors, Inc. Delaware 50
Gould Instrument Systems, Inc. Ohio 100
Gould Instrument Systems GmbH Germany 100
NORAN Instruments GmbH Germany 100
Gould Instrument Systems Limited United Kingdom 100
Nicolet Technologies Ltd. United Kingdom 100
Gould Instruments S.A. France 100
Nicolet Instrument Technologies Inc. Wisconsin 100
Nicolet Technologies S.A.R.L. France 100
NORAN Instruments Inc. Wisconsin 100
Quest-Finnigan Holdings Inc. Virginia 100
Quest-TSP Holdings Inc. Delaware 100
ThermoQuest Corporation Delaware 100
(50% of which shares are owned
directly by Quest-Finnigan Holdings Inc.)
Extrel FTMS, Inc. Delaware 100
Finnigan Corporation Delaware 100
Finnigan Instruments, Inc. New York 100
Finnigan International Sales, Inc. California 100
Finnigan MAT China, Inc. California 100
Finnigan MAT (Delaware), Inc. Delaware 100
Finnigan MAT Instruments, Inc. Nevada 100
Finnigan MAT International Sales, Inc. California 100
Finnigan MAT (Nevada), Inc. Nevada 100
Finnigan MAT AG Switzerland 100
Finnigan MAT Canada, Ltd. Canada 100
Finnigan MAT S.A.R.L. France 100
Finnigan MAT S.R.L. Italy 100
Thermo Separation Products S.R.L. Italy 100
Thermo Instruments Australia Pty. Australia 100
Limited
ThermoQuest Ltd. United Kingdom 100
Finnigan MAT Ltd. United Kingdom 100
Finnigan MAT AB Sweden 100
Thermo Separation Products Ltd. United Kingdom 100
Finnigan Properties, Inc. California 100
Thermo Instrument Systems (France) S.A. France 100
Thermo Separation Products S.A. France 100
Thermo Separation Products AG Switzerland 100
Thermo Separation Products Inc. Delaware 100
ThermoQuest GmbH Germany 100
Finnigan MAT GmbH Germany 100
Thermo Separation Products GmbH Germany 100
ThermoQuest K.K. Japan 100
Page 6PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
SID Instruments Inc. Delaware 100
ARL Inc. Delaware 100
FI Instruments Inc. Delaware 100
FI Ltd. United Kingdom 100
HB Instruments Inc. Delaware 100
Masslab Limited United Kingdom 100
NK Instruments Inc. Delaware 100
Thermo Elemental Limited United Kingdom 100
Thermo FAST UK Limited United Kingdom 100
Thermo Haake Ltd. United Kingdom 100
Thermo Labsystems Limited United Kingdom 100
Thermo SID (Australia) Pty. Ltd. Australia 100
Spectrace Instruments Inc. California 100
Thermo BioAnalysis Corporation Delaware 80.23**
(7% of which shares are owned directly by
Quest-TSP Holdings Inc. and 3% of which
shares are owned directly by Quest-Finnigan
Holdings Inc.)
BioAnalysis International Sales Inc. Delaware 100
DLW Inc. Virginia 100
Dynatech Deutschland GmbH Germany 100
Dynatech Laboratories spol. s.r.o. Czech Republic 100
Thermo BioAnalysis (Guernsey) Limited Channel 100
Islands
Thermo BioAnalysis Ltd. United Kingdom 100
Thermo BioAnalysis S.A. France 100
Thermo Environmental Instruments Inc. California 100
Thermo Instrument Controls Inc. Delaware 100
Thermo Instrument Controls de Mexico, S.A. Mexico 100
de C.V. (1% of which shares are owned
directly by Thermo Instrument Systems Inc.)
Thermo Instruments do Brasil Ltda. Brazil 100
(1% of which shares are owned directly
by Thermo Jarrell Ash Corporation)
Thermo Instruments F.S.C. Inc. U.S. Virgin 100
Islands
TN Technologies Inc. Texas 100
TN Technologies Canada Inc. Canada 100
Van Hengel Holding B.V. Netherlands 100
Baird Europe B.V. Netherlands 100
Baird France S.A.R.L. France 100
Thermo Instrument Systems B.V. Netherlands 100
Euroglas B.V. Netherlands 100
Hilkomij B.V. Netherlands 100
NORAN Instruments B.V. Netherlands 100
Thermo Automation Services (ThAS) B.V. Netherlands 100
Van Oortmerssen B.V. Netherlands 100
Page 7PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Thermo Instrument Systems GmbH Germany 100
(24% of which shares are owned directly
by Thermo Instrument Systems Inc.)
Eberline Instruments GmbH Germany 100
Thermo Instruments GmbH Germany 100
Thermo Jarrell Ash (Europe) B.V. Netherlands 100
Thermo Jarrell Ash, S.A. Spain 100
Thermo Separation Products B.V. Netherlands 100
Thermo Separation Products B.V. B.A. Belgium 100
TN Spectrace Europe B.V. Netherlands 100
Westronics Inc. Texas 100
Thermo Power Corporation Massachusetts 63.07**
NuTemp, Inc. Illinois 100
Takepine Limited United Kingdom 100
Tecogen Securities Corporation Massachusetts 100
ThermoLyte Corporation Delaware 77.89**
Thermo TerraTech Inc. Delaware 80.90**
Holcroft (Canada) Limited Canada 100
Holcroft Corporation Delaware 100
Holcroft GmbH Germany 100
Metallurgical, Inc. Minnesota 100
Cal-Doran Metallurgical Services, Inc. California 100
Normandeau Associates, Inc. New Hampshire 100
Thermo Analytical Inc. Delaware 100
Skinner & Sherman, Inc. Massachusetts 100
Thermo Consulting & Design Inc. Delaware 100
Engineering Technology and Knowledge Delaware 100
Corporation
Elson T. Killam Associates, Inc. New Jersey 100
Bettigole Andrews Clark & Killam New York 100
Associates Inc.
N. H. Bettigole Co., Inc. Delaware 100
N. H. Bettigole, P.A. New Jersey 100
N. H. Bettigole, P.C. New York 100
Duncan, Lagnese and Associates, Pennsylvania 100
Incorporated
E3-Killam, Inc. New York 100
Killam Associates, Inc. Ohio 100
Killam Management and Operational New Jersey 100
Services, Inc.
Fellows, Read & Associates, Inc. New Jersey 100
Killam Associates, New England Inc. Delaware 100
George A. Schock & Associates, Inc. New Jersey 100
Jennison Engineering, Inc. Vermont 100
Thermo EuroTech N.V. Netherlands 62.27**
Amerika Tankinstallaties B.V. Netherlands 100
Page 8PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
Grond- & Watersaneringstechniek Nederland Netherlands 100
B.V.
High-Tech Trouble-Shooters B.V. Netherlands 100
Jac. Amerika en Zonen B.V. Netherlands 100
Refining & Trading Holland B.V. Netherlands 100
Thermo Remediation Inc. Delaware 67.61**
(additionally, 1.26% of the shares are owned
directly by The Thermo Electron Companies
Inc.)
Eberline Holdings Inc. Delaware 100
Eberline Analytical Corporation New Mexico 100
Thermo Hanford Inc. Delaware 100
TMA/NORCAL Inc. California 100
Remediation Technologies, Inc. Delaware 100
RETEC Thermal, Inc. Delaware 100
ReTec/Tetra L.C. Texas 50*
Thermo Fluids Inc. Delaware 100
TPS Technologies Inc. Florida 100
TPST Soil Recyclers of California Inc. California 100
California Hydrocarbon, Inc. Nevada 100
TPST Soil Recyclers of Maryland Inc. Maryland 100
Todds Lane Limited Partnership Maryland 100*
(1% of which is owned directly
by TPS Technologies Inc.)
TPST Soil Recyclers of New York Inc. New York 100
TPST Soil Recyclers of Oregon Inc. Oregon 100
TPST Soil Recyclers of South Carolina Delaware 100
Inc.
TPST Soil Recyclers of Virginia Inc. Delaware 100
TPST Soil Recyclers of Washington Inc. Washington 100
TMA/Hanford, Inc. Washington 100
Thermo Securities Corporation Delaware 100
Thermo Soil Recyclers Inc. Massachusetts 100
Thermo Technology Ventures Inc. Idaho 100
Plasma Quench Investment Limited Partnership Delaware 60*
ThermoTrex Corporation Delaware 50.83**
ThermoLase Corporation Delaware 64.74**
CBI Laboratories, Inc. Texas 100
ThermoTrex East Inc. Massachusetts 100
Trex Medical Corporation Delaware 91.48**
Bennett X-Ray Corporation New York 100
Bennett International Corporation U. S. Virgin 100
Islands
Eagle X-Ray, Inc. New York 100
Island X-Ray Incorporated New York 100
Thermo Lorad F.S.C. Inc. U. S. Virgin 100
Islands
Page 9PAGE
<PAGE>
Thermo Electron Corporation - Subsidiaries of the Registrant
At March 6, 1996, Thermo Electron Corporation owned the following companies:
STATE OR
JURISDICTION
NAME OF PERCENT OF
INCORPORATION OWNERSHIP
- -------------------------------------------------------------------------------
TMO, Inc. Massachusetts 100
TMO TVL Investments Inc. Delaware 100
TMOI Inc. Delaware 100
Thermo Biomedical Inc. Delaware 100
Thermo Electron Export Inc. Barbados 100
(equally owned among TMO, TMD, TCA, TCK, TFT, THI,
THP, TTT, TVL, TLZ, THS, Thermo BioAnalysis
Corporation, Thermo Optek Corporation, ThermoQuest
Corporation and Trex Medical Corporation)
Thermo Electron F. S. C. Inc. U. S. Virgin 100
Islands
Thermo Electron (London) Ltd. United Kingdom 50
Thermo Finance (UK) Limited United Kingdom 100
* Joint Venture/Partnership ** As of 12/30/95
Exhibit 23
Consent of Independent Public Accountants
-----------------------------------------
As independent public accountants, we hereby consent to the incorporation
by reference of our reports dated February 15, 1996 (except with respect to
the matters discussed in Note 16 as to which the date is March 1, 1996)
included in or incorporated by reference into Thermo Electron Corporation's
Annual Report on Form 10-K for the year ended December 30, 1995 into the
Company's previously filed Registration Statement No. 33-00182 on Form S-8,
Registration Statement No. 33-8993 on Form S-8, Registration Statement No.
33-8973 on Form S-8, Registration Statement No. 33-16460 on Form S-8,
Registration Statement No. 33-16466 on Form S-8, Registration Statement No.
33-25052 on Form S-8, Registration Statement No. 33-37865 on Form S-8,
Registration Statement No. 33-37867 on Form S-8, Registration Statement No.
33-36223 on Form S-8, Registration Statement No. 33-52826 on Form S-8,
Registration Statement No. 33-52804 on Form S-8, Registration Statement No.
33-52806 on Form S-8, Registration Statement No. 33-52800 on Form S-8,
Registration Statement No. 33-37868 on Form S-3, Registration Statement No.
33-35657 on Form S-3, Registration Statement No. 33-34752 on Form S-3,
Registration Statement No. 33-39434 on Form S-3, Registration Statement No.
33-12748 on Form S-3, Registration Statement No. 33-39773 on Form S-3,
Registration Statement No. 33-40669 on Form S-3, Registration Statement No.
33-41256 on Form S-3, Registration Statement No. 33-42694 on Form S-3,
Registration Statement No. 33-43706 on Form S-3, Registration Statement No.
33-45401 on Form S-3, Registration Statement No. 33-45603 on Form S-3,
Registration Statement No. 33-50924 on Form S-3, Registration Statement No.
33-51187 on Form S-8, Registration Statement No. 33-51189 on Form S-8,
Registration Statement No. 33-54185 on Form S-3, Registration Statement No.
33-54347 on Form S-8, Registration Statement No. 33-54453 on Form S-8,
Registration Statement No. 33-59544 on Form S-3, Registration Statement No.
33-58487 on Form S-8, Registration Statement No. 333-00197 on Form S-3,
Registration Statement No. 033-65237 on Form S-8, Registration Statement
No. 033-61561 on Form S-8, and Registration Statement No. 033-58487 on Form
S-8.
Arthur Andersen LLP
Boston, Massachusetts
March 11, 1996
<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMO
ELECTRON CORP.'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 30,1995
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER> 1,000
<S> <C>
<PERIOD-TYPE> YEAR
<FISCAL-YEAR-END> DEC-30-1995
<PERIOD-END> DEC-30-1995
<CASH> 461,983
<SECURITIES> 593,802
<RECEIVABLES> 504,500
<ALLOWANCES> 28,021
<INVENTORY> 318,182
<CURRENT-ASSETS> 2,021,226
<PP&E> 967,069
<DEPRECIATION> 254,224
<TOTAL-ASSETS> 3,744,908
<CURRENT-LIABILITIES> 714,836
<BONDS> 1,116,011
<COMMON> 87,863
0
0
<OTHER-SE> 1,211,971
<TOTAL-LIABILITY-AND-EQUITY> 3,744,908
<SALES> 1,802,371
<TOTAL-REVENUES> 2,207,417
<CGS> 1,064,775
<TOTAL-COSTS> 1,376,759<F1>
<OTHER-EXPENSES> 124,402<F2>
<LOSS-PROVISION> 5,473
<INTEREST-EXPENSE> 76,961
<INCOME-PRETAX> 299,495
<INCOME-TAX> 98,900
<INCOME-CONTINUING> 140,080
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 140,080
<EPS-PRIMARY> 1.67
<EPS-DILUTED> 1.48
<FN>
<F1>THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT ACCOUNTS: "COST OF
PRODUCTS", "COST OF SERVICES", AND "RESEARCH AND DEVELOPMENT CONTRACTS".
<F2>THIS LINE IS MADE UP OF THE FOLLOWING INCOME STATEMENT ACCOUNTS: "COSTS
ASSOCIATED WITH DIVISIONAL AND PRODUCT RESTRUCTURING", "INTERNALLY FUNDED
RESEARCH AND DEVELOPMENT" AND "OTHER EXPENSES FOR NEW LINES OF BUSINESS".
</FN>
</TABLE>
